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Abstract 
 
“Life is pleasant.  Death is peaceful.  It’s the transition that’s troublesome” 
Isaac Asimov (1920 – 1992) 
 
Mitochondrial cytochrome c (Cc) is a small haem protein, primarily involved in 
electron transfer, but is an example of an extreme multifunctional protein with roles in 
several stages of apoptosis through interaction with phospholipids and Apaf-1.  The 
switch in function is associated with an interaction with cardiolipin (CL) and gain of 
peroxidase activity.  Mutations in the Cc gene lead to Thrombocytopenia 4, a disease 
associated with enhanced apoptotic activity.  The Y48H variant is found in the 40-57 
W-loop, the lowest free-energy foldon.  A 1.36 Å resolution X-ray structure of the 
Y48H variant reveals minimal structural changes to that of the wild-type protein and 
G41S variant (also associated with Thrombocytopenia 4).  Despite this, the intrinsic 
peroxidase activity is enhanced, implying that a penta-coordinate haem species is more 
prevalent in the Y48H variant, corroborated through determination of a Met80 off-rate 
of > 125 s-1 compared with ~ 6 s-1 for the wild-type protein.  Heteronuclear NMR 
experiments with the ferric Y48H variant have revealed heighted dynamics relative to 
the WT protein in the 40-57 and 71-85 W-loops, the latter being the loop containing the 
Met80 ligand, suggesting communication between these two substructures.  When 
these results are considered in relation to the G41S variant, a dynamic picture emerges 
in which heightened dynamics in key substructures of the Cc fold facilitate an increased 
population of a penta-coordinate, peroxidase active species of the order wild-type < 
G41S < Y48H.  Studying the alkaline transition through pH jump stopped-flow 
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spectroscopy has revealed that not only is the pK695 is reduced by ~ 1 pH unit compared 
to that of the wild-type protein, but also the pK of the trigger is lowered.  In contrast, 
variants in the 71-85 W-loop do not alter the pK of the trigger but are nevertheless 
associated with enhanced peroxidase activity relative to the wild-type protein, due to 
enhanced local dynamics within the haem crevice.   
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Spinning SS-NMR  
MES – 2-(N-morpholino)ethansulfonic 
acid 
Met – Methionine 
MIM – Mitochondrial Inner 
Membrane  
MIS (Mitochondrial Inter-membrane 
Space) 
mm – Millimetre  
MOM – Mitochondrial Outer 
Membrane  
MOMP – Mitochondrial Outer 
Membrane Permeabilisation  
MRE – Mean Residue Ellipticity  
mV – Millivolts  
NaCl – Sodium chloride  
NaOH – Sodium hydroxide  
NaPi – Sodium Phosphate  
NH – Amide  
NMR – Nuclear Magnetic Resonance 
ns – Nanosecond  
O2 – Oxygen  
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OH – Hydroxide  
OH – Hydroxyl group  
PCR – Polymerase Chain Reaction  
PDB – Protein Data Bank  
PEG – Polyethylene glycol 
PF – Potassium fluoride  
PhD – Doctor of Philosophy  
Phe – Phenylalanine 
pK695 – pK of the alkaline transition 
pKa – Acid dissociation constant  
PLS – Proton Loading Site  
Pro – Proline  
PS – Phosphatidylserine  
ps – Picosecond  
RO – Reverse Osmosis  
ROS – Reactive Oxygen Species  
SDS-PAGE – Sodium Dodecyl 
Sulphate Polyacrylamide Gel 
Electrophoresis  
Ser – Serine  
SHE – Standard Hydrogen Electrode  
SMAC/DIABLO – Second 
Mitochondria-derived Activator of 
Caspases/Diablo homolog  
SP – Sulfopropyl  
SS-NMR – Solid-State NMR  
t-Bid – Truncated Bid  
TB – Terrific Broth  
TEMED – 
Tetramethylethylenediamine  
TFA – Trifluroacetic acid  
THC-4 – Thrombocytopenia 4 
Thr – Threonine  
TOCL – 1, 1’, 2, 2’-tetraoleoyl 
cardiolipin  
Trp – Tryptophan  
Tyr – Tyrosine  
UV – Ultra Violet  
V – Volts  
Val – Valine  
Zn2+ – Zinc  
Dym – Membrane potential  
e - Extinction Coefficient  
µM – Micrometre
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Chapter 1 
General introduction on the properties and the 
physiological/pathophysiological roles of 
cytochrome c 
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1.1  Cytochrome c classes  
Cytochromes c belong to one of four subclasses based on their structural and 
physicochemical properties (Ambler, 1991). 
 
Class I cytochromes consist of the soluble mitochondrial and bacterial 
cytochromes c (Ambler, 1991).  They are characterised by the low spin state of the six 
coordinate haem iron and in the axial haem ligands whereby the haem iron is 
coordinated towards the N-terminus by a proximal histidine and at the C-terminal end 
by a distal methionine ligand (Ambler, 1991).  Ambler (1991) recognised a further five 
subclasses of Class I cytochromes, Classes Ia-e.  Class Ia include the “long” Cc2 and 
Cc-550 from Rhodospirillum rubrum and Aquaspirillum itersonii respectively (Ambler, 
1991).  Class Ib consist of both eukaryotic mitochondrial cytochrome c (Cc) (Figure 
1.1, left) and the prokaryotic “short” Cc2 of Rhodopila globiformis (Ambler, 1991).  
The Class Ic cytochromes possess a ‘split alpha band’ or widened alpha band in the 
UV-visible spectra and display lower absorptivity, with this sub class consisting of the 
dihaem Cc4, monohaem Cc6 and Cc-554 (Ambler, 1991).  Class Id only consist of 
bacterial cytochromes such as Cc-551 of the Pseudomonas spp., Cc-552 of 
Hydrogenobacter thermophiles and Cc-553 of Rhodocyclus tenuis (Ambler, 1991).  
 
Figure 1.1  X – ray crystal structures of the class I human cytochrome c (left), the 
class II cytochrome c’ (middle) and the class III cytochrome c7 (right) (Rajagopal et 
al., 2013, Enguita et al., 2006, Czjzek et al., 2001).   
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Ambler (1991) noted that Class Id cytochromes possess several proline residues around 
the methionine ligand and a highly conserved tryptophan residue around the C-termini 
of the proteins.  
Class II cytochromes c primarily include the high spin Cc’ (Figure 1, middle) 
but also low-spin cytochromes such as Cc-556 (Ambler, 1991).  Characteristically, the 
haem attachment site is located towards the C-terminus of the proteins (Ambler, 1991), 
but Cc’ are also able to bind carbon monoxide, nitric oxide and cyanide, with 
significantly lower rate and equilibrium constants (100 – 1,000,000 fold lower) than 
other high-spin haemproteins, such as myoglobin (Kassner, 1991).  Based on these 
properties, Moore and Pettigrew (1991) suggested that Cc’ functions as an electron 
transfer protein rather than a terminal oxidase.   
Class III cytochromes c comprise the multi-haem cytochromes with low redox 
potentials such as the trihaem Cc7 (Figure 1.1, right), tetrahaem Cc3 and the 
hexadecahaem high molecular weight Cc (Coutinho and Xavier, 1994).  All of the class 
III cytochromes c have approximately 30-40 residues per haem group and all haems 
are bis-histidinyl coordinated (Coutinho and Xavier, 1994).  These cytochromes are 
therefore non-equivalent, both structurally and functionally and possess ranges in redox 
potential from 0 to -400 mV versus the Standard Hydrogen Electrode (Coutinho and 
Xavier, 1994).  All of the class III cytochromes c consist of 4-5 a-helices and 2 b-
sheets surrounding 4 non-parallel haems thus conferring high solvent exposure, and 
overall the structural properties of these cytochromes are highly conserved (Coutinho 
and Xavier, 1994).  
Class IV cytochromes c consist of complex proteins which do not contain c-
type haems, but instead contain other prosthetic groups, examples include 
flavocytochromes c and cytochromes cd (Ambler, 1991). 
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1.2  Mitochondrial cytochromes c 
 Mitochondrial cytochromes c (Cc) are a family of small (104 ± 10 amino acids), 
globular, water soluble, haem proteins that primarily function as electron carriers in the 
electron transfer chain (ETC) (Pettigrew, 1987).  The haem is attached covalently via 
two thioether bonds between two cysteines and two haem vinyl groups, as part of a 
penta-peptide motif of CXXCH with the histidine acting as the proximal ligand 
(Pettigrew, 1987).  A second axial ligand to the haem by way of a methionine residue 
is also present (Battistuzzi et al., 2001).  In its role as a redox protein Cc can alternate 
between two oxidation states, the ferrous Fe(II) diamagnetic state and the ferric Fe(III) 
paramagnetic state (Moore and Pettigrew, 1991).  Thus, the haem confers the electron 
transfer ability to the holoenzyme and the polypeptide is responsible for the redox 
potential of the iron and correct subcellular localisation and subsequent docking with 
redox partners (Baxter and Fetrow, 1999).  
 
1.3  Cytochrome c:  Interactions with cytochrome bc1  
 Cytochrome bc1, also known as Cytochrome c Reductase (CcR), is a 
homodimeric multisubunit integral membrane protein complex (Trumpower, 1990a).  
The catalytic core of CcR is composed of cytochrome b (Cb) with two non-covalently 
attached haem b groups, a Rieske centre composed of an iron-sulphur protein (ISP) 
with a 2Fs-2S cluster, and cytochrome c1 with a covalently attached haem c prosthetic 
group (Alvarez-Paggi et al., 2017).  CcR’s primary enzymatic role is in the catalysis of 
electron transfer from ubiquinol (QH2) to Cc:  QH# + 2C'() + 2H(*+ → Q+ 2C'(# + 4H(./0 
The above reaction summarises what is known as the Q-cycle, which couples electron 
transfer to proton translocation across the inner mitochondrial membrane, thereby 
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contributing to the generation of the proton gradient (Trumpower, 1990b, Trumpower 
and Gennis, 1994).  This process proceeds as follows, an ISP accepts one electron from 
quinol in the Qo site of Cb followed by dissociation from Cb and subsequent 
conformational change prior to docking with Cc1 and resulting electron transfer 
(Alvarez-Paggi et al., 2017).  An electron transfer reaction then proceeds from Cc1 to 
Cc, which can then shuttle an electron to cytochrome c oxidase (CcO) (Alvarez-Paggi 
et al., 2017).   
 Elucidation of the interaction site between CcR and Cc has been problematic 
due to discrepancy between mutational and functional studies and the more recently 
obtained X-ray crystal structures (Alvarez-Paggi et al., 2017).  Seminal mutational 
studies conducted on mammalian Cc suggested that part of the Lys patch (Lys8, 13, 
27, 72, 86 and 87) are key members of the binding process, with Lys73 and 79 also 
playing a minor role (Speck et al., 1979, Smith et al., 1981, Ahmed et al., 1978, Konig 
et al., 1980, Rieder and Bosshard, 1980).  Hunte and colleagues have, to date, provided 
the only X-ray crystal structures of the CcR/Cc complex, using iso-1-Cc of S. 
cerevisiae and have provided contradictory information to the previous mutational 
studies (Lange and Hunte, 2002, Solmaz and Hunte, 2008, Hunte et al., 2002, Nyola 
and Hunte, 2008).   
 Through analysis of the contact interface, Hunte and colleagues have 
demonstrated that the interaction site is not formed from modules of closely interacting 
residues, but instead through individual contacts that are dispersed over the small 
interface (Alvarez-Paggi et al., 2017).  The CcR/Cc complex consists of a small 
hydrophobic channel surrounded by a half ring of charged residues and proceeds via 
an apparent two-step process, in which an encounter complex first forms proceeded by 
an electron transfer competent reorganisation (Alvarez-Paggi et al., 2017).  Hunte and 
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colleagues suggest that Lys16, 91 and 92 (iso-1-Cc numbering) are the unspecific 
electrostatic contacts which drive complex formation through establishing long-range 
interactions with negatively charged Asp and Glu residues in the c1 subunit of CcR.  As 
the distances involved are from 5-9 Å none form salt bridges or intermolecular H-
bonds.  Conversely, specific hydrophobic contacts are established by Ala86, Val33 and 
Thr17, and a cation-p interaction between a Phe and an Arg are observed.  The complex 
is further stabilised by a number of H2O molecules situated between CcR and Cc, 
however, the water molecules do not mediate H-bonds between protein surfaces in the 
X-ray crystal structure.  Interestingly, the redox state of CcR does not affect the 
complex bound state (Nyola and Hunte, 2008).   
 Surprisingly, Hunte and colleagues found that despite the highest binding 
affinity was observed at low ionic strength (< 160 mM), a bell-shaped dependence in 
enzymatic activity was observed (Hunte et al., 2002).  The authors attribute the low 
enzymatic activity observed at low ionic strength to stronger electrostatic stabilisation 
between CcR and Cc thereby inhibiting electron transfer.  Furthermore, intermediate 
ionic strength may weaken the electrostatic interactions in which complex 
rearrangement to a more electron transfer competent structure is facilitated.  
Conversely, high ionic strength would destabilise the electrostatic contacts inhibiting 
complex formation.   
EPR spectroscopy has provided an alternative interpretation to the relationship 
between CcR/Cc enzymatic activity and complex binding affinity through the 
interrogation of short-lived complexes (Sarewicz et al., 2008).  It has been 
demonstrated that at low ionic strength the electron transfer is fast, but the turnover rate 
is hindered by complex dissociation.  By increasing the ionic strength, the complex 
dissociation rate is increased until an optimal concentration is reached.  As ionic 
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strength increases further, well-oriented complex formation is rate limiting because the 
electrostatic attraction between CcR and Cc is lost.  The premise of this interpretation 
is based on diffusion-coupled reactions between soluble electron carriers and 
membrane complexes and could therefore be applicable to other protein complexes 
(Hackenbrock et al., 1986, Gupte et al., 1984).  The CcR crystal structure displays only 
a single Cc molecule bound to monomer B of the homodimer, conferring a structure in 
which haem’s c and c1 are in close proximity (Fe-Fe distance of 17.4 Å, haem-haem 
distance of 9 Å and a 1000 Å2 interaction surface) (Alvarez-Paggi et al., 2017).  The 
interaction surface is smaller than the average protein-protein interface, but consistent 
with other transient electron transfer complexes (Lo Conte et al., 1999).  Interestingly, 
the observation that only one Cc binds to only one CcR monomer is not attributed to 
an artefact of crystallisation.  This assertion arises from the differences in the 
ubiquitinone reduction site, despite both CcR monomers being conformationally 
identical (Solmaz and Hunte, 2008).  These differences mainly involve the head domain 
of the ISP and the QCR6p subunit of each monomer (Solmaz and Hunte, 2008).  The 
QCR6p subunit is highly acidic and has therefore been proposed to guide Cc docking 
to Cc1 (Bogan and Thorn, 1998).  The ISP has been suggested to play a regulatory role 
in the mechanistic alternating site model in which only one CcR monomer is active at 
a time, the ISP physically cross-links the two functional units of the intertwined dimer 
(Wenz et al., 2007).  Hunte and colleagues have suggested that the structural 
differences suggest coordinated binding of both electron acceptors for quinol 
oxidations, perhaps in order to circumvent the production of toxic intermediates or 
catalytic side products.  In order for such a coordinated model to be employed, there 
must be long-range communication within CcR, which would be achieved through 
redox-induced conformational change, changes in protonation state of interior residue 
 26 
side chains or long range electrostatic interactions (Lange and Hunte, 2002).  The 
validity of this model has been challenged on the basis of the complex lifetimes, which 
appear to be far shorter than those required for such rearrangements to take place 
(Sarewicz et al., 2008).   
Rather surprisingly, the crystallographic structure demonstrates that the 
conserved lysine residues that were previously shown to be involved in Cc binding do 
not participate in short-range interactions, but instead they may play a role in Cc 
orientation on the surface of Cc1 or in the formation of transient complexes involved in 
binding/unbinding, or finally that the interactions are exclusively long-range and do 
not participate in H-bonds or the formation of salt bridges (Lange and Hunte, 2002, 
Nyola and Hunte, 2008).  These proposed roles of the conserved lysine residues are not 
consistent with the previously reported equilibrium studies (Ahmed et al., 1978, Rieder 
and Bosshard, 1980) and the X-ray crystal structure reveals no steric constraints that 
would prevent side-chain reorganisation leading to the formation of H-bonds and/or 
salt bridges.  MD simulations with the CcR/Cc complex highlight the significance of 
dynamics, as the residues involved are highly mobile and do take place in short-range 
interactions (Kokhan et al., 2010).  The authors speculate there is potential for crosstalk 
between both Cc1 monomers involving finger-like b-strands, the result of which could 
alter the affinity of one monomer following subsequent binding of the other monomer 
by altering the position of the acidic residues involved in binding.  This would therefore 
provide a mechanism for the one Cc per dimer binding scenario (Alvarez-Paggi et al., 
2017).   
Schulten and colleagues have recently published a MD study that yields new 
insights into the Cbc1/Cc2 complex from Rhodobacter sphaeroides, with binding 
information expected to be extrapolated to mammals and bacteria (Moser and Dutton, 
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1988).  Their calculations demonstrate that an ensemble of near identical, yet 
conformationally slightly disordered complexes is formed with a short haem edge-
haem edge distance (8.5 Å) thereby contradicting the crystallographic structures of a 
single structurally well-resolved docking complex.  As a result of these findings, the 
scenario is compatible with a dynamic docking mechanism for the electron transfer 
reaction (Alvarez-Paggi et al., 2017).  The authors suggest that complex formation 
involves the complementary charged residues within the peripheral half ring structure 
that encloses the polar and hydrophobic core, thus allowing close inter-haem proximity 
and direct electron transfer (Alvarez-Paggi et al., 2017).  Consistent with the 
crystallographic information, the distances between electrostatically interacting 
residues does not allow for direct short-range interactions, instead, dynamic long-range 
interactions occur.  The binding interface is stabilised by H2O molecules that mediate 
the majority of interactions yet are excluded from the space separating the haem 
cofactors.  The authors suggest that these interactions occur concomitantly with Cc 
conformational change that are associated with the loss of several internal H-bonds that 
are reasonable for maintaining the native fold of Cc.  However, loss of these H-bonds 
does not result in protein unfolding or denaturation.  Schulten and colleagues state that 
protein fluctuations resulting in a loss of electrostatic interactions play a crucial role in 
complex dissociation following electron transfer.  Following from the loss of 
electrostatic contacts, the H2O exposed surfaces force the hydrophobic residues to bury 
themselves within the surface of the respective protein matrix, the result of which is a 
loosening of the interface and subsequent complex disruption thus preventing back 
electron transfer (Alvarez-Paggi et al., 2017).   
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Figure 1.2  Schematic depiction of the latter half of the ETC.  The ETC is comprised 
of 4 membrane bound complexes (I-IV, with complexes III and IV shown), in which 
the flow of electrons (black arrows) is facilitated with a number of electron carriers; 
ubiquinone (coenzyme Q), Cc (grey circle) and iron-sulphur proteins.  The shuttling 
of electrons yields an exergonic reaction in which protons are pumped from the 
mitochondrial matrix across the inner membrane.  The result of the proton pumping is 
the generation of the membrane potential (Dym) and electrochemical energy in the 
form of a proton-motive force.  The proton gradient is dissipated through a proton 
pore complexed to an ATP synthase (F1 F0 ATP synthase).  Adapted from (Ow et al., 
2008).   
4H+ 2H+
H+
H2OO2
ADP + Pi ATP
Cyt 
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1.4  Cytochrome c:  Interactions with cytochrome c oxidase 
 Cytochrome c Oxidase (CcO) is the terminal electron acceptor in the 
mitochondrial respiratory chain (Yoshikawa and Shimada, 2015).  CcO pumps four 
protons from the mitochondrial matrix into the intermembrane space using four 
electron supplied from Cc, the result of which is the generation of the electrochemical 
gradient used to produce ATP via the F1F0 ATP-synthetase complex (Figure 1.2) 
(Alvarez-Paggi et al., 2017).  The respiratory chain concludes with the electrons finally 
transferred to molecular O2 to form H2O:   41'#( + 83(*+ +	5# 	→ 	41')( +	23#5 +	43(./0 
 Mammalian CcO is a large dimeric macromolecular complex with each 
monomer composed of 14 subunits and several redox centres, namely: two haem 
cofactors, a CuA site and a CuB site (Ramirez et al., 1995).  Electron flow within CcO 
commences when Cc docks near the CuA site, which functions as the primary electron 
acceptor.  The electron is subsequently transferred to a species-specific haem cofactor 
and then transferred on to a binuclear centre that is formed from haem a3.  The binuclear 
centre is the site at which reduction of molecular O2 to H2O takes place.   
 Since the late 1970’s many groups have contributed to the elucidation of the 
binding interface between Cc and CcO, using techniques such as chemical modification 
of surface lysine residues (on Cc) (Ferguson-Miller et al., 1978, Smith et al., 1977) and 
chemical modification/protection and monoclonal antibody studies on CcO (Millett et 
al., 1982, Millett et al., 1983, Taha and Ferguson-Miller, 1992) provided a range of 
residues potentially involved in complex formation.  The following residues were 
identified: Lys8, 13, 72, 86 and 87 of Cc and Asp112, Glu114 and 198 within the 
soluble domain of CcO subunit II (Alvarez-Paggi et al., 2017).  The CcO/Cc complex 
structure, as determined by X-ray crystallography, has recently been reported (Shimada 
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et al., 2017).  Despite this, due to the large size of eukaryotic CcO and the transient 
nature of the interaction with Cc, more detailed and dynamically relevant structural 
information has been hindered.  This issue has been, to some extent, circumvented by 
structural and spectroscopic studies on bacterial and eukaryotic variants.  The aa3-type 
CcO from Paracoccus denitrificans (Pd) has been studied extensively and is composed 
of only four heterogenous subunits (Alvarez-Paggi et al., 2017).  Subunits I, II and III 
are the largest and possesses high homology to the mitochondrion-encoded 
components of eukaryotes that form the enzyme’s catalytic core, thus the bacterial 
complex serves as a suitable model system in the context of complex formation 
processes (Richter and Ludwig, 2003).  The model system also consists of the redox 
partner Cc552, a membrane-anchored protein that can be expressed as a 100 residue 
soluble fragment (Alvarez-Paggi et al., 2017).  Studies have been employed using this 
model system, consisting of biochemical, kinetic, mutational and spectroscopic 
methodologies (Maneg et al., 2004).  Ludwig and colleagues demonstrated that the 
glutamates and aspartates within subunits I and II of CcO mediate the binding of Pd-
CcO to eCc (Witt et al., 1998a).  Furthermore, Ludwig’s study found evidence of the 
contribution of hydrophobic residues to the interaction, of which Trp121 (Pd 
numbering) acts as the electron entry site (Witt et al., 1998b).   
 Bertini and colleagues found through combining NMR data and docking 
calculations (Bertini et al., 2005) that there are multiple possible complex structures 
related through rotations of Cc552 round the intermolecular axis defined by two docked 
structures, thus suggesting considerable dynamics are involved in scanning for optimal 
orientation.  Furthermore, the authors found that the binding interface includes a region 
of hydrophobic residues involving Phe120, Trp121, Tyr122 and Leu137 on CcO and 
residues Ala16, Val26, Ala79, Phe80 and Ala81 on Cc552.  Acidic residues surround 
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the hydrophobic core of CcO forming salt bridges with Lys residues, whereas the 
exposed haem edge of Cc552 is in close proximity to the indole ring of Trp121 of CcO 
when in the proposed electron transfer active conformation.  Electrostatic interactions 
are intermittently formed whilst Cc scans the surface of CcO, thus preserving the 
transient complex.  Furthermore, the authors suggest that Cc forms electrostatic 
interactions with subunit I of CcO, in addition to subunit II.  Thus these findings are 
consistent with the two-step docking mechanism first proposed by Ludwig and co-
workers (Witt et al., 1998b), in which the protein encounter is mediated by long-range 
electrostatic interactions followed by a second “fine” rearrangement that is mediated 
through hydrophobic interactions that maximise the electronic coupling HDA and 
therefore consistent with a Gated Docking (GD) scenario (Alvarez-Paggi et al., 2017).  
Ludwig however, suggests from EPR experiments that a dynamic ensemble of protein-
protein distances is compatible with either a GD or Dynamic Docking (DD) scenario 
(Lyubenova et al., 2007).  A GD scenario is consistent with the low electron transfer 
rate from Cc to CcO (10 – 100 s-1).   
 Ishimori and colleagues have recently investigated the nature of the 
gating/binding process in CcO/Cc complex formation, through the use of spectroscopic 
and functional studies (Sakamoto et al., 2011, Sato et al., 2016).  The authors found 
that the negatively charged residues and the Lys residues are involved in complex 
formation, the result of which is a weakening of the overall electrostatic contribution 
(Sakamoto et al., 2011).  Furthermore, the authors demonstrated that the hydrophobic 
cluster of CcO, comprising Trp104, Tyr105, 121 and Phe206, surrounding the CuA site 
participates in the dominant interaction for redox centre positioning.  Through the 
combined use of steady-state kinetics, docking and MMPBSA calculations, the authors 
estimated the different contributions to DG for the binding process (DGbind) (Alvarez-
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Paggi et al., 2017).  By determining the Km values, the authors were able to group 
residue mutations, such as Lys to Leu and Ile to Ala, based on their observed effect.  
The authors demonstrated that the largest impact on Km was observed by substitution 
of Lys13, 86 and 87, a moderate effect is observed by substitution of Lys7, 8, 72 and 
79, and no effect was observed by substitution of Ile9, 11, 81 or Lys39.   
 Molecular Mechanics combined with Poisson-Boltzmann Surface Area 
(MMPBSA) calculations suggest the overall electrostatic component of the binding 
between CcO and Cc is destabilising, as the favourable electrostatic interactions 
between charged residues, such as the Lys from Cc and the carboxylic acids on CcO, 
are overcompensated by the large destabilisation involved in desolvation (Alvarez-
Paggi et al., 2017).  Despite this, the Coulombic interaction is dominant in determining 
the differences in DG between mutants, therefore rationalising the increase in Km for 
the various Lys mutants.  Furthermore, the authors suggests that the predominant 
stabilising interactions mediated by Lys13 and 86 are due to van der Waals and non-
polar interactions, the former of which mediated by hydrophobic residues are dominant 
contributors to complex stabilisation, electrostatic contributions on the other hand 
contribute to the binding orientation of Cc to CcO (Alvarez-Paggi et al., 2017).  This 
interpretation of Cc binding to CcO is supported by their rapid co-evolution in early 
anthropoid primates (Pierron et al., 2011, Schmidt et al., 2005, Pierron et al., 2012).  It 
has been proposed that a reduction in the number of electrostatic interactions between 
CcO and Cc increases respiratory efficiency (Pierron et al., 2011, Schmidt et al., 2005, 
Pierron et al., 2012).  This has been surmised due to the substitution of charged residues 
within half of the amino acids on CcO that are involved with Cc interaction (Pierron et 
al., 2011, Schmidt et al., 2005, Pierron et al., 2012).  Ishimori and colleagues obtained 
the chemical shift perturbations upon binding of oxidised and reduced Cc to CcO and 
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in doing so were able to speculate on the nature of the electron transfer gating step 
(Sakamoto et al., 2011, Sato et al., 2016).  The authors propose that despite being of 
similar magnitude, the binding of ferrous Cc to CcO is of higher affinity than ferric Cc.  
They demonstrate that the binding of ferrous Cc induces structural changes in both the 
N- and C-terminal helices different to those which take place when binding ferric Cc, 
which the authors ascribe to suggesting that protein rearrangement takes place 
primarily at the N-terminal helix and therefore constituting a possible gating step 
(Alvarez-Paggi et al., 2017).  Interestingly, the strong interactions between the C-
terminal helix and the CcO are still present in the ferric form following the redox 
reaction, thus it is possible that the ferric Cc/CcO complex could supress the binding 
of ferrous Cc in which the respiratory rate is regulated.  The authors suggest that Lys13 
could play a regulatory role in preventing back electron transfer through redox-linked 
structural rearrangements, the e-amino group could move towards the haem c iron 
resulting in a decrease of electron affinity of the oxidised haem c.  Furthermore, the 
authors suggest that as Lys13 is located at the centre of the Cc/CcO interaction site, in 
which the side chain is buried within the protein interior, this would preclude 
protonation of the e-amino group (Alvarez-Paggi et al., 2017).  Instead, they suggest 
that the nitrogen atom is negatively polarised, therefore following complex formation, 
the e-amino group could move toward the haem c iron, in which there is a decrease of 
electron affinity of ferric haem c thus preventing back electron transfer.  
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Figure 1.3  X-ray crystal structure of the mammalian Cc/CcO complex, viewed from 
the trans-membrane surface (left) and the positive side (middle).  The right panel shows 
an expanded view of the binding interface between Cc and CcO subunit II.  Figure 
taken from (Shimada et al., 2017).   
 
 A 2 Å X-ray crystal structure of the mammalian CcO/Cc complex has recently 
been reported (Shimada et al., 2017) (Figure 1.3) and is in agreement with the 
previously determined key residue; namely Lys8, 13 and 87 and Gln12, and in 
agreement with recent kinetic studies (Sato et al., 2016).  The authors suggest that the 
key residues are functionally relevant and not only involved in a redox-inactive 
encounter complex.  The predicted electron transfer pathways that arise from the crystal 
structure do not involve a tryptophan residue in CcO, instead, it is suggested that the 
dominant pathway involves haem c, Cys14 and Lys13 from Cc.  This is followed by a 
through-space jump to Tyr105 of CcO that is in close proximity to Met207 (the axial 
ligand of the CuA site) (Alvarez-Paggi et al., 2017).  The authors describe a novel 
scheme for the interaction between Cc and CcO, coined “soft and specific” (Figure 
1.4).  This docking scheme is characterised by “a few “long arms” of hydrophilic 
residues, a small contact interface, a long span between the proteins, the presence of 
three solvent layers in the interface that form a H-bond network between both proteins 
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and a fluctuating Cc that uses the interacting residues with CcO as a fulcrum” (Alvarez-
Paggi et al., 2017).  
 36 
 
 
Figure 1.4  (Left)  During interaction between Cc and CcO, three layers of H2O 
molecules are formed due to preservation of surface H2O molecules being preserved 
on each respective protein during the encounter phase.  Cc and CcO interact specifically 
via the long sidechains arms of hydrophilic residues.  H2O molecules on the surface of 
each respective protein are represented by the red and green circles, blue circles 
represent the non-interacting H2O molecules.  The sidechains of residues involved in 
protein-protein interactions are represented by the black circles and semicircles.   
(Right)  Traditionally in other electron transfer systems, the complex forms by 
excluding H2O molecules on the surface of each protein.  Surface H2O molecules are 
represented by orange and grey circles of their respective proteins colour.  The main 
chains of residues involved in protein-protein interactions are represented by magenta 
circles and semicircles.  Sidechains of residues involved in protein-protein interactions 
are represented by the black circles and semicircles.  Figure taken from (Shimada et 
al., 2017).   
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 Finally, there are two competing models which describe the dynamics of 
association between Cc and CcO.  The diffusion of Cc within the intermembrane space 
may be governed by 3D Brownian motion in the bulk solvent, in which the motion is 
only affected by electrostatic interactions between the two respective proteins (Spaar 
et al., 2009, Gupte and Hackenbrock, 1988).  Alternatively, there may be 2D diffusion 
along the membrane surface (Spaar et al., 2009, Gupte and Hackenbrock, 1988).  
Despite there being no clear evidence in favour of either model, it is likely that at 
physiologically relevant ionic strengths the 3D Brownian diffusion scenario is most 
probable (Gupte and Hackenbrock, 1988).   
 
1.5  Cytochrome c and apoptosis 
 Apoptosis, a form of programmed cell death, has been appreciated for its 
physiological significance since the latter part of the 20st Century (Kerr et al., 1972, 
Liu et al., 1996, Kluck et al., 1997, Newmeyer et al., 1994, Paweletz, 2001, Kerr, 2002).  
Apoptosis displays a wide array of unique morphological features that are unique to 
programmed cell death (cell shrinkage, plasma membrane blebbing, chromatin 
condensation, nuclear membrane breakdown and formation of apoptotic bodies) and 
are distinguishable from cells undergoing senescence or necrosis (Kerr et al., 1972, 
Horvitz, 1999).  Physiologically apoptosis serves to prevent an inflammatory response, 
as cells which have undergone apoptosis are rapidly cleared by phagocytes, apoptosis 
also contributes to the development of multicellular organisms, the prevention of 
cancers, immunological function, remodelling in the adult (such as mammary changes 
during pregnancy) and wound healing (Nijhawan et al., 2000, Opferman and 
Korsmeyer, 2003, Greenhalgh, 1998, Osborne, 1996, Tilly et al., 1991, Lund et al., 
1996).  It is of the utmost importance that apoptosis is tightly controlled for the 
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aforementioned reasons, particularly when one considers estimates that in an adult 
human ~ 10 billion cells are made every 24 hours to compensate for the apoptotic losses 
(Renehan et al., 2001).  The molecular basis of apoptosis was elucidated during the 
1990s by Horvitz and co-workers, who elegantly showed that in Caenorhabditis 
elegans there is intrinsic control of cell death in neuronal cells during development 
(Horvitz et al., 1994).  In subsequent years, it was established that in C. elegans there 
are both positive and negative regulators of programmed cell death (Hengartner, 1999, 
Liu and Hengartner, 1999, Horvitz, 1999).  Egl-1 initiates the apoptotic pathway by 
antagonising the negative regulator cell death abnormal (Ced)-9, facilitating release of 
Ced-4 which is subsequently able to recruit Ced-3 (Hengartner and Horvitz, 1994).  
Ced-3 is a cysteine protease and plays a pivotal, orchestrating role in apoptosis of C. 
elegans (Hengartner and Horvitz, 1994).   
 Subsequent research has shown that there are many human homologues of the 
pro- and anti-apoptotic proteins in C. elegans, highlighting that in both worms and 
mammals, apoptotic control is highly conserved (Hengartner and Horvitz, 1994, Zou 
et al., 1997, Hengartner et al., 1992, Vaux et al., 1992, Yuan et al., 1993, Yuan and 
Horvitz, 1992).  Specifically, Ced-9 is homologous to the human oncogene product B-
cell lymphoma-2 (Bcl-2) (Hengartner and Horvitz, 1994).  Bcl-2 is associated in B-cell 
lymphoma following translocation and overexpression, as Bcl-2 negatively regulates 
apoptosis (Tsujimoto et al., 1985b, Tsujimoto et al., 1985a, Cleary et al., 1986, 
Graninger et al., 1987, Raffeld et al., 1987, Vaux et al., 1988, Hockenbery et al., 1990).  
This information highlighted how fundamentally linked apoptosis and oncogenesis are, 
as cancer can develop not only as a result of cell over-proliferation, but also through 
inhibition of apoptosis (Jiang and Wang, 2004).  In addition to Ced-9 and the Bcl-2 
proteins, the mammalian homologue of Ced-3 are the cysteine proteases known as 
 39 
caspases (Thornberry and Lazebnik, 1998, Budihardjo et al., 1999).  Under normal 
physiological conditions caspases are inactive in their zymogen form, however, prior 
to apoptosis procaspases are proteolytically cleaved to create a small and large subunit 
within the protein.  This allows for two cleaved procaspases to interact and form a 
heterotetramer, at which point the substantial conformation change reveals the catalytic 
pocket and therefore activates the enzyme (Jiang and Wang, 2004, Walker et al., 1994, 
Wilson et al., 1994, Rotonda et al., 1996, Blanchard et al., 1999, Watt et al., 1999).  
Certain caspases can self-activate through autocatalysis, and these are known as 
initiator caspases, whilst others require activation though an upstream caspase 
(Thornberry and Lazebnik, 1998, Budihardjo et al., 1999, Jiang and Wang, 2004).  An 
initiator caspase, once self-activated, triggers a cascade resulting in the activation of 
executioner caspases that abolish normal physiological cellular functions and activate 
other pro-apoptotic factors that result in programmed cell death (Thornberry and 
Lazebnik, 1998, Budihardjo et al., 1999).   
 Cc plays a crucial role in apoptosis.  Further research discovered that dATP, 
Apoptotic protein activating factor-1 (Apaf-1), Caspase-9 and Cc must be present to 
activate caspase-3 (Zou et al., 1997, Li et al., 1997, Liu et al., 1996).  Bcl-2 inhibits 
apoptosis by its ability to inhibit Cc release from the mitochondrion (Yang et al., 1997).  
Cc binds to Apaf-1 in a dATP/ATP dependent manner to form the apoptosome, the 
major caspase activating octomeric complex in mammalian cells (Zou et al., 1999).  
Proper regulation of apoptosis is vital for mammalian development and in the 
protection against cancers (Yoshida et al., 1998, Cecconi et al., 1998, Hakem et al., 
1998, Kuida et al., 1998, Li et al., 2000, Soengas et al., 1999, Wang, 2001, Soengas et 
al., 2001).  
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Figure 1.5  Schematic overview of extrinsic and intrinsic apoptosis pathways.  The 
extrinsic pathway is initiated by a transmembrane death receptor upon binding a death 
ligand, for example FAS and FASL respectively.  The result of this interaction is the 
formation of the death-inducing signalling complex (DISC), which facilitates the auto-
activation of various caspases.  In contrast, the intrinsic “mitochondrial” pathway is 
activated by various stimuli in which the outer mitochondrial membrane becomes 
permeabilised enabling the release of intermembrane space proteins into the cytosol.  
Cc is a critical component of apoptosis due to its caspase activating role when 
associated with Apaf-1 in the apoptosome.  Taken from (Ow et al., 2008).   
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The Cc mediated, type 2 intrinsic (Figure 1.5) apoptotic pathway is significant, as can 
serve to amplify caspase activation occurring though alternative pro-apoptotic routes, 
such as the death receptor pathway and the cytotoxic T-lymphocyte-mediated pathways 
(Budihardjo et al., 1999, Luo et al., 1998, Lord et al., 2003, Li et al., 1998, Barry et al., 
2000).  This occurs as a result that, in these pathways, despite downstream executioner 
caspases being activated by the upstream proteases caspases-8 and -10, and Granzyme 
B for the death receptor and cytotoxic T-lymphocyte pathways respectively, these 
upstream caspases can both cleave and activate the pro-death member of the Bcl-2 
family, Bid (Jiang and Wang, 2004, Luo et al., 1998).  Truncated Bid (t-Bid), localises 
to the mitochondrion and induces Cc release (Luo et al., 1998).  The support provided 
by the Cc mediated apoptotic pathway to other pro-apoptotic pathways is of paramount 
importance in Type 2 cells, as in these cells death receptor-mediated apoptosis is 
regulated by the Cc/mitochondrial pathway, and the consequence of this is that it can 
be blocked by Bcl-2 anti-apoptotic members (Scaffidi et al., 1998).  The mechanism 
by which this occurs is that the death-receptor pathway can be inhibited by Inhibitor of 
Apoptosis Proteins (IAPs), which serve to inhibit caspase activity, and to counter this 
inhibition the mitochondrial proteins SMAC/DIABLO must be released into the 
cytosol to antagonise the IAPs (Srinivasula et al., 2000, Sun et al., 2002).  Cc’s role in 
the amplification of the death-receptor mediated apoptosis pathway has profound 
implications with regard to therapeutics, both current and future, as chemotherapeutic 
drugs targeted to multiple pro-apoptotic pathways have, when combined, a synergistic 
effect that might overcome poor efficacy with an individual drug (Jiang and Wang, 
2004).  One would assume this cocktail approach would be of particular benefit to 
cancers of Type 2 cell origin (Jiang and Wang, 2004).   
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Ca2+ ion fluctuations also play a role in the release of Cc, as apoptosis that 
occurs as a result of Ca2+ ionophores is dependent on the Bcl-2-like protein 11 (BIM) 
(Bouillet et al., 1999).  Elevation in intracellular Ca2+ induces a permeability transition 
resulting in a positive feedback loop increasing the concentration of both Cc and Ca2+ 
in the cytosol (Kroemer et al., 2007, Grimm and Brdiczka, 2007).  In the early stages 
of apoptosis, low levels of Cc are released from the mitochondrion, in which they 
interact with inositol-1,4,5-triphosphate receptors (InsP3R) (Kroemer et al., 2007).  
Ca2+ interacts with InsP3R, and in doing so functions as an inhibitor, the binding of Cc 
to InsP3R relieves the inhibition, thus resulting in Ca2+ ion release from the 
endoplasmic reticulum and further Cc release (Kroemer et al., 2007, Mootha et al., 
2001, Wei et al., 2001).   
 
1.6  Cytochrome c:  The mitochondrion and interactions with cardiolipin  
 It is known that the proteins Bak and Bcl-2-like protein 4 (Bax), members of 
the pro-apoptotic group of Bcl-2 family proteins, function as the final gateway to Cc 
release from the mitochondrion (Gross et al., 1999, Adams and Cory, 2001).  However, 
it is also known that Bak and Bax function is regulated by the mitochondrial specific 
phospholipid, cardiolipin (CL) (Lutter et al., 2000, Kuwana et al., 2002).   
The release of Cc into the cytosol occurs via two phases, mobilisation followed 
by translocation through the outer mitochondrial membrane (OMM) (Ow et al., 2008).  
It has been suggested that mobilisation occurs through cristae remodelling, in which 
fusion of individual cristae and subsequent opening of junctions between cristae and 
the intermembrane space is required (Pellegrini and Scorrano, 2007).  Kalanxhi and 
Wallace (2007) suggest that there is a significant proportion of Cc associated with CL, 
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and that for Cc to be effectively released from the inner mitochondrial membrane 
(IMM) the Cc/CL complex must first be dissociated.  
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Figure 1.6  A model for Cc release in which there is first mobilisation followed by 
translocation through the outer mitochondrial membrane, as a result of cristae 
remodelling followed by the opening of junctions between cristae and the 
intermembrane space (Pellegrini and Scorrano, 2007).  Gonzalvez and Gottlieb have 
stated that a substantial fraction of Cc is associated to the anionic phospholipid 
cardiolipin and it has been suggested that there is a high thermodynamic barrier to 
breaking the Cc/CL complex (a) (Gonzalvez and Gottlieb, 2007, Kalanxhi and 
Wallace, 2007).  (b)  The oxidation of cardiolipin which occurs through a number of 
process, one of which is the CL/Cyt c complex, following the breaking of the complex 
there is an immediate increase in ROS through ETC dysfunction (Mootha et al., 2001, 
Zhao et al., 2003).  As ROS can oxidise CL, the result is a positive amplification loop.  
Taken from (Ow et al., 2008).   
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Several works have demonstrated that the electrostatic interaction between 
basic Cc and acidic phospholipid exist in rapid equilibrium under low ionic strength 
conditions (Nantes et al., 2001, Rytomaa and Kinnunen, 1994, Rytomaa et al., 1992).  
The lipid anchorage between Cc and CL can be considered a rate-limiting step in the 
overall strong binding interaction between Cc and the phospholipid membranes 
(Kalanxhi and Wallace, 2007).  The reason for the rate limitation, is that there is likely 
to be a particularly high thermodynamic barrier associated with the passage of an 
anionic CL acyl chain, through the polar surface of the lipid bilayer (Kalanxhi and 
Wallace, 2007).  This thermodynamic barrier can be overcome by CL oxidation, in 
which the affinity for Cc is decreased (Figure 1.6) (Ow et al., 2008).  There are four 
known oxidising agents of CL, phospholipase A2, reactive oxygen species (ROS), an 
increased intracellular Ca2+ concentration and rather significantly, the Cc/CL complex 
(Ow et al., 2008).  It has been proposed that during pro-apoptotic events, there is a 
positive-feedback mechanism, of sorts, within the mitochondrion, in which following 
permanent Cc detachment from the IMM, there is a rapid increase in the concentration 
of ROS due to ETC dysfunction, thereby providing a powerful stimulus for the further 
release of Cc (Mootha et al., 2001, Zhao et al., 2003).   
The electrostatic interaction between Cc and CL is benign in relation to 
apoptosis, it is instead the far less frequent hydrophobic interaction (i.e. insertion of an 
acyl chain into the Cc molecule) (Figure 1.7) which confers the peroxidase activity in 
Cc (Kagan et al., 2005, Belikova et al., 2007).  The peroxidase active Cc can then 
oxidise the CL, breaking the protein-lipid complex, and allowing the CL to translocate 
to the OMM, whereby it can relieve the inhibition on the Bak and Bax proteins resulting 
in Mitochondrial Outer Membrane Permeabilisation (MOMP) and Cc release into the 
cytosol (Kagan et al., 2005, Belikova et al., 2007).  
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Figure 1.7  Schematic illustration of three of the proposed cardiolipin acyl chain 
insertion sites (Sites A, C and L) mapped onto the X-ray crystal structure of Cc.  It is 
not known whether one, or two cardiolipin acyl chains are inserted into the hydrophobic 
interior of Cc.  Adapted from (Alvarez-Paggi et al., 2017).  
 
In multiple cell types, Cc release causing apoptosis is a rapid, complete and 
ultimately irreversible process (Goldstein et al., 2000).  Apoptosis is likely the most 
significant decision a cell makes, and therefore this process is regulated by multiple 
layers of control with much degeneracy/redundancy (Ow et al., 2008).  The apoptosis 
antagonists of the Bcl-2 family function to prevent MOMP, by directly interacting with 
Bak and Bax thus inhibiting their oligomerisation, or by interacting with BH (Bcl-2 
homology) 3-only proteins and disrupting their function (Youle and Strasser, 2008).   
 The BH3-only proteins BID and BIM are known to be the primary activators 
of Bax and Bak (Green, 2006).  tBID (the truncated “active” form of BID) induces the 
oligomerisation of Bax and Bak thereby regulating the pore formation in the OMM 
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which allows for the release of Inter Membrane Space (IMS) pro-apoptotic factors into 
the cytosol (Wei et al., 2001, Eskes et al., 2000, Desagher et al., 1999, Kluck et al., 
1999).  An additional function of tBID is how it causes the cristae remodelling, when 
complexed with CL, that promotes Cc mobilisation (Balakrishnan et al., 2007, Kim et 
al., 2004).  It is known that the addition of tBID to cells having undergone MOMP 
results in a reduction in the concentration of CL, probably because of CL hydrolysis 
(Basanez et al., 2002, Giordano et al., 2005).  It has been suggested that there is a 
temporal separation between BID and Cc during their interactions with CL, in order to 
circumvent Cc and BIDs conflicting pro-apoptotic activity, as it is known that tBID 
completely sequesters the peroxidase activity of the Cc/CL complex (Tyurin et al., 
2007). 
 
1.7  Cytochrome c, cardiolipin and the extended lipid anchorage model 
 The Cc mediated apoptosis pathway is well established, with its physiological 
and pathological significance clearly defined by research at the biochemical, genetic 
and cellular levels (Jiang and Wang, 2004).  However, despite this, there are still 
fundamental questions that have yet to be conclusively answered, ranging from tissue 
specific regulation of these pathways and how this relates to development, to how these 
pathways are regulated in cells undergoing oncogenesis.  One such question that 
remains unanswered is: what is the precise molecular mechanism by which Cc 
undergoes a switch in function that results in transformation from electron shuttle into 
a powerful pro-apoptotic effector? 
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CL (Figure 1.8) was first isolated by Pangborn (1942), the origin of the name 
stems from the fact that it was isolated from beef heart.  However, it was Nicholls 
(1974) who conducted research into membrane interactions involving Cc, which 
ultimately stimulated research into the Cc/CL interactions.  Cells experiencing normal 
physiological conditions contain CL exclusively located within the mitochondrion, and 
this is essential in the proper function of several enzymes required for energy 
metabolism (Hasan et al., 2011).  CL may behave as a molecular chaperone in the sense 
that is able to bind with high affinity, and non-covalently, with a wide number of 
proteins such as Complexes I, III, IV and V of the respiratory chain including Cc and 
creatine kinase (Schlame et al., 2000).  Successful crystallographic studies have yielded 
insights about the potential binding site and biological function of CL in the CcR and 
CcO complexes (Shinzawa-Itoh et al., 2007) and have identified hydrogen bonding 
between the phosphate groups of CL and van der Waals interactions with the fatty acid 
acyl chains of CL (Lange et al., 2001).   
 
Cardiolipin 
 
Figure 1.8  Chemical structure of Cardiolipin (diphosphatidylglycerol), with 
oxidisable acyl chains shown.  Figure adapted from (Rajagopal et al., 2013).   
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To date there is no conclusive atomic resolution structural information on the 
Cc/CL interaction.  As CL contains two negatively charged phosphate head groups, 
and as Cc bears a strong net positive charge at physiological pH, it is inevitable that 
electrostatic interactions will play a significant role in complex formation.  Some study 
utilising model lipid bilayers has suggested that there is a strong electrostatic 
interaction between the negatively charged phospholipid and the positively charged Cc 
which results in partial unfolding (Kagan et al., 2009b).  These electrostatic interactions 
revolve around two sites, the A-site, (residues Lys72, Lys73, Lys86 and Lys87), and 
the L-site, (residues Lys22, Lys25, His26, Lys27 and His33) (Figure 1.7) (O'Brien et 
al., 2015) and it has been shown that these sites can be attenuated through salt titration 
(Kagan et al., 2009b).  There is a third suggested interaction site, termed the C-site 
(Figure 1.7), incorporating a H-bonding interaction between Asn52 and a protonated 
CL head group (Rytomaa and Kinnunen, 1994).  In addition, and perhaps surprisingly, 
it has become apparent that hydrophobic interactions are essential in the switch of Cc 
function (Kalanxhi and Wallace, 2007).   
Kinnunen and colleagues suggested a model for the interaction, in which a 
phospholipid acyl chain could enter the hydrophobic interior of Cc (Kinnunen, 1992, 
Kinnunen et al., 1994, Rytomaa and Kinnunen, 1995).  A similar model was suggested 
by Stewart et al. (2000), who observed a spin-state change in the haem iron, and 
suggested that acyl chain insertion causes dissociation of the distal Met80 haem ligand.  
Tuominen et al. (2002) were the first to provide experimental support via a 
spectroscopic  
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investigation involving dibrominated CL and Zn2+ substituted Cc, this model became 
known as the ‘extended lipid anchorage’ model.  Although this model was used to 
describe the interaction with ferrous (Fe2+) Cc, it is also likely to account for the ferric 
(Fe3+) form by unlocking the haem peroxidase potential (Kapralov et al., 2007, 
Kapetanaki et al., 2009).  Despite the initial belief that the double bonds in the acyl 
chains were required to induce peroxidase activity (Belikova et al., 2006, Kagan et al., 
2005), more recent research (Abe et al., 2011) has shown that these double bonds are 
not required.  Early solid-state NMR (SS-NMR) studies (Spooner and Watts, 1991) 
suggested that the intercalation of an acyl chain in the hydrophobic interior of the 
protein causes partial unfolding driving the dissociation of the Met80 distal ligand.   
The nature and location of the entry site(s) for acyl chain insertion are not 
unequivocally determined, however, there are two proposed sites that both rely on 
 
 
Figure 1.9  X-ray crystal structure of yeast cytochrome c (pdb entry 1YCC).  A  
Circled regions highlight the proposed CL interaction sites based on the extended lipid 
anchorage model.  The haem and both axial ligands are shown in stick form with the 
Asn52 highlighted.  B  provides a more detailed view of all residues involved in the 
cleft capable of accommodating a single CL acyl chain. The H-bonds which stabilise 
the cleft are shown as dashed lines.  C  provides a view of the putative hydrophobic 
channel situated bellow the cleft that functions to stabilise the CL acyl chain.  Taken 
from Rajagopal et al. 2012).  
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surface openings which form hydrophobic channels that direct the acyl chain to the 
Met80 ligand (Figure 1.9A) (Rajagopal et al., 2012, Sinibaldi et al., 2010, Kalanxhi 
and Wallace, 2007).  Studies with yeast ferrocytochrome c and CL found changes in 
binding strength between protein and liposomes were dependent on alterations in the 
electrostatic surface potential in localised areas (Stewart et al., 2000, Kalanxhi and 
Wallace, 2007).  It was determined, based on the charge location on the surface of Cc, 
that two parallel polypeptide strands corresponding to residues 67-71 and 82-85 formed 
clefts amenable to acyl chain insertion (Kalanxhi and Wallace, 2007).  These chains 
form a hydrophobic channel situated to one side of the Met80 ligand, and thus could 
stabilise the interaction with a CL acyl chain (Stewart et al., 2000, Kalanxhi and 
Wallace, 2007). 
Located at the top of the cleft lies the invariant Arg91 which participates in H-
bonds particularly with the side chain OH group of Ser65 in yeast Cc (Figure 1.9B) 
(Rajagopal et al., 2012).  The invariant Asn70 forms a H-bond to the backbone carbonyl 
of Phe82, whilst the backbone carbonyl of Leu68 forms a H-bond to the backbone NH 
of the residue at position 84 (Figure 1.9B) (Rajagopal et al., 2012).  Kalanxhi and 
Wallace (2007) suggested that Lys72 and 73, which are situated at the bottom of the 
cleft, facilitate an electrostatic interaction with the negatively charged head group of 
CL, serving two purposes, firstly, aiding stability of the complex, and secondly, 
facilitating the acyl chain to move through the cleft and into the hydrophobic channel.  
It has also been suggested that the neighbouring Lys86 and 87 form part of the binding 
surface (Kawai et al., 2005, Kostrzewa et al., 2000).  
Studies on ferricytochrome c have identified the binding process to consist of 
two steps (Sinibaldi et al., 2008, Sinibaldi et al., 2010).  The first of these requires 
binding to an electrostatic “A-site”, a high affinity interaction, and secondly a lower 
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affinity hydrophobic interaction at the “C-site” (Figure 1.7) (Sinibaldi et al., 2008).  
The aforementioned A-site is suggested to be located near to Lys72 and 73 and the C-
site near the invariant Asn52 (Sinibaldi et al., 2010).  Sinibaldi and colleagues 
perturbed the second binding transition to CL through mutagenesis of the Asn52 to an 
Ile, and in doing so demonstrated the C-sites significance (Figure 1.7) (Sinibaldi et al., 
2010).  This is believed to suggest that the second insertion site for an acyl chain for an 
individual CL is localised around Asn52, whilst the first site is localised to the cleft at 
residues 67-71 and 82-85, obtained from studies involving ferrocytochrome c 
(Sinibaldi et al., 2008, Sinibaldi et al., 2010, Kalanxhi and Wallace, 2007).   
A hydrophobic interaction is also required in activating the peroxidase activity 
in the Cc/CL complex (Basova et al., 2007), which arises through the dissociation of 
the distal haem iron Met80 ligand, resulting in a penta-coordinate haem.  The newly 
acquired peroxidase activity allows Cc to carry out the oxidation of a single fatty acid 
chain in the CL molecule (Kagan et al., 2005).  The oxidised CL results in dissociation 
of the Cc/CL complex, with the oxidised CL then acquiring the function of a 
downstream effector in the apoptosis signalling pathway (Kagan et al., 2005).  Under 
apoptotic conditions the OMM has high concentrations of CL due to migration from 
the IMM (Kagan et al., 2005), resulting in MOMP and the release of pro-apoptotic 
factors, including Cc into the cytoplasm, although the exact mechanisms of pore 
opening are yet to be fully elucidated (Ow et al., 2008).  Bergstrom and colleagues have 
provided insight into Cc/CL mediated MOMP, by describing a direct visualisation of 
fluorescent Cc crossing synthetic CL-containing membranes in the absence of other 
proteins (Bergstrom et al., 2013).  Bergstrom and colleagues presented a model for Cc 
leakage through the permeabilised OMM, where the formation of toroidal lipid pores 
is driven by initial Cc-induced negative spontaneous membrane curvature and 
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subsequent protein unfolding interactions (Bergstrom et al., 2013).  Ultimately, their 
work demonstrated how the Cc/CL interaction is sufficient to enable Cc escape from 
the mitochondrion, demonstrating that Cc contributes to its own release during 
apoptosis (Bergstrom et al., 2013).   
 Cc also binds to phosphatidylserine (PS), a plasma membrane anchored 
phospholipid which is also able to induce peroxidase activity in Cc (Kagan et al., 2000).  
The Cc/PS interaction plays a significant role in the cell death process, as it has been 
demonstrated that externalization of PS facilitates macrophage clearing of apoptotic 
cells (Kagan et al., 2002).  Jiang et al. (2004) showed that Cc functions as a catalyst to 
selectively oxidize PS.  Cc therefore not only carries out an essential respiratory 
function, but also crucial activities at the initial and end stages of apoptosis.  
 
1.8  Structural studies of the Cc/CL interaction  
The current evidence of the Cc/CL interaction, the method of interaction and 
crucially its relation to apoptosis presents a paradox; how is it that this mechanism does 
not constantly result in a significant fraction of partially unfolded, peroxidase active 
Cc in vivo?  The result of which would be both a vastly diminished capacity to shuttle 
electrons in the ETC, and abhorrent apoptotic signalling.  It has been proposed that 
partitioning of CL away from Cc in the IMM contributes to regulating this process, 
however, this does not have definitive experimental support (Kagan et al., 2009a), 
particularly when considering that CL associates specifically with complex III and 
complex IV (Bazan et al., 2013) and that this interaction is essential for the proper 
formation of super-complexes containing complexes III and IV (Bazan et al., 2013, 
Pfeiffer et al., 2003).  For Cc to perform its primary biological role, CL must bind to 
each of these complexes.   
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 The majority of approaches to characterise the interaction between Cc and CL 
have essentially relied on either planar or positively curved lipid bilayers (O'Brien et 
al., 2015).  However, the micro-environment of the IMM is quite different, as the 
cristae form extensive invaginations that result in high negative curvature, and 
therefore impose significant confinement (O'Brien et al., 2015).  To obtain information 
of greater ecological validity on the Cc/CL interaction, Wand and co-workers utilised 
the interior water core of a reverse micelle to solubilise Cc, and then relied on the 
exterior surfactant shell as a host for CL to great effect (O'Brien et al., 2015, Nucci et 
al., 2014).  Under suitable conditions, it is possible to not only encapsulate proteins 
within micelles, but when used with solvents of sufficiently low viscosity high 
resolution NMR data can be obtained enabling full structural characterisation of not 
only the protein, but also the interaction with ligands embedded in the surfactant wall, 
or dissolved in the aqueous core (Nucci et al., 2014, Wand et al., 1998, Babu et al., 
2001, Valentine et al., 2010, O'Brien et al., 2015).  The result of Wand and colleagues 
work supported for the electrostatic interactions at the A- and L-sites, however, they 
both elucidated a previously unidentified binding site encompassing residues Phe36, 
Gly37, Thr58, Trp59 and Lys60, and found no evidence of local unfolding, but instead 
found the tertiary structure of Cc to remain fully intact (O'Brien et al., 2015).   
 Techniques involving SS-NMR spectroscopy have been used to shed further 
light on the interactions between Cc and CL.  Previous studies have demonstrated that 
the interaction with Cc and CL results in partial unfolding of the protein, as a precursor 
to the apoptotic response (Spooner and Watts, 1991, Kagan et al., 2009b, Muenzner et 
al., 2013), however, a limitation of previous studies is not only a lack of site resolution, 
but also a lack of membrane curvature thus not reflecting the micro-environment within 
the mitochondrion (O'Brien et al., 2015).  Further support for the interaction between 
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Cc and CL without the induction of unfolding comes from the work of van der Wel and 
colleagues who used Magic Angle Spinning NMR (MAS-SS-NMR) spectroscopy to 
identify the site specific conformational changes that occur in both the ferric and 
ferrous forms of 15N, 13C uniformly labelled equine Cc (eCc) when bound to CL 
bilayers (Mandal et al., 2015).  The use of MAS-SS-NMR and Fourier Transform 
infrared spectroscopy (FT-IR) revealed that CL membrane bound Cc displays 
significant dynamics, yet maintains its secondary structure (Mandal et al., 2015).  
Furthermore, in both two and three dimensional MAS-SS-NMR spectra they report that 
the CL bound Cc displays a spectral resolution characteristic of a folded protein, and 
therefore exhibits structural homogeneity that is fundamentally inconsistent with the 
extensive membrane-induced unfolding previously reported (Mandal et al., 2015).  
They conclude that Cc interacts with the CL membrane interface without significantly 
perturbing the lipid bilayer, and therefore despite membrane binding resulting in the 
Cc pro-apoptotic peroxidase gain of function, they do not observe evidence of large 
scale unfolding events or penetration into the membrane core (Mandal et al., 2015).  
Thus, these two recent manuscripts oppose the long-held view that the Cc/CL complex 
is a highly heterogeneous ensemble, whereby there is no “static” interaction between 
protein and lipid.  Instead, the long-held view has been that the hydrophobic Cc/CL 
interaction results in considerable disruption of the native compact protein structure 
resulting in intermediate conformations (Kagan et al., 2009b).  These intermediate 
conformations would lie somewhere between the fully folded and unfolded tertiary 
structural states, known as a “molten globule”, defined as a compact conformation 
possessing a secondary structure comparable to that of the native state, but with greater 
tertiary structural fluctuation as a result of enhanced intramolecular motions (Pinheiro 
and Watts, 1994, Pinheiro et al., 1997, Muga et al., 1991, Spooner and Watts, 1992). 
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1.9  Human cytochrome c and thrombocytopenia 4 
 Knock-in mice with a mutant Cc having a disrupted intrinsic apoptosis 
signalling pathway, so that Cc is unable to activate Apaf-1, but still retain the ETC 
activity display enlarged brains and abnormal lymphocyte homeostasis (Hao et al., 
2005).  Despite these drastic developmental and physiological abnormalities other 
tissues display minimal phenotypic abnormalities (Hao et al., 2005).  This information 
raises the question; is mitochondrial Cc-induced caspase activation rate limiting in 
apoptosis (Ekert and Vaux, 2005).  As the knock-in mice seldom survive it was 
previously not possible to evaluate the role of Cc in apoptosis after birth (Ekert and 
Vaux, 2005).   
 However, Morison and colleagues studied a large New Zealand family with a 
6-generation pedigree of mild autosomal dominant thrombocytopenia, 
thrombocytopenia-4 (THC-4) (Morison et al., 2008).  The average platelet count of the 
29 family members was 109 x 109/l (healthy range 150 – 450 x 109/l), however the 
platelet morphology and volume were normal, in addition to other peripheral blood 
counts (Morison et al., 2008).  Interestingly, the clinical observations of 
thrombocytopenia were either mild or absent, individuals displayed normal longevity, 
fertility and fitness, additionally there was no evidence of neurodegenerative, muscular, 
eye, renal diseases or diabetes (Morison et al., 2008).   
 Morrison and colleagues identified a G-to-A substitution at nucleotide 132 of 
exon 2 in the CYCS gene on chromosome 7p15.2, the result of which is a protein level 
substation at residue 41 in Cc (G41S) (Morison et al., 2008).  Cc is highly conserved, 
and Gly41 is invariant in 113 eukaryotic species (Banci et al., 1999).  A total of 26 
family members were found to be heterozygous for the G41S mutation, with a 
WT/G41S ratio of 2:1 (Morison et al., 2008).  Platelets form in the bone marrow, where 
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megakaryocytes undergo a compartmentalised activation involving the intrinsic 
apoptosis pathway, but without nuclear DNA fragmentation (De Botton et al., 2002).  
The protoplatelets circulate for 10 days before undergoing apoptosis and subsequent 
phagocyte clearing (Mason et al., 2007).  Thrombocytopenia results from either 
inefficiency in platelet formation, or their premature death.  However, in the case of 
the G41S variant phenotypes, it is a reduction in platelet formation resulting from 
increased apoptosis which is responsible (Morison et al., 2008).   
 The G41S mutation is located near to Lys39, a residue known to be involved in 
the interaction between hCc and Apaf-1, and it was shown that the G41S variant of hCc 
results in significantly greater cleavage of the caspae-3 substrate DEVD-AMC 
(Morison et al., 2008, Olteanu et al., 2003, Yu et al., 2001).  G41S was the first variant 
of hCc know to increase cellular apoptotic activity, indeed, engineered mutations 
previously studied either had no effect, or decreased apoptotic activity (Morison et al., 
2008, Olteanu et al., 2003, Sharonov et al., 2005).   
 In 2013, De Rocco and colleagues reported on the second novel mutation of the 
CYCS gene (Y48H), present in a small Italian family with 4 individuals affected by 
THC-4 (De Rocco et al., 2014).  As in the case of the G41S variant, individuals carrying 
the Y48H variant have platelets that are both of normal size and morphology and only 
partially reduced in number (De Rocco et al., 2014).  The measured platelet count in 
individuals expressing the Y48H phenotype was comparable to that of the G41S 
carriers, with a range of 73 – 135 x 109/L, however, interestingly, the respiratory 
competency of both G41S and Y48H were shown to be lower than that of the WT 
protein by some 30 % in mammalian cell experiments, with G41S conferring the 
greatest loss of respiratory efficiency (De Rocco et al., 2014).   
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 Johnson and colleagues have recently published their genomics work using 
next-generation sequencing to study the exomes of 55 patients consisting of 37 index 
cases and 18 additional family members (Johnson et al., 2016).  Their work has 
highlighted a number of genes that display pathogenic, or likely pathogenic variation 
at the protein level associated with Thrombocytopenia (Johnson et al., 2016).  
Interestingly, they identify the third novel missense mutation in the CYCS gene, coding 
for A51V, and designate the mutation as “likely pathogenic” (Johnson et al., 2016).  As 
the A51V mutation is in the 40-57 W-loop, as is the case with both G41S and Y48H, 
one speculates that the A51V mutation is also pathogenic to a comparable extent to that 
of the G41S and Y48H variants.  Unfortunately, there is extremely limited clinical 
information on the A51V variant, and yet to be biochemical or biophysical 
investigation into the proteins structural dynamics or spectroscopic features.   
 
1.10  Peroxidase activity 
 As in the case of classical peroxidases (Veitch, 2004, Volkov et al., 2011), Cc 
follows a mechanism in which H2O2 reacts with the Fe(III) resting state producing 
“Compound I”, with a Fe(IV)=O haem and an adjacent radical (Yin et al., 2017).  The 
resting state is regenerated by the subsequent abstraction of H from organic substrates 
(Lawrence et al., 2003), and reactions between the newly formed radicals and O2 yield 
the stable oxidation products (Xu and Chance, 2007, von Sonntag and Schuchmann, 
1991).  In contrast to Cc, classical peroxidases possess a penta-coordinate haem, in 
which the distal (hexa-coordinate) site is either vacant or loosely occupied by a bound 
H2O (Veitch, 2004, Volkov et al., 2011).  The penta-coordinate haem enables Fe/H2O2 
interactions that are essential for initiating the catalytic cycle (Godoy et al., 2009, Bren 
and Raven, 2017, Abe et al., 2011, McClelland et al., 2014, Diederix et al., 2002, Wang 
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et al., 2007).  It is therefore paradoxical that Cc can be peroxidase active given its hexa-
coordinate haem (Bushnell et al., 1990).  A likely explanation lies in the transient 
formation of a penta-coordinate species (Hannibal et al., 2016, Nold et al., 2017, 
Milazzo et al., 2017, Amacher et al., 2015, Karsisiotis et al., 2016, Diederix et al., 2002, 
Sutin and Yandell, 1972, Xu et al., 1998, Garcia-Heredia et al., 2010).  It is known that 
rupture of the Met80-Fe bond through protein unfolding (Bren and Raven, 2017, 
Diederix et al., 2002), chemical (Hannibal et al., 2016, Capdevila et al., 2015, Chen et 
al., 2002, Amacher et al., 2015, Wang et al., 2014, Abriata et al., 2009), or mutational 
modification (Godoy et al., 2009, McClelland et al., 2014, Wang et al., 2007, Moreno-
Beltran et al., 2017, Karsisiotis et al., 2016, Wang et al., 2014, Josephs et al., 2014, 
Tognaccini et al., 2016) enhance Cc peroxidase activity.   
 The proximal His18-Fe ligand is robust in Cc, whereas the distal Met80 ligand 
is located within a flexible 71-85 W-loop (Xu et al., 1998) and allows for non-native 
ligands (Hannibal et al., 2016, Gu et al., 2017).  Alkaline solution conditions result in 
“alkaline conformers” in which the Met80 is replaced by either Lys72, 73 or 79 as the 
hexa-coordinate distal haem ligand (Nold et al., 2017, Garcia-Heredia et al., 2010, 
Abriata et al., 2009, Assfalg et al., 2003, Döpner et al., 1998).  The displacement of 
Met80 can occur in neutral pH ranges through a variety of means (Hannibal et al., 2016, 
Amacher et al., 2015, Abriata et al., 2009, Gu et al., 2017, Garcia-Heredia et al., 2011), 
including Tyr67 modification (Tognaccini et al., 2016, Gu et al., 2017, Ying et al., 
2009).  It is also known that Cc/CL binding (Abe et al., 2011, Kagan et al., 2009b, 
Serpas et al., 2016) can cause the displacement of Met80 by a Lys or His (Bradley et 
al., 2011, Milazzo et al., 2017, Yanamala et al., 2014).   
 Interestingly, and counterintuitively, the non-native alkaline conformers of Cc 
display enhanced peroxidase activity to that of the native protein, despite their hexa-
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coordinate haem ligation (Godoy et al., 2009, Abe et al., 2011, Hersleth et al., 2006, 
Diederix et al., 2002, Wang et al., 2007, Amacher et al., 2015, Abriata et al., 2009, 
Garcia-Heredia et al., 2011, Belikova et al., 2006), and due to the Lys-Fe bond being 
more stable than the Met80-Fe bond (Kitt et al., 2017, Amacher et al., 2015, Abriata et 
al., 2009, Garcia-Heredia et al., 2011, Belikova et al., 2006, Capdevila et al., 2015).  
This further suggests that the transient population of a penta-coordinate haem species 
facilitates catalysis (Hannibal et al., 2016, Nold et al., 2017, Milazzo et al., 2017, 
Amacher et al., 2015, Karsisiotis et al., 2016, Diederix et al., 2002, Sutin and Yandell, 
1972, Xu et al., 1998, Garcia-Heredia et al., 2010).   
 Certain catalysed reactions display an initial lag-phase, from a variety of 
mechanistic origins, though the behaviour is often interpreted to reflect the in-situ 
activation of a pre-catalyst species (Widegren et al., 2003, Haw et al., 2003, Wunder et 
al., 2011).  Native Cc peroxidase assays display an initial lag phase (McClelland et al., 
2014, Garcia-Heredia et al., 2010, Radi et al., 1991, Karsisiotis et al., 2016), Yin and 
co-workers have considered this lag phase and provided further mechanistic insights 
into the structural modifications that result in Cc peroxidase activity using mass 
spectrometry (Yin et al., 2017).   
Yin and co-workers were able to demonstrate the occurrence of Cc self-
oxidation in the presence of H2O2, in which the generation of oxidised proteoforms 
possess enhanced peroxidase activity (Yin et al., 2017).  Their work demonstrates that 
H2O2-induced modifications proceed initially with oxidation of Tyr67, followed by the 
permanent displacement of the hexa-coordinate Met80 (Yin et al., 2017).  They propose 
that the actual peroxidase activation step corresponds to side chain carbonylation, 
which they speculate likely occurs at Lys72/73 (Yin et al., 2017).  Ultimately, they 
demonstrate that the Tyr67-oxidised/carbonylated form, with penta-coordinate haem, 
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is in fact the true peroxidase-active structure of Cc (Yin et al., 2017).  This work has 
provided insight into the structure-function mismatch of hexa-coordinate haem 
resulting in peroxidase activity in native Cc.   
It has been known for some time that the loss of axial coordination of Met80, 
driven by CL binding, causes an open haem structure which facilitates the haems 
peroxidase potential, in which the porphyrin molecule of the haem functions as a source 
of electrons (Diederix et al., 2002).  However, Josephs et al. (2014) have found that 
mutations at residue 41 in both human and mouse Cc can enable peroxidase activity 
without prior loss of Met80 haem coordination and protein unfolding.  They also found 
that the effects of CL binding and residue 41 mutation did not result in cumulative 
peroxidase enhancement, suggesting that CL binding confers peroxidase activity in the 
protein through the same mechanism as residue 41 mutation, which they suggest is due 
to disruption of the 40-57 W-loop and the resulting H-bonds which bind to haem ring 
A, ultimately facilitating H2O2 access to the haem (Josephs et al., 2014).  The work by 
Josephs and colleagues is however, conflicting with peroxidase activity assays by 
Rajagopoal and co-workers, and the data presented in Chapter 4 (Rajagopal et al., 2013, 
Karsisiotis et al., 2016).   
The Pletneva group have utilised Dansyl variants of eCc to probe the steps in 
this functional structural transformation.  5(DimethylAmino)Napthalene-1-Sulfonyl 
chloride (Danysl chloride) is a highly sensitive fluorescent reagent used in 
Fluorescence Resonance Energy Transfer (FRET) experiments to study protein folding 
and dynamics (Gray, 1967).  Muenzner and co-workers were able to show the 
occurrence of four discrete steps involving rapid protein/liposome binding, 
rearrangement of substructures with small unfolding energies, partial insertion of 
protein into the lipid bilayer and lastly extensive restructuring resulting in an open 
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conformation ensemble (Muenzner et al., 2013).  Pletneva and colleagues found that 
the open conformation also serves to free the C-terminal helix to facilitate Cc 
translocation through CL membranes (Muenzner et al., 2013).  Previous studies by 
Pletneva and co-workers have used time-resolved FRET (TR-FRET), fluorescence 
correlation spectroscopy and biolayer interferometry to measure the interconversion 
between the open and closed conformation states and found that Cc/CL binding is a 
peripheral binding event rather than deep protein insertion into the membrane.  Hanske 
and colleagues conducted a TR-FRET investigation measuring four Dansyl labelled 
variants of Cc and found that a fraction of the Cc/CL ensemble is substantially 
denatured resembling the Guanidine hydrochloride unfolded state (Hanske et al., 
2012).  Their findings support previous works showing that electrostatic interactions 
particularly in the C-terminus of the protein are involved in CL induced unfolding.   
 
1.11  Scope of this Thesis 
 The work reported in this thesis aims to meet two main goals, the first being to 
develop a solution-based NMR spectroscopy technique based on previously established 
Hydrogen-Deuterium (H/D) Exchange methodologies, that would provide a platform 
to study soluble protein/phospholipid interactions.  This H/D exchange methodology 
would, in principle, provide salient structural information on the hCc/CL interaction, 
yielding much needed structural insights at the single amino acid residue resolution.   
 The second goal of this PhD project is to further our insights into the 
mechanism(s) behind hCc’s switch from the primary, life sustaining respiratory role, 
to that of a powerful peroxidase active pro-apoptotic effector.  Reported in this Thesis 
is a range of biochemical and biophysical techniques, which one hopes, provide a 
coherent and consistent picture behind hCc’s disease mechanism.   
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 In addition to studying the disease variants G41S and Y48H in the 40-57 W-
loop of hCc, other variants in the 71-85 W-loop I81A, V83G and a double mutant 
I81A/V83G were also constructed and studied in addition to the WT protein.  
Specifically, this Thesis uses 1-, 2- and 3-dimensional solution NMR spectroscopy to 
obtain structural and dynamic information on the disease variants of hCc, in addition 
to that of the WT protein.  Circular Dichroism spectroscopy has been used to report on 
both the secondary structural content of the aforementioned proteins, but also to 
determine their chemical stability through GuHCl denaturation titrations.  The X-ray 
crystal structure of the Y48H variant has been determined, providing direct 
comparisons with the previously determined WT hCc and G41S variant X-ray crystal 
structures (Rajagopal et al., 2013).  UV-visible spectroscopy has been used to 
characterise the optical spectra of the variant proteins and stopped-flow spectroscopy 
has been used extensively to determine the mechanism behind hCc’s peroxidase 
activity, further probing the properties of the aforementioned variants.  Finally, 
Electron Paramagnetic Resonance (EPR) spectroscopy has been used to determine the 
properties of a high-spin intermediate species, observed during pH-jump stopped-flow 
experiments. 
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Chapter 2 
Backbone resonance assignments of ferric human 
cytochrome c under native aqueous conditions and 
acid-denatured in dimethylsulfoxide 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results from this Chapter has been published in:  
 
Karsisiotis, A.I., Deacon, O.M., Rajagopal, B.S., Macdonald, C., Blumenschein, 
T.M.A., Moore, G.R., Worrall, J.A.R.  “Backbone resonance assignments of ferric 
human cytochrome c and the pro-apoptotic G41S mutant in the ferric and ferrous 
states” (2015) Biomol. NMR Assign., 9, 415-419.   
 
Karsisiotis, A.I., Deacon, O.M., Macdonald, C., Blumenschein, T.M.A., Moore, G.R., 
Worrall, J.A.R.  “Near-complete backbone resonance assignments of acid-denatured 
human cytochrome c in dimethylsulfoxide:  A prelude to studying interactions with 
phospholipids” (2017) Biomol. NMR Assign., 11, 165-168.
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2.1  Introduction 
2.1.1  NMR spectroscopy 
Nuclear Magnetic Resonance (NMR) is a physical phenomenon in which 
certain atomic nuclei absorb and re-emit electromagnetic radiation.  Select elemental 
nuclei possess a variety of characteristic spins (I), a quantum phenomenon that exists 
as either an integral value I = 1, 2, 3…., a fractional spin whereby I = ½, 3/2, 5/2….. or 
no spin I = 0 (Keeler, 2010).  The most useful nuclei for NMR spectroscopic purposes 
are the I = ½ nuclei (1H, 15N, 13C, 19F and 31P).  Such nuclei, when in the presence of 
an external magnetic field (B0) display two precisely opposing spin states, either the 
ground state (I = + ½), or a higher energy level state (I = – ½) (Figure 2.1).  These are 
respectively known as the “up and down” spin states as the magnetic moment of I = + 
½ spin is pointing along the north pole of B0, whereas the higher energy level I = – ½ 
spin is pointing towards the south pole of B0 (Figure 2.1).  The nuclear spin vectors do 
not align perfectly with or against B0, thus a permanent torque is applied on the 
magnetic moment (µN) (Campbell, 1984).  NMR active nuclei also possess the property 
of angular momentum as a result of their nuclear spin.  The net result of angular 
momentum and torque is precession, the frequency of which is defined as w0 = gB0, 
where g is the unique proportionality constant of a given nuclei and w0 is the Larmor 
frequency (Campbell, 1984).  Figure 2.2 illustrates how in the absence of an external 
magnetic field, the energy separation between the two quantum spin states of a nuclei 
is 0, and that upon increasing field strength, this energy separation is increased.   
 I = > ½ nuclei are also able to interact with magnetic fields, however, they have 
an additional property known as a nuclear quadrupole moment (Q).  A Q allows the 
nuclei to interact with the electric fields that are produced by neighbouring electrons 
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and nuclei, and these interactions leads to significant spectral modifications that 
complicate NMR spectroscopy. 
 
 
 
 
 
 
Figure 2.1  Schematic depiction of the opposing spin states of I = ½ nuclei in an 
external magnetic field (B0). 
 
Figure 2.2  Schematic representation of the increasing energy separation between 
nuclei with spins of I = ½ in an increasing external magnetic field (B0). The “down” 
spin state (southward facing arrow) is at a higher energy level, then that of the 
“upward” spin state (north facing arrow). 
B0
E
Spin state
Spin state
500 MHz 800 MHz
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2.1.2  Magnetisation  
As samples used in NMR spectroscopy have a large number of spins, classical 
physics can be used to describe the properties of nuclear magnetisation, defined as the 
magnetic moment per unit volume of sample (Campbell, 1984).  The magnetisation is 
a vector, the specific components of interest in NMR spectroscopy are the Mz (defined 
along the B0 direction) and the Mx and My components (defined at right angles to B0) 
(Figure 2.3) (Campbell, 1984).  The Mz component depends on the population 
difference between the up and down spins with respect to B0, namely the N1 and N2 
spins respectively (Campbell, 1984).  	 
MZ = gh (N1 – N2) 
The Mxy components arise because the spins do not align perfectly along B0.  In 
an NMR sample, each individual spin is precessing about B0 and so it is convenient to 
bring all of the spins to a common origin, as shown in Figure 2.3.  Under equilibrium 
conditions the spins are randomly distributed in which there is no net Mxy component 
(Mxy = 0) (Campbell, 1984).  On application of a rotating radiofrequency (RF) field that 
precisely matches the frequency of precession (w0 = gB0), the spins resonate and the 
random distribution changes to a coherent one in which there is net a Mxy component 
(Figure 2.3).  Such spin systems are said to be phase coherent, due to their net Mxy 
component (Campbell, 1984).
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Figure 2.3  The numerous individually precessing spins in an NMR sample have a 
common origin.  In a) there are a greater number of spins oriented along the B0 direction 
(+ z).  The result of which is a net Mz vector with no phase coherence in which Mxy = 
0.  
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2.1.3  Data acquisition   
Usually in spectroscopy a spectrum is measured by sweeping the applied 
radiation frequency.  An alternative approach is the transient-response method, which 
forms the basis of modern NMR spectroscopy (Campbell, 1984).  The transient in 
NMR spectroscopy, known as the Free Induction Decay (FID), is a complex sinusoidal 
signal that contains all of the samples frequencies.  In order to interpret the FID, so that 
the individual frequencies may be resolved, a Fourier Transform must be carried out.   
 A typical NMR experimental setup is as follows:  A large B0 field, typically 2 
– 21 T is applied to the sample.  In order to increase the B0 field homogeneity, the 
sample is spun about its vertical axis.  In order to generate phase coherence amongst 
the nuclear spins, a rotating magnetic field is applied at right angles to the B0 field (B1).  
The result of the B1 field are net Mxy components that precess at frequency 
w0 (Campbell, 1984).  Phase coherence is lost via Relaxation processes, with 
equilibrium reached (Mxy = 0) after longer timescales.  This relaxation process typically 
results in an exponential decay of Mxy with time constant T2.  The result of which is a 
transient signal with frequency w0 and decay rate 1/T2 (Campbell, 1984).  The FID is 
complex as contains many signals with different frequencies (w0) and decay rates 
(1/T2).  However, as mentioned previously the FID’s time and frequency domains are 
linked by FT, and in carrying out a FT on the FID generates the NMR spectrum (Figure 
2.4).  
 The signal-to-noise ratio from a single NMR experiment is usually very poor, 
so it is possible to conduct multiple scans which use time averaging to improve the 
signal.  After N number of scans the protein signal will be N times greater, however, as 
the noise is random it increases at the square root of N, hence it is routinely possible to 
vastly improve the spectral quality through multiple scans (Keeler, 2010).  The 
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intensity of an NMR signal can be increased through higher field strength 
spectrometers, which increase the equilibrium magnetisation by increasing the energy 
separation between the opposing spin states (Figure 2.2) (Keeler, 2010).  However, 
NMR signal intensity is also dependent on the gyromagnetic ratio (g) of the detected 
nuclei (Keeler, 2010).  For example, 1H nuclei have a g of 267.513 106 rad s-1 T-1, 
whereas 13C and 15N nuclei have a g of 67.262 and -27.116 106 rad s-1 T-1, respectively.  
This variation in nuclei sensitivity is exploited in an Insensitive Nuclei Enhanced by 
Polarisation Transfer (INEPT) experiment, whereby weaker signals from lower 
sensitivity nuclei can be enhanced through the transfer of equilibrium magnetisation 
from a higher sensitivity nuclei (Keeler, 2010).  This is fundamental in the context of 
multi-dimensional NMR spectroscopy, such as the 2D Heteronuclear Single Quantum 
Correlation (HSQC) which correlates the single bond proton coupling to either the 13C 
or 15N nuclei and reports on the NH groups of a protein. 
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Figure 2.4  Schematic representation of the basic description of all spectroscopies, 
whereby a photon is absorbed so long as its energy (hv) matches the difference in 
energy between the two energy levels (Eupper – Elower). This gives rise to an absorbance 
signal in the resulting spectrum at frequency v.  Adapted from Keeler (2010).   
Eupper
Elower
Energy 
Level
hv = ΔE
v
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The applied pulse B1 can be defined in terms of angles.  Precession can be 
extended to the rotating B1 field by the expedient of using a rotating reference frame 
that matches the frequency of B1.  Figure 2.5 displays the instant at which B1 is applied, 
with B1 along the rotating x’ axis and the equilibrium magnetisation along the z axis.  
The M0 component precesses around B1, with the frequency of precession defined as 
w1 = gB1 (Campbell, 1984).  w is an angular frequency and therefore the M0 angle of 
rotation is θ = gB1t, where t is the duration of the B1 pulse.  Following a 90 ° pulse, Mxy 
= M0, whereas following a 180 ° pulse, Mz = -M0 and Mxy = 0 (Campbell, 1984).
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Figure 2.5  The effect upon application of a rotating B1 field on the magnetisation M0.  
x’ and y’ are rotating reference frames of equal frequency to B1.  b) and c) correlate to 
90 ° and 180 ° pulses, respectively.  Adapted from (Campbell, 1984).  
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2.1.4  NMR spectral parameters  
 There are four phenomena that constitute an NMR spectrum of a particular 
group:  The intensity/area (I); the chemical shift (d) that defines the position on a 
frequency scale; the multiplet structure which relates to the J-constant and finally the 
T2 relaxation time that influences linewidth (Campbell, 1984).  A fifth phenomenon is 
the T1 relaxation time, though this relates to the lifetime of a spin within an energy 
level.   
 
2.1.5  Chemical Shift  
 Atomic nuclei are shielded from the B0 field due to the presence of the 
surrounding electrons.  The B0 field induces currents within the electron clouds that 
reduce the effective field experienced by the nucleus, as the electrons typically oppose 
B0.  These induced fields are directly proportional to B0 and can be written as  
Beff = B0(1 - s) 
where s is a shielding constant dependent on the nature of the surrounding electrons 
(Campbell, 1984).  Thus, different nuclei within a sample experience different 
magnetic fields depending on their local chemical environment.  The chemical shift 
scale is a normalised frequency scale with units in parts per million (ppm) and is 
advantageous due to its B0 field strength independence.  The chemical shift is defined 
as 
6 = 10: ;6<=> −	6@AB6<=> C 
where dref is the position observed for a reference compound measured in hertz and 
dobs is the position of the signal of interest (Campbell, 1984).   
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 There are two classes of chemical shift; an intrinsic or primary shift that is 
diagnostic of a specific chemical group, and an induced or secondary chemical shift 
that arise from the influence of neighbouring magnetic centres, either through bond 
and/or through space couplings.  The intrinsic shifts vary considerably between 
different groups and nuclei and are sensitive to ionisation state.  Secondary shifts play 
an important role in defining the spectrum of macromolecules, the spectrum of a folded 
globular protein is completely different to its respective unfolded spectrum.  This 
spectral variation arises from the small but significant contribution of secondary shifts, 
as in a folded protein spectrum each chemical group is in a well-defined environment.   
 It is possible to quantify some secondary shifts, particularly in the case of 
aromatic rings and paramagnetic ions.  Aromatic rings confer ring-current effects due 
to the electron delocalisation.  When B0 is applied perpendicular to the plane of the 
aromatic ring, the delocalised electrons generate a field that opposes B0 (Campbell, 
1984).  The field generated is a diploe µ of magnitude B0e2a2 / 4m, in which e is the 
charge of an electron, a the aromatic ring radius and m the electron mass (Campbell, 
1984).  The field and induced dipole are averaged due to molecular tumbling in 
solution.   
 
2.1.6  Spin-Spin coupling and multiplet structure  
 NMR spectra display a multiplet structure that arises from weak interactions 
between magnetic nuclei.  These interactions arise from the electrons involved in 
bonding and the size of the interaction is known as the spin-spin coupling constant (J) 
and is expressed in hertz (Campbell, 1984).   
 In the case of two bonded nuclei, each respective nucleus can be oriented in two 
ways (spin up or down) (Figure 2.1).  The effect of these two orientations is minor 
 76 
variation in electron distribution causing minor chemical shifts, the result of which is 
a splitting of the two individual resonances into a pair of doublets (Figure 2.6).  A 
nucleus coupled to two equivalent nuclei yields a triplet spectrum, with ratio of 
intensities 1:2:1 as a result of the following nuclear spin orientations: 
 
 
 
Figure 2.6  Illustration of J-coupling between nuclei, in spectrum (A) there is a single 
peak present from two different spin systems at a frequency v1. If however there is a 
J-coupling in this spin system, then the individual peak splits symmetrically into a 
doublet as shown in the lower spectrum (B).  The splitting within each doublet is the 
coupling constant labelled J12.  It is possible to interpret each respective peak within 
a doublet as representing the “up” and “down” spin states of each coupled spin, as 
seen by the adjacent blue arrows.  Adapted from Keeler (2010). 
v1
J12
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↑↑, ↓↑, ↑↓, ↓↓ in which pair two and three are equivalent.  This phenomena is extended 
to three equivalent nuclei that yield a quartet of intensity ratios 1:2:2:1 (Campbell, 
1984).   
 The relative magnitudes of d and J also influence the appearance of a multiplet.  
If the ratio of d/J >> 1 then a pair of doublets is observed.  However, with decreasing 
d/J ratios quantum mechanics dictates the probabilities of the outer peaks on a multiplet 
spectrum decrease with respect to the inner peaks, to the point where when d = 0 the 
nuclei are equivalent and so no multiplet structure is observed.  As multiplet structures 
arise from through-bond interactions, the magnitude of J is affected by the type and 
number of bonds involved (Campbell, 1984).   
 Spin-coupling multiplets can be removed by chemical exchange, in which the 
relative orientation of coupled nuclei changes rapidly with respect to 1/J.  This rapid 
reorientation can arise form a number of means, firstly if the relaxation time of one 
nuclei is very short, and secondly is by selective irradiation of a group by a 
radiofrequency pulse (B2) (Campbell, 1984).  Use of a radiofrequency pulse in such a 
way is known as double resonance and the phenomena by which there is collapse of 
the nuclear spin multiplets is known as decoupling (Campbell, 1984). 
 
2.1.7  T2 relaxation time and linewidth 
 The T2 relaxation time is defined as the time constant of the decay of the Mxy 
components.  The T2 time is related to linewidth by the relationship:   
∆HI/# = 	 1KL# 
Inhomogeneity affects NMR spectral linewidths and FID decay due to the fact that a 
range of field strengths yields a range of frequencies (Campbell, 1984).  Despite this, 
there are methods to reduce the effect of field inhomogeneities allowing a T2 value to 
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be determined.  One such example is a 90 ° - t – 180 ° – t pulse sequence, which 
generates an echo at time 2t.  The decay of this echo is rather insensitive to 
inhomogeneous field effects (Campbell, 1984).   
 
2.1.8  T1 relaxation time  
 The T1 relaxation time is defined as the time constant of the recovery of Mz after 
perturbation.  Mz can be perturbed in multiple ways, for example, if B1 is applied for 
long duration than the population difference between the energy levels is destroyed (Mz 
= 0), a process known as saturation (Campbell, 1984).  Another, more practical way in 
which Mz can be perturbed is through the use of a 180 ° and 90 ° B1 pulse.  When Mz is 
perturbed by a 180 ° - t – 90 ° pulse sequence, the 180 ° pulse inverts the nuclear spin 
populations in which M0 = - M0.  The recovery of M0 along the z-axis occurs with a rate 
constant of 1/T1.  Therefore, Mz as a function of time is  MN(0) = 	MQ R1 − 2ST UVIW 
It is not possible to directly observe the recovery as it takes place along the z-axis, in 
which there is no Mxy components and thus no phase coherence.  To overcome this, 90 
° pulses are applied at intervals to flip the magnetisation into the xy-plane so that the 
recovery may be observed (Campbell, 1984).   
 
2.1.9  Causes of T1 relaxation  
 1/T1 defines the rate at which a Boltzmann distribution of populations is setup 
amongst the energy levels.  Spontaneous emission is negligible in the context of NMR 
spectroscopy; therefore, all NMR transitions are caused by fluctuations in magnetic 
fields at frequencies related to w0 (Campbell, 1984).  The Boltzmann distribution is 
setup due to thermal motion of the molecules within the sample, that in turn causes 
 79 
fluctuating local fields at the nuclei of interest.  As these molecular motions also have 
an energy distribution, the probability of inducing upward and downward transitions is 
not equal, such that there is a minor increase in the population within the lower energy 
level (Campbell, 1984).   
 There are numerous sources of fluctuating magnetic fields caused by molecular 
motion, however, in the context of I = ½ nuclei the most significant is typically dipole-
dipole interactions.  The field exerted by one magnetic moment on another is (3 cos2q 
– 1) / r3 (Campbell, 1984).  If the magnetic moments µ1 and µ2 are part of the same 
molecule, then their separation (r) is fixed and as the molecule tumbles in solution the 
spins maintain their orientation within the field.  Therefore, q varies randomly due to 
Brownian motion whereas µ1 produces a fluctuating field at µ2 and vice versa 
(Campbell, 1984).   
The time scale of the random motion is defined by the function g(t).  This 
function is often exponential and can therefore be expressed as exp(-t/tc).  tc is the 
correlation time, in which the probability of there being a correlation between the 
vector orientation and a defined direction exponentially decreases with time constant 
tc (Campbell, 1984).   
The probability of a field fluctuation to induce a transition between energy 
levels depends on there being a component of the correct frequency, but also the 
amplitude of said fluctuation.  The amplitude of a dipole-dipole interaction is given by 
µ0µ1µ2 / 4pr3.  The magnitude of a nuclear magnetic moment is given by XℏZ with the 
transition probability dependent on the amplitude squared (Campbell, 1984).  When 
two spins with equal T1 and g1 = g2, T1 is fully expressed by 1LI = 	3K0#X1\ℏ#160K#^: _ `a1 + b#`#' + 4`a1 + 4b#`#'c 
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As both w and 2w cause transitions, there are separate terms for J(w) and J(2w) 
(Campbell, 1984).   
 
2.1.10  T2 relaxation processes 
 As mentioned previously, a 90 ° RF pulse causes M0 to flip into the xy-plane 
resulting in Mz = 0.  However, there are additional ways in which Mxy components are 
lost.  For example, if there are a range of w0 values due to local field effects within the 
NMR sample, or alternatively as a result of chemical exchange, then T2 can be 
decreased.  Therefore, the general scheme is that T2 < T1.  In the case of dipolar 
interactions, the equation for T2 is given by:  (Campbell, 1984) 
 1L# = 3K0#X\ℏ#320K#^: R3`a + 5`a1 + b#`'# + 2`a1 + 4b#`'#W 
 
2.1.11  The Nuclear Overhauser Effect  
 The Nuclear Overhauser Effect (NOE) is the transfer of nuclear spin 
polarisation from one spin system to another via cross-relaxation, a through space 
effect (Campbell, 1984).  As mentioned previously, the primary way in which I = ½ 
nuclei relax arises from dipole-dipole interactions.  The double-resonance that results 
causes intensity changes in other spin systems through irradiation with a B2 field.  This 
is due to the irradiation of one pair of spins influencing the T1 relaxation.  In the case 
of two nuclear-spin dipoles termed I and S, by saturating the S-resonance (Mz = 0) 
through B2 irradiation causes a NOE that is described by   
e = 	 fafg + fh XiXg  
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in which h is the fractional change in intensity of resonance I, gS and gI are the 
gyromagnetic ratios of the I and S nuclei, RI is the dipolar relaxation rate due to S, Rx 
is the relaxation rate from all other sources than I, and Rc is the cross-relaxation rate 
between I and S.  Rc = RI/2 when wtc = << 1and Rc = -RI when wtc = >> 1 (Campbell, 
1984).   
The following section describes, in brief, the NMR experiments used for the 
work presented in this Thesis, particularly but not exclusively with regard to resonance 
assignments of native WT hCc in aqueous solution conditions and acid-denatured in 
dimethylsulfoxide (DMSO).  
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2.1.12  Heteronuclear Single Quantum Correlation   
A HSQC is a type of 2D NMR experiment in which magnetisation is first transferred 
from the 1H to the covalently bound 15N of the amide, due to the J-coupling, the 
chemical shift is evolved to the lone 15N and then subsequently transferred back to the 
1H for detection (Bodenhausen and Ruben, 1980) (Figure 2.7).  The HSQC experiment 
is therefore able to show all amide (NH) connections in a protein, which primarily 
correspond to the backbone NH group of the polypeptide, however tryptophan side 
chains (Nε-Hε groups) and asparagine and glutamine side chain Nδ-Hδ/Nε-Hε groups 
are also observed (Bodenhausen and Ruben, 1980).  Under low pH conditions the 
arginine Nη-Hη and lysine Nζ-Hζ groups can also be visible (Bodenhausen and Ruben, 
1980).
 
 
Figure 2.7  Schematic representation of magnetisation transfer in a HSQC pulse 
sequence.  Orange atoms are observed in the spectrum with the blue arrow showing the 
path that magnetisation evolves during the experiment.  Adapted from (Higman, 2012, 
Cavanagh, 2006).  
Hy Cy Hy
Tb Cb Hb
Ca
Ha
C’
O
N
HN
Hy Cy Hy
Hb Cb Hb
Ca
Ha
C’
O
N
HN
i-1 i
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2.1.13  HNCO 
A HNCO is a 3D experiment in which magnetisation is transferred from the 1H 
to the 15N nuclei and then to the carbonyl group 13C via the single bond J-coupling of 
15NH-13CO, the magnetisation is then transferred back to the 1H from the 15N to enable 
detection (Figure 2.8).  As the chemical shift is evolved on all three of the nuclei, a 
highly sensitive 3D spectrum is obtained (Kay et al., 1990a).  The HNCO correlates 
not only the backbone CO-N-HN, but also asparagine and glutamine side chain peaks 
are visible, which in sequential assignment therefore provides a link to the carbonyl of 
the i-1 residue in a given NH strip (Kay et al., 1990a).  
 
 
 
 
Figure 2.8  Schematic representation of magnetisation transfer in a HNCO pulse 
sequence.  Orange atoms are observed in the spectrum with the blue arrows showing 
the path that magnetisation evolves during the experiment (Kay et al., 1990b, Grzesiek 
and Bax, 1992c, Muhandiram and Kay, 1994).  Adapted from (Higman, 2012).   
Hy Cy Hy
Hb Cb Hb
Ca
Ha
C’
O
N
HN
Hy Cy Hy
Hb Cb Hb
Ca
Ha
C’
O
N
HN
i-1 i
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2.1.14  HN(CA)CO 
In a HN(CA)CO experiment the magnetisation is transferred from the 1H to the 
15N and then through the J-coupling to the 13Cα.  The magnetisation then transfers to 
the 13CO through the 13Cα-13CO J-coupling, however the magnetisation is transferred 
back through the same pathway before being detected (Clubb et al., 1992) (Figure 2.9).  
As the NH group nitrogen is bonded both to the Cα residue i and to the i-1 residue, the 
magnetisation transfer occurs in both residues and therefore for a given amide NH 
group two CO groups are observed in the spectra, although that of the i-1 residue is 
weaker due to the weaker coupling to the nitrogen (Clubb et al., 1992).  The 
HN(CA)CO experiment can be used in conjunction with the HNCO experiment in 
backbone sequential assignment strategies.   
 
 
 
 
Figure 2.9  Schematic representation of magnetisation transfer in a HN(CA)CO pulse 
sequence.  Orange atoms are observed in the spectrum with the blue arrows showing 
the path that magnetisation evolves during the experiment (Clubb et al., 1992).  
Adapted from (Higman, 2012).   
Hy Cy Hy
Hb Cb Hb
Ca
Ha
C’
O
N
HN
Hy Cy Hy
Hb Cb Hb
Ca
Ha
C’
O
N
HN
i-1 i
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2.1.15  CBCA(CO)NH 
In a CBCA(CO)NH experiment magnetisation is first transferred from the 1Hα 
and 1Hβ to the 13Cα and 13Cβ respectively, before transferring from the 13Cβ to the 13Cα.  
Next the magnetisation is transferred to the 13CO and then to the 15NH before reaching 
the 1HN for detection (Figure 2.10).  Due to the chemical shift evolution occurring 
simultaneously in the 13Cα 13Cβ, these peaks appear in one dimension and the 15NH and 
1HN in the other two dimensions (Grzesiek and Bax, 1992a).  For most residues, two 
peaks are observed corresponding to the Cα and Cβ of the i-1 residue.  
 
 
 
 
Figure 2.10  Schematic representation of magnetisation transfer in a CBCA(CO)NH 
pulse sequence.  Orange atoms are observed in the spectrum with the blue arrows 
showing the path that magnetisation evolves during the experiment (Grzesiek and 
Bax, 1992a).  Adapted from (Higman, 2012).   
Hy Cy Hy
Hb Cb Hb
Ca
Ha
C’
O
N
HN
Hy Cy Hy
Hb Cb Hb
Ca
Ha
C’
O
N
HN
i-1 i
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2.1.16  HNCACB 
In a HNCACB experiment magnetisation is first transferred from the 1Hα and 
1Hβ to the respective 13Cα and 13Cβ, then the magnetisation is transferred from the 13Cβ 
to the 13Cα.  The magnetisation is then transferred to the 15NH and then finally the 1HN 
for detection (Figure 2.11).  However, the magnetisation from the 13Cα of residue i and 
i-1 is transferred to the 15N of residue i, therefore for each respective NH group two Cα 
and Cβ peaks are visible.  As the chemical shift is evolved simultaneously on the 13Cα 
and 13Cβ the peaks appear in one dimension, the other two dimensions occupy the 
chemical shifts of the 15NH and 1HN (Grzesiek and Bax, 1992b).  The HNCACB can be 
used in conjunction with a CBCA(CO)NH as an experiential pair in backbone 
sequential assignment strategies.  
 
 
 
 
Figure 2.11  Schematic representation of magnetisation transfer in a HNCACB pulse 
sequence.  Orange atoms are observed in the spectrum with the blue arrows showing 
the path that magnetisation evolves during the experiment (Grzesiek and Bax, 1992b).  
Adapted from (Higman, 2012).   
Hy Cy Hy
Hb Cb Hb
Ca
Ha
C’
O
N
HN
Hy Cy Hy
Hb Cb Hb
Ca
Ha
C’
O
N
HN
i-1 i
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2.1.17  HNN 
In a HNN experiment, magnetisation is transferred from the 1H of the NH then 
to the covalently bound 15N of residue i (Panchal et al., 2001).  From this 15N, the 
magnetisation is evolved to the Cα of the i-1 residue, then transferred to the covalently 
bound 15N and 1H (Panchal et al., 2001).  This therefore confers i and i-1 residue 
connectivity, however, unlike the above experiments, magnetisation is also evolved 
from the covalently bound 15N of residue i to the Cα of i and then evolved to the 
covalently bound 15N and 1H of the i+1 residue (Panchal et al., 2001) (Figure 2.12).  In 
doing so the HNN provides i, i-1 and i+1 connectivity, and is therefore a very powerful 
tool in unfolded protein sequential assignment strategies.  This is due to not only the 
three connections provided, but largely because the HNN exploits the 15N chemical 
shift dispersion, rather than 1H dispersion which is typically very poor in disordered or 
unfolded proteins (Panchal et al., 2001).  
 
 
 
Figure 2.12  Schematic representation of magnetisation transfer in a HNN pulse 
sequence.  Orange atoms are observed in the spectrum with the blue arrow showing 
the path that magnetisation evolves during the experiment (Panchal et al., 2001).  
Adapted from (Higman, 2012).   
Hy Cy Hy
Hb Cb Hb
Ca
Ha
C’
O
N
HN
Hy Cy Hy
Hb Cb Hb
Ca
Ha
C’
O
N
HN
i-1 i
Hy Cy Hy
Hb Cb Hb
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Ha
C’
O
N
HN
i+1
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2.1.18  Scope of chapter  
This Chapter reports on the backbone sequential assignment strategies for ferric WT 
hCc in both native aqueous conditions and acid-denatured in the aprotic solvent 
DMSO.  The obtained assignments have been used in studies that address the role of 
hCc in complex with the mitochondrial phospholipid CL and to assess the role of 
dynamics in its apoptotic function.   
 
2.2  Materials and methods 
2.2.1  Isotopic labelling and purification of human cytochrome c in Escherichia coli 
A co-expression system consisting of the DNA inserts to encode for WT hCc 
and the yeast haem lyase in a pUC19Amp vector was used to over-express the mature 
hCc (Rajagopal et al., 2013).  This vector was transformed into Escherichia coli BL21 
(DE3) RIL cells (Invitrogen) and overnight transformants were used to inoculate 3 ml 
Terrific Broth (Melford Chemicals) starter cultures grown at 37 oC, 220 rpm for ~ 4 h.  
Once starter cultures showed signs of turbidity, ~ 3 ml of culture was added to ~ 330 
ml of minimal media in 2 L Erlenmeyer flasks.  The minimal media consisted of 
autoclaved M9 salts supplemented with 0.8 g/L 15NH4Cl, 5 g/L 13C6-glucose, 5 g/L 
thiamine and 1 mM final concentrations of the antibiotics Chloramphenicol and 
Ampicillin (Cai et al., 1998).  To further aid haem biosynthesis, the first committed 
precursor, 5-aminolevulnic acid, is added to a final concentration of 0.1 mM.  The 
cultures are then incubated at 37 oC with shaking at 250 rpm until the point of induction 
(OD600 0.6 – 0.8), usually occurring after ~ 6 h of growth, protein expression is induced 
through the addition of Isopropyl-b-D1-thioglactopryanoside (IPTG) (Melford 
Chemicals) at a final concentration of 1 mM.   
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Cells were harvested after ~ 16 h by centrifugation with a Sorvall SLC-6000 
rotor at 3325 RCF for 20 min, 4 oC (Pollock et al., 1998, Rajagopal et al., 2013).  
Following centrifugation, the cells were re-suspended in a lysis buffer consisting of 50 
mM Tris/HCl, 100 mM NaCl, 1 mM EDTA, 50 mM MgCl2 pH 8.0 and lysed using a 
C3 Emulsiflex (Avestein).  The protein/cell debris solution was then centrifuged with 
a Sorvall SS-34 rotor at 38724 g for 20 min to isolate the protein solution within the 
supernatant.  The protein solution was stirred continuously at 4 oC and (NH4)2SO4 
(Fischer Scientific) added gradually over the course of 15 min to a final concentration 
of 164 g/L and incubated for a further 45 min.  As Cc is highly water soluble, it remains 
in solution with 164 g/L of (NH4)2SO4, less soluble proteins are precipitated and 
therefore following centrifugation at 38724 g for 20 min, the Cc can be recovered in 
the aqueous phase whilst the precipitate is discarded.  Due to the high salt content of 
protein solution, the protein is dialysed overnight against 4 L of 20 mM NaPi, pH 7 in 
a 3,500 Da MW cut-off (MWC) dialysis membrane (Fischer Scientific).  The following 
morning the dialysis buffer was replaced with a fresh buffer and dialysed further to 
remove additional salt.  Following dialysis, the protein solution was centrifuged at 
38724 g and diluted ~ 100 % v/v with 20 mM NaPi, pH 7 (Buffer A).  An XK-26 
column containing SP-Sepharose resin (GE-Healthcare) was equilibrated with Buffer 
A and the protein solution loaded using a peristaltic pump.  Once loaded the column is 
attached to an ÄKTA purification system and the hCc eluted by a salt gradient against 
20 mM NaPi, 1 M NaCl, pH 7 (Buffer B) over the course of 70 min with a 3 ml/min 
flow rate, yielding fractions from ~ 65 – 90 ml.  These fractions were collected, pooled 
and concentrated in 5,000 Da MWC concentrators (Fischer Scientific) to a final volume 
of < 2 ml, so that the protein can be loaded to an XK-16 column containing G75 
sephadex resin (GE-Healthcare) equilibrated with 20 mM NaPi, 150 mM NaCl, pH 7.  
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The protein eluted at ~ 95 – 105 ml and the resulting fractions collected, pooled, 
concentrated and buffer exchanged to a working buffer via a PD10 de-salting column 
(GE Healthcare).  Samples were aliquoted and frozen at -20 oC until required. 
 
2.2.2  Sample preparation  
Ferric hCc was oxidised through the addition of a 2-fold excess of K3[Fe(CN)6] 
(Sigma) with the subsequent excess of K3[Fe(CN)6] and K4[Fe(CN)6] removed and 
exchanged into 20 mM NaPi, 50 mM NaCl, pH 6.8 using a PD-10 desalting column 
(GE-Healthcare).  All hCc samples were between 1 – 1.8 mM in concentration.  Protein 
concentrations were determined spectrophotometrically using a Cary 60 UV-Visible 
spectrophotometer.  Samples were reduced through addition of excess ascorbic acid 
and the absorbance at 550 nm was recorded and concentration determined using an 
extinction coefficient (e) of 27500 M-1cm-1.  All NMR samples were lyophilised prior 
to acquisition of NMR spectra.  For acid-denatured samples, hCc was oxidised, buffer 
exchanged and concentrated in the same method as previously described, however, the 
protein was exchanged into 20 mM NaPi, pH 7 and acid-quenched with 0.3 % v/v 
Trifluroacetic acid (TFA) (Acros Chemicals) prior to lyophilising at a working volume 
of 500 µl.   
 
2.2.3  NMR spectroscopy 
All NMR spectra were acquired on a Bruker 800 MHz spectrometer equipped 
with a 5 mm HCN inverse triple resonance z-axis gradient probe.  For the acquisition 
of NMR assignment spectra of doubly labelled 13C,15N oxidised hCc under aqueous 
conditions, samples were re-suspended on the day with deionised MilliQ H2O and 8 % 
D2O (Sigma), for the spectrometer lock, to a final volume of 500 µl.  A set of 2D [1H, 
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15N]-HSQC and 3D HNCACB and CBCA(CO)NH spectra were recorded at 293 K.  
For acquisition of assignment spectra in DMSO 13C,15N oxidised hCc samples were 
resuspended in 100 % DMSO (Sigma) and supplemented with a small amount of D2O 
for lock and 0.2 % v/v TFA to maintain protein solubility to a final volume of 500 µl.  
A set of HSQCs and the triple resonance CACB pair experiments HNCACB and 
CBCACONH were recorded at 308 K.  All spectra were processed using TopSpin 
(Bruker BioSpin) and assignments determined using the graphical NMR assignment 
programs CCPN Analysis (Vranken et al., 2005) and Sparky (Goddard, 2008, Lee, 
2015). 
 
2.3  Results and Discussion 
2.3.1  Assignment strategy and backbone resonance assignments for human 
cytochrome c under aqueous conditions 
For native oxidised WT hCc in aqueous solution conditions, the assignment 
strategy consisted of the conventional CACB pair, CBCA(CO)NH and HNCACB 
experiments, being used to sequentially assign the backbone NH groups observed in 
the [1H, 15N]-HSQC spectra.  These CACB pair spectra are displayed with the 1H and 
13C dimensions on the x and y axis respectively, whilst the 15N dimension is represented 
along the z axis.  The HNCACB typically displays 4 peaks of two differing intensities 
on a given strip, correlating to the Ca and Cb resonances of residue i and i-1 (Figures 
2.11 and 2.13).  In the case of the CBCACONH experiment, only two peaks are 
typically observed correlating the Ca and Cb resonances of residue i-1 (Figures 2.10 
and 2.13).  These CACB pair spectra were used in conjunction to assign the [1H, 15N]-
HSQC NH peaks in the following way.  Firstly, a non-side chain peak is selected from 
the HSQC and used to navigate to the respective triple resonance strip in the CACB 
 92 
pair experiments.  The experiments are “linked” in the sense that the [1H, 15N]-HSQC 
pulse sequence form the base for the triple resonance experiments and therefore the 1H 
and 15N dimensions correlate with residue i between experiments.  The intra-residue 
connections are based on the 13C dimension and due to the distinct Ca and Cb chemical 
shift patterns of certain residues (Thr, Ser, Ala and Gly) it is possible to tentatively 
assign sequential stretches of the protein.  The assignment procedure relies on taking 
precise note of the 13C chemical shift of a given residue and then searching for two 
differing intensity peaks that precisely match the “marked” chemical shift, but 
crucially, on a different 15N plane.  Figure 2.13 illustrates how this assignments 
procedure works on a five residue sequentially connected strip within the CACB pair 
experiments.  It is clear how the CBCACONH i-1 peaks are used to support i-1 
assignments in the HNCACB spectrum (which can, at times, be somewhat ambiguous).  
It should also be clear how these experiments are used in conjunction to sequentially 
connect stretches of the protein, working either towards the N- or C-termini. 
The triple resonance experiments allowed for the assignment of corresponding 
Ca and Cb carbons, and in the case of the WT protein enabled for all but two NH 
resonance assignments of the 99 non-proline residues to be assigned, with the 
exceptions being Glu21 and Thr28 as resonances were simply not observed (Figure 
2.14).  It is noted that there is a strongly upfield shifted NH resonance at 4.29 ppm 1H 
and 104.25 ppm 15N in the WT protein.  This has also been noted in the ferric G41S 
variant of hCc (Karsisiotis et al., 2015) and has been assigned to Gly84 based on the 
original identification in heart eCc, whereby the extreme shift is attributed to the 
proximity of the Phe82 phenol ring, which would subsequently impose a strong ring-
current effect (Volkov et al., 2012).  A similar case can be made for WT hCc due to the 
X-ray crystal structure displaying a similar orientation of the Phe82 side chain 
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(Rajagopal et al., 2013).  It is also worth noting that the spectral dispersion observed in 
the aqueous WT HSQC is very good, which facilitated the assignment process of the 
triple resonance datasets in the conventional way (Figure 2.14). 
Backbone (HN, Ca and Cb) resonance assignments for ferric WT hCc have 
been deposited in the Biological Magnetic Resonance Data Bank (BMRB) database 
under the accession number 25,418 and reported in Appendix A. 
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Figure 2.13  Strips illustrating the sequential C
a and C
b resonance assignm
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 spectra typically display 4 peaks on a given strip, tw
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ith greater intensity, 
corresponding to the “i” spin system
 and the w
eaker peaks corresponding to the spin system
 of i-1. The corresponding CB
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A
C
O
N
H
 spectra is 
displayed adjacent to the H
N
C
A
C
B and typically only show
 2 peaks on a given strip corresponding to the preceding i-1 residue.  U
sed in 
conjunction, it is possible to sequentially navigate through the protein either tow
ards the N
-term
ini (as illustrated), or tow
ards the C
-term
ini.  
H
orizontal lines are used to illustrate the precise overlap in 13C
 chem
ical shift, betw
een the connected residues, thus allow
ing for sequential 
connections to be m
ade. 
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2.3.2  Assignment strategy and backbone resonance assignments for acid-denatured 
human cytochrome c in DMSO 
For an interrupted H/D exchange NMR method to be developed, which would 
in theory provide insights into the structural interaction(s) between hCc and the 
mitochondrial phospholipid CL (Chapter 3), NH assignments of acid-denatured hCc in 
an aprotic solvent are required.  Samples must be acidified in aqueous conditions 
through the addition of Trifluroacetic acid (TFA).  TFA then functions as a counter ion 
to solubilise the freeze-quenched protein when re-suspended, post freeze drying, in 
high concentration solutions of the aprotic organic solvent DMSO.  The result of this 
acidic pH, is that the 1H chemical shift dispersion is extremely narrow due to the protein 
being extensively denatured.  The spectral overlap therefore severely affects the 
traditional CACB pair experiments as seen in Figure 2.15 and as a result, assignment 
progress was impossible using these conventional experiments as illustrated in Figure. 
2.13.  Therefore, in addition to the CACB pair, triple resonance experiments that confer 
CO connections (HN(CA)CO and HNCO) were acquired.  However, it was apparent 
that although somewhat improved, spectral overlap was still a significant problem, 
which meant that the HN(CA)CO and HNCO experiments were used to further 
corroborate assignments rather than be used as the main assignment tool.   
The main experiment used in the DMSO assignment protocol was the HNN, 
which confers i-1, i and i+1 connections and is extremely useful in unfolded proteins 
as it takes advantage of the 15N chemical shift dispersion which is significantly less 
affected from overlap (Panchal et al., 2001).  On any given 1H-15N plane the NH group 
of residue i is connected to both the preceding and proceeding NH groups (Figure 2.16).  
The sign of these triplet peak strips is dependent on the type of adjacent residue in the 
sequence, particularly with respect to Gly and Pro residues (Panchal et al., 2001).  
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Figure 2.14 [1H, 15N]-HSQC spectra of WT hCc at 293 K in 20 mM NaPi, 50 mM 
NaCl, pH 6.8.  The backbone NH resonance assignments are presented.  
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Despite the utility of the HNN experiment, this was still susceptible to spectral 
overlap on certain residues, thus the assignment protocol relied on the combination of 
these five triple resonance experiments in conjunction to assign most of the NH 
resonances (85 % of the non-proline residues) (Figure 2.17).  It was however, 
impossible to assign the following residues under the experimental conditions 
employed: Lys7, Cys17, Thr19, Glu66, Tyr67, Leu68, Glu69, Tyr74, Ile75, Met80, 
Lys87, Lys88, Glu89, Glu90 and Lys100.  This was due to either the residues simply 
not being observed, or due to consistent spectral overlap in all triple resonance 
experiments.  It was possible to tentatively assign certain residues in two stretches of 
the protein, corresponding to region 66-69 and 87-90, however, as these were 
ambiguous these have been excluded from the deposited assignments.  Backbone (HN, 
N, Ca, Cb and CO) resonance assignments have been deposited in the BMRB database 
under the accession number 26973 and are reported in Appendix A.   
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Figure 2.15  An example of a typical 15N plane within an HNCACB spectrum of 
acid-denatured WT hCc in the aprotic solvent DMSO at 308 K.  Positive Ca peaks 
are displayed in blue, whilst negative Cb peaks are displayed in red.  Note the narrow 
spectral dispersion in the 1H dimension, leading to extensively overlapped datasets. /Users/omd/HNCACB_DMSO_Overlap.pdf Wed Mar 22 13:53:23 2017
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Figure 2.16  Strips of the HNN experiments used primarily, but in conjunction with 
several other triple resonance experiments to assign WT hCc in an acid-denatured 
state in DMSO.  Displayed are three sequential spin systems ranging from Val20 
to Lys22.  On any given strip, there are typically three peaks observed, the positive 
peak (orange) relates to the spin system of residue i, whilst the other two negative 
peaks (blue) represent sequentially connected preceding residue i-1 and the 
proceeding i+1 residue.  Adapted from Karsisiotis et al. (2017).   
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Figure 2.17  [1H, 15N]-HSQC spectrum of acid-denatured WT hCc at 308 K in the 
aprotic, organic solvent, DMSO.  The backbone NH resonance assignments are 
included.  Adapted from Karsisiotis et al. (2017).   
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2.4  Conclusions 
In summary, to assign acid-denatured hCc in DMSO is more challenging than 
in aqueous conditions and requires a comprehensive assignment strategy utilising 
several different triple resonance experiments.  The extremely narrow 1H dispersion 
which leads to heavily overlapped triple resonance datasets making sequential 
assignment difficult was somewhat overcome through the use of the HNN experiment, 
which not only provides three sequential residue connections, but crucially exploits the 
15N dispersion which is significantly less effected in disordered or denatured proteins 
(Panchal et al., 2001).  The successful assignments of oxidised hCc in aqueous and 
DMSO conditions now enables for the backbone NH assignments to be used in further 
studies reported in the proceeding Chapters of this thesis. 
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Chapter 3 
Interrupted H/D exchange:  A new approach to 
study protein/lipid interactions?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of iH/D exchange experiments lead by Dr Andreas Ioannis Karsisiotis  
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3.1  Introduction  
3.1.1  Conventional H/D exchange 
 Hydrogen-Deuterium (H/D) Exchange methodologies are based on the fact that 
the proton of a protein backbone amide (NH) group is chemically labile and therefore 
constantly in exchange with solvent protons.  Secondly, as protons and deuterons are 
highly NMR active and inactive nuclei, respectively, it is possible to exploit this 
exchange property and follow the continual reduction in both the number of NH groups 
and their respective peak intensities by conventional solution NMR spectroscopy using 
the HSQC (or variations of) experiment (Figure 3.1A).  H/D exchange was first 
conceptualised and developed by the works of Kaj Ulrik Linderstrøm Lang and co-
workers over 60 years ago (Linderstrøm-Lang, 1955a, Linderstrøm-Lang, 1955b, 
Linderstrøm-Lang, 1958, Linderstrøm-Lang, 1959).  Since then, H/D exchange 
methodologies have been used to provide structurally related dynamic information on 
proteins within a single reside resolution (Bai et al., 1994, Bai et al., 1993, Bedard et 
al., 2008, Dyson et al., 2008, Nishimura et al., 2005, Alexandrescu, 2013).  The primary 
H/D exchange methodology used is conventional H/D (cH/D) exchange, which has 
provided insights into protein folding and dynamics studies, as demonstrated by the 
pioneering work of Englander and colleagues (Bai et al., 1995a, Bai and Englander, 
1996, Bai and Englander, 1994, Bai et al., 1994, Bai et al., 1993, Bai et al., 1995b, 
Connelly et al., 1993, Calhoun and Englander, 1985, Houry et al., 1998, Englander and 
Kallenbach, 1983, Zhang et al., 1995).   
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3.1.2  Concepts and theories of H/D exchange 
H/D exchange methodologies work because the rate at which the proton of a 
given amino acid NH group exchanges with solvent protons/deuterons varies 
significantly by a number of key factors.  These are namely the residue type, 
temperature, solvent conditions, pH (as both acids and bases can catalyse the exchange 
reaction), however crucially, in the context of structural biology and protein dynamics, 
the presence of higher order structures i.e. protein secondary structure, or structural 
elements.  In order for the exchange reaction to occur, the NH group must be freely 
exposed to the solvent, and therefore the presence of hydrogen bonding (H-bonding) 
provides considerable protection from exchange.   
 
 
Equation 3.1 represents the intrinsic exchange rate constant of a hydrogen atom in a 
freely exposed amide (Hoshino et al., 2007).  kint represents the observed exchange rate 
constant, kw represents the spontaneous rate constant for water, kacid[H+] and kbase[OH-
] are the second order rate constants for the acid and base catalysed reactions 
respectively (Hoshino et al., 2007).  Bai and colleagues demonstrated that the kint value 
of a given amino acid is highly dependent on pH producing “V-shaped” curves 
whereby minimal exchange occurs at approximately pH 3 in an aqueous environment 
(Bai et al., 1993).  The exchange rates vary by one order of magnitude between a single 
pH unit shift and can be significantly reduced by bulky neighbouring residues due to 
steric blocking, or facilitated by inductive affects from polar residues (Bai et al., 1993).  
Bai and colleagues have determined the kint values for every amino acid in a sequence 
using dipeptide models, furthermore, their work demonstrated both the inductive and 
kint = kw + kacid[H+] + kbase[OH-]             [3.1] 
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steric blocking effects of neighbouring residues  using oligo- and polypeptide models, 
demonstrating approximately one order of magnitude variability (Bai et al., 1993).   
As mentioned above, the H/D exchange rates of folded proteins are also further 
reduced by the formation of H-bonds which form between the hydroxyl and carbonyl 
groups.  Additionally, hydrophobic protection of protons located within the 
hydrophobic core of a folded protein also provides significant exchange protection 
(Hoshino et al., 2007).  The observed reduction in exchange rate of folded proteins 
directly correlates to the formation of higher order structures and therefore the ratio 
between the observed and intrinsic exchange rates of freely exposed sites is a 
significant value, known as the protection factor (P), first defined by (Houry et al., 
1998).  The P is the temperature corrected value used to report on all H/D exchange 
data and is defined as in equation 3.2.   
 
 
In this equation kint is the intrinsic exchange rate constant under reaction 
conditions considering the effects of amino acid sequence, pH and temperature by 
calculating these factors as a function and kex is simply the observed experimental 
exchange rate (Hoshino et al., 2007).  As mentioned earlier the intrinsic exchange rate 
varies by an order of magnitude depending on the local amino acid environment, 
therefore, the observed exchange rate is dependent on the term defining the structural 
stability of the protein and the local amino acid sequence effects (from neighbouring 
residue steric blocking and facilitating polar residues), therefore, the conversion 
process from the obtained exchange rate to the protection factor serves to rectify this 
problem and in doing so provides thermodynamic stability of specific sites when the 
EX2 exchange conditions are satisfied (Hoshino et al., 2007).  Protection in the native 
P = kint / kex              [3.2] 
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state of globular proteins show very high protection patterns usually in the region of 
104-106 s-1. 
 
3.1.3  Exchange Mechanisms 
In order for a hydrogen atom in an NH group that forms a stable H-bond or that 
is located in the hydrophobic core to undergo exchange, the hydrogen must be in an 
exchange competent state.  This can be achieved by either small-scale local structural 
fluctuations (local unfolding, known as “breathing”) or by complete, transient, 
unfolding (global unfolding) (scheme 3.1) (Englander and Kallenbach, 1983).  NHc and 
NHo represent, respectively, the closed and open conformations under local unfolding 
conditions and the folded and unfolded conformations under global unfolding 
conditions (Hoshino et al., 2007).   
 
 
ND represents the deuterium exchanged amide, ko and kc are the opening i.e. unfolding 
and closing i.e. folding rate constants respectively, kint is the intrinsic exchange rate 
constant for an unprotected state (Hoshino et al., 2007).  In this schematic, backward 
exchange from ND to NHo is not required due to massive excess of the solvent D2O in 
respect to the concentration of protein.  Therefore, the exchange rate constant when 
under steady-state conditions is expressed by equation 3.3.  However, most H/D 
exchange experimental conditions significantly favour the folded condition therefore 
kc >> ko.  This allows equation 3.3 to be approximated as equation 3.4.  
        [Scheme 3.1] 
                        [3.3] 
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Crucially, there are two limits to the above equation 3.4.  Firstly, when kc >> kint, a 
scenario associated with low pH and temperature, the subsequent exchange rate 
becomes equation 3.5.   
 
Where by Ko = ko/kc represents the equilibrium constant between the unfolded and 
folded conformations.  This scenario is known as the bimolecular exchange (EX2) 
limit, where the H/D exchange rate expressed by the P states the thermodynamic site 
stability as equation 3.6.   
 
 
Where ΔGex is the Gibbs free energy of unfolding at the NH site, R is the gas constant, 
and T is absolute temperature.  However, there is another limit to equation 3.3, known 
as the monomolecular (EX1) exchange limit, a condition usually considered at high pH 
and temperature (Hoshino et al., 2007).  Under EX1 conditions kc << kint and therefore 
the exchange reaction is limited by the unfolding event at the particular NH site, the 
result of which is that equation 3.3 is simplified to equation 3.7 (Hoshino et al., 2007).   
 
 
                        [3.4] 
             [3.5] 
                [3.6] 
                   [3.7] 
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The EX1 condition exchange rate constant is the unfolding kinetic constant and 
therefore conversion to a protection factor is unnecessary.  The pH dependence of the 
exchange rate allows identification of whether the reaction is controlled by the EX1 or 
EX2 limit, if EX2, the exchange rate is proportional to the intrinsic exchange rate and 
is highly dependent on pH (Hoshino et al., 2007).  Whereas the EX1 limit displays a 
near pH-independent observed exchange rate (Hoshino et al., 2007).   
 
3.1.4  Interrupted H/D exchange in dimethylsulfoxide   
The aprotic solvent DMSO can be used in a relatively new type of H/D 
exchange methodology, interrupted H/D exchange (iH/D exchange).  iH/D exchange 
is not like cH/D exchange, which is based on one live sample that evolves over time 
(Figure 3.1A), instead, a number of separate samples have the exchange reaction 
quenched.  This can be achieved either by flash freezing or pH drop (through addition 
of trifluroacetic acid (TFA)) or both and then freeze dried and resuspended in DMSO 
in order to prevent any further exchange occurring (Figure 3.1B) (Zhang et al., 1995, 
Hoshino et al., 2007).   
Zhang and colleagues investigated the exchange rate constant of a model 
peptide in DMSO and found an approximate 100-fold decrease in H/D exchange rate 
when in 90-95% DMSO compared to that of aqueous solvents (Zhang et al., 1995).  
Their work also found differences in the pH dependence of the rate constant when 
compared to an aqueous solvent and that the characteristic minimal exchange rate 
associated with aqueous conditions at pH 3 was increased by 2 pH units to an 
approximate observed pH of 5 in 95 % DMSO.  It was reasoned that the differences in 
exchange rate are caused by the transient formation of deprotonated NH groups which 
are required for the base catalysed exchange reaction and subsequently become 
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increasingly unfavourable in high concentrations of aprotic organic solvents such as 
DMSO (Scheme 3.2) (Zhang et al., 1995).   
 
Roder and co-workers have demonstrated that iH/D exchange experiments can 
provide insight into local structural dynamics on the sub-millisecond timescale 
(Fazelinia et al., 2013).  This was achieved through the development of an ultra-rapid 
microfluidic mixing device able to extend the temporal resolution of cH/D exchange 
experiments down to 60 µs (Fazelinia et al., 2013).  They successfully demonstrated 
that during the first 140 µs of refolding in ferric eCc, three helical regions form in the 
60s, 70s and C-terminal helices of the native protein structure, but no secondary 
structure formation in the N-terminal half of the protein (Fazelinia et al., 2013).  By 
allowing the protein to refold under refolding conditions of a given time and then 
rapidly quenching the exchange reaction with an acidic quenching buffer, the number 
of visible backbone amid peaks in a 2D [1H-15N] HSQC experiment vary.  
Extrapolation of exchange rate constants show local, residue specific secondary 
structural information.  The more uniformly exposed a protein is to the solvent, the 
greater the exchange rate, therefore, regions which fold are protected from exchange 
and thus in turn highlight regions that have adopted ordered structural features.  
 iH/D exchange has been used to study several protein systems such as GroES, 
amylin and melittin (Chandak et al., 2013, Alexandrescu, 2013, Zhang et al., 1995).  In 
particular, iH/D exchange has been used to great effect within the mammalian 
cochaperone Aha1 system, whereby Dyson and co-workers were able to define the 
interaction sites with the middle domain of the chaperone Hsp90 (Dyson et al., 2008).  
Not only were their findings consistent with the X-ray crystal structural data obtained 
              [Scheme 3.2] 
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from the homologous yeast complex, but they also were able to identify a secondary 
interaction site within this protein complex (Dyson et al., 2008). 
 
3.1.5  iH/D exchange to study lipid binding sites? 
 iH/D exchange has not been used previously to study a holo-haem protein, and 
so during the course of this PhD research, the primary initial goal was to develop an 
iH/D exchange methodology that would provide salient structural information on 
soluble protein/phospholipid interactions.  Protein/lipid interactions are not amenable 
to X-ray crystallography due to the heterogeneity of the subsequent solutions, and 
lipids are too large for conventional solution NMR spectroscopy.  Solid State NMR 
(SS-NMR) traditionally has also not been appropriate for these systems as a protein 
precipitate will not be representative of the dynamics present with the lipid under 
aqueous conditions.  However, recently the technology and methodologies have 
advanced sufficiently to provide structural information on such systems as described 
below.   
Alternative solution NMR techniques have been used recently by Wand and co-
workers to study the Cc/CL interaction through the use of reverse micelle encapsulation 
(O'Brien et al., 2015).  Previous studies have demonstrated that the interaction with Cc 
and CL results in partial unfolding of the protein, as a precursor to the apoptotic 
response, however, a limitation of previous studies is not only a lack of site resolution, 
but also a lack of membrane curvature thus not reflecting the micro-environment within 
the mitochondrion (O'Brien et al., 2015).  Wand and co-workers used reverse micelle 
encapsulation to mimic the effects of confinement on the interaction between Cc and 
CL using ferric eCc and reverse micelles prepared in pentane (O'Brien et al., 2015).  
The results of their investigation supported the previously defined electrostatic A- 
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(Lys72, Lys73, Lys86 and Lys87) and L- (Lys22, Lys25, His26, Lys27 and His33) 
sites, but also identified a new binding site incorporating residues Phe36, Gly37, Thr58, 
Trp59 and Lys60 (O'Brien et al., 2015).  The work of Wand and co-workers also found 
no evidence of local Cc unfolding, instead they found the tertiary structure to remain 
fully intact upon interaction with CL (O'Brien et al., 2015).  Such a finding contradicts 
many previous studies (vide infra).   
Further support for the interaction between Cc and CL without unfolding comes 
from the work of van der Wel and colleagues who used Magic Angle Spinning Solid-
State NMR spectroscopy (MAS-SS-NMR) to identify the site specific conformational 
changes that occur in both the ferric and ferrous forms of 15N, 13C uniformly labelled 
eCc when bound to CL bilayers (Mandal et al., 2015).  The use of MAS-SS-NMR and 
Fourier Transform infrared spectroscopy (FT-IR) revealed that CL membrane bound 
Cc displays significant dynamics, yet maintains its secondary structure (Mandal et al., 
2015).  Additionally, in both two and three dimensional MAS-SS-NMR spectra they 
report that the CL bound Cc displays a spectral resolution characteristic of a protein 
exhibiting structural homogeneity, a result that is therefore, fundamentally inconsistent 
with the extensive membrane-induced unfolding previously reported (Mandal et al., 
2015).  They conclude that Cc interacts with the CL membrane interface without 
significantly perturbing the lipid bilayer, and therefore despite membrane binding 
resulting in the Cc pro-apoptotic peroxidase gain-of-function, they do not observe 
evidence of large scale unfolding events or penetration into the membrane core 
(Mandal et al., 2015).   
 Despite the complications of studying such a system, preliminary work prior to 
this PhD Thesis in the Worrall Group has revealed that the addition of TFA to WT 
hCc/CL solutions causes dissociation of CL.  This therefore means that if the 
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protein/lipid complex were allowed to exchange for discrete time durations, then the 
addition of TFA would not only separate the lipid and simultaneously quench the 
exchange reaction, but it would also  
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Figure 3.1  Schematic illustration of Traditional (conventional) H/D exchange (upper 
inset) and the established interrupted H/D exchange methodologies (middle inset).  
The lower inset illustrates how interrupted H/D exchange theoretically can be utilised 
to resolve lipid binding site information on a per residue resolution, through the use 
of acid quenching (with TFA) and the aprotic organic solvent DMSO.   
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allow for the isolation of the aqueous protein components from the mixture via the 
addition of diethyl-ether (DEE) (Figures 3.1 lower and 3.8).  It would then be possible 
to carry out the iH/D exchange methodology using DMSO and acquire HSQC 
experiments (Figure 3.1C).  Theoretically, there would be a specific iH/D exchange 
profile displayed in the absence of lipid, which differs from that of a lipid bound 
dataset, in which there might be a few residues that display increased H/D exchange 
protection, i.e. slower experimental exchange rates that one would attribute directly to 
the physical protection conferred by the lipid (through H-bonding) (Figure 3.1 lower). 
 This chapter documents the research into both iH/D exchange of holo-WT hCc, 
and the integration of the hCc/CL interaction into said iH/D exchange methodology 
with the aim of extracting information as to which structural regions of hCc are 
interacting with CL.   
 
3.2  Materials and Methods  
3.2.1  Over-expression and purification of WT human cytochrome c 
 The over-expression and purification of hCc were as reported in Chapter 2. 
 
3.2.2  Protein preparation 
 All WT hCc preparations were oxidised to the ferric haem state and equilibrated 
in 20 mM sodium phosphate, pH 7 as described in Chapter 2.   
 
3.2.3  NMR spectroscopy  
 Full details of NMR sample preparations, experimental conditions and 
assignment procedures are described in Chapter 2.   
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3.2.4.  Cardiolipin-liposome preparation 
 Cardiolipin liposomes consisting of a 1:1 molar ratio of TOCL (1, 1’, 2, 2’-
tetraoleoyl CL) and DOPC (1, 2-dioleoyl-sn-glycero-3-phosphocholine) (Avanti Polar 
Lipids) were used for the NMR experiments reported in this chapter and in the ABTS 
peroxidase activity assays reported in Chapters 4 and 5.  Lipid stocks stored in 
chloroform were aspirated in an atmosphere of argon (BOC) to prevent oxidation.  
During aspiration, the lipid solution is kept in continual motion to produce a uniformly 
thin and dry film at the base of the glassware prior to sealing with Parafilm.  The lipids 
were re-suspended in 20 mM sodium phosphate, pH 6.5 by vortexing for ~ 10 min 
yielding a 2.5 mM stock.  Once a homogenous, cloudy solution is achieved, liposomes 
were made of uniform size by sonication at 4 ̊C for ~ 15 min, or until a clear solution 
was achieved.  Liposome solutions were used within 24 hours of preparation. 
 
3.3  Results and Discussion  
3.3.1  Initial attempts of observing iH/D exchange in DMSO  
 
Figure 3.2  Schematic illustration of the iH/D exchange methodology.  Multiple protein 
samples are used, that in theory represent a discrete exchange time-point.  hCc is 
resuspended in 100 % D2O and the exchange reaction allowed to proceed for a 
predetermined time.  At a desired time, the exchange reaction is quenched in the 
aqueous phase through the addition of TFA.  The protein solution is lyophilised and 
then resuspended in a high concentration DMSO solution at the time of measurement.  
 116 
iH/D exchange is visualised in DMSO, where theoretically different exchange profiles 
are present based on exchange duration.   
 
Initial attempts to observe iH/D exchange in DMSO were setup in accordance 
with the relatively few protocols described in the literature (Dyson et al., 2008, 
Chandak et al., 2013, Alexandrescu, 2013, Fazelinia et al., 2013).  A set of iH/D 
exchange 15N WT hCc samples (250 µM, 20 mM sodium phosphate, 50 mM NaCl) 
were quenched with an optimised amount of TFA (1.8 % v/v) (Figure 3.2) that 
conferred excellent protein solubility once redissolved in a DMSO/D2O mixture (99.6 
%, 0.4 %, respectively) post lyophilising (Figure 3.2).  The following exchange time 
points were used; 0.169, 1.027, 3.085, 7.717, 24.018 and 48.028 h.  [1H-15N] HSQC 
spectra were acquired on the Bruker 500 MHz spectrometer (Chapter 2 materials and 
methods).  Analysis of each respective sample did not indicate iH/D exchange, 
furthermore, significant and non-uniform spectral shifts were observed with respect to 
the triple resonance assignment spectra, which one may attribute to more acidic 
solution conditions and increased salt content.   
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3.3.2  Varying TFA concentration  
 
Figure 3.3  Schematic illustration of the iH/D exchange methodology.  Annotated red 
arrows highlight the two experiential stages in which TFA is used.  The “aqueous 
quench phase” represents the point at which the exchange reaction is first suppressed.  
“TFA added to DMSO resuspension mixture” represents the second experimental stage 
in which TFA is added to the protein solution, in order to solubilise the hCc in DMSO.   
 
Further work demonstrated that additional TFA was a necessity in the DMSO 
resuspension mixtures (Figure 3.3), as an inadequate TFA concentration correlated 
with considerable, or total protein precipitation.  In contrast, an excessive TFA 
concentration led to protein denaturation, loss of haem coordination and poor NMR 
spectral quality.  Unfortunately, an ideal TFA concentration, with respect to protein 
solubility, in the DMSO resuspension mixture, or an excess of TFA added at the 
aqueous quench phase (Figure 3.3) correlated with no observable iH/D exchange.  
These negative results are most likely attributed to an inappropriate quench pH in the 
“aqueous quench phase” and/or from an inappropriate “apparent” pD in DMSO (Figure 
3.3).  It was discovered that there are two crucial factors in maintaining the H/D 
exchange status, namely the aqueous solution pH at the “aqueous quench phase” 
(Figure 3.3), in which the addition of 1.8 % v/v TFA was inappropriate, but also the 
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apparent pD in the redissolved d6-DMSO/D2O/TFA mixtures, which literature explains 
by preventing back exchange (Hoshino et al., 2007).   
Attempts to prevent back exchange involved experiments using four samples (a 
no exchange control, 10 min exchange, 3 h exchange and 24 h exchange) with the low 
salt 20 mM sodium phosphate, pH 6.5 buffer, with 0.2 % v/v TFA used to quench the 
exchange reaction, followed by sample resuspension in DMSO/D2O/TFA mixtures of 
95 %, 5 % and 0.1 % v/v respectively (Figure 3.3).  It was determined that the use of 
0.1 % v/v TFA in DMSO is appropriate for protein solubility only if used with a pre-
mixed resuspension solution (if added separately 0.2 % v/v TFA is required).  
Unfortunately, these experiments showed no indication of iH/D exchange and 
demonstrated that with increased D2O content higher TFA concentrations are required 
in the DMSO resuspension solution, in order to maintain protein solubility.   
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3.3.3  Evidence of iH/D exchange in water  
 
Figure 3.4  Schematic illustration of the experiment described in section 3.3.3.  
Samples were allowed an initial exchange period (8 h “t = a”) in D2O, at which point 
the reaction was quenched with varying amounts of TFA to access performance.  
Following the quench, samples were allowed an additional longer time interval (16 h 
“t = b”), in order that any samples which were not successfully quenched through the 
addition of TFA would continue to exchange.  Samples were then flash frozen, 
lyophilised and resuspended in H2O at the time of measurement.   
 
 In order to obtain evidence as to whether iH/D exchange is possible for the hCc 
system, an experiment was designed in which the two respective stages (quenching in 
water and resuspending in DMSO) were separated.  The data reported in this sub-
section (3.3.3) arise from measuring iH/D exchange samples in water, in order to access 
the efficacy of quenching the exchange reaction in aqueous conditions (Figure 3.4).   
The experimental design was as follows; samples were allowed an initial 
exchange period of 8 h in D2O, samples were then quenched with varying TFA 
concentrations (0.15, 0.1, 0.075, 0.05, 0.025 % v/v) and allowed a second longer 
exchange period of 16 h before being flash frozen in liquid N2 and lyophilised.  The 
purpose of the second exchange  
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Figure 3.5  Individual residue peak height intensity of all experimental samples and 
the no-exchange control (Control 1), plotted as a percentage of Control 2, the control 
sample that only experiences the initial deuteration period (Figure 3.4).  As explained 
in section 3.3.3 NMR HSQC spectra have been acquired in H2O buffer conditions.  
Individual data points are fitted to a simple polynomial function to observe general 
trends in the data sets.   
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interval following the addition of TFA, was in order to allow any non-quenched 
samples to further exchange.  Samples containing 250 µM hCc in 20 mM sodium 
phosphate, pH 6.5 were produced and by varying the quench TFA concentration and 
therefore, the corresponding pH values, a range of conditions was sampled.  Two 
controls were used, the first (Control 1) a no deuterium exchanged sample and the 
second (Control 2) a sample only allowed the initial exchange period.  Both controls 
received the addition of 0.05 % v/v TFA.   
Samples were re-suspended in water and observed by acquisition of HSQC 
spectra in H2O buffer conditions.  The decision to acquire the NMR spectra in H2O was 
made with the two following considerations:   
a) That the relatively short interval in H2O between sample resuspension and data 
acquisition is negligible in terms of re-protonation when compared to the far 
longer deuteration exchange period.  
b) Detection in aqueous conditions allows for the use of the full set of resonance 
assignments as used in the cH/D exchange experiments, in contrast to the 
limited subset of assignments obtained in DMSO.   
This experiment enabled both the visualisation of iH/D exchange information and 
allowed one to identify more suitable quenching conditions in H2O (0.05 % v/v TFA).  
These conclusions were determined from comparison of polynomial fits to the 
experimental datasets vs the no-exchange control (Control 1) (Figure 3.5).  In Figure 
3.5 the intensity of each residue is plotted for all samples as a percentage of Control 2, 
the control sample that received only the initial exchange period.  As the experimental 
sample quenched with 0.05 % v/v TFA shows the greatest intensity of all experiential 
samples, and therefore the highest protonation state, it can be concluded that during the 
second exchange interval following the aqueous quench phase, that this experimental 
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sample has “evolved” the least, i.e. not significantly exchanged further.  This 
conclusion is valid when the previously stated assumption is made that the re-
protonation in H2O (at the time of measurement) is insignificant when compared with 
the timescales involved for deuteration.   
 Following from the success of the aqueous quench optimisation experiment, a 
repeat experiment was conducted in order to further refine aqueous conditions as much 
as practically possible.  Eight samples were produced, quenched with 0.07, 0.065, 0.06, 
0.055, 0.05 % v/v TFA respectively.  Two control samples were used as per the 
previously described experiment that received the addition of 0.05 % TFA.  Analysis 
of this follow up optimisation experiment revealed that the optimal quench conditions 
in H2O had been further refined, with 0.065 % v/v TFA providing the best quality 
preservation of H/D exchange data (Figure 3.6).   
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Figure 3.6  Individual residue peak height intensity of all experimental samples and 
the no-exchange control (Control), plotted as a percentage of Control 2, the control 
sample that only experiences the initial deuteration period (Figure 3.4).  As explained 
in section 3.3.3 NMR HSQC spectra have been acquired in H2O buffer conditions.  
Individual data points are fitted to a simple polynomial function to observe general 
trends in the data sets.   
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3.3.4  Attempts to observe iH/D exchange in DMSO  
 In order to address the issue of maintaining the quenched H/D exchange 
reaction in DMSO, a number of samples were produced so that systematic variation of 
d6-DMSO/D2O/TFA ratios in the resuspension solution (Figure 3.3) could be explored.  
The aim of this systematic variation was to determine an optimal apparent pD in DMSO 
between ~ pD 3.5 – 5.5 based on literature for minimising back exchange (i.e. D > H 
exchange) (Alexandrescu, 2013, Dyson et al., 2008, Hoshino et al., 2007, Fazelinia et 
al., 2013).  Samples consisted of TFA ranges as follows; 0.1, 0.15, 0.175, 0.2, 0.21, 
0.225, 0.25, 0.3, and 0.4 % v/v.  The control had no exposure to deuterium but was 
quenched with 0.065 % v/v TFA, then following lyophilisation the control was 
redissolved with 0.25 % v/v TFA in d6-DMSO.  The data showed that resuspending in 
DMSO with 0.25 % v/v TFA, resulting in an apparent pD ~ 4 yields the best-preserved 
H/D exchange profile, whilst the extremes of the dataset (0.1 and 0.4 % v/v 
respectively) resulted in the worst exchange profiles, due to an inappropriate pD of 7.4 
and 3.44 respectively in DMSO.   
 Despite these optimisations, it was still not possible to obtain quantitatively 
useful exchange state information in DMSO.   
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3.3.5  Using FAST-HSQC to monitor sample evolution in DMSO 
 It became apparent that the use of a single high-quality HSQC spectrum 
obtained over ~ 45 min – 1 h was not sufficient to observe iH/D exchange, due to the 
limited observation window.  All previously documented attempts at observing iH/D 
exchange had been conducted on the Bruker 500 MHz spectrometer (Chapter 2 
materials and methods) as the 800 MHz spectrometer had been off-line for a 
considerable duration for extensive repair work.  The use of the 800 MHz spectrometer 
enabled the FAST-HSQC pulse sequence to be used on all subsequent iH/D exchange 
samples, with a series of consecutive HSQC spectra acquired for each respective time 
point.  As the acquisition time with the FAST-HSQC pulse sequence was ~ 5 min, the 
acquisition of multiple spectra enabled the theoretical zero time point to be determined, 
through back extrapolation of fits to the HSQC data obtained over multiple time points 
after protein dissolution.  The use of multiple FAST-HSQC spectra for each sample, 
followed by back extrapolation, is an approach used by Wright and colleagues to great 
effect on apomyoglobin (Nishimura et al., 2005).   
By switching from a single high-resolution HSQC spectrum for each respective 
time point, to a series of consecutive FAST-HSQC spectra using the optimised DMSO 
conditions allows the H/D exchange reaction to be followed once the samples are 
reconstituted in DMSO.  Experiments conducted using the FAST-HSQC approach 
illustrated the efficiency of following the H/D exchange process and therefore sample 
evolution over time.  Residues which display different types of H/D exchange profile 
(based on the cH/D exchange experiments) can be followed in real time in terms of 
their respective NMR peak intensities, which can be predicted to some extent.  It is 
inevitable that the chosen quench and solution conditions could be improved further, 
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but it is clear that the exchange reaction is sufficiently quenched in order to monitor 
the intensities in real time, in which it is possible to back extrapolate to time zero.   
Through a detailed attempt at observing iH/D exchange in DMSO a wide 
variety of exchange time points were used (8, 24, 48, 72, 96 and 168 h) in conjunction 
with consecutive HSQC spectra using the FAST-HSQC pulse sequence with detection 
in DMSO (0.25 % d-TFA, 99 % d6-DMSO, 1 % D2O).  Differences were observed 
between the fast and slow exchanging residues (categorised by the cH/D exchange 
experiments for WT hCc).  However, it is only for the very slow exchanging residues 
in which differentiation in the exchange profiles are observed (Figures 3.7 – 3.10).   
 
 
 
Figure 3.7  Plot of intensity as a function of time (min) for Ser47 using the FAST-
HSQC pulse sequence with data fitted to a polynomial equation.  The following 
exchange time points were used; 8 h (T1), 24 h (T2), 48 h (T3), 72 h (T4), 96 h (T5) 
and 168 h (T6), with a no exchange control (N1).   
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Approximately a third of the residues exchange within the first 10 min, though 
their peak intensities increase throughout data acquisition as a result of re-protonation.  
Theoretically time zero intensity should be near zero, however, NMR detection is not 
sufficiently fast to provide information before the re-protonation of these initially fully 
exchanged residues occurs.  As a result, it is only for the very slow exchanging residues 
in which differences between time points could be extrapolated, but for all other 
suitable residues (based on the cH/D exchange experiments), it is not possible to 
discern differences between time points.  Due to this result, the realisation is that 
quantitative characterisation of an iH/D exchange dataset for WT hCc is certainly of 
extreme technical difficulty, or perhaps impossible with current methods.  However, 
qualitative characterisation could be possible for this system, in the sense that one 
might be able to discern whether the H/D exchange profile of a particular residue, or 
group of residues, is altered upon interaction with CL liposomes through comparisons 
between the lipid unbound and lipid bound iH/D exchange datasets.   
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Figure 3.8  Plot of intensity as a function of time (min) for Thr49 using the FAST-
HSQC pulse sequence with data fitted to a polynomial equation.  The following 
exchange time points were used; 8 h (T1), 24 h (T2), 48 h (T3), 72 h (T4), 96 h (T5) 
and 168 h (T6), with a no exchange control (N1).   
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Figure 3.9  Plot of intensity as a function of time (min) for Trp59 using the FAST-
HSQC pulse sequence with data fitted to a polynomial equation.  The following 
exchange time points were used; 8 h (T1), 24 h (T2), 48 h (T3), 72 h (T4), 96 h (T5) 
and 168 h (T6), with a no exchange control (N1). 
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Figure 3.10  Plot of intensity as a function of time (min) for Leu94 using the FAST-
HSQC pulse sequence with data fitted to a polynomial equation.  The following 
exchange time points were used; 8 h (T1), 24 h (T2), 48 h (T3), 72 h (T4), 96 h (T5) 
and 168 h (T6), with a no exchange control (N1). 
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3.3.6  iH/D exchange conclusions from WT hCc 
 From experiments conducted it has been possible to conclude that evidence of 
iH/D exchange is possible in water (section 3.3.3).  Furthermore, the solution 
conditions are optimised to the practical limit, in water and DMSO.  Despite these 
optimisations, it has been demonstrated that in it is only for the very slow exchanging 
residues in which differences in the H/D exchange profile may be determined, an 
observation fundamentally inconsistent with the exchange information determined by 
the cH/D exchange methodology.   
 An advantage was gained using the 800 MHz spectrometer, enabling the 
acquisition of multiple sequential HSQC spectra using the FAST-HSQC pulse 
sequence.  The benefit of acquiring consecutive HSQC’s over ~ 1 h duration, is that it 
enables the sample evolution (variation in protonation state) within DMSO to be 
followed.  Using the protocol described by Nishimura and colleagues, it was possible 
to back extrapolate to a theoretical time-zero from exponential fits to the datasets 
(Nishimura et al., 2005).   
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3.3.7  Attempts of integrating CL liposomes into the iH/D exchange methodology  
 
Figure 3.11  Schematic illustration of an iH/D exchange methodology that incorporates 
soluble protein/phospholipid complexes.  The general scheme is as follows, a fully 
protonated hCc/CL complex is allowed to exchange in D2O for discrete durations, as 
per an iH/D exchange protocol.  At pre-determined time points, the exchange reaction 
is quenched, the complex disrupted, and the soluble protein isolated through the 
addition of diethyl-ether (Figure 3.12).  The recovered protein is then lyophilised and 
resuspended in high concertation DMSO solutions at the time of NMR data acquisition.  
In theory, such a technique would allow for either quantitative and/or qualitative 
comparisons to be made between a lipid unbound and bound dataset, thus providing 
direct evidence of the binding interface.   
 
As a result of the difficulties in optimising the conditions necessary to truly 
preserve the exchange data from the WT hCc iH/D exchange data sets, it was decided 
that the scope of the methodology should be expanded to include iH/D exchange 
samples with CL liposome complexes.  Preparations of DOPC-TOCL liposomes, in 
addition to TOCL only were incorporated into the experimental routine, with 
protein/lipid complex formation, viability and long-term stability assessed through 
guaiacol and ABTS peroxidase activity assays.  As introduced in Chapter 1 (reported 
in Chapters 4 and 5), hCc/CL complex formation results in enhanced peroxidase 
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activity.  Variations in the protein/liposome ratio were explored and correlated with 
long term complex stability.  Following from this preliminary work, it was determined 
that a 1:5 protein to lipid molar ratio is optimal, as any further increase in lipid 
concentration results in decreased complex stability, increased solution heterogeneity 
and no additional increase in peroxidase activity.   
In order to develop the iH/D exchange protocol for use with protein/liposome 
complex samples also required the optimisation of the diethyl-ether (DEE) separation 
protocol.  This necessary organic phase separation is carried out following the H/D 
exchange quench process with TFA, so that the protein/lipid complex is dissociated, 
but also crucially that the exchange reaction is quenched.  Through gentle but thorough 
mixing, it is possible to form a lipid emulsion layer between the organic phase (top) 
and the aqueous phase (bottom) (Figure 3.12).   
 
 
 
 
Figure 3.12  Organic and aqueous phase separation following addition of Diethyl 
ether and mixing.  The lipid emulsion forms between the organic and aqueous phases, 
however, unusually the organic phase lies on top of the aqueous phase.  
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Unbound hCc exists in the aqueous phase and can be extracted through the organic and 
lipid emulsion phases using a Hamilton syringe (Figure 3.12).   
 
3.3.8  Attempts of observing iH/D exchange with hCc/CL separated samples in DMSO 
Initial attempts of observing iH/D exchange with the dissociated WT hCc/CL 
complexed samples led to a new set of technical problems.  The most significant issue 
is how to deuterate the complex, as despite the hCc/CL complex formation occurring 
rapidly, approximately a third of all residues will exchange with equal speed or 
significantly faster.  As a result, it is essential that the hCc/CL complex is formed prior 
to exposure of D2O.  Unfortunately, the protein/lipid complex is not sufficiently robust 
to survive lyophilising, as determined from ABTS peroxidase activity assays.  
Therefore, it is not possible to simply remove all H2O by lyophilisation and then 
resuspend the complex in D2O (the conventional approach with un-complexed 
samples).   
There are two main approaches which could achieve complex deuteration, the 
first is dilution in D2O followed by concentration of the complex, the second approach 
is to expose the complex to D2O through a PD10 desalting column pre-equilibrated in 
deuterated buffer (20 mM NaPi, pH 6.5).  The first iH/D exchange experiment with 
lipid complex data comprised the dilution/concentration approach, specifically, four 
samples were constructed as follows; a no H/D exchange and no lipid control (C1N), a 
no H/D exchange with lipid control, a H/D exchange no lipid control (C3X) and an 
experimental sample with H/D exchange and lipid (L4X).  The DMSO resuspension 
solution consisted of 0.25 % TFA, 98.75 % d6-DMSO and 1 % D2O.  Whilst analysis 
of the data demonstrated differences between the lipid complexed control and 
experimental samples (L2N and L4X samples, respectively), ultimately it was apparent 
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that the optimised quench TFA concentration of 0.065 % v/v and/or resuspension with 
0.25 % v/v TFA in the DMSO mixture is not correct for use with lipid complexed 
samples.  This is due to fact that iH/D exchange methodologies are system specific and 
therefore the integration with lipid solutions represents and significant departure from 
the previously refined experimental conditions.   
 
3.3.9  Efforts to develop the hCc/CL complex deuteration protocol and subsequent 
attempts of observing iH/D exchange with hCc/CL separated samples in water  
Due to the technical difficulties of observing iH/D exchange in DMSO and the 
additional complications of integrating liposomes into the methodology, the decision 
was made to again evaluate the iH/D exchange data in water.  As mentioned in section 
3.3.3, by acquiring the HSQC datasets in water allows for the full set of resonance 
assignments to be used, but also provides superior spectral quality.   
Of the two complex deuteration techniques stated in 3.3.6 (dilution 
concentration and the PD10 approaches), the latter PD10 approach proved the most 
promising technique, as this is both gentle to the complex (supported by good quality 
NMR spectra) and allows for the majority of the H2O to pass through the column, 
allowing for a conservative < 5 % H2O presence in the final D2O exchanging sample.  
It is also possible to maintain reproducibility through identical sample treatment.  The 
alternative dilution/concentration method is less successful both in terms of the 
resulting NMR spectral quality, but also the residual H2O content which is between 5-
10 % depending whether a 1:20 or 1:10 D2O dilution is used, respectively.   
In order to assess the success of the PD10 approach, dual samples were used 
reflecting the pre- and post-DEE separation in both D2O and H2O conditions.  Despite 
a prominent lipid layer forming following addition of DEE, there was no other sign of 
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complex formation, specifically no line broadening in NMR spectra prior to lipid 
separation.  These NMR spectra also showed signs of hCc auto-reduction suggesting 
that the PD10 approach required further optimisation.  
Despite conventional solution NMR spectroscopy not being amenable to study 
complexes such as hCc/CL, titrations of WT hCc with both TOCL and DOPC/TOCL 
liposomes were performed.  The purpose of this was to quantify the timeframe required 
for complex formation.  However, it was again the case that no line broadening was 
observed suggesting that what is in fact observed during a lipid titration is an ever-
diminishing fraction of free (unbound) protein.  The reduction in concentration of free 
Cc was the result of both lipid binding, but also proportional to the increase in 
protein/lipid precipitate, particularly at higher lipid concentration.  At the end of the 
titration no NMR signals were observable due to complete protein/lipid complex 
formation and high levels of precipitation.  An interesting observation from titrating 
both TOCL and DOPC/TOCL liposomes, is that the binding of lipids proceeds 
differently for the two liposomes.  Changes with TOCL liposomes occurs earlier in the 
titration, starting between 1 and 2 equivalents but also at a later point between 4 and 5 
equivalents.  Changes with DOPC/TOCL liposomes occur later in the titration, largely 
between 2 and 3 equivalents.   
Both the PD10 and dilution/concentration approaches were evaluated in terms 
of complex stability using ABTS peroxidase activity assays.  Upon dilution and 
concentration, a significant amount of the hCc/CL complex is lost, however, it is not 
the dilution which breaks the complex, but rather the subsequent concentration using 
spin concentrators.  Despite this, it is known that the hCc/CL complex precipitates in 
low ionic strength solutions, due to the formation of orderly nanospheres surrounding 
Cc in what is essentially a hydrophobic CL monolayer (Vikulina et al., 2015).  It is 
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plausible that the high centrifugal forces used in concentrators irreparably disrupt this 
arrangement in a proportion of the protein/lipid complex.   
An interesting observation with the PD10 approach, was the necessity of NaCl 
in order to elute the complex.  The low salt buffer (20 mM NaPi, pH 6.5, in D2O) used 
throughout the work reported in this Thesis failed to elute the majority of the 
protein/lipid complex with resulting fractions displaying varying degrees of peroxidase 
activity.  Despite trialling a variety of NaCl concentrations, it was only when eluting 
with molar concentrations of salt (20 mM NaPi, 1 M NaCl, pH 7, in D2O) that the 
hCc/CL complex could be reliably eluted, as confirmed by ABTS peroxidase activity 
assays.  Unfortunately, the consequence of this is a further dilution step in order that 
the samples have a suitable salt content for NMR spectroscopy (max ~ 150 mM NaCl).  
As low salt fractions contained the majority of the protein content which existed as free 
protein, the final protocol for complex deuteration was elution with a single high salt 
fraction in order to maximise the resulting protein concentration post separation at the 
spectrometer for NMR detection. 
A significant drawback to the PD10 approach for complex deuteration is two-
fold:  Firstly, the technique requires significant amounts of D2O, but secondly, the 
PD10 approach is very sensitive to high concentrations of hCc/CL complex and as a 
result, upscaling the deuteration process with higher protein concentrations is not 
feasible, as the result is a significantly higher probability of precipitate and thus loss of 
sample.  This is therefore a contributor to the high D2O cost of the technique.   
Furthermore, when using the PD10 approach it is likely that during deuteration 
there is a significant fraction of the protein population which is “free” protein, the 
precise quantity is difficult to quantify, but it is likely proportional to the loss in 
peroxidase activity.  This results in a significant technical issue, in that during the 
 138 
exchange intervals there will be two exchange profiles occurring, one for the 
protein/liposome complex and the other for the free protein.  The result of this, is that 
the exchange information for the lipid-protected dataset is corrupted to a varying extent 
by the presence of the free protein H/D exchange profile.   
Complicating matters further is the quench TFA concentration and 
corresponding pH value.  Unfortunately, the concentration of TFA required for free 
hCc (0.065 % v/v TFA) proved inappropriate for use with the hCc/CL complex.  An 
iH/D exchange experiment in which all previously optimised conditions (for PD10 and 
dilution/concentration approaches) failed to show any indication of lipid protected and 
persevered exchange information, furthermore, the overwhelming majority of residues 
showed relatively unchanged NMR signal intensities throughout the detection 
regardless of the H/D exchange duration.   
 
3.3.10  Reverse D/H exchange measured in water; a possible way forward?  
Most of the technical issues encountered revolve around an appropriate way to 
expose the hCc/CL complex to deuterium.  It is a lack of control over the deuteration 
process which has proved difficult, if not impossible to overcome.  A simple method 
which helps solve some of these issues is to proceed with the H/D exchange reaction 
in reverse, starting with fully deuterated protein and CL liposomes prepared in D2O.  
Solution volumes (in D2O) can be kept to a minimum as the concentration of hCc in 
D2O can be kept high and simple dilution in H2O is sufficient to allow for protonation.  
An additional benefit of this approach is that it is more cost effective due to the lower 
consumption of D2O.   
As per the previous experimental efforts described in sections 3.3.3 and 3.3.7, 
the decision was made to observe the following iH/D exchange datasets in water.  The 
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purpose of this was to not introduce further complications until the methodology was 
robust enough, but also due to measuring the protonation states in real time using the 
FAST-HSQC pulse sequence means that time-zero intensities can be determined.  
Furthermore, as explained in section 3.3.3, an additional benefit of measuring in 
aqueous buffer conditions is that it is possible to follow a greater number of residues, 
due to the complete NH resonance assignment set obtained for the WT hCc.  A final 
benefit of observing iH/D exchange data in aqueous buffer conditions is that it allows 
for direct comparison with the detailed cH/D exchange dataset obtained for WT hCc, 
facilitated by the fact that D/H and H/D exchange rates are comparable.   
In order to determine a more appropriate TFA quench concentration for use 
with lipid bound samples, a repeat experiment was designed as per the H2O quench 
optimisation experiments previously described in section 3.3.3.  However, the 
exchange reaction would occur in  
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reverse, starting from a fully deuterated sample, which is subsequently allowed to 
exchange in H2O.  Six samples (S1 – S6 Figure 3.13) quenched with 0.065 %, 0.075 
%, 0.085 %, 0.100 %, 0.115 % and 0.130 % v/v d-TFA respectively, were produced.  
Samples S1 (0.065 % v/v TFA) and S2 (0.075 % v/v TFA) resulted in a solution pH of 
5.04 and 5.16 respectively and showed a complete inability to arrest exchange (Figure 
3.13).  Analysis of the four remaining samples, ranging from 0.085 – 0.13 % v/v d-
 
 
Figure 3.13  Average residue peak intensities obtained from iH/D exchange 
experiments using the FAST-HSQC pulse sequence, measured in water.  Average 
“quenched” peak height intensity of entire protein (black), select residues (grey) and 
based on the cH/D exchange profile of WT hCc (Karsisiotis et al., 2016) immediately 
exchanged residues (blue), fast exchanging residues (aqua), medium exchanging 
residues (yellow), slow exchanging residues (orange) and very slow exchanging 
residues (red).  Sample TFA quench concentrations are as follows; 0.065 %, 0.075 %, 
0.085 %, 0.100 %, 0.115 % and 0.130 % v/v for samples S1 – S6 respectively.   
In
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TFA, yielding pH values < pH 3.6 revealed low exchange rates, with 0.1 % identified 
as the optimal condition (S4 Figure 3.13).  0.1 % v/v TFA was determined to be 
optimal, as it can be seen from Figure 3.13 that “overall” there is the lowest intensity 
across all residues based on the exchange rate framework (very fast, fast, medium, slow 
and very slow exchange groupings), as determined by the cH/D exchange experiment 
for WT hCc. 
 
3.3.11  “Dry” DMSO 
A final avenue of iH/D exchange exploration reported in this Chapter is the use 
of “dry” DMSO using molecular sieves (Dr Joseph Wright’s Group, University of East 
Anglia).  An experiment was designed in which iD/H exchange samples would be 
resuspended in “dry” DMSO with all sample preparation conducted under anaerobic 
conditions (anaerobic chamber and sealable NMR tubes), prior to measuring.  A 
preliminary 1D 1H NMR experiment comparing the H2O contamination within “dry” 
DMSO obtained through molecular sieves vs the d6-DMSO in sealed ampules (as used 
for the majority of experiments documented in this chapter) revealed that there was 
significantly less H2O content in the previously used d6-DMSO ampules than in the 
“dry” DMSO.   
 
3.3.12  Conclusions and summary of methodology achievements  
 Ultimately the aforementioned attempts at optimising conditions in order to 
preserve and observe iH/D exchange data for WT hCc has proved unsuccessful.  The 
issue of preserving exchange state data in DMSO has been a constant challenge 
throughout the method development.  It is possible to preserve exchange information 
for a variety of residues in water, however, in DMSO it is only possible to extract 
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exchange information for the very slow exchanging residues.  Due to the difficulties 
encountered with DMSO, qualitative data analysis has been more feasible than 
quantitative.   
Integration of liposome preparations into the iH/D exchange methodology, 
including characterisation of the hCc/CL complex, both in terms of stability and the 
necessary conditions needed for post quench separation using an organic phase has 
been achieved.  Detailed work has determined the most suitable approach for 
deuterating the protein/lipid complex and highlighted the shortcomings of the PD10 
column and dilution/concentration approaches.  Other issues such as the appropriate 
quench pH with lipids, the impact of each treatment to the stability of the hCc/CL 
complex and the optimisation of every sub-step of the process has been investigated in 
the context of all previous observations.  Finally, the re-protonation (D/H exchange) 
approach is essentially the most promising way to observe iH/D exchange of the 
hCc/CL complex, both in terms of practical feasibility but also in terms of control over 
each individual step in the technically challenging process, without compromising 
complex stability.  Summaries of the iH/D exchange methodology development and 
various exchange protocols used with the protein/lipid complex are provided in 
Appendix C.   
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Chapter 4 
Dynamics of G41S and Y48H variants of human 
cytochrome c regulate an apoptotic role  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results from this Chapter have been published in:  
Karsisiotis, A.I., Deacon, O.M., Wilson, M.T., Macdonald, C., Blumenschein, T.M.A., 
Moore, G.R., Worrall, J.A.R.  “Increased dynamics in the 40-57 W-loop of the G41S 
variant of human cytochrome c promote its pro-apoptotic conformation” (2016) Sci. 
Rep. 6, 30447.   
Deacon, O.M., Karsisiotis, A.I., Moreno-Chicano, T., Hough, M.A., Macdonald, C., 
Blumenschein, T.M.A., Wilson, M.T., Moore, G.R., Worrall, J.A.R.  “Heightened 
Dynamics of the Oxidised Y48H Variant of Human Cytochrome c Increases Its 
Peroxidatic Activity” (2017) Biochemistry 56, 6111-6124.
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4.1  Introduction  
hCc is a well-known multifunctional haem protein that functions as an electron 
carrier in the electron transfer chain between the cytochrome bc1 and CcO aa3 
complexes (Ferguson-Miller and Babcock, 1996).  More recently hCc has been shown 
to play two crucial roles in apoptosis (Ow et al., 2008, Huttemann et al., 2011); one 
function is a lipid peroxidase in the early stages of the intrinsic apoptosis pathway, as 
part of the process of creating a pore in the OMM (Kagan et al., 2005), and the second 
set of roles is as a structural component of multi-protein complexes, including: the 
apoptosome (Wang, 2001), heat shock protein 27 (Bruey et al., 2000) and inositol 
triphosphate receptors of the endoplasmic reticulum (Boehning et al., 2003).  hCc also 
plays a functional role as an inhibitor of a histone chaperone activity in the nucleus 
following DNA damage by binding to a nucleosome assembly protein (González-
Arzola et al., 2015) and as an extracellular ligand to serum leucine-rich alpha-2-
glycoprotein-1 (Cummings et al., 2006), an important interaction aiding lymphocytes 
survival from the toxicity resulting from hCc release in apoptosed cells. 
Cc has also been shown to function as a signalling molecule regulating the 
activity of the nuclear oncoprotein complex SET/template-activating factor-
Ib (SET/TAF- Ib) (Li et al., 1997, Kagan et al., 2005, Huttemann et al., 2011, 
González-Arzola et al., 2015).  Under physiological conditions hCc has a hexa-
coordinate haem iron, in which the proximal and distal axial ligands are His18 and 
Met80 respectively.  The haem is buried within the hydrophobic core of the protein, an 
environment formed by 5 a-helices and 3 W-loops.  Under native physiological 
conditions oxidised hCc possesses a low level of intrinsic peroxidase activity, which 
has been shown to facilitate the regulation of ROS (Diederix et al., 2002).  The 
peroxidase activity arises from an equilibrium in oxidised Cc between a hexa-
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coordinate haem form and a penta-coordinate form, with the latter arising from 
dissociation of the Met80 ligand (Sutin and Yandell, 1972).  Prior to mitochondrial 
degradation and subsequent release of hCc into the cytosol, hCc forms a complex with 
CL, a phospholipid localised to the IMM (Kagan et al., 2005).  The hCc/CL complex 
causes dissociation of the Met80 haem ligand yielding the peroxidase active penta-
coordinate haem form and this complex greatly boosts peroxidase activity (Vladimirov 
et al., 2013).  Under alkaline conditions, oxidised hCc has access to a conformation in 
which the Met80 ligand is replaced by a Lys (either Lys73 or Lys79) within the 71-85 
Ω-loop (Rosell et al., 1998).  This alkaline isomerisation, known as the “alkaline 
transition” occurs in Cc with an apparent pKa ~ 9 which is dependent on the ionic 
strength and temperature (Wilson and Greenwood, 1996).  Ferric hCc therefore has a 
variety of energetically accessible conformational states that confer very different 
properties than that of the native form (Karsisiotis et al., 2016).   
Autosomal dominant Thrombocytopenia 4 (THC4; OMIM 612004) is an 
inherited disease which arises from mutations in the hCc gene CYCS and results in 
enhanced mitochondrial apoptotic activity (Morison et al., 2008).  To date, there have 
been three mutations in the CYCS gene which yield the protein variants G41S, Y48H 
and A51V (Morison et al., 2008, De Rocco et al., 2014, Johnson et al., 2016).  All 
mutations reside in the 40-57 W-loop (Hunte et al., 2000, Lange and Hunte, 2002, 
Sakamoto et al., 2011, Volkov et al., 2011), which Englander and co-workers found to 
be the foldon (a cooperative folding/unfolding unit within the polypeptide) with lowest 
free energy of the five foldons identified (Krishna et al., 2003a, Krishna et al., 2006).  
In the absence of CL, the oxidised G41S variant displays greater peroxidase activity 
than that of the WT protein (Rajagopal et al., 2012, Josephs et al., 2014).  High 
resolution X-ray structures have been determined for WT and the G41S variant of hCc 
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and have shown minimal structural changes, but with perturbations near the mutation 
sites that influence the H-bonding arrangements with haem propionate-7 (HP-7) 
(Liptak et al., 2011, Rajagopal et al., 2013).  These altered interactions with the haem 
propionates, as seen in the G41S variant, may well be of significance as it is known 
that the electronic properties of haem propionates impact haem reactivity (Moore and 
Pettigrew, 1990).  The G41S variant haem environment displays greater polarity as a 
result of rotation of the Arg38 sidechain and the presence of additional H2O molecules 
which might also contribute to H2O2 access to the haem, thus directly impacting 
peroxidase activity (Josephs et al., 2014, Josephs et al., 2013).  Despite small 
conformational differences between the WT and G41S proteins, there is a substantial 
difference in global stability where the free energy of denaturation for WT being 10.5 
kcal mol-1, representing a 2.6 kcal mol-1 greater stability than that of the G41S variant 
(Rajagopal et al., 2013).   
As both the WT and G41S variant of hCc are able to access non-native 
conformations, it was postulated that the G41S variant would perturb the energy 
landscape of the ferric protein, thus changing the relative populations and kinetics of 
conversion between the native state and non-native conformer and therefore help to 
explain the pro-apoptotic behaviour of the G41S variant (Karsisiotis et al., 2016).  To 
support this hypothesis, it has been demonstrated that the 40-57 W-loop, the lowest free 
energy foldon as determined by Englander and co-workers (Hoang et al., 2003, Maity 
et al., 2004, Maity et al., 2005), along with the W-loops 71-85 and 19-35 display 
increased dynamics in the G41S variant as determined by HDX and 15N relaxation 
experiments (Karsisiotis et al., 2016). 
This chapter describes stopped-flow kinetics of azide binding to the WT 
protein, G41S and Y48H variants, peroxidase activity assays, as well as the dynamics 
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of the Y48H variant as determined through heteronuclear H/D-exchange and relaxation 
measurements.  This enables for a comparison to be made between the WT protein and 
the two pro-apoptotic variants in terms of their dynamics in the haem environment and 
their main-chain dynamics.  A direct conformational link between the 40-57 W-loop 
and the dynamical properties of the axial Met80 ligand is found and placed in the 
context of small fluctuations in the energy landscape that leads to an increased 
population of the penta-coordinate peroxidase active form.   
 
4.2  Materials and Methods 
4.2.1  Site-directed mutagenesis  
The Y48H variant was produced using the Quickchange mutagenesis protocol 
(Stratagene).  The following forward and reverse mutagenic primers were used: 5’-
GCCCCTGGATACTCTCATACAGCCGCCAATAAGAAC-3’ and 5’-GTT 
CTTATTGGCGGCTGTATGAGAGTATCCAGGGGC-3’, respectively.  A PCR 
reaction mixture consisting of primers (75 ng/µl), WT template (15 ng/µl), 10 mM 
dNTPs (Fermentas), Pfu Turbo polymerase (Stratagene), 10 x Pfu Buffer (Agilent) and 
deionised H2O to yield a final volume of 50 µl was used.  This reaction mixture was 
subjected to the following PCR protocol; 95 °C – 3 min, (95 °C – 1 min, 65 °C – 1 min, 
72 °C – 6 min) x 18 cycles, 72 °C – 10 min.  PCR products were digested with DpnI 
(Fermentas) and transformed into DH5a Escherichia coli cells.  Isolated clones were 
DNA sequenced to corroborate the presence of the expected nucleotide change. 
 
4.2.2  Over-expression and purification of the G41S and Y48H variants 
The over-expression and purification protocols for Y48H and G41S hCc 
variants were identical to that of the WT protein reported in detail in Chapter 2.   
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4.2.3  Protein preparation 
 All proteins were oxidised to the ferric haem state through addition of a 2-fold 
excess of K3[Fe(CN)6], followed by removal of K3[Fe(CN)6] and K4[Fe(CN)6] and 
exchanged into the desired buffer using a PD-10 desalting column (GE Healthcare).  
Protein concentrations were determined with a Cary 60 spectrophotometer (Agilent) 
and a molar extinction coefficient of e = 106 mM-1 cm-1 at 409 nm.  The ferrous proteins 
were formed through addition of a 2-fold excess of sodium ascorbate (Sigma).  Excess 
sodium ascorbate was removed, and the protein exchanged into the desired buffer using 
a PD-10 desalting column (GE Healthcare) and protein concertation determined using 
the absorbance at 550 nm with an e = 27.5 mM-1 cm-1. 
 
4.2.4  NMR spectroscopy  
 All NMR data were collected with a Bruker 500 MHz (H/D exchange) or 800 
MHz (1D, 15N relaxation and sequence specific resonance assignments) spectrometer, 
both equipped with 5 mm HCN inverse triple-resonance z-axis gradient probes.  
Samples for 1D 1H NMR were oxidised and buffer exchanged in 20 mM sodium 
phosphate (pH 6.5) as described previously (Chapter 2) and lyophilised.  Samples were 
redissolved in 500 µL of 99.9 % D2O (Sigma) and allowed to deuterate at room 
temperature for ~ 72 h.  4,4-Dimethyl-4-silapentane-1-sulfonic acid (DSS) (Sigma) 
(final concentration of 200 µM) and K3[Fe(CN)6] (final concentration of 100 µM, to 
maintain an oxidising environment) were added to each sample and 1D 1H spectra 
recorded at temperatures ranging from 288 K to 313 K using presaturation to supress 
the solvent signal, with spectral widths of 20 and 80 ppm.  TopSpin (Bruker BioSpin) 
was used for spectral processing.   
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 Singly (15N) and doubly (15N and 13C) labelled samples of the Y48H variant 
were prepared as previously described (Chapter 2).  NMR samples of ferric Y48H hCc 
were prepared in 20 mM sodium phosphate (pH 6.5) and contained 1 mM protein with 
10 % D2O (Sigma) for the spectrometer lock.  A set of 2D 1H-15N HSQC and 3D 
HNCACB and CBCA(CO)NH spectra were acquired at 288 K, with TopSpin (Bruker 
BioSpin) again used for spectral processing.  Sequence specific resonance assignments 
were obtained using both the CCPN Analysis and Sparky applications (Vranken et al., 
2005, Goddard, 2008, Lee, 2015).   
 H/D exchange NMR data were acquired at 288 K.  Lyophilised samples of the 
ferric Y48H variant (1 mM) were redissolved in 20 mM sodium phosphate (pH 6.5) 
and 50 mM NaCl premade in 99.9 % D2O (Sigma).  Spectra were recorded as matrices 
of 1024 x 64 complex data points with four scans and spectral widths of 15 (1H) and 
42 (15N) ppm centred at 4.7 and 118.6 ppm, respectively.  The acquisition of 
consecutive 1H-15N HSQC spectra started ~ 5 min after sample resuspension with an 
acquisition time of ~ 5 min per spectra.  A total of 191 experiments were acquired, the 
first 100 with 10 s delays between each experiment to ensure maximum resolution of 
the fast-exchanging residues, with the following 74 experiments at 45 min intervals, 
followed by 17 experiments at 4 h intervals.  H/D exchange analysis was conducted in 
the CCPN Analysis application, where peak volumes were fitted as a function of time 
to a two-parameter single exponential decay function (Vranken et al., 2005).  Protection 
Factors (PF) were determined from these extracted exchange rates following the 
protocol of Bai et al. and Hoshino et al. as described in Chapter 3 (Bai et al., 1993, 
Hoshino et al., 2007).  The prerequisite intrinsic exchange rate constants were 
determined as described in Bai et al. whilst ΔGex values were obtained from the 
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equitation ΔGex = -RTln(PF) from Hoshino et al. where R is the gas constant and T is 
the temperature in Kelvin (Bai et al., 1993, Hoshino et al., 2007). 
 15N T1, T2 and [1H]-15N NOE data were acquired at 800 MHz as matrices of 
1024 x 256 complex data points, with 8 scans for T1 and T2 data, and 64 scans for [1H]-
15N NOE experiments.  Spectral widths of 15 (1H) and 39.3 (15N) ppm centred at 4.7 
and 118.6 ppm respectively were used.  T1 experiments were acquired with the 
following relaxation delays, 10, 50, 80, 200, 500, 750, 2000 and 3500 ms with 
duplicates of 10, 200 and 500 ms.  T2 experiments were acquired with the following 
relaxation delays, 16.96, 33.92, 50.88, 67.84, 101.76, 135.68, 203.52 and 254.4 ms, 
with duplicates at 16.96, 50.88 and 101.76 ms.  Both experiments used a 5 ms recycle 
delay.  The repeated relaxation delays were used to settle peak height uncertainties as 
documented in (Palmer et al., 1991), whilst the first T1 delay of 20 ms was set due to 
limitations in the pulse sequence (Karsisiotis et al., 2016).  To reduce sample heating, 
T1 and T2 experiments were acquired with interleaved delay values.  To determine T1 
and T2 values, peak heights were fitted as a function of the relaxation delay to a two-
parameter single exponential decay function using the “follow intensity changes” 
function within CCPN Analysis (Karsisiotis et al., 2016).  T1 and T2 rates were 
converted to the relaxation rates R1 and R2 with R1 = 1/T1 and R2 = 1/T2 (Karsisiotis et 
al., 2016).  Fit errors for T1 and T2 were converted to their corresponding R1 and R2 
errors through the equality of the T1/T2 and R1/R2 errors (Karsisiotis et al., 2016).  The 
heteronuclear [1H]-15N NOE experiments were acquired with a 1H saturation duration 
of 5 s, interleaved saturated and unsaturated experiments were acquired in triplicate so 
that experimental error could be determined as the standard deviation from the average 
NOE value (Karsisiotis et al., 2016).  The NOE values were determined by taking the 
ratio of peak height with and without 1H saturation. 
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4.2.5  Stopped-flow spectroscopy 
All kinetic experiments were conducted with an Applied Photophysics 
(Leatherhead UK) SX20 stopped-flow spectrophotometer equipped with both 
photomultiplier and photodiode array detection systems, thermostatted at 25 °C.  
Various stocks of buffer consisting of 2 M sodium azide (N3-), 50 mM sodium 
phosphate and 50 mM MES, pH 7, were diluted to desired N3- concentrations with 
identical buffer except with 2 M N3- substituted for 2 M NaCl to maintain equal ionic 
strength (Karsisiotis et al., 2016).  Reaction time-courses are recorded at 420 nm with 
known N3- concentration, ranging from 0.08 – 2 M prior to mixing, and 10 µM protein 
also prior to mixing.  Traces were fitted to a single exponential function giving pseudo 
first-order rate constants and amplitudes, with all reported errors being standard errors 
(Karsisiotis et al., 2016). 
 
4.2.6  Peroxidase assays 
Phospholipid liposomes consisting of a 1:1 ratio of TOCL (1, 1’, 2, 2’-
tetraoleoyl CL) and DOPC (1, 2-dioleoyl-sn-glycero-3-phosphocholine) (Avanti Polar 
Lipids) were used.  Lipids stored in chloroform were aspirated in an atmosphere of 
argon (BOC) to prevent oxidation.  During aspiration, the lipid solution is kept in 
continual motion to produce a uniformly thin and dry film at the base of the glassware 
prior to sealing with Parafilm.  The lipids were re-suspended in 20 mM sodium 
phosphate, pH 6.5 by vortexing for ~ 10 min yielding a 2.5 mM stock.  Once a 
homogenous, cloudy solution is achieved, liposomes were made of uniform size by 
sonication in a high-power sonicating water bath at 4 ̊C for ~ 15 min, or until a clear 
solution was achieved.  All peroxidase assays were carried out on a Hewlett-Packard 
8453 photodiode-array spectrophotometer scanning from 190 – 730 nm, thermostatted 
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at 20 °C.  Assay conditions consisted of 5 µM protein, 200 µM 2,2-Azinobis(3-
ethylbenthiazoline-6-sulfonic acid) (ABTS), 1 mM H2O2 (Sigma) with and without 25 
µM TOCL-DOPC liposomes.  Assay volumes were set at 3 ml with a 1 cm path length, 
as this volume facilitated mixing with H2O2 during the initial phase of the assay.  To 
maintain a consistent start-point for the assays, H2O2 was added at ~ 40 s after scanning 
commenced and then proceed to run for 1000 s.  The absorbance changes were 
monitored at 730 nm, with a single reference wavelength of 475 nm.  The maximum 
rate of absorbance change was taken from the initial slope after the addition of H2O2, 
which in the absence of lipid for WT hCc occurred after a short initial lag phase.  The 
slope of each trace was determined from the first linear portion of the traces post-lag 
phase, thus providing rates in AU/s.  To convert rates from AU/s to µM/s, the rates are 
divided by the extinction coefficient of oxidised ABTS at 730 nm (14 mM-1 cm-1).  
Assays were repeated in triplicates, so the average of the three rates obtained for each 
protein under both conditions are plotted with the error reported as standard deviation.   
 
4.2.7  Circular Dichroism spectroscopy 
Circular Dichroism (CD) spectra were recorded from 190 – 250 nm with an 
Applied Photophysics Chirascan CD spectrophotometer (Leatherhead, UK), 
thermostatted at 15 ̊C.  Sample conditions consisted of 20 µM protein, 10 mM 
potassium phosphate pH 7, 50 mM KF in a final volume of 200 µl in a 0.1 cm path 
length cuvette.  The raw data was converted from millidegrees to Mean Residue 
Ellipticity (MRE) using equation 4.1, where θ is the circular dichroism, 0.1 refers to 
the cuvette path length in cm, 20 x10-6 is the protein concentration (M) and 104 is the 
number of residues in hCc.  
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MRE = (θ / 10 x 0.1 x (20 x 10-6) x 104)                [4.1] 
 
Chemical denaturation studies were carried out using Guanidinium 
hydrochloride (GuHCl; Fluka) using CD spectroscopy at 15 °C through monitoring the 
change in ellipticity at 222 nm.  The proteins were equilibrated in 20 mM sodium 
phosphate, 50 mM NaCl pH 6.5 to a starting working volume of 1 ml and 20 µM 
protein.  A 3 ml cuvette with 1 cm path length was used for the titration, in which 
various additions of a stock 6 M GuHCl solution in 20 mM NaPi, 50 mM NaCl pH 6.5 
were added to the cuvette so that each point in the titration reflected a 0.1 M increase 
in GuHCl.  Measurements in triplicates of each protein were carried out and raw data 
in millidegrees converted to Fraction Denatured (FD) using equation 4.2, where αN and 
βN represent the respective values for the lowest and highest values of the slope in the 
folded state during the titration and the αD and βD represent the highest and lowest 
values of the slope in the unfolded state during the titration and R is the gas constant 
(J/mol).  DG, Cm and “m” values are ultimately determined from fits to equation 4.3, 
following an initial fit to the raw data using equation 4.2.   
 
 
         [4.3] 
      [4.2] 
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4.2.8  Static pKa titrations 
All static pKa titrations have been carried out at room temperature up to three 
times and in different batches for each respective protein.  Buffer conditions consisted 
of 20 mM sodium phosphate, pH 6 and 100 µM protein concentration in a quartz 
cuvette (Hellma).  Additions of 0.3 µl – 1 µl of 1 M NaOH were used to gradually 
increase pH to a final concentration of ~ pH 11, with pH measurements taken using a 
semi-micro glass pH electrode (Corning) in the cuvette prior to scanning.  The 
absorbance changes were monitored at the 695 nm band and data plotted after baseline 
subtracting the absorbance at 800 nm to account for any baseline shifts that occurred 
during the titrations.  The data is fitted to a one-proton ionisation equilibrium equation, 
y = P1+((P2*(10^(x-P3)))/(1+10^(x-P3)))), yielding the apparent pKa of the 695 nm 
band.   
 
4.2.9  Y48H crystallisation and structure determination 
Crystals were grown using the sitting-drop vapour diffusion method at 18 °C.  
A 0.2 µl solution containing 56 mg/ml of the ferric Y48H hCc variant in 20 mM sodium 
phosphate pH 6.5 was used to screen for crystallisation conditions using an ARI 
Gryphon crystallisation robot (Art Robbins Instruments).  A successful crystal hit was 
found in conditions of 33 % PEG 6000, 100 mM Tris/HCl pH 7.5.  Single crystals were 
transferred to a cryoprotectant solution containing the reservoir solution and 15 % 
glycerol, prior to flash cooling in liquid nitrogen.  Crystallographic data were measured 
at the Swiss Light Source (SLS, Villigen, Switzerland) at beamline X10SA with a 
wavelength of 1 Å using a Pilatus 6M-F detector (Dectris).  The collected data were 
indexed, integrated and merged using XDS (Kabsch, 2010) and Aimless (Evans and 
Murshudov, 2013) in the CCP4 suite with the CCP4i2 graphical user interface.  The 
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Y48H structure was solved by molecular replacement within Phaser using the structure 
of WT hCc (3zcf) as a template, as previously reported (Kabsch, 2010, Evans, 2006, 
Rajagopal et al., 2013).  Structural refinement and model building cycles were 
conducted in Refmac5 and Coot, respectively.  Riding hydrogen atoms were added 
after the protein refinement had converged with final structure validation through the 
MolProbity server (Murshudov et al., 1997, Emsley and Cowtan, 2004, Davis et al., 
2007). 
 
4.3  Results  
4.3.1  UV-Visible and far UV CD spectroscopy 
 The optical absorbance of the WT protein and Y48H variant of hCc in the 
oxidised and reduced forms are indistinguishable and shown in Figure 4.1.  The far-
UV CD spectra of the WT protein G41S and Y48H variants display two negative 
 
 
Figure 4.1  UV visible spectra of the WT protein and Y48H variant of hCc in both 
the ferric and ferrous forms at pH 6.5 (20 mM NaPi) and at room temperature.   
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minima at 208 and 222 nm indicating significant a-helical content and is a good 
indication that all proteins are folded (Figure 4.2).  Furthermore, both variants appear 
to have a higher helicity than the WT protein.   
 
Determination of the DGunf 
 Far-UV CD spectroscopy was used to assess the stability of the WT protein and 
the G41S and Y48H variants by means of chemical denaturation through addition of 
increasing concentrations of GuHCl.  It is known that chemical denaturation is superior 
to thermal melts in the context of determining Cc thermodynamic stability parameters, 
as it has been extensively reported in literature that for Cytochromes c thermally 
induced denaturation of the protein is not an entirely reversible process, therefore 
opposing the assumptions made by the model used to determine said thermodynamic 
stability parameters.  Figure 4.3 displays typical denaturation profiles for the three 
proteins with fits to equation 4.3 yielding the thermodynamic unfolding parameters 
 
 
Figure 4.2  Far-UV CD spectra of ferric WT, G41S and Y48H hCc at pH 7.0 and 
15 ̊C.   
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reported in Table 4.1.  The data show that there is a progressive decrease in the 
cooperativity of unfolding (WT > G41S > Y48H), with the Y48H variant having the 
lowest global stability (DGunf, Table 4.1).  The m-value (Table 4.1) quantifies a measure 
of the change in hydrophobic surface area that has become desolvated upon 
denaturation, also decreases in the order of WT > G41S > Y48H, suggesting that the 
disease variants of hCc have an increasingly more compact denatured state relative to 
the WT protein (Shortle, 1995).  The K54H variant of S. cerevisiae iso-1 Cc stabilises 
the denatured state through a His-haem loop which results in a decreased m-value in 
relation to the WT protein (Hammack et al., 2001).  Two possible interpretations of 
this in relation to the Y48H variant, are either that a similar effect occurs, or, that the 
Y48H variant is simply partially unfolded in solution (Godbole et al., 1997, Hammack 
et al., 2001).  The latter is perhaps more likely, as it is supported by the NMR data 
presented in Figure 4.13. 
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Table 4.1  Summary of the thermodynamic and kinetic parameters for the Y48H 
variant, in comparison with that of the G41S variant and WT proteins.   
                      GuHCl denaturation               Azide binding 
Protein DGunf  
(kcal mol-1) 
Cm (M) m  
(kcal mol-1 Mol-1) 
pK695 Kapp 
(M) 
k1 (s-1) k-2 (s-1) 
WT 10.65 ± 0.55 2.6 ± 0.05 4.10 ± 0.25 9.3 ± 
0.2 
0.31 
± 
0.03 
5.77 ± 
1.5 
3.5 ± 
0.44 
G41S 6.75 ± 0.10 2.25 ± 
0.05 
3.00 ± 0.10 8.5 ± 
0.2 
0.11 
± 
0.01 
45 ± 18 8.9 ± 0.3 
Y48H 5.09 ± 0.16 1.98 ± 
0.05 
2.57 ± 0.10 8.4 ± 
0.1 
0.07 
± 
0.01 
> 125 12.1 ± 
1.1 
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4.3.2  The pH dependence of the 695 nm absorption band 
The UV-visible spectrum of ferric hCc is pH dependent.  Below the pKa of the 
optical transition hCc primarily populates the hexa-coordinate “acid” form of the 
protein, in which the proximal and distal field haem ligands are His18 and Met80 
respectively.  During a pH titration, in which the pH of the protein solution is gradually 
increased, spectral changes occur as a result of haem ligation changes, namely Met80 
is replaced by a Lys (Lys73 or Ly79) resulting in a low-spin hexa-coordinate haem 
species, lacking the 695 nm band (Figure 4.4).  This phenomenon is known as the 
“alkaline transition” of Cc, and the point at which the protein occupies an equal 
distribution of both acid and alkaline forms is the pKa of the 695 nm band.   
 
 
 
 
Figure 4.3  Equilibrium unfolding by GdnHCl of the WT protein, and the G41S 
and Y48H variants of hCc at pH 7 and 15 ̊C.   
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It is generally regarded that the pK695 is composed of two components, a de-protonation 
event in a “trigger” group and a conformational change resulting in the bleached 695 
nm band.  In the case of hCc, when going from acidic to more alkaline pH, it is the de-
protonation of the trigger group which precedes the conformational change, in which 
the haem goes from His18 and Met80 coordination to His18 and Lys (either Lys73 or 
Lys79) coordination.  Scheme 4.2 depicts this, whereby Ka is the equilibrium constant 
of the acid, protonated Met80 conformer (CH), this conformation possesses the 695 nm 
band (+ 695).  An equilibrium then exists between the de-protonated (H+), acid form 
of the protein with Met80 bound (C) and the 695 nm band still present.  Following this 
de-protonation event, there is an equilibrium which forms from a conformational 
change in the protein whereby the Met80 ligand is replaced with a Lys (either Lys73 
or Lys79), this haem conformation does not produce the 695 nm band (- 695). 
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The alkaline transition therefore reports on the lability of the Met80-Fe(III) bond, as a 
Cc variant with a more labile haem ligand will exhibit a lower pKa.  Both G41S and 
Y48H variants have pK695 values more than one pH unit lower than that of WT hCc 
(Table 4.1), suggesting that both protein variants possess a more labile Fe(III)-
S(Met80) bond.   
 
 
 
Figure 4.4  The pH dependence of the 695 nm band for WT, G41S and Y48H hCc 
fitted to a one-proton equilibrium equation.  The pKa695 values are reported in Table 
4.1.   
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4.3.3  X-ray crystal structure of the Y48H human cytochrome c variant 
The X-ray crystal structure of the Y48H variant of hCc was resolved to 1.36 Å 
(Figure 4.5), with the asymmetric crystallographic unit composed of two protein 
molecules in the P21 space group, contrasting the reported X-ray structures of the WT 
protein (Rajagopal et al., 2013) and G41S variant (Liptak et al., 2011), both of which 
had four hCc molecules in the P1 space group.   
 
 
Despite crystallization solutions containing ferric Y48H, it is likely that the X-ray beam 
intensity from the synchrotron would have reduced the protein into the ferrous state 
 
 
Figure 4.5  X-ray crystal structure of the Y48H variant of hCc.  A)  Ribbon 
representations of a Ca superposition of the Y48H variant (green; pdb 5O10) with the 
G41S variant (red; pdb 3nwv) and WT protein (blue; pdb 3zcf).  The haem groups are 
shown in sticks.  B)  A cartoon and stick representation of the region between residues 
37 and 49 of the WT protein (blue), the Y48H (green) and G41S (red) variants.  The 
coordinate bonds (black dashes) of the axial His18 and Met80 ligands to the haem iron 
in the Y48H variant are indicated and H-bonding is represented as red dashes.  The 
side chain position of His48, Asn52 and Tyr67 in the Y48H variant are shown together 
with the side chain position of Arg38 in all three structures.  Water molecules are 
shown in red spheres for the WT and Y48H structures and in grey for the G41S variant.  
Figure taken from (Deacon et al., 2017).   
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during data acquisition, as the 2.54 MGy diffraction-weighted dose (Zeldin et al., 2013) 
incurred during data acquisition greatly exceeds that required to fully reduce ferric 
haem proteins to the ferrous form (typically tens to hundreds of kGy) (Beitlich et al., 
2007, Kekilli et al., 2017).  Thus, in light of the extensive previous studies measuring 
the typical radiation doses required for ferric to ferrous haem protein reduction, one 
may conclude that the Y48H structure is predominantly that of the ferrous state.  
Despite this, the crystal structure is likely to reflect that of the ferric protein, with 
electron density around the haem diagnostic of a hexa-coordinate ligand coordination 
between the Ne2 atom of His18 and the Sd atom of Met80.  To this effect, it is important 
to note that in the case of tuna Cc (Takano and Dickerson, 1981) and Saccharomyces 
cerevisiae iso-1 Cc (Brayer and Murphy, 1996) with significantly lower X-ray doses 
than used for the Y48H dataset, showed that the protein conformation is largely 
independent of the haem oxidation state.  Each molecule of Y48H displays the same 
overall fold within the asymmetric unit to that of both the WT and G41S variant of 
hCc, with Ca positions varying by a RMS deviation of 0.18 Å between the three 
respective proteins (Table 4.2, Figure 4.5A).  It is noted that between residues 37 and 
61, the Ca deviation increases to 0.27 Å.  The apparent effects on protein structure by 
replacing Tyr48 with a His residue in the Y48H variant appears to alter the H-bonding 
arrangement with the haem propionates (Figure 4.5).  There are differences and 
similarities in this respect between all three proteins, in the case of the WT protein, the 
sidechain OH group of Tyr48 is involved in a H-bond of 2.57 Å to the O1A atom of 
Haem Propionate-7 (HP-7) (Rajagopal et al., 2013).  In contrast, this polar interaction 
is not present in the Y48H variant, which instead displays the Nd1 atom from the His48 
sidechain favourably oriented to from a medium length polar interaction with the O2D 
atom of Haem Propionate-6 (HP-6) (3.19 Å) (Figure 4.5B).  The OD2 atom of HP-6 is 
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therefore involved in a greater number (two rather than one, as in the WT protein) of 
H-bonds, with the second H-bond involving the backbone NH of Thr49.  A second 
polar interaction of medium length (3.19 Å) is noted between the Nd1 atom of His48 
and the OD1 atom of Asn52.  This interaction confers communication between His48 
and the distal Met80 ligand through a H-bond (involving an H2O molecule) network 
extending from Asn52 to Tyr67 (Figure 4.5B).  An interesting similarity between the 
Y48H variant and WT protein is that the sidechain of Arg38 is orientated in the same 
position to that of the WT protein, where the e-amido group is coupled to HP-7 via a 
single H2O molecule (Figure 4.5B).  In contrast, the G41S variant Arg38 sidechain is 
positioned away from HP-7 enabling the presence of an additional two H2O molecules 
(Figure 4.1B).  The result of this positioning in G41S, is that the e-amido group of 
Arg38 remains coupled to HP-7 via a “forked” H-bond network (Figure 4.1B).  The X-
ray crystal structures of WT, G41S and Y48H hCc show no other discernible 
differences and thus display remarkable overall similarity (Figure 4.5).   
 
Table 4.2  Crystallographic data processing and refinement statistics for the Y48H 
variant of hCc.  Values in parenthesis refer to the outermost resolution shell 1.36 – 1.39 
Å.   
Parameter Y48H hCc 
Space group P21 
Unit cell a = 56.9, b = 36.5, c = 60.7 Å, b = 
116.7o 
Resolution (Å) 1.36 
Rmerge 0.072 (1.115) 
Unique reflections 45812 (2124) 
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Mn (I/SD) 13.3 (1.4) 
CC1/2 0.998 (0.512) 
Completeness (%) 95.3 (90.2) 
Redundancy 6.2 (5.4) 
Rcryst 0.144 
Rfree 0.175 
RMS dev. bond lengths (Å) 0.015 
RMS dev. bond angles (o) 2.18 
Ramachandran favoured (%) 97.0 
Accumulated dose (MGy) 2.54 
PDB accession code 5O10 
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4.3.4  N3- binding kinetics  
Exogenous ligand binding to ferric hCc, monitored by stopped-flow 
spectroscopy, was used to further probe the Fe(III)-S(Met80) bond lability.  Upon 
mixing N3- with ferric hCc an optical transition is observed, characterised as the 
dissociation of Met80 from the haem and subsequent association of N3- in its place.   
 
 
Support for this characterisation comes from additional experiments at higher protein 
concentration, which allowed for the 695 nm band to be assessed (Figure 4.6).  For 
WT, G41S and Y48H hCc, interaction with N3- results in a quenching of the 695 nm 
band, diagnostic for the loss of Met80 haem coordination.  The reaction time-course of 
this transition conformed to a simple exponential at all wavelengths, with no detectable 
intermediates observed (Karsisiotis et al., 2016, Deacon et al., 2017).  Normalised 
 
 
Figure 4.6  N3- binding to ferric G41S hCc variant at 25 °C, pH 7.0.  425 µM protein 
and 0.5 M N3- (both after mixing) were mixed and the difference spectra recorded 
from 565 – 895 nm.  The bleaching of the 695 nm band is observed and the inset 
depicts the time courses and their respective fits to a single exponential at 697 nm 
(descending) and 595 nm (ascending).  Adapted from (Karsisiotis et al., 2016).   
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amplitudes of the corresponding reaction time courses, observed over a wide range of 
N3- concentrations, fit consistently to a simple hyperbolic function yielding the 
apparent equilibrium dissociation constants (Kapp) reported in Table 4.1 (Figure 4.7A).  
The observed rate constant (kobs) for N3- binding in all three proteins was determined 
from the measurable range of N3- concentration, which appear almost linear (Figure 
4.7B).   
 
 
Due to the pK695 for the WT protein being approximately a pH unit higher than 
that of the G41S and Y48H variants (Table 4.1), N3- binding experiments were also 
conducted using stopped-flow spectroscopy at higher pH values for WT and G41S hCc 
 
 
Figure 4.7  Stopped-flow kinetics of N3- binding to ferric hCc at 25 °C, pH 7.0.  A)  
Normalised amplitudes of the time courses recorded at 420 nm plotted as a function 
of N3- concentration.  The subsequent binding curves are fitted to a hyperbolic 
equation (equation 4.4) yielding the Kapp values reported in Table 4.1.  B)  The rate 
constant (kobs) determined for N3- binding fitted to equation 4.5 yielding k1 and k2 
values reported in both the main text and Table 4.1 where k1 and k2 refer to the Met80 
and N3- dissociation rate constants, respectively.   
A B
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(Figure 4.8), in which the fraction of the alkaline conformer is/are increased thus 
allowing one to determine whether or not the presence of any fraction of the alkaline 
conformer would have on N3- binding.  The optical transitions observed upon mixing 
ferric hCc with N3- revealed that the alkaline form(s) react far more slowly than that of 
the native, acid form.  Furthermore, pH-jump experiments revealed that the rate 
constant for binding to the alkaline form was very close in value to that of the 
conversion rate between the Lys-bound ferric hCc to the native Met80-bound form.  
For example, Figure 4.8 displays the optical transition observed when ferric G41S (pH 
9) binds to 1 M N3-.  The optical transition was characterised by a small fast phase 
followed by a large slow phase, with rate constants of 19 s-1 and 0.086 s-1 respectively.  
The amplitudes of these phases revealed that their respective proportions conformed to  
 
 
 
Figure 4.8  N3- binding to the ferric WT protein and the G41S variant at pH 9.0, 25 
°C.  hCc at a concentration of 5 µM after mixing was mixed with 1 M N3- (after mixing) 
and the time courses recorded at 416 nm.  The inset shows an expanded view of the 
initial two seconds of the time courses. Adapted from (Karsisiotis et al., 2016) SI.   
 169 
expectations for binding to the neutral and alkaline forms respectively.  The rate 
constant for the fast phase displayed N3- dependence, whereas the slow phase rate 
constant did not.  A consistent pattern of results was obtained from the WT ferric 
protein, in which the rate constants were 6.1 s-1 and 0.085 s-1 respectively.  
 The interconversion rate of conformers within the G41S variant were 
investigated further through a pH jump experiment, in which the pH of a solution was 
rapidly changed from ~ pH 7 to pH 9.  The optical transition observed (Figure 4.9) was 
consistent with that of a Met80 to Lys haem ligation change.  This transition comprised 
a single exponential with rate constant of 0.167 s-1, and therefore close to that of the 
 
 
Figure 4.9  Stopped flow analysis of a pH jump experiment from pH 7 to pH 9 with 
ferric WT hCyt c at 25 °C.  The displayed spectra are generated from global analysis 
of the full data set and depict the initial spectrum at pH 7 (black) and the final spectrum 
at pH 9 (blue).  Inset (upper) illustrates a time course at 416 nm, fitted to a single 
exponential.  Inset (lower) shows the bleaching of the 695 nm band at pH 9 through 
an expanded spectrum.  The ferric WT hCyt c (10 µM) was prepared in 2 mM sodium 
phosphate, pH 7 and mixed with equal volume 20 mM borate, 100 mM NaCl yielding 
a final solution pH of pH 9.   
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value obtained from N3- binding to the alkaline form of 0.085 s-1.  The reason for the 
slight discrepancy in rate is due to a small term involving the back reaction at this pH 
(Davis et al., 1974), as the rates of the reactions involving the alkaline conformers are 
so slow, and due to their N3- concentration independence, one may conclude that these 
are not significant in the binding of N3- at pH 7 as reported in Table 4.1.  These higher 
pH experiments revealed that the variation in pK695 values between the three proteins 
is insignificant in the context of N3- binding at pH 7.0.   
Exogenous ligand binding to ferric Cc is widely regarded to occur via an SN1 
mechanism (Figure 4.10), in which the hexa-coordinate haem exists in equilibrium with 
a penta-coordinate form characterised by a lack of Met80 coordination.  The hexa-
coordinate form is the most populated with the equilibrium lying strongly in its favor.  
N3- binds to the penta-coordinate form yielding a characteristic low-spin, hexa-
coordinate N3- adduct.  This SN1 reaction is amenable to kinetic analysis, however, the 
process is greatly simplified with the following assumptions, firstly, that the minor 
population of penta-coordinate species is in steady-state throughout the reaction 
(Rafferty et al., 1996) and, secondly, that the reaction can be considered pseudo-first 
order due to the large excess of N3- in relation to hCc (Rafferty et al., 1996).   
 
Figure 4.10  Schematic representation of the SN1 reaction of hCc binding N3-.  k1 and 
k-1 are the Met80 dissociation and association rate constants respectively, whilst k2 and 
k-2 are the N3- association and dissociation rate constants, respectively. Adapted from 
(Karsisiotis et al., 2016).   
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As a result of these simplifying kinetic assumptions, it is possible to derive 
equations 4.4 and 4.5 which describe both Kapp and kobs respectively, as a function of 
N3-.  K = k1/k-1, with k1 and k-1 being the respective rate constants for Met80 dissociation 
and association, respectively.  KD = k-2/k2, where k2 is the pseudo-first order rate 
constant for N3- binding (i.e. k2 = k’[N3-], where k’ is the second-order rate constant and 
kobs is ~ k1 at high N3- concentration.  It is possible to predict from equation 4.5 that 
plots of kobs vs [N3-] (Figure 4.7B) follow hyperbola that intercept the kobs axis at the 
value of k-2 (N3- dissociation rate constant) and plateau at k1, the Met80 dissociation 
rate constant.  Fits of the normalised amplitude data are satisfactory and yield the values 
of Kapp reported in Table 4.1.   
When kobs data are plotted as a function of N3-, a hyperbolic trend is followed 
that intercepts the kobs axis at k-2 (the N3- dissociation rate constant) and plateau at k1 
(the Met80 dissociation rate constant).  When data displayed in Figure 4.7B is fitted to 
equation 4.5, the following k-2 values reported in Table 4.1 are determined.  
Unfortunately, due to experimental limitations of N3- concentration, the predicted 
hyperbola are not discerned for the Y48H variant, thus resulting in a somewhat 
unreliable Met80 dissociation constant (k1).  However, it is entirely possible to predict 
a minimal value of k1 (125 s-1), reported without error in Table 4.1, that is both 
consistent with equation 4.5 and produces, subjectively, good quality fits to the data.  
Despite this limitation, it is apparent that the Y48H variant has a Met80 off-rate (k1) 
".// = 	"1(3453 )   (4.4) 
 789: = (;<=;>?)[AB>]DE<FE><EG H4[AB>] + 7=I  (4.5) 
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significantly higher than that of the WT protein and G41S variant.  Furthermore, 
equation 4.4 shows that Kapp is ~ KD/K when K < 1, as is the case under these 
experimental conditions due to the concentration of the penta-coordinate species being 
low, in which Kapp ~ KD/K.  From the assumption that distant mutations in the protein 
do not directly influence the binding of N3- to penta-coordinate haem, then KD will be 
similar for WT, G41S and Y48H, with ratio of Kapp (WTKapp/G41S or Y48HKapp) reflecting 
the ratio of K values (G41S or Y48HK/WTK).  On this basis, as can been seen in Table 4.1, 
Y48HK > G41SK > WTK, one may conclude that the penta-coordinate form is more 
populated in the Y48H variant than in both the WT protein and G41S variant.   
The k1 values determined for WT hCc are comparable to that of eCc (11-16 s-1) 
derived from non-linear curve fitting to data using N3- as a competitor ligand (Sutin 
and Yandell, 1972).  Bowler and colleagues suggest that due to the sequence difference 
between eCc and hCc at residue 83, there are effects on dynamics due to sequence 
variation within the 71-85 Ω-loop (McClelland et al., 2014).  Despite G41S and Y48H 
mutations occurring within the 40-57 Ω-loop, due to the substantially higher k1 rates 
observed in both proteins, one may conclude that there is a larger proportion of penta-
coordinate haem in both the G41S and Y48H variants than that of the WT protein, 
suggesting that these variants possess a more flexible and labile haem crevice.   
 
4.3.5  Peroxidase Assays 
Peroxidase activity of WT, G41S and Y48H hCc was directly measured by 
monitoring ABTS oxidation in the presence of H2O2.  Preliminary tests with various 
excess of lipid to protein (2.5-fold to 10-fold) showed no additional gain in peroxidase 
activity beyond a five-fold excess and afforded good solution stability, thus all assays 
recorded with lipid were at a five-fold excess.  Figure 4.11A shows the average of three 
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traces for each respective protein under the experimental conditions employed.  From 
the reaction time-courses of the WT protein, there is a gradual increase in basal 
peroxidase activity throughout the experimental time course following an initial lag 
phase (~ 160 s).  However, when complexed with CL liposomes, there is not only a 
substantial increase in the rate of peroxidase activity, but also, the initial lag phase is 
abolished (Figure 4.11A).  In contrast, both the G41S and Y48H variants do not exhibit 
this initial lag phase, instead, peroxidase activity commences immediately after 
addition of H2O2 (Figure 4.11A).  The G41S and Y48H variants also exhibit greater 
peroxidase activity than that of the WT protein, both in the absence and presence of 
lipid, however, to a lesser extent in the G41S variant than that of the Y48H variant 
(Figure 4.11B).  The progressive increase in peroxidase activity correlates with an 
increase in the level of cooperative global unfolding (Figure 4.3).  No change in 
peroxidase activity is observed for the Y48H variant in the presence of CL liposomes, 
in contrast to both the WT protein and G41S variant (Figure 4.11B).  The secondary 
increase displayed in the WT and G41S proteins when in the presence of CL, suggests 
that the hCc/CL complex pushes the equilibrium between hexa- and penta-coordinate 
haem state towards the latter.  This finding further conforms to the interpretation from 
the N3- binding kinetics, that in the case of the Y48H variant, the penta-coordinate form 
of the oxidised protein is energetically more favourable than it is in the G41S variant 
and WT protein (Deacon et al., 2017).  That being said, an alternative interpretation 
that is still theoretically possible, is that it is not the penta-coordinate form which is 
more energetically favourable, but instead the hexa-coordinate form is less favourable 
in the disease variants than in the WT protein.   
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4.3.6  1D 1H NMR spectroscopy of WT human cytochrome c and the disease variants 
G41S and Y48H  
The 1D 1H NMR spectrum of ferric Cc displays numerous peaks that can be 
either upfield or downfield shifted.  This is due to the nuclei experiencing a hyperfine 
interaction from the unpaired electron on the haem iron (Wüthrich, 1969).  These 
signals arise from paramagnetism and can yield insights into both the electronic 
structure of the haem group and provide valuable information into haem-ligand 
dynamics and non-native haem ligation states (Ubbink et al., 2002).  Figure 4.12A 
displays the 1D 1H NMR spectrum of WT hCc with several resonances of known 
assignment labelled (Santos and Turner, 1987, Feng et al., 1990).  In the case of the 
WT and G41S proteins, the traditional pattern of haem-methyl signals 8 > 3 > 5 > 1 is 
followed and thus consistent with expectations (Senn and Wuthrich, 1985).  The 
 
 
Figure 4.11  A)  Absorbance changes monitored at 730 nm on a photodiode-array 
spectrophotometer, thermostatted at 20 ̊C of WT, G41S and Y48H hCyt c both in 
the absence and presence of CL liposomes.  The absorbance changes refelect the 
oxidation of ABTS in the presence of H2O2.  B)  Histogram of the average turnover 
rates for each of the above-mentioned proteins with standard errors reflecting the 
experimental error.  Figure taken from (Deacon et al., 2017).   
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hyperfine chemical shift for both the 8- and 3-methyl groups, and the upfield hyperfine 
resonances of the protons from the axial His18 and Met80 field ligands of the WT 
protein and G41S variant follow a Currie-type dependence upon increasing 
temperature (from 283 to 313 K) (Figure 4.12B and C), whereas the 5-methyl group 
displays an anti-Curie temperature dependence.  In contrast to both WT and G41S hCc, 
the Y48H variant displays significant spectral changes in both upfield and downfield 
shifted regions (Figure 4.12B and C), for example, at 283 K the hyperfine peak found 
at ~ 36 ppm is split (Figure 4.12B).  The 3-methyl peak displays excess line broadening 
in comparison to other haem methyl groups in both the WT protein and G41S variant 
consistent with expectations from other mitochondrial ferric Cc, such as eCc (Burns 
and La Mar, 1979, Burns and La Mar, 1981).  It is reported that a splitting of the 3-
methyl peak into two components is observed at low temperatures (266 to 278 K), this 
activity is consistent with exchange induced line broadening from the very fast 
interconversion between heterogeneous protein environments surrounding the 3-
methyl group (Burns and La Mar, 1981, Burns and La Mar, 1979).  
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Figure 4.12  A)  1D 1H NMR spectra of WT hCc with almost all backbone NH groups 
deuterated and haem-methyl resonances of known assignment labelled.  B)  The 
downfield region of WT, G41S and Y48H hCyt c at a temperature range of 283 to 313 
K.  C)  The upfield region of WT, G41S and Y48H hCyt c.  Figure taken from (Deacon 
et al., 2017).   
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As a result of this behaviour in the 3-methyl of other ferric Cc, the split peak observed 
at ~ 36 ppm in the Y48H variant is therefore consistent with the 3-methyl group (Figure 
4.12B).  As the temperature is raised, the interconversion rate between these two 
species is increased to a rate beyond that of the experimental pulse sequence and thus 
the two individual components are dynamically averaged yielding a single broadened 
peak (Figure 4.12B).  It is therefore clear that the factors at play which result in 
conformational heterogeneity affecting the 3-methyl group are perturbed in the Y48H 
variant, resulting in a reduction in the interconversion rate thus enabling the two species 
to be resolved under far more moderate temperatures.  It has been demonstrated at 298 
K, pH 5.8 that the rate of exchange in oxidised eCc was ~ 103 s-1 (Burns and La Mar, 
1981).  A similar rate is obtained for the Y48H variant at 283 K, pH 6.5, through the 
chemical shift difference between the 3-methyl resonances in the two respective 
environments (Figure 4.12B).  This rate is therefore considerably faster than the rate 
(k1) determined for the Fe(III)-Met80 bond dissociation (Table 4.1), suggesting that the 
atypical dynamic behaviour observed for the 3-methyl group of the Y48H variant is 
not directly related to the formation of the penta-coordinate species.  Another 
significant change observed in the Y48H spectrum, is that the pattern of haem-methyl 
chemical shifts is altered, displaying a 3 > 8 > 5 > 1 pattern.  This pattern of haem-
methyl chemical shifts has not been previously reported in either mitochondrial or 
bacterial ferric Cc, which so far have only displayed the following 8 > 3 > 5 > 1 or 5 > 
8 > 1 > 3 whereby the 8-methyl is always ahead of the 3-methyl and the 5-methyl is 
always ahead of the 1-methyl in all S = ½ ferric Cc (Zhong et al., 2004).  These haem-
methyl patterns are limited due to the orientation of haem axial ligands and the 
orientation of the Met80 side chain through the possible inversion of the Met thioether 
sulphur bond (Senn and Wuthrich, 1985).  The peaks associated to the protons of the 
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His18 and Met80 sidechains are observed in the upfield region in both the WT and 
G41S proteins, however, in the Y48H variant there are substantial changes (Figure 
4.12C).  One possible interpretation of this atypical haem-methyl peak pattern in the 
upfield region of the Y48H variant, is an alternate orientation of the axial haem ligands 
that would result in a change in the electronic structure of the haem.  Fluxional solution 
behaviour of the Met80 haem ligand was shown by Bren et al. to be a regular 
occurrence in Cc’s (Zhong et al., 2004), and so in the context of the Y48H variant, 
altered fluxional behaviour results in a change in the magnetic susceptibility axes thus 
perturbing the 3- and 8-methyl chemical shifts respectively.  A final observation is that 
in the case of the disease variants G41S and Y48H, both proteins display non-native 
hyperfine signals in the downfield region between 18 to 26 ppm at temperatures of 303 
K and above (Ångström et al., 1982) (Figure 4.12B).  These hyperfine features may 
therefore be attributed to a change in the ligation of the haem axial field ligands from 
His18 and Met80 to His and Lys coordination in accordance with the non-native hexa-
coordinate haem species observed in ferric eCc at temperatures of 315 K or greater 
(Ångström et al., 1982).  This ligation change is observed only in the G41S and Y48H 
variants at higher temperatures, therefore, it is proposed that these mutations shift the 
equilibrium between the hexa- and penta-coordinate haem species towards the latter.  
It is important to note that the N3- binding study with the ferric G41S variant showed 
that under the same experimental conditions used for these NMR measurements the 
fraction of the alkaline form(s) was not significantly populated (Karsisiotis et al., 
2016).  When considering both the higher protein concentrations and longer 
experimental acquisition times required for NMR data acquisition, it is readily apparent 
that at elevated temperatures the alkaline conformer(s) become populated.  These 
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findings are consistent with expectations as it is apparent that these pro-apoptotic 
disease variants possess a more labile Fe(III)-Met80 ligand.   
 
4.3.7  Backbone resonance assignments of the ferric Y48H human cytochrome c variant 
 There are clear differences in the [1H, 15N]-HSQC spectrum of the Y48H 
variant in relation to that of the WT protein as can be seen in Figure 4.13, where the 
two respective spectra are overlaid.  The most significant observation is the substantial 
number of backbone amide resonances absent from the Y48H spectrum in relation to 
that of the WT protein, 64 vs 97 out of the 99 non-proline resonances respectively (for 
resonance assignments, see Appendix A).  The majority of the missing resonances are 
found within the 40-57 W-loop encompassing helix-II and the 71-85 W-loop.  
Interestingly, no new peaks are observed in the [1H, 15N]-HSQC spectrum at lower 
magnetic field strength (500 MHz), which when considered with the increased line 
 
 
Figure 4.13  An overlay of the 800 MHz [1H, 15N]-HSQC spectrum of the Y48H 
variant (blue), with most backbone NH resonances assigned (blue), and the WT protein 
spectrum (orange) at 288 K overlaid.   
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widths of the backbone amide resonances observed at 800 MHz is indicative of the 
Y48H variant having significantly greater conformational heterogeneity compared to 
that of the WT protein (Karsisiotis et al., 2016, Karsisiotis et al., 2015). 
 
4.3.8  Hydrogen Deuterium exchange of the Y48H variant of human cytochrome c  
In order to explore the dynamics of the ferric Y48H variant of hCc so that a 
comparison can be made with the WT protein and G41S variant, 15N backbone amide 
H/D exchange experiments using NMR spectroscopy were conducted.  The H/D 
exchange profile of the ferric Y48H variant of hCc was monitored and the backbone 
amide PFs (the defined ratio between the observed experimental and intrinsic exchange 
rates (kex/kint) determined (Bai et al., 1993) (see Chapter 3, for PFs see Appendix B).  
As the exchange rates of the backbone amide groups are influenced by H-bonding, 
particularly pertaining to protein secondary structure and subsequent solvent 
accessibility, they report on protein dynamics on an individual residue resolution 
(Englander and Kallenbach, 1983).  The backbone amide H/D exchange profile for the 
Y48H variant is extreme, with 32 of the 64 assigned residues exchanged within the first 
10 min, and therefore leaving only 32 residues for which H/D exchange behaviour 
could be analysed (Figure 4.14).  Of these 32 residues, PFs could be calculated for only 
29 residues as 3 residues simply exchanged too slowly to calculate a PF within the 
experimental timeframe (Figure 4.14).  Figure 4.14 shows the sequence dependence of 
the rapid H/D exchange profile and subsequent 28 missing backbone amide resonances 
observed in the ferric Y48H variant of hCc.  It can be seen that only the interlocking 
helices-I and –V, in addition to small portions of helix-III and the 32-36 turn which 
exhibit various levels of protection, thus suggesting that the remainder of the protein is 
likely to be undergoing extensive dynamic fluctuations. 
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Figure 4.14  Protection Factors (PFs) determined for WT hCc (A) and the disease 
variants G41S (B) and Y48H (C) plotted against residue number.  For the residues in 
which PFs could be determined, 3 residues underwent fast-exchange (logPF ≤ 1), 13 
medium exchange (1 ≤ logPF ≤ 2), 10 slow (2 ≤ logPF) and 3 extremely slow 
exchange whereby the residues proton occupancy > 80 % after ~ 134 h and thus 
corresponding to exchange rates < 0.003 h-1 which prove unable to mathematically 
fit (shown in red).  The 5 a-helices comprising hCc secondary structure is indicated 
by the I-V numbered red squares, whereas the isolated red squares above indicate Pro 
residues.  Unassigned and very fast exchanging residues are indicated in blue and 
yellow squares respectively.  The 3 residues that were not amenable to PF calculation 
are indicated by black squares.  Figure adapted from (Deacon et al., 2017, Karsisiotis 
et al., 2016).   
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4.3.9  15N Relaxation 
For the Y48H variant of hCc the 15N relaxation parameters T1, T2, and NOE 
were acquired for 55 residues.  Figure 4.15 shows plots of these parameters vs residue 
number.  The average relaxation rates obtained were R1 = 1.08 ± 0.03 s-1 and R2 = 14.99 
± 0.72 s-1 with an average NOE = 0.84 ± 0.06.  These values are comparable to that of 
the WT protein (R1 = 0.99, R2 = 14.23 and NOE = 0.84) and the G41S variant (R1 = 
1.07, R2 = 14.48 and NOE = 0.84) (Karsisiotis et al., 2016).  The T1 values, which report 
on ns-ps motions are relatively constant throughout the Y48H protein sequence, 
however, there are two exceptions, His18 and Ile75 (Figure 4.15A).  In contrast, the T2 
plot (Figure 4.15B) reveals significant changes to that of the WT and G41S proteins 
with multiple residues falling below the average, and thus reflecting contributions from 
slower conformational exchange equilibria (Deacon et al., 2017).  By plotting the R2/R1 
ratio it is possible to visualise residues that experience chemical exchange (Figure 
4.15C).  Despite the relaxation dataset of Y48H being considerably smaller than that 
obtained for the G41S variant (55 vs 92 residues, respectively), a similar pattern of 
residues that experience slow conformational exchange (15-36, 40-57 and 71-85 W-
loops) emerges and is also consistent with regions which experience rapid H/D 
exchange (Figure 4.14).   
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4.4  Discussion 
For hCc to gain peroxidase activity, access to an alternative structural state, or 
conformer, is required.  This peroxidase active form could arise due to the hCc/CL 
interaction resulting in a conformational change, in which a peroxidatic state is created, 
or, because the ground state structure is in equilibrium with one or more higher-energy 
forms of different structure.  The CL interaction with the latter scheme would displace 
the equilibrium by binding preferentially to a higher energy state.  It has been shown 
previously that the pro-apoptotic G41S variant, the first variant of hCc responsible for 
the disease Thrombocytopenia 4, that enhanced conformational dynamics within the 
40-57 W-loop exists (Karsisiotis et al., 2016).  This increase in conformational 
dynamics is directly linked to the dissociation of the Met80 haem Fe(III) ligand, 
through communication between the 40-57 and 71-85 W-loops and results in an 
increased population of a penta-coordinate species (Karsisiotis et al., 2016).  This 
penta-coordinate form of hCc is peroxidatic, and under healthy physiological 
 
 
Figure 4.15  15N relaxation parameters for the Y48H variant of hCc acquired at 800 
MHz and 288 K.  Insets A and B display T1 and T2 times plotted against their 
respective residue number.  Black open circles from inset C shows the R2/R1 ratio 
whilst the blue circles represent the [1H]-15N NOE, again plotted against the 
respective residue number.  Figure taken from (Deacon et al., 2017).   
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conditions is one of the mechanisms by which the cell regulates levels of ROS (Bayir 
et al., 2006).  However, during the initial stages of apoptosis, the inner mitochondrial 
membrane lipid CL is peroxidated, and once hCc is released from the mitochondrion, 
it has been shown to carry out the peroxidation of the plasma membrane lipid 
phosphatidylserine (Bayir et al., 2006).   
More recently, a second mutation in hCc was discovered, which also causes 
Thrombocytopenia 4 (De Rocco et al., 2014).  Interestingly, this mutation (Y48H), is 
also located within the 40-57 W-loop.  The 40-57 W-loop is of significant importance, 
as this loop is not only the least conserved region in Cc evolution, but also possesses 
the lowest free energy of the five cooperative folding/unfolding units, termed “foldons” 
by Englander and co-workers (Krishna et al., 2003b, Krishna et al., 2006).  As a result, 
and consistent with expectation, the Y48H variant displays both enhanced mobility and 
dynamics.  However, it is consistently apparent that both the local and global dynamics 
of the Y48H variant are further enhanced than that of the G41S variant.  Evidence from 
the global perspective, is initially shown from the ~ 35 % loss of observed NH 
resonance peaks within a [1H-15N]-HSQC spectrum.  In contrast, the WT protein and 
G41S variant have only 2 and 6 % missing assignments respectively, under the same 
conditions.  With the exception of Ala43, the 40-57 W-loop is missing in its entirety, 
along with the second half of the 71-85 W-loop, corresponding to residues 79-85, the 
second least stable foldon that contains the Met80 haem Fe(III) ligand (Krishna et al., 
2006).  It is likely that these unobserved resonances in the Y48H variant, are as a result 
of a decreased T2 relaxation time, due to exchange between different conformations.  
Unfortunately, it is not possible to show unequivocally that the Y48H variant displays 
enhanced dynamics on the µs-ms timescale from direct NMR measurements, by 
compute Rex terms.  However, for the resonances that allow for an NH H/D exchange 
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PF to be calculated, which encompasses residues within the N- and C- terminal helices, 
the end of the 14-36 W-loop and parts of helix-III, it is possible to say that these are 
generally smaller for the Y48H variant than for the G41S variant and WT proteins 
(Karsisiotis et al., 2016).  One can appreciate the increase in dynamics going from WT 
< G41S < Y48H from Figure 4.16A, in which the H/D exchange NH PF’s obtained 
from the three proteins are mapped onto their respective X-ray crystal structures 
(Karsisiotis et al., 2016).  It is apparent that in the case of the WT protein and disease 
variants G41S and Y48H, that in helices I, III and V, similar H/D exchange profiles are 
maintained, but with mutations resulting in more rapid exchange and thus enhanced 
dynamics (WT < G41S < Y48H) in the 40 – 57 and 71-85 W-loops, in addition to helix 
II (Figure 4.16A).   
 Englander and co-workers elegantly revealed how Cc folds, by uncovering its 
foldon substructure (Krishna et al., 2003b, Krishna et al., 2006).  Of the five foldon 
units identified, the two with the lowest free energy are the 40-57 and 71-85 Ω-loops 
(Maity et al., 2005, Hu et al., 2016).  From the data reported in this Chapter, it is readily 
apparent that the dynamics of the 40-57 Ω-loop is directly linked to the dissociation of 
the Met80 ligand and the formation of the penta-coordinate form, which is in turn 
governed by the dynamics of the 71-85 Ω-loop.   
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There is indeed a striking correlation between the conformational dynamics linking the 
G41S and Y48H variants with the displacement of the Met80 ligand and the energetic 
impact on their respective foldon substructures.  If the following assumptions are made, 
that the penta-coordinate form of ferric Cc is equivalent to the partially unfolded form 
of the two lowest energy foldon units, in which the penta-coordinate state represents a 
6 kcal/mol increase in free energy above that of the ground state structure, in 
accordance with the analyses of Hu and colleagues (Hu et al., 2016).  Furthermore, 
 
 
Figure 4.16  Comparative dynamics of the thrombocytopenia 4 causing mutants of 
hCc Y48H and G41S compared to that of the WT protein.  Inset A shows the 
Protection Factors (PFs) obtained from all three hCc proteins mapped onto their 
respective X-ray crystal structures, with PFs colour coded as indicated.  Data for the 
WT and G41S proteins was taken from (Karsisiotis et al., 2016), whilst data for the 
Y48H variant is taken from Figure 4.14.  The haem and its axial ligands are displayed 
as sticks.  Inset B shows schematic energy diagrams illustrating the calculated 
differences in free energy (DDG) between the penta-coordinate and hexa-coordinate 
forms in the various protein species.  This data is derived from DG = -
RTln(WTKapp/variantKapp) from stopped flow N3– binding kinetics.  Figure taken from 
(Deacon et al., 2017).   
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when also assuming the energetics of eCc are the same as those of hCc, then using the 
equation ΔG = -RTln(WTKapp/Y48HKapp), obtained from the interpretation of the N3- 
binding kinetics, it is possible to determine the ΔΔG of the penta-coordinate state for 
WT, G41S and Y48H hCc (as illustrated, by the schematic energy level diagram in 
Figure 4.16B).  As described in the results of the N3- binding kinetics, the ratio of 
WTKapp/Y48HKapp reflects the ratio of equilibrium constants for dissociation and re-
association of the Met80 haem ligand (Y48HK/WTK), in which the assumption is that the 
free energy of the ground state structure is equivalent for the disease variants G41S and 
Y48H, to that of the WT protein.  Figure 4.16B illustrates how the penta-coordinate 
form of G41S and Y48H are 0.6 and 0.9 kcal/mol, respectively, lower in energy than 
that of the WT protein.  For every kcal/mol change in free energy, there is a 5-fold 
change in the equilibrium constant that governs the distribution of the hexa- and penta-
coordinate species.  As the minor fraction, in this case the penta-coordinate form, plays 
a significant mechanistic role in this enzyme, then a single kcal/mol change in stability 
represents a 5-fold increase in the concentration of the penta-coordinate form.  The 
suggestion that the G41S and Y48H variants cause small changes in the oxidised Cc 
energy landscape should be considered with regard to the recent finding that the Fe(III)-
S(Met80) bond is weak and therefore requires constraints from the protein structure, 
such as extensive H-bonding between neighbouring residues maintained under 
physiological conditions (Kroll et al., 2014, Mara et al., 2017).  The process in which 
the protein structure stabilises a weak bond is an example of entasis, a concept 
originally proposed to account for some of the unusual properties of metalloproteins 
by suggesting that the metal centre “constituted an energetically poised domain” 
(Vallee and Williams, 1968).  Mara and colleagues have determined that the protein 
entatic contribution to the Fe(III)-S(Met80) bond is ~ 4 kcal/mol (Mara et al., 2017).  
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Therefore, it is clear that relatively minor changes within the energy landscape of a 
protein, can have significant mechanistic effects.   
A noteworthy finding from the peroxidase activity assays is that the turnover of 
H2O2 by the Y48H variant is not enhanced in the presence of CL liposomes, as in the 
case of the WT protein and G41S variant (Figure 4.11B).  An absence of the CL rate 
enhancement for G41S has been reported by others (Josephs et al., 2014), which 
therefore contradicts the previous works from the Worrall group using Amplex red 
assays (Rajagopal et al., 2013) and the ABTS assay data presented in this Chapter.  The 
findings that there is an enhancement in peroxidase activity in the G41S variant is 
entirely consistent with the dynamic appraisal of the disease variants G41S and Y48H 
presented in this Thesis.  The Y48H variant is more dynamic than the G41S variant, 
which in the case of the peroxidase activity assays, reveal how in the case of the Y48H 
variant, the equilibrium between the hexa- and penta-coordinate forms is no longer rate 
limiting in the turnover of H2O2, as the peroxidase activity of Y48H is not increased in 
the presence of CL liposomes, unlike the WT protein and G41S variant (Figure 4.16B).   
There are two potential explanations for this, firstly, that the concentration of 
the peroxidase active penta-coordinate form is increased, as seen in Figure 4.16B, but 
another reason could be that the access of H2O2 to the haem Fe(III) is facilitated.  Arg38 
has been proposed to function as a gatekeeper of H2O2, specifically in the G41S variant, 
in which rotation of the Arg38 side chain creates a channel, stabilised by 2H2O 
molecules (Rajagopal et al., 2013, Liptak et al., 2011).  Further support for this comes 
from the crystal structure of the K72A variant of Saccharomyces cerevisiae Cc that 
displayed a penta-coordinate haem, in which the Met80 ligand was dissociated and the 
Arg38 sidechain position was in the “out” position, as in the G41S variant of hCc 
(McClelland et al., 2014).  As a consequence of the Met80 dissociation, there is forked 
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hydrogen bond network of H2O molecules that connect from the Met80 side of the 
haem to the bulk solvent (McClelland et al., 2014).  This Arg38 repositioning results 
in an altered haem propionate environment, particularly HP-7, and it has been 
suggested that these changes link the dynamics between the 40-57 and 71-85 W-loops, 
which result in the dissociation of the Met80 ligand (Karsisiotis et al., 2016, Rajagopal 
et al., 2013).  Perhaps surprisingly, the Arg38 sidechain orientation in the Y48H variant 
is orientated as in the WT protein, as illustrated in the Y48H X-ray crystal structure 
(Figure 4.5).  The introduction of the 41S and 48H mutations in the G41S and Y48H 
variants respectively, creates the opportunity for both side chains to form hydrogen 
bonds with the side chain of Asn52, which can then interact with the Met80 ligand 
though further H-bonding as illustrated in Figure 4.5B.  As a result of this dynamic and 
structural information, there are ultimately two available conformational routes in 
which dynamic changes at the base of the haem can impact on the Met80 ligand.  There 
is extensive documentation in the literature that the 40-57 W-loop and haem crevice 
have a significant conformational linkage.  However, this was not always appreciated, 
as in the case of Robinson et al., who showed through an incomplete NMR dataset, that 
under native conditions the residues within the 40-57 W-loop undergo rapid 
interconversion between local conformational states (Robinson et al., 1983).  In 
contrast, the suggested role of Asn52, as presented in this Chapter, is indeed consistent 
with the work of Schejter et al. (Schejter et al., 1994).  An NMR structure obtained of 
a triple variant of S. cerevisiae Cc, designed to stabilise the alkaline conformation (the 
His/Lys hexa-coordinate haem form) supports the link that the alkaline isomerisation 
of ferric Cc also plays a role in the linkage with the Met80 dynamics, as in addition to 
the 71-85 W-loop (housing the displaced Met80 ligand), the 40-57 W-loop was the most 
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perturbed feature compared with the native structure (Maity et al., 2006, Assfalg et al., 
2003).  
 The latest studies have shown that Cc function can be controlled through 
phosphorylation, in which phosphorylation inhibits the ETC flux thus preventing 
hyperpolarization of the IMM, a known trigger of ROS and apoptosis (Huttemann et 
al., 2012, Huttemann et al., 2008).  There have been three phosphorylation sites 
identified on a variety of tissue isolates of bovine Cc, Thr 28, Tyr48 and Tyr97 (Lee et 
al., 2006, Yu et al., 2008, Mahapatra et al., 2017).  Tyr48 is of particular interest, as 
when considering the pro-apoptotic behaviour of the Y48H variant, and indeed the 
disease phenotype in which it confers, as Tyr48 when phosphorylated abolishes 
apoptotic activity at the apoptosome level (De Rocco et al., 2014, Pecina et al., 2010, 
Moreno-Beltran et al., 2017).  A current study has characterised a Tyr48 
phosphomimetic, termed Tyr48p using a non-native amino acid in order to assess the 
effect of phosphorylation at this position on the hCc structure (Moreno-Beltran et al., 
2017).  It is important to note that the structural studies were conducted with the ferrous 
form of Cc, the hexa-coordinate form responsible for the donation of a single electron 
to CcO (Ferguson-Miller and Babcock, 1996).  The ferrous form is not the state which 
gives rise to the penta-coordinate, peroxidase active form fundamental to the work 
reported in this Thesis.  The ferrous form of hCc under native physiological conditions 
has both a more ridged structure than its ferric counterpart, but also an equilibrium 
constant between the Met80-on and Met-80 off species has not been detected under 
non-apoptotic physiological conditions (Moore and Pettigrew, 1990).  Despite these 
functional and molecular differences between the ferric and ferrous forms of Cc, the 
dynamics reported on the µs-ms timescale for the Tyr48p variant of Cc showed 
increased dynamics to that of the WT protein, particularly within the 40-57 W-loop, 
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however, this increase is still significantly lower than that reported for the ferric forms 
of the Y48H and G41S variants of hCc.  Additionally, increased dynamics were also 
reported in the 71-85 W-loop, specifically pertaining to residues 75-78 for the ferrous 
Tyr48p Cc, thus providing further support that the 40-57 W-loop and Met80 ligand are 
dynamically linked.  A possible explanation for the decreased dynamics observed in 
the ferrous form of Cc stems from the fact that the thioether sulphur of the Met80 
residue has a far greater affinity for ferrous Fe(II) to that of Fe(III) (Moore and 
Pettigrew, 1991).  Despite this, when in the ferric state the Tyr48p displays a 3-fold 
boost in peroxidase activity in relation to that of the WT protein (Moreno-Beltran et 
al., 2017).  The Y48H variant on the other hand, displays a 7-fold increase in peroxidase 
activity as seen in Figure 4.11B.  However, the Tyr48p peroxidase activity is boosted 
when complexed with CL, where there is a 7-fold increase in relation to that of the WT 
protein.  These data therefore suggest that the equilibrium constant between the hexa- 
and penta-coordinate species lies in favour of the hexa-coordinate form in the Tyr48p 
relative to that of the Y48H variant, thus enabling CL to further boost the peroxidase 
activity of the phosphorylated protein.  There may therefore be consequences in regard 
to both the pro- and anti-apoptotic behaviour as the data outlined in this Chapter has 
shown that the penta-coordinate haem species is critical in this respect.   
 Due to the thousands of biochemical reactions which occur within a cell, and 
the relatively few genes present in a genome, it was discovered that many proteins have 
more than one biological function (Henderson and Martin, 2014, Jeffery, 2014).  
Jeffrey coined the term “moonlighting” and listed several mechanisms by which a 
protein could switch between different biological roles (Jeffery, 1999).  Such 
mechanisms include differential localisation within the cell, intracellular/extracellular 
localisation, oligomerization, variable ligand/substrate concentrations, chemical 
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regulation or activity, different binding sites for a variety of partner molecules and a 
component of multi-protein complexes (Jeffery, 1999).  The notion that different 
protein structures would be involved with different biological roles was not considered, 
however, advances in this field have led to a rebranding of the term “moonlighting” to 
“Extreme Multifunctional Proteins” (EMF), in order to create focus on the functional 
attributes of the phenomena rather than the mechanistic routes (Chapple et al., 2015, 
Chapple and Brun, 2015).  However, from a biochemical perspective, it is essential to 
understand how moonlighting/EMF proteins function.  Energy landscape theory 
(Bryngelson et al., 1995) provides an explanation as to how proteins can moonlight, in 
which the ground-state structure (the prevalent form under physiological conditions) is 
in equilibrium with a small fraction of higher-energy form(s) that are structurally 
distinct.  Protein folding, ligand binding and enzyme catalysis studies have identified 
such excited states in numerous systems (Henzler-Wildman and Kern, 2007, Baldwin 
and Kay, 2009) and therefore it is reasonable to conclude that this theory offers a route 
enabling proteins to moonlight.  Interestingly, in the context of hCc’s roles as a histone 
chaperone inhibitor (González-Arzola et al., 2015) and as a component of the 
apoptosome (Yu et al., 2001), hCc binds to the relevant partner proteins at sites 
overlapping hCc’s binding sites to the cytochrome bc1 and CcO aa3 complexes (Speck 
et al., 1979, Rieder and Bosshard, 1980).  Thus, in these moonlighting roles hCc is 
indeed consistent with the possible mechanisms given by Jeffery (Jeffery, 1999).  From 
the work presented in this Chapter, the mechanism by which hCc carries out one of its 
moonlighting functions, its peroxidase activity, occurs through the population of an 
excited state structure lying energetically close to that of the ground state structure, and 
is not previously suggested or described in the literature on moonlighting or EMF 
proteins.  Despite this, the mechanism is likely to be employed by other proteins, 
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particularly metalloproteins, as the energetic differences between different metal ion 
coordination schemes, such as loss of a coordinating ligand or changes in the second 
coordination sphere, which can be particularly subtle, can have considerable chemical 
consequences in regard to the reactivity of the metal ion.  Currently, there are very few 
metalloproteins which are described as moonlighting or EMF proteins, for example 
there are only two iron dependent proteins and one zinc dependent protein listed in the 
moonlighting protein database, yet a bioinformatics study has suggested that 10 % of 
human proteins contain zinc (Andreini et al., 2006).  As a result of this, it is likely that 
the number of discovered moonlighting metalloproteins shall increase in the future.   
 In conclusion, the data reported in this Chapter has demonstrated that the 
disease variants G41S and Y48H, when in the ferric haem state, are more peroxidatic 
than the ferric WT protein of the order WT < G41S < Y48H.  In the case of the Y48H 
variant, the dynamic fluctuations in the 40-57 W-loop resulting in cross-talk with the 
71-85 W-loop housing the Met80 ligand are further enhanced than in the G41S variant.  
Consequently, the Y48H variant has intrinsic peroxidase activity that is no longer 
enhanced in the presence of CL, due to an increased population of an excited penta-
coordinate haem state structure with an energy that is close to that of the ground state 
Met80 coordinated structure.  This finding is fundamental in the proposal that hCc’s 
EMF switch in function from electron transfer protein, to peroxidase is, at least partly, 
a result of the preexisting conformational equilibrium involving an excited penta-
coordinate state.  The third naturally occurring variant of hCc, A51V, also implicated 
in Thrombocytopenia 4, has not yet been characterised.  However, due to its location 
within the 40-57 W-loop, one may predict that the A51V variant has similar traits to 
that of the G41S and Y48H variants.  It would therefore be interesting to ascertain 
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where the A51V variant is located within the dynamic window (WT < G41S < Y48H) 
that has emerged from studies thus far.   
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Chapter 5 
The contribution of W-loops in triggering the 
alkaline transition of cytochrome c 
 
 
 
 
 
 
 
 
 
 
 
 
Results from this Chapter have been submitted as:  
Deacon, O.M., Svistunenko, D.A., Moore, G.R., Wilson M.T., Worrall, J.A.R.  
(2018) “Naturally occurring disease-related mutations in the 40-57 W-loop of human 
cytochrome c control triggering of the alkaline isomerisation”.  Biochemistry.
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5.1  Introduction 
5.1.1  The alkaline transition  
 Theorell and Åkesson investigated the effects of pH on ferric and ferrous Cc, 
and showed that over the pH range 0-14 there are five pH dependent optical spectral 
states (Theorell and Åkesson, 1941).  These five states are linked by protonation events 
that correspond to four distinct pK values.  In contrast to the ferric protein, the reduced 
protein has access to only three states which are linked by two de-protonation events.  
These findings are summarised below:  
 
Ferricytochrome c:   I   >   II   >   III   >   IV   >   V  State  
      0.4      2.5      9.35      12.5  pK 
Ferrocytochrome c:          I   >   II   >   III   State  
      < 4   >12   pK 
 
In addition to increasing pH, it is also possible to induce these molecular 
reorganisations with high temperature and via the use of protein denaturants and other 
chaotrophic agents (Schejter and George, 1964, Greenwood and Wilson, 1971).  The 
work reported in this Chapter will focus on transition III > IV, known as the “alkaline 
transition” and is associated with a bleaching of the 695 nm absorption band.   
 The first structure of eCc confirmed that it is Met80 which is the hexa-
coordinate haem iron ligand (Dickerson et al., 1971), first postulated by (Aviram and 
Schejter, 1969, Schechter and Saludjian, 1967).  Following from this structural work, 
spectroscopic investigations confirmed the accepted notion that it is the sulphur atom 
on the Met80 sidechain which bonds with the central haem iron atom giving rise to the 
695 nm absorbance band, which at high pH is lost during the state III > IV transition 
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(Stellwagen and Cass, 1974).  Further work revealed that all cytochromes possessing 
the 695 nm absorbance band possess a Methionine residue as the hexa-coordinate axial 
haem ligand (Moore and Pettigrew, 1990). 
 There are many possibilities for the origin of the 695 nm band in Cc, however, 
the most widely accepted view is that the band represents the porphyrin > Fe(III) 
transition (Smith and Williams, 1970, Makinen, 1983).  The band is z-polarised with a 
transition from a porphyrin p > Fe dxz and dyz orbitals, the energy of which is governed 
by the interaction between the haem and Met80 ligand (Scott and Mauk, 1996).   
 The 695 nm band in Cc display a well resolved CD spectrum which is abolished 
at high pH (Greenwood and Wilson, 1971).  It is known that both the magnitude and 
sign of this CD differs between Cc of different species, which has been correlated 
through 1H NMR spectroscopy to reveal that the orientation by which the Methionine 
axial ligand interacts with the haem iron varies.  Specifically that a lone pair orbital on 
the Methionine sulphur atom are directed to different pyrrole rings (Senn and Wuthrich, 
1985, Senn, 1985).   
 Despite the alkaline transition appearing simple at face value and occurring in 
a relatively small protein whose structure is well resolved, the precise mechanism 
remains obscure.  As a result, it is the nature of the alkaline transition, i.e. displacement 
of the intrinsic methionine axial ligand and subsequent molecular rearrangement which 
has been the subject of considerable interest over the years since it was first discovered 
by (Theorell and Åkesson, 1941).  The alkaline transition can be described as a 
“triggered”, limited, conformational change that is coupled to a large redox potential, 
and therefore is likely to play a critical role in the ETC and energy transduction (Scott 
and Mauk, 1996).   
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5.1.2  Spectroscopic characteristics of the alkaline transition 
 Ferric Cc possesses a low-spin hexa-coordinated haem at both neutral and 
alkaline pH.  The forms of the protein under these conditions have been studied by 
spectroscopic techniques which have elucidated the local environment surrounding the 
iron, and the transition which connects the two species.  Lambeth and co-workers 
demonstrated the pH dependence of the EPR spectrum of ferric Cc and revealed that 
despite the low-spin haem signal remaining at high pH, the signal is distinctly different 
(Lambeth et al., 1973).  At neutral pH the EPR signal of g = 3.07, whereas at high pH 
this signal is replaced by a signal at g = 3.42.  The loss of the signal at g = 3.07 coincides 
with the bleaching of the 695 nm band under identical conditions.  Gadsby and co-
workers used magnetic-CD (MCD) to illustrate pH dependence, in which a band 
observed in the near infrared spectral region at 1725 nm at pH 7 is replaced by a band 
at 1465 nm at pH 11 (Gadsby et al., 1987).  Interestingly, the pK of this transition is 
identical to that observed by either EPR or UV-visible spectroscopy and therefore 
provide consistent data that the Fe-S bond is broken at high pH.  Conclusive evidence 
that the Met80 ligand dissociation occurs at high pH came from two magnetic 
spectroscopic studies, Wooten and colleagues used Cc enriched with CD3 or 13CH3 to 
illustrate that the methionine ligand was dissociated from the paramagnetic iron with a 
pKa of ~ 9 (Wooten et al., 1981).  MCD has also proved to be a very powerful technique 
in determining haem ligands, it was Thomson and colleagues who established the 
spectroscopic signatures of a number of haem axial ligands, which in turn were 
correlated with their respective EPR signals.  The major species at neutral pH 
displaying a band at 1725 nm, was conclusively assigned to His-Met ligation, in 
agreement with the X-ray crystal structure and the loss of the band at 1725 nm at high 
pH, providing irrefutable evidence of the dissociation of Met80 (Gadsby et al., 1987).   
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 As mentioned earlier, ferric Cc possesses a low-spin haem at high pH values, 
therefore, the Met80 dissociation must be followed by the ligation of another strong 
distal field ligand.  Spectroscopic studies revealed that this second distal ligand is that 
of a Lysine NH3+ group, as a result of the MCD band present at 1425 nm and high pH 
being consistent with the wavelength range for His-NH3+ ligation.  An example from 
the work of Gadsby and co-workers is the n-butylamine complex of leg haemoglobin, 
which displays a band at 1550 nm with consistent EPR data (Gadsby et al., 1987).  
Further support for this high pH hexa-coordinate ligation came from a 2D NMR 
spectroscopic study by Hoang and Dixon where chemical shift data was in agreement 
with His-NH3+ ligation (Hong, 1989).   
 The alkaline transition, in which there is a switch from Met80 to Lys ligation is 
more complex than one would imagine, as both EPR and NMR have confirmed that 
the alkaline from of the protein is not a single species.  EPR spectra display g values of 
a minor species at 3.17, 3.6 and the major species at 3.42 confirm the mixed nature of 
the alkaline form (Gadsby et al., 1987).  2D NMR support came from the work of Hong 
and Dixon, who revealed the presence of at least two coexistent basic forms above pH 
9.5 (Hong, 1989).  Additional support came from the earlier broad titration conducted 
by Wooten and colleagues, who suggested the complex pH-dependent behaviour 
observed by NMR spectroscopy does not follow the simple n = 1 protonation-
deprotonation transition that is observed through the optical, magneto-optical and EPR 
spectroscopies (Wooten et al., 1981).   
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5.1.3  What is the replacement axial ligand?  
 By examining the 3D tertiary structure of tuna ferric Cc several possible 
alkaline distal ligands were identified, particularly as it was known that no gross 
structural reorganisation occurred during the alkaline transition and therefore a 
restricted number of options are available (Greenwood and Wilson, 1971).  The options 
included a number of Lys residues (72, 73, 79, 86, 87 and 88) and Arg91 (Greenwood 
and Wilson, 1971).   
 Despite extensive work from a number of laboratories over the years, 
conclusive evidence as to the identity of the alkaline ligand(s) remains somewhat 
obscure, for example Bosshard and co-workers argued that none of the possible Lys 
residues could be the replacement ligand due to their acetylation rates (Bosshard, 
1981).  Further support for this notion came from the work of Wallace and Corthésy 
(1987) who used alkylamine derivatives of Cc (Wallace and Corthesy, 1987).  
However, following the work of Wallace (1984) and future studies, this notion has been 
successfully countered through the use of MCD and NMR data, which has strongly 
suggested that it is in fact Lys73 and/or Lys79 that are the replacement ligands 
(Wallace, 1984, Rosell et al., 1998).   
 Identifying the alkaline ligand is problematic as the alkaline form of Cc does 
not comprise a single species, instead there are at least two species which exist 
(possibly with two different distal ligands) in a conformational equilibrium (Scott and 
Mauk, 1996).  Unfortunately experiments that endeavour to determine whether a 
specific Lys is the correct ligand prove unsuccessful, giving negative results, as 
modification to the Lys in question will inevitably perturb the conformational 
equilibrium in favour of non-native conformations (Scott and Mauk, 1996).   
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5.1.4  The “trigger” hypothesis 
 Although it is widely regarded that the alkaline ligands of Cc are Lys residues 
(Lys 73 and 79), it is not the case that deprotonation of a Lys residue is the driving 
force resulting in dissociation of the intrinsic Met80 distal ligand (Scott and Mauk, 
1996).  The initial view was that a deprotonated e amino group (NH2) of a Lys residue 
will out compete the Met80 ligand due to its high affinity for ferric iron (Scott and 
Mauk, 1996).  However, this is not the case as experiments which have rendered the 
entire compliment of Lys residues within Cc modified by either trifluroacetylation, or 
guanidination, resulting in the protein being high-spin at high pH, unlike the native 
protein (Stellwagen et al., 1975).  As the pKa values of the modified and native proteins 
are so close at 9.9 and 8.8 respectively, it is clear that the trigger remains intact, as in 
the case of the modified protein the incoming Lys residue no longer acts as a strong 
field ligand (Scott and Mauk, 1996).   
 There are multiple candidates proposed as the trigger group ranging from a 
tyrosine, arginine, the proximal field ligand His18, HP-6, or a buried water molecule 
(Scott and Mauk, 1996).  Luntz and colleagues dismissed the possibility that Tyr67 is 
the ionisable group that regulates the alkaline transition, as they showed that the Y67F 
mutation does not abolish the transition despite an increase in the pK of 1.1 pH units 
(Luntz et al., 1989).  Furthermore, Schejter and co-workers demonstrated that a double 
Cc variant of Y67F/P30A results in the pK of the alkaline transition reverting to pH 
9.5, very close to that of the WT protein (Schejter et al., 1992).  Pro30 interacts with 
the proximal haem ligand His18 via a H-bond between the backbone carbonyl of Pro30 
and the imino nitrogen of His18, therefore the two substitutions are distant and located 
on opposite sides to the haem (Scott and Mauk, 1996).  Schejter and colleagues state 
that the exact mechanism by which the above mutations confer their effect is open to 
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discussion, however, they suggest that Tyr67 is not the trigger, but instead it is the other 
components of the alkaline transition which are modified (Schejter et al., 1992).  
Frauenhoff and Scott (1992) suggest that Tyr67 forms a H-bond to the alkaline hexa-
coordinate Lys ligand and in turn this interaction stabilises the alkaline conformation, 
thereby raising the pK (Frauenhoff and Scott, 1992).  However, in order for this 
argument to hold water, the assumption that the Tyr67-Met80 bond does not stabilise 
the native haem pocket structure must be made (Scott and Mauk, 1996).  This is 
difficult to believe as Tyr67 is a highly conserved residue and likely plays a role in 
limiting the access of a second water molecule into the haem crevice, thus maintaining 
Cc’s high redox potential (Scott and Mauk, 1996).  Frauenhoff and Scott (1992) 
demonstrated that the Y67F substitution lowers Cc’s redox potential by 50 mV, and 
NMR experiments by Hong and Dixon (1989) have eliminated Tyr67 as the ionising 
group (Hong and Dixon, 1989).   
 Arg91 has been discounted both on terms of its very high pK and that 
substitution of Arg91 leaves the pK695 unchanged.   
 Gadsby and colleagues made an interesting suggestion as to the identity of the 
trigger, from a result of combined MCD and EPR experiments in 1987 (Gadsby et al., 
1987).  They determined the pH dependence of the 1-methylimidazole complex of eCc 
and found that the pK of the transition of the proximal His18 to Histidinate was 11.6, 
close to the value of the kinetically determined trigger.  Figure 5.1 illustrates this 
hypothesis in conjunction with the spectral features of the alkaline species and the 
single de-protonation event leading to the alkaline transition.   
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Figure 5.1  Schematic depiction of the low-spin intermediate (histidinate) first 
identified by (Kihara et al., 1976), adapted from (Gadsby et al., 1987) and (Scott and 
Mauk, 1996).   
 
Figure 5.1 demonstrates that de-protonation of the proximal His18 yielding a 
Histidinate results in the dissociation of the trans Met80, thus exposing the ferric iron 
to an incoming Lys residue whose pK is lowered upon binding the iron.  Finally, the 
dissociated proton from the newly coordinated Lys restored the proximal Histidinate 
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to Histidine.  The result of this series of events is the substitution of the Met80-S to a 
Lys amino group and the bleaching of the 695 nm band with an observed pK of 9.3.   
 Moore and colleagues have proposed that Haem Propionate-6 (HP-6) is the 
likely trigger of the alkaline isomerisation, based on denaturation-induced proton 
uptake studies using 1H NMR spectroscopy and Trp59 fluorescence (Hartshorn and 
Moore, 1989, Tonge et al., 1989).  The assumption of this work is that the surface 
groups are not perturbed by denaturation and subsequently analysis of their data has 
shown that one of the haem propionic acid substituents of ferric Cc has a pK of < 4.5, 
in contrast to the other which has a pK of > 9.  Fourier-Transform Infrared (FT-IR) 
spectroscopy was used by Tonge and colleagues to identify an asymmetric carbonyl 
stretch at 1571 cm-1 characteristic of carboxylate anion formation at alkaline pH (Tonge 
et al., 1989).  This spectral feature titrated with a pK of 6.14 in Cc551 which is in close 
agreement to the value reported by Leitch et al (1984) for Haem Propionate-7 (HP-7) 
(Leitch et al., 1984).  In tuna Cc, a comparable spectral feature is observed at 1565 cm-
1 which titrates with a pK of 9.35, a value close to that of the alkaline transition (Scott 
and Mauk, 1996).  In trifluroacetylated tuna ferric Cc, where all Lys amino groups are 
modified, the transition from low-spin to high-spin haem upon increasing pH occurred 
with a pK of 10.2, whereas the carboxylate formation, as determined by FT-IR, 
occurred with a similar pK of 10.36.  Due to these similarities, Tonge et al (1989) 
suggested that it is in fact the de-protonation of a haem propionate that triggers the 
alkaline transition (Tonge et al., 1989).  In native WT ferric Cc, the de-protonation of 
a haem propionate should occur with a pK of ~11 and therefore it is HP-6 which has 
been tentatively assigned as the trigger group (Scott and Mauk, 1996).  In Cc HP-6 is 
buried in a hydrophobic environment, likely accounting for the abnormal pK value 
(Scott and Mauk, 1996).  Unfortunately, there is no conclusive experimental evidence 
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to account for the abnormally high pK values determined for HP-6, examination of the 
local environment of HP-6 and -7 also provides little insight as to their significantly 
differing pK’s (Scott and Mauk, 1996).  Cutler and colleagues made substantial changes 
to the environment of HP-7 via a R38A mutation, however, this resulted in only a 
minimal change to the observed pK (Cutler et al., 1989).  The change in pK is therefore 
likely to be attributed by a break in the peptide bond either before or after Arg38, this 
would considerably alter the local environment of the propionate and confer a 
drastically different pK of the alkaline transition (Wallace, 1987).  It is still unknown 
whether this is a result of a change in the pK of a propionate as a result of increased 
solvent exposure, or a general change in protein tertiary structure (Scott and Mauk, 
1996).   
 Analysis of the X-ray crystal structure of Cc has revealed the presence of a 
buried water molecule near to the iron sulphur bond with Met80.  This region confers 
the possibility of H-bonding and structural changes following de-protonation of the 
water molecule (Scott and Mauk, 1996).  It has been suggested that the breaking of the 
H-bond to Thr78 is what triggers the alkaline transition (Takano and Dickerson, 1981), 
a view supported by Luntz and colleagues who have demonstrated that the buried water 
molecule is stabilised by H-bonds to Tyr67, Thr78 and Asn52 due to the pK of a Y67F 
variant being raised to 11 (Luntz et al., 1989).  Additional support for the buried water 
molecule theory comes from Pseudomonas Cc551, a Cc which does not possess the 
buried water molecule and also display a pK of 11 (Scott and Mauk, 1996).   
 In ferrous Cc, the buried water molecule moves ~ 0.5 Å away from the Fe-S 
bond and therefore confers a lesser destabilising effect raising the pK (Mathews, 1985).  
Schejter and Plotkin (1988) however, give a more plausible reason for the greater 
stability at alkaline pH, that is due to the Met80 sulphur atom being a strong field ligand 
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of ferrous iron due to the p-acid nature of Met80 and subsequent orbital overlaps 
(Schejter and Plotkin, 1988).   
 The identity of the trigger group remains a mystery, however, it is clear from 
available experiential data that neither Tyr67 or a lysine amino are candidates, Arg91 
is also unlikely due to its high pK value (Scott and Mauk, 1996).  Evidence for HP-6 
relies on the abnormally high pK value of a carbonyl group within ferric Cc.  De-
protonation of a buried water molecule and the proximal His18 are plausible due to 
their proximity to the Fe-S bond, however, it is possibly more likely to involve a 
mechanism involving the histidine-histidinate transition, as this is trans to the Fe-S 
bond and it is known that trans effects such as binding of NO weakens the trans 
ferrous-histidine bond (Traylor and Sharma, 1992).  It is challenging to explain how 
His- weakened the trans Fe(III)-S bond, in fact, it is likely to impart more ferrous 
character and therefore bind the Met80 ligand more tightly, as suggested by (Schejter 
and Plotkin, 1988).  An additional complication is that this raises the question: if there 
is a trans effect why does it not occur in the same pH range in Cc and Cc551 of P. 
aeruginosa, where the pK of the alkaline transition is ~ 11 (Scott and Mauk, 1996)?  
Pearce and colleagues have argued against the proximal His18 hypothesis, as their 
experimental data from Phe82 variants has shown a decrease in the pK of 2 pH units, 
contradicting what would be expected if His18 is the trigger, in which there should be 
an increase in the pK (Pearce et al., 1989).  The buried water molecule is the more 
likely trigger candidate; however, the precise identity of the trigger is yet to be 
elucidated.  Further support for the buried water molecule comes from Aviram and 
Schejter (1972) who demonstrated that when the buried water molecule is removed, by 
lyophilising, the 695 nm band is abolished, suggesting a loss of Met80 coordination, 
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however, when re-hydrating the protein the 695 nm band is restored and therefore 
Met80 coordination. 
 
5.1.5  Kinetics of the alkaline transition 
 The variety of spectroscopic evidence available has revealed that the alkaline 
transition involves a ligand replacement from a sulphur to a nitrogen and may therefore 
be represented by a two-state transition coupled to a de-protonation event (Scheme 
5.1).   
 
          [Scheme 5.1] 
 "J = ;K;L              [Equation 5.1] 789: = 	79 +	7M 3N3N4[OF]             [Equation 5.2] 
 
In equations 5.1 and 5.2, KH and KC denote the respective equilibrium constants for the 
deprotonation and conformational change respectively, whilst kf and kb are the rate 
constants for the conformational transition, as described in Scheme 5.1 (Scott and 
Mauk, 1996).  As it is de-protonation which is linked to ligand exchange, the pH jump 
methodology provides powerful insights into the kinetics of the transition.  Davis and 
colleagues (1974) conducted the initial work into kinetics of the alkaline transition by 
following the absorbance changes at 695 nm whilst rapidly changing the pH of the 
solution (Davis et al., 1974).  They were able to show that it is unambiguously a de-
protonation event which precedes the spectral changes, as the experimentally observed 
!" # − %&''' − ( 	↔ # − %&''' − ( ⇌ (− %&''' − (kf
kb
H+ 
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rates showed strong pH dependency, with rates increasing significantly at pH’s above 
the pK of the protein.  This conclusion is entirely consistent with the view that it is de-
protonation of a trigger group which precedes Met80 dissociation and ligand exchange.  
At 25 °C pKH and Kc were determined to be 11 ± 0.1 and 125 ± 36 respectively and 
therefore, the overall pK is close to that of the pK of the alkaline transition, determined 
by taking the log of the reciprocal of the products KH and KC (Scott and Mauk, 1996).  
Davies et al (1974) determined the thermodynamic parameters of the conformational 
change, which are in close agreement with values determined by other methods (where 
the values of kb and kf were reported as 0.049 and 6.1 ± 1.8 s-1 respectively), such as 
pH jump experiments by (Kihara et al., 1976), redox experiments by (Wilson and 
Greenwood, 1971), 1H NMR experiments by (Hong and Dixon, 1989) and ligand-
replacement techniques by (Alayash, 1979).  For the forward and back reactions, the 
associated activation energies were reported to be Eaf = 28 kcal mol-1 and Eab = 16 kcal 
mol-1 by (Davis et al., 1974).  Pearce and colleagues have furthered our insights into 
the mechanism and kinetics of the alkaline transition using pH jump experiments with 
variants of yeast iso-1-Cc, in which mutations were created at Phe82 (Pearce et al., 
1989).  They found reductions in the overall pK by substituting Phe82, with the pKH 
lowered by 1.5 pH units, which considering the pKH is the pK of the trigger group, 
allowed them to conclude that the proximal His18 favoured by (Gadsby et al., 1987) is 
not the likely trigger group, as mutation at Phe82 would not further lower the 
abnormally high pK of this group.  Rosell and colleagues determined the pKa of the 
conformational equilibrium between states III and IV of WT iso-1 Cc protein (8.7) to 
be intermediate to that of Lys73 (8.44) and Lys79 bound (8.82) alkaline conformers, 
respectively (Rosell et al., 1998).   
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As it is now known that there are at least two alkaline conformers, with two 
different lysine’s coordinated, the model produced from the data obtained by Davis et 
al (1974) and Pearce et al (1989) must be taken further, however, this added complexity 
is not amenable to analytical solution.  Computational simulations for the multiple 
alkaline ligands by Wilson and Hogg ((Wilson) unpublished result) support the 
conclusions of Davis et al (1974), in which the overall pK of the transition consists of 
the pK of a triggering group that is coupled to a conformation change.  It is also likely 
that modelling the alkaline transition must account for the transient intermediate 
identified by (Kihara et al., 1976).  This intermediate is supported by (Uno et al., 1984), 
who used stopped-flow resonance Raman spectroscopy to identify the presence of both 
high- and low-spin intermediates in pH jump experiments.   
 
5.1.6  Carboxymethyl cytochrome c 
 (Schejter and George, 1965) demonstrated that carboxymethylation of Met80 
renders the ligand unable to bind to the haem iron and therefore abolishes the 695 nm 
band in the ferric protein.  This modification can serve as an effective model of the 
alkaline form, as at high pH values both carboxymethyl Cc (CM-Cc) and the native 
protein display similar affinities for extrinsic haem ligands, such as cyanide, with Kass 
values of 1.8 x 104 M-1 and 5.5 x 104 M-1 respectively (Saleem and Wilson, 1988).  
Interestingly, at neutral and near neutral pH values, the native protein displays a lower 
affinity for extrinsic ligands, as a result of competition with the Met80 distal ligand 
(Scott and Mauk, 1996).   
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5.1.7  The alkaline transition, W-loops and cytochrome c biological function 
 As mentioned previously, the identity of the trigger group(s) has not been 
satisfactorily deduced and therefore intense debate exists in the Cc literature.  As 
described above, extensive spectroscopic studies have formulated several possible 
groups that could serve as the trigger (Greenwood and Wilson, 1971, Bosshard, 1981, 
Wallace and Corthesy, 1987, Wallace, 1984, Rosell et al., 1998).  Most recently, studies 
have favoured the notion that deprotonation of the incoming hexa-coordinate Lys 
residue (Lys73/79) is itself the trigger.  Alternatively, other groups have been 
suggested, namely Tyr67, an internal H2O (wat166 in yeast) and HP-7.  The latter three 
groups are significant, as interestingly they interact through an extensive H-bond 
network that also includes Asn52 and Thr78, culminating in the OH group of Tyr67 H-
bonding to the Sg atom of Met80.  This extensive H-bond network confers 
communication between the 40-57 and 71-85 W-loops.  These structural units are the 
first to unfold on the Cc unfolding pathway and interestingly, the unfolding rate of the 
71-85 W-loop matches the rate of the slow conformational change that is associated 
with Lys coordination as the distal ligand following Met80 dissociation (Hoang et al., 
2003, Maity et al., 2006).  The 40-57 W-loop unfolding rate is equal to that of an internal 
deprotonation rate at pH values greater than 10.5, an ionisation process not attributed 
to the trigger group (Hoang et al., 2003, Maity et al., 2006).  The suggestion is that the 
trigger mechanism and the formation of the alkaline conformer appear to be governed 
by the interplay between the two W-loops.   
 Under neutral conditions, it is state III of ferric Cc which can access a non-
native conformer that is peroxidase active.  The peroxidase activity arises through a 
dynamic equilibrium between the hexa- and penta-coordinate species.  Despite the 
population of the penta-coordinate species being exceptionally low, it is nevertheless 
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responsible for the intrinsic peroxidase activity present in Cc when in the presence of 
H2O2.  The penta-coordinate species helps regulate the concentration of ROS, however, 
as has been discussed in previous Chapters, during the initial stages of apoptosis it is 
responsible for the peroxidation of CL.  As shown in Chapter 4, the NMR studies 
reported provide firm evidence that the increased population of a penta-coordinate form 
in the G41S and Y48H variants arises through extensive dynamic fluctuations in the 
40-57 W-loop and to a lesser extent in the 71-85 W-loop (Deacon et al., 2017, 
Karsisiotis et al., 2016).  These works support the notion that a dynamic coupling 
between these two structural units play a key role in accessing the peroxidatic 
conformer of hCc, as is also the case for the formation of the alkaline conformer.   
 hCc peroxidase activity is required under normal physiological conditions, 
despite this, Bowler and colleagues have proposed the hypothesis that the 71-85 W-
loop of hCc has evolved (based on sequence variation at the 81 and 83 positions) to 
supress the intrinsic peroxidase activity in comparison to that of lower eukaryotes, such 
as yeast Cc (McClelland et al., 2014).  An Ala and Gly are found at the 81 and 83 
positions respectively, in yeast iso-1 Cc, in contrast to the more sterically restrictive Ile 
and Val in hCc.  The X-ray crystal structure of the K72A variant of yeast iso-1 Cc 
revealed a protein conformer in which the hexa-coordinate Met80 ligand is replaced by 
a H2O molecule (McClelland et al., 2014).  The result in this altered hexa-coordinate 
ligation was significant movement of Ala81 and Gly83 resulting in an open haem 
crevice conformation (McClelland et al., 2014).  The ~ 30-fold increase in peroxidase 
activity present in yeast iso-1 Cc compared with WT hCc, has been attributed, based 
on the aforementioned structural observations, to altered residue volume at the 81 and 
83 positions (McClelland et al., 2014).  Bowler and colleagues argue that steric 
hindrance at these positions minimises access to the Cc conformers that give rise to the 
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peroxidase activity (McClelland et al., 2014).  Further support for this hypothesis 
comes from studies with the A81H variant of yeast iso-1 Cc, which demonstrated that 
increased steric size at the residue 81 position inhibits Met80 dissociation (Bandi and 
Bowler, 2015).   
 The work presented in this Chapter has investigated the effect of steric control 
in the 71-85 W-loop, at positions 81 and 83 in hCc, both in terms of peroxidase activity 
and ligand binding kinetics.  Furthermore, the conformational transition that leads to 
the ligand switch in the alkaline conformer has been probed for both the G41S and 
Y48H variants in the 40-57 W-loop and the residue 81 and 83 variants in the 71-85 W-
loop.  The data presented in this Chapter furthers our understanding of the roles played 
by titratable groups and the overall dynamics associated with this conformational 
change for these respective W-loop variants.  Specifically, the findings reveal that the 
conformational transitions in the 71-85 W-loop, which give rise to both the alkaline and 
peroxidase active conformers, are controlled by the dynamics of the 40-57 W-loop, 
which also appears to regulate the pKa values of two ionisable groups that are involved 
in Met80 dissociation.  The results are discussed in terms of a mechanistic model, 
which although likely simplified, brings the various conformational and 
protonation/de-protonation events into a consistent picture, thus providing a platform 
from which future experimental approaches may be designed.   
 
5.2  Materials and Methods  
5.2.1  Site-directed mutagenesis  
 The 71-85 W-loop variants of hCc (I81A, V83G and I81A/V83G) were 
produced using the Quickchange mutagenesis protocol (Stratagene).  The following 
forward and reverse mutagenic primers were used:  I81A-F 5’-
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GGAACAAAAATGGCCTTTGTCGGCATTAAG-3’, I81A-R 5’-
CTTAATGCCGACAAAGGCCATTTTTGTTCC-3’, V83G-F 5’-
GGAACAAAAATGATCTTTGGCGGCATTAAGAAG-3’, V83G-R 5’-
CTTCTTAATGCCGCCAAAGATCATTTTTGTTCC-3’, I81A/V83G-F 5’-
GGAACAAAAATGGCCTTTGGCGGCATTAAGAAG-3’, I81A/V83G-R 5’-
CTTCTTAATGCCGCCAAAGGCCATTTTTGTTCC-3’.  A PCR reaction mixture 
consisting of primers (75 ng/µl), WT template (15 ng/µl), 10 mM dNTPs (Fermentas), 
Pfu Turbo polymerase (Stratagene), 10 x Pfu Buffer (Agilent) and deionised H2O to 
yield a final volume of 50 µl was used.  This reaction mixture was subjected to the 
following PCR protocol; 95 °C – 3 min, (95 °C – 1 min, 60 °C – 1 min, 53 °C – 1 min, 
72 °C – 6 min, 72 °C – 10 min) x 18 cycles, 72 °C – 10 min.  PCR products were 
digested with DpnI (Fermentas) and transformed into DH5a Escherichia coli cells.  
Isolated clones were DNA sequenced to corroborate the presence of the expected 
nucleotide change(s). 
 
5.2.2  Protein over-expression and purification 
 The over-expression and purification protocols for the hCc variants I81A, 
V83G and I81A/V83G were identical to that of the WT protein and Y48H variant as 
described in Chapter 2.1.   
 Equine heart carboxymethyl Cc was prepared from an adapted method 
(Silkstone et al., 2005) previously described (Schejter and George, 1965) and the 
concentration determined using the e at 414 nm of 219 x 103 M-1 Cm-1 for the ferrous 
CO complex (Brunori et al., 1972).   
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5.2.3  Stopped-flow kinetics – pH jump experiments 
 All kinetic experiments were conducted with an Applied Photophysics 
(Leatherhead UK) SX20 stopped-flow spectrophotometer equipped with both 
photomultiplier and photodiode array detection systems, thermostatted at 25 °C.  
Various high pH buffers consisting of 50 mM KCl, 50 mM boric acid (pH 7 - 9) or 50 
mM CAPS (pH 9 - 13) were produced.  Protein stocks were oxidised and equilibrated 
(as described in Chapter 2) in H2O and diluted to experimental concentrations in 50 
mM KCl, to maintain ionic strength during mixing in the spectrophotometer, to ~ pH 
7.  The protein solutions were mixed with equal volume high pH buffer in the stopped-
flow spectrophotometer.  First order rate constants (kobs) were obtained by fitting 
reaction time-courses to either a single, or at pH values above 10.5 a double exponential 
function.  All kinetic analysis was conducted using the ProKineticist software (Applied 
Photophysics). 
 
5.2.4  Stopped-flow Kinetics – N3- binding 
 Experiential protocols for eCc and the 71-85 W-loop variants were identical to 
those reported in Chapter 4.2.5.  
 
5.2.5  Electron Paramagnetic Resonance spectroscopy  
 All EPR samples were frozen in Fluorochem SQ EPR tubes (Derbyshire, UK).  
Tube sizes with an outer diameter of 4.05 ± 0.07 mm and an inner diameter of 3.12 ± 
0.04 mm (mean ± range) were used in order to minimise the effect on quantitative 
results.  Random error in the EPR signal intensities was low (1-3 %).  Two sample 
freezing methods were used for the low temperature EPR measurements, a slow freeze 
and Rapid Freeze Quench (RFQ) approach.  For slow frozen samples, 250 µl of protein 
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was dispensed into the bottom of an EPR tube and placed into methanol stored in dry 
ice.  Once frozen, the tube was transferred to liquid nitrogen and stored until 
measurement.  The RFQ approach consisted of the combined use of an Update 
Instrument (Madison, WI) mixing machine and a home-built apparatus for freezing the 
ejected mixtures onto the surface of a rapidly rotating aluminium disk at liquid nitrogen 
temperature.  The RFQ methodology has been described previously (Thompson et al., 
2010).  All EPR spectra were measured at 10 K on a Bruker EMX EPR spectrometer 
(X-band) with a high-quality spherical Bruker resonator (SP 9703) and an Oxford 
Instruments liquid helium system.   
In order to estimate the concentrations of the high- and low-spin ferric haem 
forms in the Y48H variant EPR spectra at pH 11, a calibration experiment was 
conducted with equine heart Cm-Cc in a range of buffers (pH 4.5 – 8.5) yielding 
samples with varying concentration of the high- and low-spin ferric haem species.  
 
5.2.6  Peroxidase assays  
 For full experimental details, see Chapter 4.2.6. 
 
5.2.7  Circular Dichroism spectroscopy 
 For full experimental details, see Chapter 4.2.7.   
 
5.2.8  Static pKa titrations  
 For full experimental details, see Chapter 4.2.8. 
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5.3  Results  
5.3.1  Global stability of the 81 and 83 variants in the 71-85 W-loop:  UV-visible and 
far-UV CD spectroscopy  
 The optical absorbance of WT hCc and the 71-85 W-loop variants in both the 
ferric and ferrous forms are shown in Figure 5.2.  As was the case with the disease 
variants G41S and Y48H, both their respective ferric and ferrous spectra are 
indistinguishable from that  
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Figure 5.2  UV visible spectra of WT hCc and the 71-85 W-loop variants I81A, V83G 
and the double mutant (I81A/V83G) in both the ferric and ferrous forms at pH 6.5 
(20 mM sodium phosphate, pH 6.5), room temperature.  
 
 
Figure 5.3  Far-UV CD spectra of ferric WT hCyt c and the steric mutants I81A, V83G 
and the double mutant I81A/V83G at pH 7.0, 15 °C.   
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of the WT protein.  The far-UV CD spectra of the 71-85 W-loop variants display two 
negative minima at 208 nm and 222 nm, thereby indicating significant a-helical content 
and that the proteins are fully folded in solution, as in the case of the WT protein (Figure 
5.3).  Similarly, as was the case with the disease variants, the 71-85 W-loop variants 
appear to display somewhat greater a-helicity than the WT protein, though this result 
is open to criticism, as given the lower absorbance at 195 nm, this suggests a 
concentration discrepancy. 
 
Table 5.1  Global stability and the kinetics of N3- binding to WT hCc and eCc, in 
addition to the series of hCc variants studied in this Thesis.   
 WT hCc WT eCc G41S Y48H I81A V83G I81A/V83G 
pK695 9.3 ± 0.2 9.2 8.5 ± 0.2 8.4 ± 0.1 9.4 10.1 ± 0.1 9.7 ± 0.1 
DGunf 9.7 ± 0.1 --- 6.75 ± 0.1 5.51 ± 0.15 9.75 ± 
0.19 
9.95 ± 
0.058 
9.2 ± 0.12 
m 3.8 ± 0.1 --- 3.05 ± 0.05 2.65 ± 0.05 3.8 ± 
0.033 
3.85 ± 
0.033 
3.65 ± 
0.033 
Cm 2.53 ± 
0.025 
--- 2.25 ± 0.05 1.93 ± 
0.025 
2.6 ± 
0.017 
2.63 ± 
0.017 
2.55 ± 
0.017 
Kapp 0.31 ± 0.03 --- 0.l1 ± 0.01 0.07 ± 0.01 0.24 ± 
0.02 
0.3 ± 0.03 0.1 ± 0.01 
k1 [Az] 5.77 ± 1.5 --- 45 ± 18 125 14.91 ± 
6.4 
4.46 ± 0.5 73.95 ± 84 
k-2 [Az] 3.5 ± 0.44 --- 8.9 ± 0.3 12.1 ± 1.1 5.94 ± 
0.49 
1.73 ± 0.17 3.06 ± 0.1 
 
 An Ala and Gly residue occupy positions 81 and 83 respectively, in yeast iso-1 
Cc.  In order to assess whether the increased residue volume, conferred by an Ile and 
Val respectively, at positions 81 and 83 in hCc, helps prevent Met80 lability and 
subsequent access to the peroxidatic conformer, both single variants (I81A, V83G) and 
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a double variant (I91A/V83G) were constructed.  The double variant essentially 
mimics the 71-85 W-loop of yeast iso-1 Cc.  The effect on the global stability of hCc 
upon introduction of these residue variants in the 71-85 W-loop was determined by 
chemical denaturation studies using GuHCl as the denaturant and far UV-CD 
spectroscopy, as reported in Chapter 4 for the disease variants G41S and Y48H.  Values 
for DGunf, Cm and m have been determined from fits to the data plotted in Figure 5.4 
and values reported in Table 5.1, together with values previously reported for the WT 
human protein under identical conditions (Karsisiotis et al., 2016, Deacon et al., 2017).  
Subtle differences are noted, the most prominent of which is the 0.7 kcal/mol decrease 
in DGunf for the double variant I81A/V83G.  Overall however, decreasing the residue 
volume at positions 81 and 83 in the 71-85 W-loop has minimal effect on the global 
stability relative to WT hCc.  This contrasts with the disease variants G41S and Y48H 
in the 40-57 W-loop, in which the DGunf, Cm and m values (Table 5.1) all decrease with 
respect to the WT protein of order Y48H < G41S < WT, suggesting a significant 
destabilisation of the folded state in these naturally occurring variants. 
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5.3.2  N3- binding to the 81 and 83 variants in the 71-85 W-loop 
 N3– binding kinetics were used to determine the effect of the 81 and 83 
mutations on the local stability of the 71-85 W-loop.  In order for N3– to bind to the 
haem of hCc, there must first be dissociation of the hexa-coordinate haem ligand 
(Met80).  Following Met80 dissociation, N3- binds through an SN1 mechanism as the 
protein exists in dynamic equilibrium between the hexa- and penta-coordinate forms.  
This reaction is widely regarded to report on the Met80-Fe(III) bond lability.  Upon 
mixing N3- with ferric hCc, an optical transition occurs as a result of the dissociation 
of the Met80 ligand from the ferric haem iron and the subsequent binding of N3- in its 
place (Karsisiotis et al., 2016).  As was the case with the disease variants (G41S and 
Y48H) and the WT protein under identical experimental condition, the reaction time-
course of this optical transition for the 81 and 83 variants conformed to a simple 
 
 
Figure 5.4  Equilibrium unfolding by GuHCl of the steric mutants of hCyt c I81A, 
V83G and the double mutants I81A/V83G, in addition to the WT protein at pH 7, 20 
°C.  Figure taken from Deacon et al., 2017 (unpublished).   
 221 
exponential (Karsisiotis et al., 2016, Deacon et al., 2017).  The amplitudes of such 
reaction time-courses follow a simple hyperbolic binding isotherm (Figure 5.5), 
determined over a broad range of [N3-], in which an apparent equilibrium constant 
(Kapp) for N3- binding may be determined using equation 4.4 and respective Kapp values 
reported for the 81 and 83 variants in Table 5.1.  One can determine from equation 4.4 
that when K is < 1, as is the case here due to the concentration of the penta-coordinate 
species being low, then Kapp is ~ KD/K.  Assuming that the polypeptide mutations do 
not directly affect N3- binding to the penta-coordinate species, then KD will be similar 
for both the WT protein and variants of hCc, in which the ratio of Kapp values 
(WTKapp/variantKapp) reflects the ratio of K values (variantK/WTK).  As I81A/V83GK > I81AK > 
V83GK = WTK it is apparent that the penta-coordinate form of the I81A/V83G variant is 
populated to a greater concentration than in either of the two single variants (I81A, 
V83G) or the WT protein.  The relationship between kobs and [N3-] for the 71-85 W-
loop variants, appears almost linear under the conditions employed, as was the 
previously reported case for the disease variants (G41S and Y48H) and the WT protein 
in Chapter 4 
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(Karsisiotis et al., 2016, Deacon et al., 2017).  Using Equation 4.5 a prediction can be 
made that the relationship between kobs vs [N3-] follows a hyperbola, in which the curve 
is expected to reach a plateau (i.e. k1, the Met80-off rate).  As was the case with the 
disease variants G41S and Y48H, reported in Chapter 4 (Karsisiotis et al., 2016, 
Deacon et al., 2017), it was not possible to explore a sufficiently high [N3-] so a plateau 
region could not be reached.  In light of this, the k1 errors are large, whereas the k-2 (the 
kobs intercept and N3- dissociation constant) values are more reliable.  Despite this, the 
k1 values determined in this way follow the same pattern as observed for K with 
 
 
Figure 5.5  Stopped-flow kinetics of N3- binding to ferric hCyt c, in addition to the 
81 and 83 variants at 25 °C, pH 7. A  Amplitudes of the time courses recorded at 420 
nm plotted as a function of N3- concentration.  The subsequent binding curves are 
fitted to equation 4.4 yielding the Kapp values reported in Table 4.1.  B  The rate 
constant (kobs) determined for N3- binding fitted to equation 4.5 yielding k1 and k2 
values reported in Table 4.1, where k1 and k2 values refer to the Met80 and N3- 
dissociation rate constants respectively.  Adapted from Deacon et al, 2017 
(submitted).   
A B
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I81A/V83Gk1 > I81Ak1 > V83Gk1 = WTk1 (Table 5.1) consistent with the interpretation from 
N3– kinetics of a more labile Met80 ligand. 
 
5.3.3  Peroxidase activity  
 Cc can function as a peroxidase, either in isolation, or in complex with CL 
during the onset of apoptosis (Kagan et al., 2005).  The peroxidase activity of the 81 
and 83 variants was determined through ABTS peroxidase activity assays, both in the 
absence and presence of CL liposomes (Figure 5.6A).  A lag phase in the peroxidase 
kinetics of Cc has been extensively reported (Karsisiotis et al., 2016, Rajagopal et al., 
2013), though recently attributed to the oxidative activation of a pre-catalytic form 
leading to the formation of oxidised proteoforms with high peroxidase activity (Yin et 
al., 2017).  These oxidised proteoforms possess a penta-coordinate haem, in which the 
intrinsic Met80 ligand is dissociated and subsequently oxidised, in addition to an 
oxidised Tyr67 and carbonylated Lys72/73 (Yin et al., 2017).  Interestingly, the 81 and 
83 variants in the absence of CL liposomes do not display the distinct lag phase after 
the addition of H2O2 (Figure 5.6A inset) associated with the WT hCc, a characteristic 
previously observed in the disease variants G41S and Y48H (see Chapter 4) (Rajagopal 
et al., 2013, Deacon et al., 2017).  The 81 and 83 variants all display increased 
peroxidase activity in the absence of CL liposomes relative to the WT protein, of order 
I81A > V83G > I81A/V83G = WT (Figure 5.6A).  In the presence of CL liposomes, 
the peroxidase activity is further enhanced, consistent with expectation, to the greatest 
extent for the I81A variant with an order of activity I81A > I81A/V83G > V83G = WT 
(Figure 5.6A).  It is important to note, that whilst the effect of decreasing residue 
volume at residues 81 and 83 does indeed yield a peroxidase rate increase, the 
enhancement is of a significantly lesser extent than that of the disease variants G41S 
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and Y48H, in which a 3- and 7-fold increase is observed respectively, relative to the 
WT protein (see Chapter 4) (Karsisiotis et al., 2016, Deacon et al., 2017).  This suggests 
that the disease variants G41S and Y48H populate a higher concentration of the 
oxidised proteoforms, that give rise to the peroxidase active Cc state. 
 
 
 
 
 
 
Figure 5.6  Peroxidase activity and the pH dependence of the 695 nm band.  A) 
Illustrative reaction time courses (inset) for the oxidation of ABTS by ferric hCc upon 
addition of H2O2 (dashed line) with (+ CL) and without CL-containing liposomes.  The 
average maximum rates of ABTS peroxidation obtained from such reaction time 
courses for the WT protein and various 71-85 W-loop variants plotted with (+ CL) and 
without CL-containing liposomes.  The error bars are obtained from the standard error 
on triplicate measurements.  B) Decrease of the 695 nm absorbance band plotted as a 
function of pH for the WT protein and 71-85 W-loop variants.  Solid lines are 
representative fits to the data using a one-proton ionisation equilibrium equation with 
the apparent pKa values reported in Table 5.1.  Taken from (Deacon et al., 2017).   
5.3.4  Equilibrium alkaline isomerisation of the 81 and 83 variants in the 71-85 W-loop 
 The 695-nm band in the absorption spectrum of Cc is assigned to the LMCT 
properties of the Met80(Sg)-Fe(III) haem bond (Stellwagen and Cass, 1974, Moore and 
Pettigrew, 1990, Theorell and Åkesson, 1941).  Alkaline pH titration of this band 
conforms to a simple transition in which a single proton is dissociated upon increasing 
pH resulting in Met80 dissociation and subsequent replacement by a Lys residue within 
the 71-85 W-loop (state III to IV transition) (Stellwagen and Cass, 1974, Moore and 
Pettigrew, 1990, Theorell and Åkesson, 1941, Smith and Williams, 1970, Makinen, 
1983, Scott and Mauk, 1996), as previously described.  As explained previously, the 
apparent pKa of the alkaline transition is generally interpreted as a reflection of the 
flexibility/stability of the 71-85 W-loop.  Interestingly, the I81A variant does not alter 
the apparent pKa relative to the WT protein (Figure 5.6B, Table 5.1), however, an 
increase of 0.8 pH units is observed for the V83G variant (Figure 5.6B, Table 5.1), 
whilst the double variant I81A/V83G possesses a pKa of only 0.4 pH units higher than 
WT hCc (Figure 5.6B, Table 5.1).  This pattern of the apparent pKa V83G > 
I81A/V83G > I81A = WT provides a clear example of biochemical epistasis, in which 
the V83G variant clearly has a different effect in combination with the I81A variant 
than in isolation.  Shifts to higher pKa values for the V83G and I81A/V83G variants is 
consistent with a destabilisation of the alkaline state, relative to the WT protein.  This 
finding is contradictory to the interpretation of enhanced Met80 ligand lability, based 
on the N3- binding kinetics, thus suggesting other underlying processes are involved.  
This contradiction between pH titration and N3- binding kinetics will be considered 
further below.  In contrast, the disease variants G41S and Y48H, in the 40-57 W-loop, 
have an apparent pKa ~ 1 pH unit lower than that of the WT protein, thus providing 
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experimental support for a stabilisation of the alkaline form relative to the WT protein 
(Table 5.1). 
 
5.3.5  Kinetics of the alkaline transition below pH 10 for the 40-57 and 71-85 W-loop 
variants 
 The mechanistic features of the alkaline transition and the impact of mutation 
within the 40-57 and 71-85 W-loop variants on this were investigated using stopped-
flow pH jump experiments.  The kinetics of the alkaline transition in Cc are generally 
described in terms of a simple model (Scheme 5.2), in which deprotonation of a group 
that is not yet definitely identified, termed the trigger, initiates a conformational change 
which subsequently leads to the substitution of the Met80 ligand by a Lys residue from 
the 71-85 W-loop.  In Scheme 5.2, Cc-Htrig depicts the protein with the trigger 
protonated, Cc the protein with the trigger deprotonated and Cc-Lys the protein having 
undergone a conformational change from the acid (Met80 bound) to alkaline (Lys 
bound) form.  Ka1 and Kc are the deprotonation and conformational equilibria 
associated with the two steps and kf1 and kb1 are the forward and backward rate 
constants associated with the second step.  A series of stopped-flow pH jump 
experiments were conducted with WT hCc and the respective variants in the 40-57 and 
71-85 W-loops.  Upon mixing WT hCc at pH 7 with buffer solutions of higher pH value, 
optical transitions were observed consistent with those reported previously for eCc and 
hCc (Karsisiotis et al., 2016).  In the pH range 7-10, the WT variant proteins displayed 
 
 
Scheme 5.2 
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a single spectral transition, in which the Soret band is blue-shifted (Figure 5.7A) and 
the 695 nm band bleached.  This transition comprises a single exponential phase (inset 
to Figure 5.7A), the rate constant of which (kobs1) increases with increasing pH (Figure 
5.7B).  This behaviour is shown in Figure 5.7B, in which, for clarity, log kobs1 is plotted 
as a function of pH.  Assuming that the de/protonation of the trigger group is rapid, 
then the model in Scheme 5.2 yields equation 5.2 thus relating kobs1 to Ka1, kf1 and kb1.   
 kQRS5 = kR5 + kT5 D UV<UV<4WFH                 (5.2) 
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This equation dictates that kobs1 follows a simple titration curve, in which kobs1 takes 
the value kb1 at low pH and kb1 + kf1 at high pH values.  kobs1 therefore increases with 
pH.  The data plotted in Figure 5.7B has been fitted to equation 5.2, yielding the pKa1 
value of the trigger (Table 5.2).  In the case of the 71-85 W-loop variants, the pKa1 
values are comparable to WT hCc and eCc (Table 5.2).  eCc was used as a control, due 
to the extensive pH jump kinetic literature with this protein.   
 
 
 
Figure 5.7  pH jump kinetics of the slow phase of ferric mammalian Cc and variants.  
A) Optical spectral transitions observed using stopped-flow spectroscopy upon mixing 
oxidising WT hCc (pH 7) with an equal volume of pH 10 buffer.  The ferric hexa-
coordinate form (state III) at t = 2.5 ms is represented by the black line, whereas the 
hexa-coordinate alkaline form (state IV) at t = 20 s is represented by the red line.  The 
spectral region between 500 – 800 nm has been magnified five-times.  Inset) A typical 
reaction time-course stopped-flow trace at 420 nm (red) together with the 
corresponding fit to a single exponential function (black line) with residuals of the fit 
shown.  B) The pH dependence of kobs1 for the slow phase of the alkaline transition.  
The lines are fits to the logarithmic transformation of equation 5.2 to yield the pKa1 of 
the trigger group.  Taken from (Deacon et al., 2017).   
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Table 5.2  Kinetic parameters determined by stopped-flow pH jump experiments 
 WT 
hCc 
WT 
eCc 
G41S Y48H I81A V83G I81A/V83G 
pKa1 
(Trigger) 
11.97 ± 
0.41 
11.46 ± 
0.08 
10.51 ± 
0.11 
10.39 ± 
0.17 
11.62 ± 
0.14 
11.74 ± 
0.24 
11.85 ± 0.20 
kf1 17.01 ± 
13 
9.46 ± 
1.19 
8.37 ± 
1.32 
7.4 ± 
1.33 
6.53 ± 
1.6 
8.91 ± 
3.36 
7.34 ± 2.46 
kb 0.0096 
± 
0.0059 
0.038 ± 
0.0068 
0 ± 0 0.029 ± 
0.053 
0.003 ± 
0.0025 
0.0012 
± 0.028 
0.02 ± 0.01 
 
The disease variants G41S and Y48H are however, distinctly different, with pKa1 
values lower by > 1 pH unit (Table 5.2).  Therefore, one may conclude that the 
mutations in the 40-57 W-loop strongly influence the de/protonation behaviour of the 
trigger, whereas the mutations in the 71-85 W-loop do not.  Furthermore, as the lowered 
pKa1 values of the disease variants are reflected in the in the pKa of the alkaline 
transition (Table 5.1), one may conclude that in all variants the value of Kc is essentially 
unchanged.  kf1 values may be determined to a reasonable degree of accuracy (Table 
5.2) from the data in Figure 5.7B.  The kf1 value determined for eCc, under the 
experiential conditions employed, correlate well with values previously reported.  The 
kf1 values of the WT hCc and variant proteins are all of the same order of magnitude to 
that of the eCc (Table 5.2).  Values of kb1 are not reported, as these are small and in the 
case of the WT protein and 71-85 W-loop variants measured from small amplitude 
changes at the end of the titration, and in the case of the disease variants G41S and 
Y48H, derived from extrapolation of the data to pH values far lower than explored in 
the experimental data set.   
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5.3.6  Kinetics of the alkaline transition above pH 10 for the 40-57 and 71-85 W-loop 
variants 
 At pH values > 10, a second rapid phase was observed for the WT protein and 
all variants, consistent with previous reports for both eCc and hCc (inset to Figure 5.8).  
The rate constant kobs2 is associated with the formation of a transient spectrum 
characteristic typical of a high-spin ferric haem species, with both a prominent band at 
600 nm and possessing long wavelength features that obscure the bleaching of the 695 
nm band at certain pH values (Figure 5.8).  Thereafter, the spectrum decays to the final 
low-spin spectrum characteristic of Cc in the alkaline conformation, in which Met80 is 
replaced by a Lys as the hexa-coordinate ligand (Figure 5.8).  Significantly, the high-
spin intermediate is populated to a greater extent in the disease variants G41S and 
Y48H than in the WT protein.  Furthermore, for all proteins studied, the rate constant 
kobs2 was also found to be pH dependent (Figure 5.9A and B).  In the case of WT hCc, 
kobs2 decreases with increasing pH in the range 10 to 11.5, taking values close to those 
of eCc (Figure 5.9A).  Scheme 5.3 represents this behaviour and has been attributed to 
arise from a coupling between a conformational change that exposes a group that then 
undergoes deprotonation leading to the stabilisation, or facilitation, of the high-spin 
haem species.   
 
 
 
 
Scheme 5.3  
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Figure 5.8  pH jump kinetics of the fast phase of the Y48H variant of hCc at pH > 
10.5.  Optical spectral transitions observed using stopped-flow absorption 
spectroscopy upon mixing ferric Y48H hCc (pH 7) with an equal volume of pH 11 
buffer.  The red line represents the ferric hexa-coordinate protein (state III) at t = 3.5 
ms, the blue line represents the high-spin penta-coordinate form at t = 36 ms and the 
red line represents the final hexa-coordinate alkaline form (state IV) at t = 1 s.  The 
spectral region between 500 – 800 nm has been magnified five-times.  Inset) reaction 
time-courses of stopped-flow traces at three wavelengths with the residuals of the 
corresponding fit to a double exponential function shown.  Taken from (Deacon et al., 
2017).   
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In Scheme 5.3 Cc-H and Cc-H* represent the buried and exposed group of Cc and Cc* 
the deprotonated high-spin haem species.  The conformational transition in which the 
group in Cc-H* is exposed, is proposed in the discussion to be the conformational 
change from hexa- to penta-coordinate haem.  Equation 5.3 may be derived from 
Scheme 5.3 enabling the relation of kobs2 with kf2, kb2 and Ka2 for the formation of the 
high-spin haem species.   
 kQRSI = kTI + kRI D WF(UV?4WF)H                (5.3) 
 
 
 
Figure 5.9  The pH dependence of kobs2.  A)  The kobs2 values for WT hCc, WT 
eCc, the G41S and Y48H variants B) and the 71-85 W-loop variants, plotted as a 
function of pH.  The lines through the data points for hCc, eCc and the 71-85 W-
loop variants is to indicate the trends in the data.  The blue line in A) is a fit to a 
one-proton ionisation equilibrium equation to yield an apparent pKa.  Taken from 
(Deacon et al., 2017).   
A B
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Consistent with observations from WT hCc and eCc in Figure 5.9A, equation 5.3 
predicts that kobs2 is inversely related to pH.  Although the experiential data are 
inadequate to provide a clear pKa2, estimates of ≤ 10 may be confidently surmised.  In 
contrast, the disease variants G41S and Y48H behave differently, in that kobs2 for the 
production of the high-spin haem species increases with pH and is readily observed at 
pH values > 10 (Figure 5.9A).  These data, when fitted to equation 5.3, yield a pKa2 of 
11.1 ± 0.2 for the exposed group (Cc-H* in Scheme 5.3).  When interpreted together, 
these data imply that it is deprotonation before the conformational change that leads to 
dissociation of the Met80 ligand from the haem iron, hence the mechanism, at least in 
terms of intermediates on the pathway (or their order), is different to that of the WT 
protein.   
 In contrast, the 71-85 W-loop variants show different behaviour in kobs2 
compared to either the WT protein, or the disease variants G41S and Y48H.  Firstly, 
from pH values 7 to 10 there is no observable high-spin haem species, likely 
attributable to a low population and hence a low signal amplitude.  Secondly, at pH 
values > 10.5, the high-spin haem species for the 71-85 W-loop variants is detected 
with values of kobs2 increasing with pH, up to pH 13 (Figure 5.9B).  This pattern is also 
observed for WT hCc and it is suggested in Figure 5.9A, that this might also be the 
case for eCc at pH values > 13.  Considering the high pH at which the increase in kobs2 
is observed, it is likely that the process though which a high-spin haem species is 
generated is related to a more general denaturation of the protein and will therefore not 
be discussed further. 
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5.3.7  EPR spectroscopy to quantify the population of high-spin species 
 In order to verify that the intermediate observed through pH jump experiments 
was indeed a high-spin species, EPR experiments were conducted.  Y48H was used for 
the EPR experiments, as based on the optical spectroscopy, the 40-57 W-loop variants 
populate a greater fraction of high-spin species.  At pH 7, slow freezing the Y48H 
variant produces a high-spin haem species (g1 = 6.03, g2 = 5.67), that is not present 
when preparing the sample through a RFQ approach (Figure 5.10A and B).  
Additionally, there are intensity differences in the low-spin ferric haem signals (g1 = 
3.05, g2 = 2.23) in the slow frozen and RFQ samples.  These results demonstrate the 
effect different freezing regimes, either slow or fast, have on the quantities of quenched 
species in the frozen samples, that when in the liquid phase exist in dynamic 
equilibrium prior to freezing.  The RFQ of the Y48H variant at 50 ms after the pH 7 – 
11 jump results in an EPR spectrum with notable intensity of the high-spin ferric haem 
signal (g1 = 3.10, g2 = 5.76) and a significantly decreased low-spin ferric haem signal, 
as can be seen from its g1 = 3.10 component (Figure 5.10B and C).  In order to 
determine the absolute concentration of the high-spin species formed in the RFQ pH 
11 sample (84 µM, Figure 5.10C), estimates were made using the Cm-Cc calibration 
experiment.  This concentration, 84 µM, constitutes ~ 42 % of the total haem 
concentration in the Y48H variant and therefore in general agreement with estimates 
made from the optical experiments.   
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Figure 5.10  The effect of pH jumping from pH 7 to pH 11 on the low-spin and high-
spin ferric haem states in the Y48H variant of hCc as determined by EPR spectroscopy.  
The final concentration of protein after mixing was 200 µM.  A)  EPR spectrum 
generated when protein (pH 7) is mixed with an equal volume of pH 7 buffer, followed 
by slow freezing.  B)  EPR spectrum generated when protein (pH 7) is mixed with an 
equal volume of pH 7 buffer, followed by RFQ at 50 ms.  C)  EPR spectrum generated 
when protein (pH 7) is mixed with an equal volume of pH 11 buffer, followed by RFQ 
at 50 ms.  The concentration of the high-spin ferric haem form (indicated in the figure) 
was estimated from comparison with the acid-alkaline transition of the high-spin and 
low-spin forms in CM-Cc.  EPR spectra were measured at 10 K.  To make all three 
spectra directly comparable, spectrum A was multiplied by a factor of 0.45 to account 
for imperfect packing of the freeze-quenched icicles in the EPR tubes.   
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5.4  Discussion 
 The production of the 81 and 83 variants of hCc result in a homologous 71-85 
W-loop to that of yeast iso-1 Cc and the hypothesis was that the steric factors within 
this loop which act to suppress peroxidase activity in WT hCc would diminish, thus 
enhancing peroxidase activity comparably to that of yeast iso-1 Cc.  On the contrary, 
the data presented in this Chapter demonstrate a minimal increase in peroxidase activity 
for both the single and double 71-85 W-loop variants (Figure 5.6A).  Significantly and 
rather surprisingly, the double variant I81A/V83G is less peroxidase active than the 
single I81A variant, suggesting that replacing Val83 with the smaller side chain volume 
of a Gly residue compromises the peroxidatic conformer in the absence of Ile81.  The 
picture is somewhat different in the presence of CL, as the compromising role of Gly83 
is somewhat relieved in the double variant (Figure 5.6A), suggesting that there are 
differences in the peroxidatic conformer formed in the absence and presence of CL.  
Nevertheless, it is clear from the results obtained with the 71-85 W-loop variants that 
the enhancement in peroxidase activity, in relation to WT hCc, is minimal compared 
with the disease variants in the 40-57 W-loop.  The disease variants G41S and Y48H, 
must therefore have higher concentrations of the oxidised proteoforms that give rise to 
peroxidase activity in Cc.  In contrast to the conclusion of Bowler and colleagues, the 
suggestion from the data presented in this Chapter is that in the case of hCc, it is not 
the side chain bulk at residues 81 and 83 in the 71-85 W-loop that is responsible for 
regulating the peroxidase active conformers, but instead the 40-57 W-loop which acts 
to regulate H2O2 access to the haem.   
 As mentioned in Chapter 4 and the above introduction to Chapter 5, 
determining the pK695 value and the use of kinetic experiments to monitor the binding 
of exogenous ligands, such as N3- to ferric Cc are generally considered to provide 
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information on the stability/lability of the Fe(III)-S(Met80) bond.  Furthermore, 
interpretation of peroxidase activity in absence of CL may also inform on these 
phenomena.  To that end, the trend in pK695 values (V83G > I81A/V83G > I81A = WT) 
is consistent with the observed peroxidase activity, in which the local stability of the 
Met80 ligand correlates with the I81A variant being the most peroxidase active form 
of the 71-85 W-loop variants.  Alternatively, it is also possible to say that based on the 
higher pK695 values, that there is a greater stabilisation of state III relative to state IV 
of the aforementioned variant order.  The N3- binding stopped-flow kinetic studies have 
yielded both affinities for N3- binding and Met80-off rates (k1), both of which follow 
the same trend (I81A/V83G > I81A > V83G = WT).  This suggests that the double 
variant has greater Met80 lability and possibly, more readily able for N3- to bind ferric 
haem, whereas the V83G variant is identical to the WT protein.  These stopped-flow 
N3- binding results are clearly contradictory to the trend observed in both the peroxidase 
activity assays and the pK695 values, instead adhering to the hypothesis that removing 
steric bulk at the 81 and 83 positions facilitates ligand binding due to conformational 
space for the Met80 ligand to move out of the way.  The contradiction between the N3- 
binding kinetics and the peroxidase activity/pK695 experiments suggests that whilst they 
are probing stability/lability of the Met80 ligand, there must inherently be other 
underlying processes at play, which deepening on the type of experiments employed 
can affect the experimental result.   
In order to provide a complete mechanistic description of both the pH 
dependencies of the equilibrium and kinetic parameters governing the transitions in 
hCc and the variants reported in this Thesis, a model that incorporates a sufficient 
number of steps is required.  In this case, there must be a minimum of two “fast” de-
protonation steps, one for the “trigger” group and one for the transition yielding the 
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high-spin species, additionally a conformational equilibrium between the hexa- 
(Met80-on) and penta-coordinate (Met80-off) forms.  A further complication, is that 
additional Lys ligation must be considered, in order to yield the final alkaline form(s) 
(state IV).  The simplest model that satisfies these requirements, yet consistent with 
Schemes 5.2 and 5.3 is shown in Figure 5.11.  In this model, the various forms of hCc 
are located at the corners of a cube, the edges of the back and front faces of the cube 
reflect the protonation/de-protonation equilibria.  The horizontal and vertical edges 
refer to the “trigger” and the second group responsible for the appearance of the high-
spin form respectively (Figure 5.11).   
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Figure 5.11  The mechanistic pathways linking de-protonation and conformational 
changes in hCc.  Two de-protonation events are represented by the three dimensions of 
the cube, relating to the “trigger” and another group, possibly His18, respectively and a 
conformational change leading to Met80 dissociation.  The penta-coordinate forms 
(pCc) are shown on the front face of the cube and can in principle bind an amino group 
donated by a Lys.  Likely routes through the framework are indicated by the larger grey 
and silver arrows for the WT protein and the 71-85 W-loop variants, whereas the pale 
blue arrows depict the route for the 40-57 W-loop variants to populate the pCc-Htrig 
species, which proceeds to follow the silver arrows.  Optical states III and IV 
represented by (III) and (IV) respectively.  
(III) 
(IV) 
(IV) 
(IV) 
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The conformational equilibria are represented by the edges linking the back to the front 
face of the cube, possibilities for Lys binding to the penta-coordinate face are also 
indicated (Figure 5.11).  In the case of WT hCc, starting in state III (back left-hand 
corner of the cube) where both ionisable groups are protonated and the protein hexa-
coordinate, Scheme 5.2 is represented by the grey arrows in which deprotonation of the 
trigger precedes conformational change to a penta-coordinate form (H-pCc), 
subsequently binding Lys.  All variants studied follow this pathway, the pKtrig however, 
is variant dependent, which in the case of the disease variants G41S and Y48H is lower 
(Table 5.2).  The experimentally observed high-spin haem species results from a 
conformational change preceding deprotonation (Scheme 5.3).  Within the cube, this 
scheme is depicted by the silver arrows, where the suggestion from N3- binding 
experiments (Karsisiotis et al., 2016) is that a minor population of the penta-coordinate 
form at pH 7 (H-pCc-Htrig) is stabilised by deprotonation of the second group.  
Therefore, the observed high-spin from is either, or both, pCc-Htrig or pCc, both of which 
decay through lysine ligation (Figure 5.11).  In the case of the 71-85 W-loop variants 
there is no deviation from this mechanism and therefore, the residue volume at the 81 
and 83 positions does not alter this ionisation process and furthermore, the route 
through the cube which can lead to the high-spin species.  In the case of the disease 
variants G41S and Y48H, a contrasting picture emerges, in which the pH dependence 
of kobs2 reflects a mechanism in which deprotonation precedes conformational change 
(Figure 5.9A).  In order to explain this behaviour consistently with the model shown in 
Figure 5.11, one would presume that the same “trigger” group is involved, however, as 
the value of pKa2 is 11.1 and therefore rather higher than the pKtrig determined for the 
G41S and Y48H variants (Table 5.2), this seems rather unlikely.  Furthermore, it is 
particularly complicated to produce a model in which a single “trigger” group can be 
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simultaneously responsible for two apparently quite different transitions, namely the 
slow (alkaline transition) and fast (formation of high-spin species) processes.   
 Following from this view, one is forced to conclude, if matters are not further 
complicated than already defined in the model shown in Figure 5.11, that in the case 
of the disease variants G41S and Y48H, it is the enhanced dynamics that make the 
second group available for deprotonation.  In this situation, the series of events follows 
that the initial step takes H-hCc-Htrig to hCc-Htrig (pale blue arrows in Figure 5.11), the 
subsequent conformational change then leads to the generation of the penta-coordinate 
high-spin haem species that is experimentally observed (Figure 5.11). 
 As the cube has been devised to depict the kinetics of the alkaline transition and 
how the respective populations of the various states may occur as a result of 
deprotonation events and conformational changes, the question arises, what are the 
titratable groups responsible for the alkaline transition and transition to the high-spin 
haem state?  Considering firstly the alkaline transition, characterised by the substitution 
of Met80 by a Lys residue with an apparent pK of ~ 9.  As previously explained, there 
is titration of a group which leads to a conformational change and the subsequent 
dissociation of Met80.  Furthermore, from consideration of the disease variants G41S 
and Y48H, it becomes apparent that mutation in the 40-57 W-loop increases the 
dynamics not only locally within the loop, but also confers greater dynamics within the 
71-85 W-loop, which significantly leads to a reduction in the pKa of the trigger.  Several 
possibilities regarding the nature of the trigger have been extensively discussed in the 
literature and whilst the work reported in this Chapter does not definitely answer the 
question, the results are illuminating as to the properties of the trigger and perhaps more 
significantly, how these properties relate to the mechanism of the alkaline transition, 
as depicted in Figure 5.11.  Solomon and colleagues (Kroll et al., 2014, Mara et al., 
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2017) have suggested that the strength of the Met80-Fe(III) bond is enhanced through 
an entatic contribution of the polypeptide, that is derived from a H-bonding network 
that includes the hexa-coordinate Met80, Tyr67/wat166, Asn52, Thr78 and, as 
proposed by the work in this Chapter, HP-7.  An appealing concept therefore, is to 
suggest that a single deprotonation event from within the linked H-bond network has a 
disrupting influence, in which the Fe(III)-S(Met80) bond is weakened.  It follows that 
due to the H-bond nature, the pKa of this deprotonation event is high and in the context 
of the disease variants G41S and Y48H, substitution in the 40-57 W-loop alters the H-
bond network to HP-7 and Asn52, in which the pKa of the stabilising unit is lowered 
and hence the measured pKa of the trigger and the pKa of the alkaline transition.   
 Interestingly, evidence has been presented which suggests that the alkaline 
coordinating Lys79 is in fact itself the trigger group.  Lys79 differs from Lys73 (the 
other alkaline hexa-coordinate ligand) as a H-bond exists between itself, the backbone 
carbonyl of Ser47 and its side chain Ne amine.  The result of this H-bonding is not only 
a stabilising influence, but also a link is formed between the 40-57 and 71-85 W-loops.  
Furthermore, the pKa of the Lys79 amine could be raised to ~ 12 and therefore in 
agreement with the experimentally determined pKa of the trigger (Table 5.2).  
Deprotonation of the H-bonded amine group may influence the dynamics of the W-
loops, in which the propensity to dissociate the Met80 ligand is enhanced.  The 
deprotonated Lys79 can now act as a coordinating ligand to ferric haem.  In this 
framework mutations in the 40-57 W-loop, i.e. the disease variants G41S and Y48H, 
that alter the H-bond pattern and themselves enhance the dynamics of the W-loops 
result in the disruption of the H-bond between Lys79 and the carbonyl of Ser47.  This 
in turn leads to the drop in the pKa of the Lys, which is reflected in the lower trigger 
pKa of the G41S and Y48H variants (Table 5.2).  Deprotonation of the proximal His18 
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has also been suggested to be the trigger group (Gadsby et al., 1987), however, whereas 
this theory cannot be discounted, a more plausible explanation consistent with the data 
reported in this Chapter arises by retaining this group for consideration as the titratable 
group reasonable for the second deprotonation step which leads to the formation of the 
high-spin species (vide infra).   
Both the optical and EPR spectroscopy experiments demonstrate that at pH 
values > 10 a high-spin haem species is indeed present.  The kinetic data presented in 
Figure 5.9B and Scheme 5.3 fully supports the conclusions of Englander and 
colleagues, who suggested that transition to the high-spin species proceeds via the 
exposure of a hidden group through a conformational change.  Upon deprotonation of 
this hidden group, a high-spin haem species is formed that subsequently decays by Lys 
coordination.  The conformational change which exposes the hidden group is unknown.  
However, for simplicity and because one desires to stabilise a high-spin form, it is 
suggested that the conformational transition seen in the WT protein leads to the 
dissociation of the Met80 ligand (Figure 5.11).  It is this conformational change in 
which a penta-coordinate high-spin species is formed in the WT protein and is the basis 
of interpretation for ligand binding, e.g. N3- and perhaps H2O2 binding to ferric Cc.  
Following from this proposoal, dissociation of the Met80 ligand exposes a group 
which, once deprotonated, stabilises the high-spin species as depicted by the silver 
arrows in Figure 5.11.   
 Gadsby and colleagues have proposed through the use of EPR and MCD 
experiments that the proximal haem ligand His18 has a pKa of 11 when the ferric 
protein-haem ligation is hexa-coordinate (His18/Met80) (Gadsby et al., 1987).  It is 
noted that deprotonation of this group has a powerful trans effect on the Fe(III)-
S(Met80) bond leading to Met80 dissociation and the subsequent formation of the 
 244 
penta-coordinate form.  The work reported in this Thesis proposes a reciprocal 
argument, namely, that the Met80 association/dissociation equilibrium in the native 
state leads to the population of a penta-coordinate form, in which the pKa of His18 is 
lower.  Thus, the mechanism depicted in Scheme 5.3 and Figure 5.11 proceeds via 
dissociation of Met80 and the stabilisation of the resulting high-spin species through 
deprotonation of the proximally coordinated His18, with a pKa now lowered to ~ 9 for 
the WT protein and the 71-85 W-loop variants (Figure 5.9).  In the disease variants 
G41S and Y48H the mechanism is changed, in which direct deprotonation of the 
proximally coordinated His18 precedes Met80 dissociation (Figure 5.9A).  Following 
from the work presented in this Chapter it is proposed that mutations in the 40-57 W-
loop which introduce hydrophilic/protonatable groups facilitate water access to the 
proximal His18.  Furthermore, Bowler and colleagues have illustrated structurally that 
a non-native state of Cc can generate a water channel involving the 40-57 W-loop and 
confer access to the proximal His18 (McClelland et al., 2014).  This view of dynamic 
access to the proximal His18 is supported by the NMR work presented in Chapter 4 
(Karsisiotis et al., 2016, Deacon et al., 2017).  Such direct deprotonation of the His18 
in the hexa-coordinate His/Met state would yield a pKa of 11 (Gadsby et al., 1987), in 
keeping with the observed pKa2 for the G41S and Y48H variants.  
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Chapter 6 
Conclusions and future work 
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6.1 Conclusions   
6.1.1  Backbone resonance assignments of WT and Y48H hCc 
The backbone NH resonance assignments of WT hCc were determined under 
aqueous and DMSO conditions, in addition, the backbone NH resonance assignments 
were determined for the Y48H variant under aqueous conditions.  The assignments 
determined under aqueous conditions allowed the cH/D exchange and 1H-15N 
relaxation experiments to be interpreted in a sequence specific context, providing 
insight into both the global and local dynamics of both proteins (Karsisiotis et al., 2016, 
Deacon et al., 2017).  Whereas the assignments determined for the WT protein under 
acid denatured DMSO conditions enabled the sequence specific interpretation of the 
iH/D exchange experiments.   
 
6.1.2  Interrupted Hydrogen/Deuterium exchange methodology 
Despite numerous attempts and optimisation experiments, the goal of 
developing a solution-based NMR technique capable of providing salient structural 
information on soluble protein/phospholipid interactions was ultimately unsuccessful.  
An inability to preserve the exchange state throughout the protein was a persistent 
issue, in which it was only for the very slow exchanging residues, in DMSO, for which 
exchange data could be followed.  Furthermore, fundamental issues were encountered 
working with the hCc/CL complex, as it is essential that the intact complex transition 
from a protonated environment, to a deuterium rich environment without any 
disruption to the complex so as to not generate a “masking” free protein exchange 
profile.  As a result of the issues encountered, it was not possible to determine 
quantitative, or qualitative binding site information on the WT hCc/CL interaction.  If 
this method is to be explored further, it would be beneficial to utilise re-protonation 
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protocols, for the greater control conferred over the exchange conditions and the lower 
material costs.  Furthermore, it would be beneficial to re-assign the WT DMSO HSQC 
spectra under less acidic conditions, so as to facilitate assignment mapping to the iH/D 
exchange samples.   
 
6.1.3  Dynamics of the disease variants G41S and Y48H  
The cH/D exchange, 15N T1, T2 and [1H]-15N NOE relaxation experiments, CD, 
UV-visible, stopped-flow and EPR spectroscopies, in addition to the ABTS peroxidase 
activity assays all provide a consistent and coherent picture of the dynamic and 
functional differences between the WT protein and disease variants of hCc.  This work 
has demonstrated how simple substitution mutations in hCc result in reduced global 
stability and a lower pK695.  The reduced stability and increased Met80 lability is 
reflected strongly in the NMR cH/D exchange and relaxation experiments, which 
demonstrate both enhanced global dynamics, but also the local dynamics in the 40-57 
(site of mutations) and 71-85 (site of Met80 haem ligand) W-loops.   
 The stopped-flow spectroscopy presented in this Thesis has demonstrated how 
the disease-causing substitutions (G41S and Y48H) result in an increased Met80 off-
rate, which, when correlated with the lowered pK695 values, confers an increased N3- 
binding affinity and binding rate due to an increased fraction of penta-coordinate haem 
under physiological conditions (Karsisiotis et al., 2016, Deacon et al., 2017).   
 Despite the comparable initial clinical characteristics reported (De Rocco et al., 
2014) between G41S and Y48H hCc, the biochemical and biophysical properties of the 
Y48H variant are more extreme than that of the G41S variant (Deacon et al., 2017).  In 
the context of the direct peroxidase activity measurements, it is clear that interaction 
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with CL is no longer a rate-limiting factor for the Y48H variant, a unique feature of all 
proteins reported in this Thesis.   
 
6.1.4  The role of W-loops in the alkaline transition  
 The CD, UV-visible and stopped-flow spectroscopy experiments have 
demonstrated that mutation around the haem crevice of hCc does not perturb the global 
stability of the protein.  Instead, the stopped-flow spectroscopy experiments suggest 
that there are local increases in dynamics within the haem crevice, in which the hexa-
coordinate haem ligation is influenced.  The increased haem crevice dynamics are 
proposed to result in both the greater N3- binding rate and binding affinity observed in 
the 71-85 W-loop variants than that of the WT protein.  However, it is clear that as the 
global stability of the protein is not significantly reduced, as evident with the disease 
variants G41S and Y48H, that the haem crevice mutations influence haem dynamics 
and peroxidase activity to a far milder extent than that of the disease variants.  
Furthermore, pH jump experiments with both the 40-57 and 71-85 W-loop variants 
have provided further insights into the mechanism behind Cc peroxidase activity, in 
which the disease variants G41S and Y48H have been shown to alter the pK of the 
trigger group, whereas the steric variants do not.  The body of work reported has 
highlighted how the hexa-coordinate Met80 ligation is more strongly influenced 
through the dynamics of the 40-57 W-loop, than the local dynamics in the 71-85 W-
loop.   
 
6.1.5  Conclusions 
Ultimately, the work reported in this Thesis has demonstrated how the 40-57 
and 71-85 W-loops are dynamically linked.  It is clear that gross tertiary structural 
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changes are not present in the disease variants of hCc, with structures virtually identical 
to that of the WT protein.  Instead, this work proposes that heightened dynamics in the 
40-57 W-loop confer heightened dynamics in the 71-85 W-loop, which in turn confer 
greater Met80-Fe(III) bond lability.  Met80 is the critical hexa-coordinate haem ligand, 
which when dissociated, unlocks the haems peroxidase potential.  Therefore, it is not 
structural changes that are responsible for hCc related disease, but instead, heightened 
dynamics in the cooperatively likened W-loops which dynamically alter the haems 
hexa-coordinate ligation. 
 
6.2  Future work 
 With the recent discovery of the A51V variant of hCc, the next logical step in 
the Cc/CL research would be to biochemically and biophysically characterise this 
variant, as has been conducted with the G41S and Y48H variants reported in this 
Thesis.  The discovery of A51V in itself further supports the argument presented in this 
Thesis that there is cooperativity between the 40-57 and 71-85 W-loops, however, it is 
important to determine the effects of this mutation on hCc, which would perhaps lead 
to increased precision regarding which part of the 40-57 W-loop is most responsible.   
As the Y48H variant peroxidase activity appears to not be rate-limited by CL, 
creating double variants (G41S/Y48H, G41S/A51V, Y48H/A51V) and a triple variant 
of G41S/Y48H/A51V would be interesting to determine whether the effects on global 
stability are additive.   
15N T1, T2 and [1H]-15N NOE relaxation experiments should be conducted on 
the 71-85 W-loop variants of hCc (I81A, V83G and the double variant I81A/V83G), as 
this would provide insight into the, currently speculative, local haem crevice dynamic 
increases that are proposed in Chapter 5.  Furthermore, the high-spin intermediate 
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partially characterised in Chapter 5 could be probed further with the use of stopped-
flow FT-IR spectroscopy.  The aim of the FT-IR experiment would be to determine 
whether the high-spin intermediate observed through high pH jump stopped-flow 
kinetic experiments is associated with the Histidine to Histidinate transition.  
Preliminary FT-IR experiments through collaboration with Dr Joseph Wright 
(University of East Anglia) and Professor Mike Wilson (University of Essex) has 
provided a proof of concept.  It is essential that deuterated solutions be used in order to 
observe the 1500 - 1550 wave number region where the high-spin intermediate is 
detected.   
Due to the limited clinical and respiratory information available on the disease 
variants, electron transfer experiments by stopped-flow spectroscopy between Cc and 
CcO would provide information on the respiratory impact of the aforementioned 
mutations.  This information would not only provide insights into the primary 
biological impact of mutation (i.e. electron transfer), but also provide further 
information linking structure, dynamics and function.  Preliminary work has been 
conducted by Mr Richard White (former Worrall group MSc Student) and Professor 
Mike Wilson, who have demonstrated that although electron transfer rates are largely 
unchanged, the access to non-native conformations influence the steady-state turnover 
of the Cc/CcO complex.   
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Appendix A 
Backbone NH and side chain Ca, Cb, CO and He 
resonance assignments of WT hCc under native 
state aqueous solution conditions and acid denatured 
in DMSO.  Additionally, the Y48H variant under 
native state aqueous solution conditions.   
 
 
 
 
 
 
 
 
 
 
 
 
Both sets of WT hCc resonance assignments have been deposited in the Biological 
Magnetic Resonance Databank under the accession numbers 25418 and 26973 for the 
aqueous and DMSO solution conditions respectively.   
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Table A.1  1H, 15N, 13Ca and 13Cb resonance assignments of WT hCc in native state 
aqueous solution conditions  
WT - Aqueous 
Assignment 1H (ppm) 15N (ppm) 13Ca (ppm) 13Cb (ppm) 
1Gly --- --- 40.34 --- 
2Asp 9.33 124.58 50.16 39.77 
3Val 8.44 123.69 63.41 29.37 
4Glu 7.97 120.43 56.50 25.91 
5Lys 7.95 121.08 56.88 29.82 
6Gly 8.53 107.06 43.87 --- 
7Lys 7.89 124.11 56.58 29.56 
8Lys 6.81 117.07 56.91 29.12 
9Ile 7.44 119.05 62.10 34.62 
10Phe 8.33 120.50 59.72 36.76 
11Ile 8.89 121.78 63.10 35.19 
12Met 7.91 117.31 55.78 30.83 
13Lys 8.46 112.48 54.00 31.54 
14Cys 7.81 114.41 51.79 34.75 
15Ser 7.99 116.41 59.70 60.85 
16Gln 
9.96 
He21 7.47 
He22 6.74 
122.75 
Ne2 111.30 
56.54 25.84 
17Cys 9.44 113.52 55.35 33.06 
18His 10.81 118.41 74.20 24.25 
19Thr 10.53 113.73 58.19 70.02 
20Val 8.86 111.92 59.46 31.85 
21Glu --- --- 54.43 27.64 
22Lys 8.95 126.93 55.64 28.64 
23Gly 9.32 117.91 42.67 --- 
24Gly 8.19 107.91 42.09 --- 
25Lys 8.71 118.95 53.58 30.74 
26His 8.75 122.15 53.67 28.08 
27Lys 8.04 126.12 52.53 29.40 
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28Thr --- --- 63.45 66.06 
29Gly 7.09 103.40 34.50 --- 
30Pro --- --- 57.62 26.86 
31Asn 11.60 127.49 53.50 38.45 
32Leu 9.49 122.12 51.68 41.68 
33His 8.01 120.30 58.04 25.99 
34Gly 8.87 115.23 43.18 --- 
35Leu 6.99 117.13 55.36 41.58 
36Phe 8.58 112.52 57.55 34.23 
37Gly 8.81 111.04 42.22 --- 
38Arg 8.00 123.65 52.35 30.64 
39Lys 8.01 122.35 53.06 30.92 
40Thr 7.45 109.73 58.69 66.01 
41Gly 8.97 109.34 43.07 --- 
42Gln 
7.63 
He21 7.32 
He22 6.81 
113.00 
Ne2 113.85 
51.72 27.26 
43Ala 8.05 125.77 49.04 15.68 
44Pro --- --- --- --- 
45Gly 8.87 115.01 43.08 --- 
46Tyr 6.70 119.37 54.27 36.04 
47Ser 6.50 122.63 53.08 58.53 
48Tyr 7.50 124.58 55.38 38.78 
49Thr 9.54 112.89 59.57 68.63 
50Ala 8.70 124.93 52.44 14.42 
51Ala 7.87 117.65 52.49 16.20 
52Asn 8.46 117.27 52.44 37.39 
53Lys 8.48 121.26 56.71 29.60 
54Asn 8.12 112.79 50.38 36.10 
55Lys 6.89 121.50 55.63 27.54 
56Gly 7.71 103.22 44.24 --- 
57Ile 6.39 110.47 54.77 38.23 
58Ile 8.10 119.19 55.99 35.44 
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59Trp 
8.56 
He1 9.40 
130.60 
Ne1 125.31 
54.35 27.23 
60Gly 7.59 111.23 41.63 --- 
61Glu 9.45 120.50 59.15 26.69 
62Asp 8.23 115.32 54.47 36.90 
63Thr 8.17 113.14 61.00 66.27 
64Leu 8.42 120.47 55.47 39.34 
65Met 7.61 118.97 55.33 28.16 
66Glu 6.71 117.76 55.68 27.14 
67Tyr 8.03 121.27 57.91 37.76 
68Leu 7.94 110.86 52.78 38.37 
69Glu 6.66 118.81 56.01 27.26 
70Asn 6.57 105.19 49.61 34.85 
71Pro --- --- 65.06 31.09 
72Lys 9.35 11.71 56.61 30.02 
73Lys 7.72 119.49 55.44 30.96 
74Tyr 8.02 120.41 59.03 37.93 
75Ile 9.35 114.82 56.89 35.52 
76Pro --- --- 61.90 28.81 
77Gly 9.29 111.74 42.08 --- 
78Thr 8.98 115.38 59.14 68.00 
79Lys 8.18 122.99 52.59 29.05 
80Met 9.18 123.25 62.19 4.09 
81Ile 8.44 135.66 58.20 33.01 
82Phe 9.04 126.34 56.42 38.73 
83Val 8.06 126.87 62.43 29.18 
84Gly --- --- 40.48 --- 
85Ile 7.80 120.25 56.67 36.53 
86Lys 8.28 127.47 55.97 29.92 
87Lys 8.16 120.26 54.22 29.95 
88Lys 8.99 129.60 57.72 29.42 
89Glu 9.20 118.00 57.12 26.15 
90Glu 6.03 116.23 55.49 27.24 
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91Arg 7.03 116.92 58.29 28.57 
92Ala 8.29 119.88 52.59 15.02 
93Asp 7.90 121.98 55.41 36.79 
94Leu 7.67 120.74 55.27 38.06 
95Ile 8.37 119.57 63.55 34.84 
96Ala 7.62 122.47 52.29 14.46 
97Tyr 7.78 117.92 58.90 34.40 
98Leu 8.61 118.77 54.96 38.76 
99Lys 8.71 123.82 56.55 29.28 
100Lys 6.60 116.85 55.32 30.61 
101Ala 8.52 119.56 52.17 16.14 
102Thr 7.78 102.04 59.54 67.05 
103Asn 6.99 118.27 49.95 38.88 
104Glu 7.32 125.06 55.38 28.49 
 
Table A.2  1H, 15N, 13Ca, 13Cb and 13CO resonance assignments of WT hCc in acid-
denatured dimethylsulfoxide solution conditions  
WT - DMSO 
Assignment 1H (ppm) 15N (ppm) 13Ca (ppm) 13Cb (ppm) 13CO 
(ppm) 
1Gly --- --- 40.56 --- 166.27 
2Asp 8.67 118.71 50.05 36.87 170.75 
3Val 7.94 114.99 58.42 30.70 171.29 
4Glu 7.98 119.75 52.57 27.75 171.49 
5Lys 7.86 117.21 52.36 31.44 176.10 
6Gly 8.69 108.77 42.15 --- 168.64 
7Lys --- --- 52.80 32.22 172.02 
8Lys 8.12 119.02 52.87 31.58 171.73 
9Ile 7.73 116.18 57.18 37.46 171.41 
10Phe 8.19 120.32 54.21 38.04 171.53 
11Ile 8.19 117.61 57.76 37.23 172.03 
12Met 8.76 121.35 53.84 34.19 173.16 
13Lys 9.49 119.47 53.86 31.55 176.48 
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14Cys 8.04 117.69 53.06 27.46 172.25 
15Ser 8.01 117.74 54.65 61.03 172.20 
16Gln 8.62 120.72 53.10 29.56 171.21 
17Cys --- --- 57.74 37.28 171.83 
18His 8.50 121.25 53.01 33.14 172.19 
19Thr --- --- 56.96 65.82 168.89 
20Val 6.71 115.24 57.10 29.99 170.63 
21Glu 7.34 119.32 51.98 27.08 171.03 
22Lys 7.54 118.35 52.55 31.78 172.15 
23Gly 8.14 106.00 41.34 --- --- 
24Gly 7.93 105.26 42.48 --- 171.23 
25Lys 8.16 117.70 52.97 31.61 172.06 
26His 8.28 116.10 51.95 27.50 170.21 
27Lys 8.08 118.80 53.20 31.67 172.32 
28Thr 7.98 111.80 58.45 67.13 170.47 
29Gly 7.88 105.92 41.99 --- 169.60 
30Pro --- --- 59.83 29.69 172.02 
31Asn 8.22 116.51 50.15 37.24 171.64 
32Leu 7.90 119.22 51.86 40.50 172.77 
33His 8.17 114.85 52.59 27.10 170.67 
34Gly 8.07 105.80 42.60 --- 169.11 
35Leu 7.91 118.50 52.63 41.27 172.22 
36Phe 7.98 116.70 54.33 37.89 171.77 
37Gly 8.14 105.81 42.50 --- 169.07 
38Arg 7.97 117.34 52.67 29.97 171.70 
39Lys 8.16 119.16 52.95 31.41 172.19 
40Thr 7.74 111.10 58.87 67.06 170.85 
41Gly 8.04 107.05 42.63 --- 169.10 
42Gln 7.91 116.83 52.53 28.64 171.14 
43Ala 8.15 122.22 46.84 17.26 173.10 
44Pro --- --- 60.15 29.55 172.38 
45Gly 7.98 104.21 42.46 --- 168.96 
46Tyr 7.80 115.95 54.48 37.35 171.81 
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47Ser 8.08 113.46 55.58 62.21 170.38 
48Tyr 7.89 118.17 54.85 36.84 171.58 
49Thr 7.87 111.05 58.53 67.11 170.11 
50Ala 7.95 122.24 48.84 18.24 172.66 
51Ala 7.98 119.30 48.88 18.19 172.73 
52Asn 8.01 115.51 50.21 37.26 171.53 
53Lys 7.89 117.39 53.00 31.31 171.91 
54Asn 8.07 116.78 50.59 37.24 171.43 
55Lys 7.86 117.35 53.07 31.37 172.19 
56Gly 8.11 105.25 42.71 --- 168.91 
57Ile 7.64 115.50 57.24 37.19 171.30 
58Ile 7.81 119.55 57.60 36.89 171.32 
59Trp 
7.91 
He1 10.74 
121.53 
Ne1 
131.02 
53.97 28.22 172.06 
60Gly 8.06 106.40 42.63 --- 169.26 
61Glu 7.98 116.46 52.55 27.96 171.74 
62Asp 8.31 118.08 50.10 36.08 171.19 
63Thr 7.63 111.05 58.89 66.83 170.33 
64Leu 7.79 119.69 51.98 40.83 172.74 
65Met 7.96 117.36 --- 31.89 172.12 
66Glu --- --- --- --- --- 
67Tyr --- --- 51.75 40.49 --- 
68Leu 8.19 114.92 50.27 40.50 171.46 
69Glu 8.05 119.47 59.14 32.28 171.56 
70Asn 8.46 118.02 50.12 37.35 176.12 
71Pro --- --- 60.32 29.63 172.07 
72Lys 7.91 116.11 52.96 30.87 171.98 
73Lys 7.65 116.45 50.14 31.66 171.39 
74Tyr --- --- --- --- --- 
75Ile --- --- --- --- --- 
76Pro --- --- 59.93 29.80 172.60 
77Gly 8.21 105.07 42.81 --- 169.70 
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78Thr 7.63 110.46 58.90 67.08 170.45 
79Lys 8.00 119.28 55.20 36.68 172.25 
80Met --- --- 52.78 31.76 171.52 
81Ile 7.70 116.34 57.78 37.21 --- 
82Phe 8.07 120.18 54.46 37.51 --- 
83Val 7.87 116.10 59.23 30.63 171.98 
84Gly 8.05 108.23 42.92 --- 169.75 
85Ile 7.85 116.60 58.26 36.86 --- 
86Lys 8.12 121.39 53.94 31.10 --- 
87Lys --- --- --- --- --- 
88Lys --- --- --- --- --- 
89Glu --- --- --- --- --- 
90Glu --- --- 53.09 27.58 --- 
91Arg 8.04 118.54 53.52 28.96 172.11 
92Ala 8.05 120.82 49.55 18.14 173.38 
93Asp 8.21 116.43 50.47 36.05 171.53 
94Leu 7.82 118.52 52.63 40.87 173.09 
95Ile 7.83 116.43 58.44 36.34 171.75 
96Ala 7.89 122.36 49.79 17.99 173.05 
97Tyr 7.76 115.26 55.49 36.79 171.79 
98Leu 7.87 118.10 52.53 40.75 --- 
99Lys --- --- --- --- --- 
100Lys 7.82 117.34 53.04 31.59 171.89 
101Ala 8.01 120.86 48.88 18.10 172.79 
102Thr 7.62 108.93 58.33 67.02 176.08 
103Asn 8.00 118.04 49.99 37.37 171.39 
104Glu 7.88 115.58 51.92 26.81 173.34 
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Table A.3  1H, 15N, 13Ca and 13Cb resonance assignments of the Y48H variant of hCc 
in native state aqueous solution conditions  
Y48H 
Assignment 1H (ppm) 15N (ppm) 13Ca (ppm) 13Cb (ppm) 
1Gly --- --- 38.23 --- 
2Asp 9.27 124.45 49.97 40.08 
3Val 8.42 123.49 63.60 29.18 
4Glu 7.91 120.32 56.58 25.73 
5Lys 7.90 120.92 56.85 29.77 
6Gly 8.44 106.99 43.76 --- 
7Lys 7.79 124.00 56.66 29.35 
8Lys 6.71 116.83 56.86 29.00 
9Ile 7.33 119.00 62.28 34.47 
10Phe 8.20 120.44 59.65 36.49 
11Ile 8.72 121.59 63.37 35.19 
12Met 7.80 117.20 55.73 30.75 
13Lys 8.41 112.36 54.10 31.40 
14Cys 7.69 114.13 51.40 34.17 
15Ser 8.00 115.80 59.28 61.26 
16Gln 9.95 122.69 56.87 25.78 
17Cys 9.61 113.63 55.69 34.41 
18His 10.97 118.47 55.65 --- 
19Thr --- --- 58.11 70.13 
20Val 8.76 112.17 59.65 31.59 
21Glu --- --- 54.37 27.40 
22Lys 8.92 126.60 55.52 28.43 
23Gly 9.28 117.69 42.73 --- 
24Gly 8.13 107.72 41.97 --- 
25Lys 8.75 118.83 53.91 30.58 
26His 8.81 122.44 56.13 29.30 
27Lys 7.75 119.96 55.56 30.57 
28Thr --- --- 69.88 73.65 
29Gly 8.05 109.30 41.43 --- 
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30Pro --- --- --- --- 
31Asn --- --- 53.60 38.28 
32Leu 9.42 122.16 51.35 41.19 
33His 7.98 120.42 55.13 27.46 
34Gly 8.83 114.94 43.00 --- 
35Leu 6.85 117.24 55.33 41.19 
36Phe 8.52 113.22 57.44 33.80 
37Gly --- --- 42.08 --- 
38Arg 7.94 123.53 52.73 30.04 
39Lys 8.00 122.81 59.64 30.04 
40Thr --- --- 59.24 67.21 
41Gly 8.34 111.13 42.68 --- 
42Gln --- --- 59.28 35.57 
43Ala 8.13 126.37 49.90 16.06 
44Pro --- --- --- --- 
45Gly 8.39 109.91 42.48 --- 
46Tyr --- --- --- --- 
47Ser 8.14 119.37 59.33 67.12 
48His --- --- --- --- 
49Thr --- --- --- --- 
50Ala --- --- --- --- 
51Ala 8.00 119.45 55.41 16.26 
52Asn --- --- --- --- 
53Lys --- --- --- --- 
54Asn --- --- --- --- 
55Lys --- --- --- --- 
56Gly --- --- --- --- 
57Ile --- --- --- --- 
58Ile 8.09 119.42 56.93 38.10 
59Trp 8.68 130.08 54.51 27.01 
60Gly 7.61 111.86 41.41 --- 
61Glu 9.38 120.56 59.52 26.37 
62Asp 8.14 114.76 54.65 36.89 
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63Thr 8.12 112.73 61.05 66.45 
64Leu 8.45 121.25 55.41 39.28 
65Met 7.68 118.06 55.50 28.58 
66Glu 6.63 116.62 55.61 30.65 
67Tyr 8.04 120.55 57.80 38.03 
68Leu 7.95 108.82 57.35 --- 
69Glu --- --- --- --- 
70Asn 6.68 106.39 55.14 35.03 
71Pro --- --- --- --- 
72Lys --- --- --- --- 
73Lys --- --- --- --- 
74Tyr --- --- 58.67 37.37 
75Ile 9.33 114.40 56.90 36.19 
76Pro --- --- --- --- 
77Gly 9.15 111.64 42.23 --- 
78Thr 8.86 116.21 57.20 70.47 
79Lys --- --- --- --- 
80Met --- --- --- --- 
81Ile --- --- --- --- 
82Phe --- --- --- --- 
83Val --- --- --- --- 
84Gly --- --- --- --- 
85Ile --- --- 56.65 36.33 
86Lys 8.32 127.63 55.96 29.76 
87Lys 8.14 120.23 54.19 29.97 
88Lys 8.96 129.64 57.92 29.56 
89Glu 9.19 117.84 57.14 25.96 
90Glu 6.01 116.19 55.51 27.00 
91Arg 7.02 116.92 58.28 28.31 
92Ala 8.29 119.85 52.64 14.77 
93Asp 7.82 121.96 55.47 36.71 
94Leu 7.59 120.56 55.36 37.95 
95Ile 8.28 119.60 63.50 34.45 
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96Ala 7.53 122.69 52.37 14.19 
97Tyr 7.67 117.96 58.72 34.14 
98Leu 8.41 118.51 54.73 39.38 
99Lys 8.56 123.72 56.69 28.98 
100Lys 6.48 116.59 55.40 30.52 
101Ala 8.39 119.38 52.09 15.89 
102Thr 7.66 101.87 59.65 66.97 
103Asn 6.92 118.34 49.81 38.82 
104Glu 7.20 124.68 55.39 28.36 
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Appendix B 
cH/D exchange rates (kex), calculated protection 
factors (LogPF), free energies of exchange (DGex) 
and proton occupancies (Occ.) of the ferric Y48H 
variant of hCc (pH 6.5 and 288 K) 
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Y48H 
Residue kex (h
-1) logPF 
∆Gex 
(kcal/mol) 
1H Occ.  
1Gly --- --- --- --- 
2Asp --- --- --- --- 
3Val --- --- --- --- 
4Glu --- --- --- --- 
5Lys --- --- --- --- 
6Gly --- --- --- --- 
7Lys 1.37E-01 1.74 2.29 0.27 
8Lys 6.23E-01 1.05 1.39 0.18 
9Ile 1.62E-02 2.22 2.93 0.18 
10Phe -1.21E-04 --- --- 0.93 
11Ile 4.90E-03 2.71 3.57 0.48 
12Met 4.14E-01 1.04 1.37 0.15 
13Lys 6.61E-03 3.02 3.98 0.43 
14Cys 1.82E-02 2.98 3.93 0.59 
15Ser 1.35E+00 1.22 1.61 0.69 
16Gln --- --- --- --- 
17Cys --- --- --- --- 
18His 4.73E-01 1.94 2.55 0.12 
19Thr --- --- --- --- 
20Val --- --- --- --- 
21Glu --- --- --- --- 
22Lys --- --- --- --- 
23Gly --- --- --- --- 
24Gly --- --- --- --- 
25Lys --- --- --- --- 
26His --- --- --- --- 
27Lys --- --- --- --- 
28Thr --- --- --- --- 
29Gly --- --- --- --- 
30Pro --- --- --- --- 
31Asn --- --- --- --- 
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32Leu --- --- --- --- 
33His 4.68E-02 1.94 2.6 0.1 
34Gly --- --- --- --- 
35Leu 8.60E-02 1.94 2.92 --- 
36Phe 1.91E+00 1.94 1.55 0.58 
37Gly 5.74E-01 1.94 1.05 0.15 
38Arg 1.04E-01 1.94 1.99 0.34 
39Lys --- --- --- --- 
40Thr --- --- --- --- 
41Gly --- --- --- --- 
42Gln --- --- --- --- 
43Ala --- --- --- --- 
44Pro --- --- --- --- 
45Gly --- --- --- --- 
46Tyr --- --- --- --- 
47Ser --- --- --- --- 
48His --- --- --- --- 
49Thr --- --- --- --- 
50Ala --- --- --- --- 
51Ala --- --- --- --- 
52Asn --- --- --- --- 
53Lys --- --- --- --- 
54Asn --- --- --- --- 
55Lys --- --- --- --- 
56Gly --- --- --- --- 
57Ile --- --- --- --- 
58Ile --- --- --- --- 
59Trp --- --- --- --- 
60Gly --- --- --- --- 
61Glu --- --- --- --- 
62Asp 1.47E-01 1.73 2.28 0.15 
63Thr --- --- --- --- 
64Leu --- --- --- --- 
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65Met --- --- --- --- 
66Glu --- --- --- --- 
67Tyr 4.15E-02 1.95 2.57 0.26 
68Leu --- --- --- --- 
69Glu --- --- --- --- 
70Asn 2.24E-01 1.66 2.19 --- 
71Pro 1.60E-02 2.67 3.51 0.16 
72Lys --- --- --- --- 
73Lys --- --- --- --- 
74Tyr --- --- --- --- 
75Ile --- --- --- --- 
76Pro --- --- --- --- 
77Gly --- --- --- --- 
78Thr --- --- --- --- 
79Lys --- --- --- --- 
80Met 5.10E-01 0.68 0.9 0.12 
81Ile --- --- --- --- 
82Phe --- --- --- --- 
83Val --- --- --- --- 
84Gly --- --- --- --- 
85Ile --- --- --- --- 
86Lys --- --- --- --- 
87Lys --- --- --- --- 
88Lys --- --- --- --- 
89Glu --- --- --- --- 
90Glu --- --- --- --- 
91Arg --- --- --- --- 
92Ala --- --- --- --- 
93Asp --- --- --- --- 
94Leu --- --- --- --- 
95Ile --- --- --- --- 
96Ala --- --- --- --- 
97Tyr 3.66E-02 2.52 3.32 0.14 
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98Leu --- --- --- --- 
99Lys 2.13E-03 3.6 4.75 --- 
100Lys 8.26E-02 2.3 3.03 0.13 
101Ala 2.37E-04 4.44 5.85 0.9 
102Thr 2.00E-03 2.93 3.86 0.79 
103Asn 4.41E-04 4.02 5.29 0.87 
104Glu 2.29E-03 3.28 4.32 0.8 
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Appendix C 
Summary of the iH/D exchange methodology 
development and the dilution/concentration, PD10 
and reverse deuteration approaches  
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Table C1.  Summary of iH/D exchange methodology development 
Section Content Exp. observations 
3.3.1 Solving solubility issues with 
increased quench TFA 
concentration 
• Excellent solubility but no 
iH/D exchange observed.   
• Significant and non-uniform 
shifts with respect to triple 
resonance spectra.   
• Possibly due to lower pH and 
increased salt content.   
3.3.2 Observing iH/D exchange in 
H2O:   
 
Determine feasibility of 
quenching iH/D exchange in 
H2O 
• Ideal quench TFA 
concentration 0.05 %.   
• Further refinement possible.   
• Narrowed down ideal quench 
TFA concentration to 0.065 
% 
3.3.3 Observing iH/D exchange in 
DMSO:  
 
Identify best resuspension 
solution to observe iH/D 
exchange in DMSO.   
• 0.25 % has the best exchange 
profile.   
• Extremes (0.15 % and 0.4 %) 
are worst.   
3.3.4 Using FAST-HSQC to 
determine time zero  
Exchange profile differences 
only observed for very slow 
exchanging residues.   
3.3.5 Incorporating CL liposomes into 
iH/D exchange methodology 
• 1:5 ratio of protein/liposome 
confers greatest peroxidase 
activity and complex 
stability.  
• Gentle, but thorough, mixing 
after addition of DEE yields 
lipid emulsion between 
organic and aqueous phases.   
3.3.6 First iH/D exchange experiment 
with protein/liposome separated 
samples  
• Significant difference 
between L2N and L4X, 
• Not clear for C1N and C3X, 
likely 0.085% (for the 
quench) and DEE results in 
not appropriate quench 
conditions 
3.3.7 Attempts at observing iH/D 
exchange with protein/liposome 
• No sign of complex 
formation (no line broadening 
observed) 
 270 
complexes in aqueous 
conditions.   
• Some sample reduction  
• Evident lipid layer upon 
extraction 
3.3.8  Re-protonation 
Determining optimal quench pH 
for the protein/lipid complex (re-
protonation) 
• Minimal solution volumes  
• Effective exchange through 
dilution in H2O 
• Reduced D2O requirement 
 
Comparable exchange rates to 
H/D exchange 
Sample 4 (0.1 % v/v TFA) 
demonstrated best preserved 
exchange.   
3.3.9  “Dry” DMSO  Lower H2O content in d6-DMSO 
from sealed ampules  
 
 
 
 
Table C2  Summary of exchange protocols used for protein/lipid complex samples 
Step PD10 Dilution/ 
Concentration 
Reverse D/H  
Exchange 
1 Liposome preparation in 
H2O 
Liposome preparation in 
H2O 
Full deuteration of hCc 
for at least 1 week at 
room temperature.  
2 Complex formation at 
1:5 ratio hCc/CL 
Complex formation at 1:5 
ration hCc/CL 
Liposome preparation in 
D2O  
3 Deuteration through D2O 
pre-equilibrated PD10 
columns followed by 
elution with high salt 
buffer (20 mM NaPi, 1 
M NaCl, pH 6.5) 
Deuteration through 10-fold 
dilution 
Complex  
4 Concentration and 
dilution repeated as 
necessary to buffer 
H/D exchange interval in 
D2O 
Reverse D/H exchange 
interval in H2O through 
10-fold dilution  
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exchange into a lower 
ionic strength buffer 
(essential).  Resulting 
volumes generally high.  
5 H/D exchange interval in 
D2O 
Concentration usually 
required as volumes typically 
high in order to minimise 
residual H2O content.  
Concentration not 
necessary as resulting 
volumes generally kept 
low.  Ideal for both 
perseveration of the 
hCc/CL complex and 
minimising the 
population of unbound 
hCyt c minimal.   
6 Quench with TFA Quench with TFA Quench with TFA 
7 Diethyl Ether separation Diethyl Ether separation Diethyl Ether separation 
8 Flash freezing in liquid 
N2 
Flash freezing in liquid N2 Flash freezing in liquid 
N2 
9 Lyophilise  Lyophilise Lyophilise 
10 NMR detection in H2O 
using a series of 
sequential FAST-HSQC 
experiments to 
determine H/D exchange 
time dependency.  
NMR detection in H2O using 
a series of sequential FAST-
HSQC experiments to 
determine H/D exchange 
time dependency. 
NMR detection in H2O 
using a series of 
sequential FAST-HSQC 
experiments to determine 
H/D exchange time 
dependency. 
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Abstract Human cytochrome c is a multi-functional
protein with key roles in both the mitochondrial electron
transfer chain and in apoptosis. In the latter, a complex
formed between the mitochondrial phospholipid cardiolipin
and cytochrome c is crucial for instigating the release of
pro-apoptotic factors, including cytochrome c, from the
mitochondrion into the cytosol. The G41S mutant of
human cytochrome c is the only known disease-related
variant of cytochrome c and causes increased apoptotic
activity in patients with autosomal dominant thrombocy-
topenia. NMR spectroscopy can be used to investigate the
interaction of human cytochrome c with cardiolipin and the
structural and dynamic factors, which may contribute to
enhanced apoptotic activity for the G41S mutant. We
present here essentially full backbone amide resonance
assignments for ferric human cytochrome c (98 %) as well
as assignments of both the ferric (92 %) and ferrous (95 %)
forms of the G41S mutant. Backbone amide chemical shift
differences between the wild type and G41S mutant in the
ferric state reveals significant changes around the mutation
site, with many other amides also affected. This suggests
the possibility of increased dynamics and/or a change in the
paramagnetic susceptibility tensor of the G41S mutant
relative to the wild type protein.
Keywords Human cytochrome c ! Mitochondria !
Apoptosis ! Paramagnetic NMR
Biological context
Mitochondrial cytochrome c (cyt c) participates in two
important cellular processes in invertebrates (Huttemann
et al. 2011). As a redox protein it shuttles electrons from
complex III to complex IV in the mitochondrial respiratory
chain leading to the production of ATP. In cells undergoing
apoptosis it first functions as a peroxidase upon complex
formation with cardiolipin (CL), prior to its release from
the mitochondrion (Kagan et al. 2005), where it is then
required along with dATP and Apoptotic peptidase acti-
vating factor 1 (Apaf-1) to form the cytosolic apoptosome
assembly that initiates caspase activity and cell death (Liu
et al. 1996; Wang 2001).
Cyt c is a small (*12.5 kDa) a-helical protein with a
c-type haem covalently attached to the polypeptide chain
via two thioether linkages arising from Cys residues
present in a CXXXCH motif (Moore and Pettigrew 1990).
The haem-iron is six-coordinate with the Ne2 atom of a
His, part of the CXXXCH motif, acting as one axial
ligand and the Sd atom of a Met residue as the second.
The haem-iron is redox active and when six-coordinate
can access the ferric (Fe3?) and ferrous (Fe2?) oxidation
states, with the ferric state paramagnetic (S = !) and the
ferrous state diamagnetic (S = 0). In the ferric form an
equilibrium between a six- and five-coordinate haem
exists, resulting from the dissociation/association of the
axial Met ligand (Moore and Pettigrew 1990). At physi-
ological pH this equilibrium lies firmly towards the six-
coordinate species. Cyt c from horse heart and Saccha-
romyces cerevisiae have been the subject of extensive
biophysical and biochemical studies over the years,
including numerous NMR studies (Pielak et al. 1996).
However, from a biophysical perspective human cyt c has
been less well studied.
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The discovery of the role in apoptotic cells of the cyt c/
CL complex has stimulated numerous biophysical investi-
gations of this complex (Bradley et al. 2011; Hanske et al.
2012; Hong et al. 2012; Rajagopal et al. 2012; Sinibaldi
et al. 2008). The interaction is proposed to cause a ‘loos-
ening’ of the cyt c structure leading to dissociation of the
axial Met ligand enabling the reactive oxygen species,
H2O2, to readily react with the five-coordinate haem,
resulting in the peroxidation of the bound CL (Kagan et al.
2005). Further interest in the biophysical properties of
human cyt c has stemmed from the discovery of the G41S
mutation in a group of patients suffering from autosomal
dominant thrombocytopenia; a condition consistent with
enhanced apoptotic activity (Morison et al. 2008). In vitro
the G41S mutant has an enhanced ability to activate cas-
pases (Morison et al. 2008). Furthermore, in its native state
and when complexed to CL the G41S mutant displays
increased peroxidatic activity (Josephs et al. 2014; Raja-
gopal et al. 2013). In the native state this likely arises from
a change in the ‘on’ rate of the axial Met equilibrium,
which may stem from changes in the dynamic properties as
a result of the mutation.
Currently, no atomic resolution information of the cyt c/
CL complex is available, but the development of new
methodologies that incorporate NMR spectroscopy to study
protein:phospholipid complexes in solution have the
potential to provide this information. Likewise, NMR is
well suited to explore dynamics over multiple time-scales,
and can therefore be suitably applied to investigate the
dynamic properties of the G41S mutant. As a prelude to the
aforementioned investigations, this assignment note reports
the backbone resonance assignments of the ferric human
cyt c and the ferric and ferrous forms of its G41S mutant
and compares backbone amide (HN) chemical shift dif-
ferences between the pair.
Methods and experiments
Protein expression and purification
Construction of the G41S mutant of human cyt c has been
previously reported (Rajagopal et al. 2013). Overexpres-
sion of uniformly-labelled 13C, 15N wild type (WT) and
G41S proteins was carried out in Escherichia coli using
BL21(DE3) RIL cells (Invitrogen) by the co-expression of
genes for the WT or G41S and yeast haem lyase in a
pUC19Amp vector. Starting cultures, consisting of 3 ml of
Terrific Broth (Melford Chemicals), were inoculated with
overnight transformants and grown at 37 "C with shaking
at 220 rpm for*4 h. Autoclaved M9 minimal media salts
were supplemented with 0.8 g/L 15NH4Cl, 5 g/L
13C6-
glucose, 10 ml/L trace elements mix, 10 ml/L vitamin mix,
10 ml/L 1 M MgCl2, and 6 ml/L thiamine as described in
(Cai et al. 1998). In addition d-aminolevulinic acid (Sigma)
as the first committed precursor of haem biosynthesis was
added to a final concentration of 0.1 mM. A 2 L flask
containing *360 ml of supplemented minimal media mix
was inoculated with 2 ml of pre-culture and growth con-
tinued at 37 "C with shaking at 250 rpm until induction at
an OD600 of 0.6–0.8 with IPTG (Melford) to a final con-
centration of 1 mM. Cells were harvested after 16 h by
centrifugation and purification was carried out as previ-
ously described (Pollock et al. 1998; Rajagopal et al.
2013).
Sample preparation and NMR spectroscopy
Ferric cyt c was prepared by the addition of 1.5-fold excess
of K3[Fe(CN)6] (Sigma) followed by removal of the excess
K3[Fe(CN)6] and K4[Fe(CN)6] and exchange into 20 mM
sodium phosphate pH 6.8, 50 mM NaCl using a PD-10
column (GE-Healthcare). For reduced samples excess
sodium ascorbate (Sigma) was added followed by removal
and exchange into the same buffer as the ferric samples.
All NMR samples contained 1 mM of the respective pro-
tein with 8–10 % D2O (Sigma) for the lock. A set of 2D
[1H, 15N]-HSQC and 3D HNCACB and CBCA(CO)NH
spectra were recorded at 293 K for ferric WT human cyt
c on a Bruker 800 MHz spectrometer equipped with a
5 mm HCN inverse triple resonance z-axis gradient probe.
For the ferrous G41S, all spectra were acquired at 288 K on
a Varian INOVA 900 MHz spectrometer equipped with a
5 mm HCN cryogenic probe, while for the G41S ferric
protein all spectra were acquired at 288 K on a Bruker
AVANCE III 900 MHz spectrometer equipped with a
5 mm TCI cryogenic probe. Both 900 MHz probes were
equipped with z-axis pulse field gradients. The same set of
spectra as for WT cyt c were acquired for the ferrous G41S
protein. Non-uniform sampling (NUS) experiments of the
3D HNCACB, CBCA(CO)NH and HNCO spectra were
collected for the ferric G41S protein, with NUS versions of
C(CCO)NH and H(CCO)NH TOCSY spectra used to
confirm assignments. Non-NUS spectra were processed
using the NMRPipe/NMRDraw software package (De-
laglio et al. 1995) or using Topspin (Bruker BioSpin). NUS
spectra were processed with software qMDD (Orekhov and
Jaravine 2011), in conjunction with NMRPipe. All
assignments were obtained using the graphical NMR
assignment program Sparky (Goddard and Kneller 2008)
and/or the CCPN Analysis program (Vranken et al. 2005).
Resonance assignments
Figure 1 shows the [1H, 15N]-HSQC spectra with reso-
nance assignments indicated for the WT and G41S mutant
A. I. Karsisiotis et al.
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Fig. 1 [1H, 15N]-HSQC spectra
of human cyt c a WT ferric
(293 K), b G41S ferric (288 K)
and c G41S ferrous (288 K).
The resonance assignments of
the backbone HN and
tryptophan indole resonances
are indicated. Aliased residues
in the 15N dimension are
marked in red
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of human cyt c. Out of the 99 non-proline residues all HN
resonances were assigned for the WT ferric cyt c, with the
exception of E21 and T28, which were not observed. These
resonances were also not observed in the ferric or ferrous
states of the G41S mutant. Resonances for these residues
are also not assigned in equine cyt c (Volkov et al. 2012). A
strongly shifted upfield HN resonance (*4.45 and
*4.29 ppm for ferric and ferrous species, respectively,
*104.25 ppm in 15N) is observed in all spectra regardless
of mutation or haem oxidation state. Volkov et al. (2012)
have assigned this resonance to G84 in horse heart cyt
c based on the HN of G84 being located close to the centre
of the F82 phenyl ring and therefore likely to experience a
strong ring-current effect. Inspection of the human cyt
c crystal structure (PDB entry 3ZCF) (Rajagopal et al.
2013), indicates a similar orientation and thus we assign
our observed upfield shifted HN resonance in human cyt
c to G84.
For the ferric G41S protein the HN resonances of T40,
Q42, N54, G56, I57 and I81 are not assigned, whilst for the
ferrous protein the HN resonances of T40, G56 and I57
remain unassigned. The HN resonances for these residues
are not observed in the [1H, 15N]-HSQC spectra and triple
resonance peaks associated are either absent or of poor
quality. This could be explained by mobility around the
mutation site in regions 40–42 and 54–57 of the G41S
mutant leading to broad resonances. Residue 81 in the
ferric G41S protein is aliased in the 15N dimension and not
observed in the NUS triple resonance spectra.
Chemical shift differences
A set of 2D [1H, 15N]-HSQC spectra of ferric and ferrous
WT human cyt c were recorded at 288 K so as to analyse
chemical shift differences between the G41S mutant. The
HN assignments for the WT ferric were transferred readily
to the 288 K spectrum, whereas assignments for the WT
ferrous spectrum were acquired from those previously
deposited (BMRB accession number 5406) (Jeng et al.
2002). Representations of the combined backbone HN
chemical shift differences between WT and the G41S
mutant in the different haem oxidation states are shown in
Fig. 2. The two pairs of HSQC spectra were referenced
with respect to each other based on their corresponding 1H
and 15N carrier frequencies where the 1H carrier was placed
on the water resonance. It is apparent that the G41S
mutation introduces large chemical shift differences in both
oxidation states for residues 41, 42 and 43 (mutation site)
as well as 48 and 53 (HN groups in hydrogen bond distance
of the S41 side-chain). However, the ferric state of the
mutant reveals more extensive changes (residues 29–38,
49–52, 55–60 and 79–80) and the magnitude of perturba-
tion is greater (Fig. 2a). The ferric state of mitochondrial
cyt c is more dynamic than the ferrous state (Barker et al.
2001; Moore and Pettigrew 1990), which could account for
some of the differences between the two oxidation states of
the G41S mutant and may also imply that the G41S protein
is more dynamic than the ferric WT. Another explanation
could be that the haem paramagnetic susceptibility tensor is
perturbed in the G41S mutant relative to the WT ferric.
This would alter the contact shift contribution (e.g. M80
Fig. 2a) and the pseudocontact contribution to the chemical
shift, with the latter experienced by many of the residues in
the protein. Further investigations into this and the
dynamics of the G41S mutant are underway.
Data bank deposition
Backbone (HN, N, Ca, Cb) resonance assignments for
ferric WT and the ferric and ferrous G41S human cyt
c have been deposited in the BioMagResBank database
under the accession numbers 25,418, 25,422 and 25,420,
respectively. For the ferric G41S protein backbone CO
resonances have also been deposited.
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Fig. 2 Backbone HN chemical shift perturbations caused by the
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Biological context
Mitochondrial cytochrome c (cyt c) is a small (~12.5 kDa) 
soluble heme containing protein that plays a key role in life 
and death decisions of the cell (Huttemann et  al. 2011). 
For life-sustaining energy production, cyt c acts as an elec-
tron carrier (redox protein) in the mitochondrial electron 
transfer chain (ETC) leading to the production of adeno-
sine triphosphate (ATP). When problems caused by stress 
outweigh the benefits of sustaining viability of a cell, vari-
ous signals can initiate the programmed cell death process 
through intrinsic (mitochondrial) type II apoptosis. In cells 
undergoing type II apoptosis, the phospholipid 1,3-bis(sn-
3′-phosphatidyl)-sn-glycerol, commonly referred to as 
cardiolipin (CL) hijacks the ETC function of cyt c to cre-
ate a protein-phospholipid complex in which cyt c is con-
verted to a peroxidase enzyme through the dissociation of 
the axial Met80 heme ligand (Kagan et al. 2005). This new 
function of cyt c when bound to CL leads to the peroxi-
dation of CL upon reaction of  H2O2 with the cyt c heme, 
resulting in the dissociation of the complex. The modified 
CL then serves as a signal for downstream events that cul-
minate in the permeabilisation of the outer mitochondrial 
membrane and subsequent release of pro-apoptotic factors, 
including cyt c, into the cytoplasm (Ow et al. 2008).
NMR spectroscopy is an amenable technique to study 
protein complexes, with complex interfaces being readily 
mapped through simple chemical shift perturbation experi-
ments (Rajagopal et al. 1997). In recent times advances in 
site-specific isotope labelling methods and the develop-
ment of paramagnetic probes have pushed the boundaries 
of conventional liquid-state NMR to encompass the study 
of large and dynamic complexes (Clore et  al. 2007). The 
characterisation of phospholipid-bound soluble proteins 
is a challenge by liquid-state NMR. One approach that we 
Abstract Human cytochrome c plays a central role in 
the mitochondrial electron transfer chain and in the intrin-
sic apoptosis pathway. Through the interaction with the 
phospholipid cardiolipin, cytochrome c triggers release of 
pro-apoptotic factors, including itself, from the mitochon-
drion into the cytosol of cells undergoing apoptosis. The 
cytochrome c/cardiolipin complex has been extensively 
studied through various spectroscopies, most recently with 
high-field solution and solid-state NMR spectroscopies, 
but there is no agreement between the various studies on 
key structural features of cytochrome c in its complex with 
cardiolipin. In the present study, we report backbone 1H, 
13C, 15N resonance assignments of acid-denatured human 
cytochrome c in the aprotic solvent dimethylsulfoxide. 
These have led to the assignment of a reference 2D 1H-
15N HSQC spectrum in which out of the 99 non-proline 
residues 87% of the backbone amides are assigned. These 
assignments are being used in an interrupted H/D exchange 
strategy to map the binding site of cardiolipin on human 
cytochrome c.
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are adapting to address this problem is to employ an inter-
rupted H/D exchange method. This relies on the dissocia-
tion of the protein-phospholipid complex under the condi-
tions that preserve the backbone amide protection patterns 
established in the complex by measuring the sample in an 
aprotic solvent, such as dimethysulfoxide (DMSO), pre-
venting further H/D exchange. In this way information 
relating to the phospholipid binding site will be preserved 
and this can be extracted by comparing backbone amide 
protection factors in the absence of the phospholipid, cre-
ating an initial snapshot of the phospholipid binding site. 
A similar approach to determine the structure of amyloid 
fibrils (Hoshino et  al. 2002), in protein-folding studies 
(Nishimura et  al. 2005) and to delineate contact sites in 
a protein–protein complex (Dyson et  al. 2008) have been 
reported.
Two recent NMR studies investigating the interac-
tion of horse heart cyt c and CL have been reported. The 
first reports on a multidimensional magic angle spinning 
(MAS) solid-sate NMR investigation with CL containing 
lipid-bilayers (Mandal et al. 2015) and the second is a liq-
uid-state study with cyt c encapsulated in a CL-containing 
micelle (O’Brien et  al. 2015). Surprisingly, both studies 
reveal only minimal chemical shift changes upon interac-
tion with CL, implying no gross structural changes. This is 
opposed to FRET and other spectroscopic studies whereby 
large structural changes are inferred to occur on binding 
CL that drive the creation of the peroxidase form (Hanske 
et al. 2012; Hong et al. 2012; Muenzner et al. 2013). We 
aim to investigate the complex of human cyt c (hcyt c) and 
CL using a tailored interrupted H/D-exchange approach as 
outlined above. As a prelude to this we report here the near 
complete 1H, 15N, 13C sequential assignments of acid-dena-
tured hcyt c in DMSO.
Materials and experiments
Sample preparation and NMR spectroscopy
Over-expression and purification of uniformly-labelled 
13C, 15N wild-type hcyt c was carried out as previously 
described (Karsisiotis et al. 2015). Ferric hcyt c was pre-
pared by the addition of 1.5-fold excess of  K3[Fe(CN)6] 
(Sigma) followed by removal of the excess  K3[Fe(CN)6] 
and  K4[Fe(CN)6] and desalted into 20 mM sodium phos-
phate pH 7 using a PD-10 column (GE-Healthcare). Sam-
ples were then concentrated using 5 kDa cut-oﬀ concentra-
tors, acid-quenched with 0.3% v/v trifluoracetic acid (TFA) 
(Acros Chemicals), flash frozen, freeze-dried overnight and 
stored at −20 °C. Lyophilised samples were dissolved in 
100% DMSO (Sigma) with the addition of a small amount 
of  D2O for the lock, supplemented with 0.2% v/v TFA to 
aid solubility during resuspension, to give a final volume 
of 500 µl and a concentration of ~1 mM. All NMR experi-
ments were performed at 308 K and acquired on a Bruker 
800 MHz spectrometer equipped with a 5 mm HCN inverse 
triple resonance z-axis gradient probe. Data were processed 
with either Topspin (Bruker Biospin) or the NMRPipe and 
NMRDraw package (Delaglio et  al. 1995) or a combina-
tion of both programs. Data analysis was performed with 
the graphical NMR assignment program Sparky (Godd-
ard and Kneller 2008) and the CCPNmr Analysis program 
(Vranken et al. 2005).
Assignments strategy
The NMR method we have been developing to investigate 
the interaction of hcyt c with CL is based around an inter-
rupted H/D-exchange approach. To arrest H/D exchange 
the pH of the sample is acidified through the addition 
of TFA, which also acts as a counter-ion in enabling the 
freeze-quenched sample at a set-exchange time point, to 
be more easily dissolved in the aprotic solvent DMSO. As 
expected therefore, the amide proton chemical shift disper-
sion of acid-denatured hcyt c in DMSO falls into a very 
narrow spectral width (Fig.  1). This caused severe over-
lap in traditional sequence specific assignment experiment 
pairs, such as the 3D HNCACB/CBCA(CO)NH spectra. 
Therefore, experiments relying on carbonyl (i) and (i − 1) 
connectivities, were additionally acquired, such as the 
HNCO/HN(CA)CO pair. However, these experiments are 
also susceptible to the narrow amide proton spectral width 
and were thus only used to corroborate existing assignment 
steps. An essential component of the assignment strategy 
to tackle resonance overlap in an unfolded protein was the 
use of the HNN experiment (Panchal et  al. 2001). This 
provides (i − 1), (i) and (i + 1) connectivities and exploits 
the 15N chemical shift dispersions which are less aﬀected 
in unfolded proteins, compared to folded proteins. Spe-
cifically, for any 1H–15N plane intra-residual (i), sequen-
tial (i−1) and (i + 1) 15N peaks are provided, thus con-
necting any amide with the amide nitrogen chemical shift 
of the preceding and the following residue. In addition, a 
very important secondary source of information is that, in 
these peak triplets, the sign of the diagonal (i) and sequen-
tial (i − 1) and (i + 1) peaks is dependent on the nature of 
adjacent residues (glycines and prolines particularly) (Pan-
chal et al. 2001). This feature provided additional sequence 
specific assignment checkpoints or starting points to use in 
conjunction with the traditional triple resonance experiment 
pairs. While the HNN experiment was particularly useful in 
the identification or verification of possible assignments, it 
was also susceptible to resonance overlap and poor spectral 
quality for some residues.
Near-complete backbone resonance assignments of acid-denatured human cytochrome c in…
1 3
Extent of resonance assignments
Backbone amide proton and nitrogen resonance assign-
ments were obtained for 87% of the 99 non-proline resi-
dues in hcyt c (Fig. 1). This compares to the 98% of back-
bone amide resonances assigned in hcyt c under native 
conditions (Karsisiotis et  al. 2015). Resonances which 
were not assigned in the present work are: K7, C17, 
T19, E66, Y67, Y74, I75, M80, K87, K88, E89, E90 
and K100. These reflect either resonances not observed 
or severe overlap that cannot be resolved. The assign-
ments for K8, H18, L68 and E69 have more ambiguity 
but they were included in the current dataset. This set 
of assignments are being used in conjunction with the 
development of an interrupted H/D exchange strategy to 
obtain both dynamic and structural information regard-
ing the cardiolipin binding site on hcyt c. Encourag-
ingly a good number of 2D 1H–15N HSQC assignments, 
between 40 and 50, are transferable between data sets, 
subject to small chemical shift perturbations when the 
acid-quench and DMSO conditions vary. However, in the 
highly-overlapped region of the spectrum (15N: 115–121 
and 1H: 7.6–8.3 ppm), assignment transfer becomes dif-
ficult or impossible. Therefore, upon finalising exchange 
method conditions, a new set of triple resonance experi-
ments is required, but the current assignments greatly 
speed up assignments of the new dataset. Alternatively, 
assignments can be transferred through a 1H–15N HSQC 
titration between the initial and final conditions. Finally, 
a factor that greatly enhances the usability of the cur-
rent assignment set is that the proposed site(s) of CL 
interaction does not encompass the residues for which 
assignments are missing (O’Brien et al. 2015).
Data bank deposition
Backbone  (HN, N, CA, CB CO) resonance assignments 
have been deposited in the BioMagResBank database under 
the accession number 26973.
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Increased dynamics in the 
40–57 Ω-loop of the G41S variant of 
human cytochrome c promote its 
pro-apoptotic conformation
Andreas Ioannis Karsisiotis1, Oliver M. Deacon1, Michael T. Wilson1, Colin Macdonald2, 
Tharin M. A. Blumenschein2, Geoffrey R. Moore2 & Jonathan A. R. Worrall1
Thrombocytopenia 4 is an inherited autosomal dominant thrombocytopenia, which occurs due to 
mutations in the human gene for cytochrome c that results in enhanced mitochondrial apoptotic 
activity. The Gly41Ser mutation was the first to be reported. Here we report stopped-flow kinetic 
studies of azide binding to human ferricytochrome c and its Gly41Ser variant, together with backbone 
amide H/D exchange and 15N-relaxation dynamics using NMR spectroscopy, to show that alternative 
conformations are kinetically and thermodynamically more readily accessible for the Gly41Ser variant 
than for the wild-type protein. Our work reveals a direct conformational link between the 40–57 Ω-loop 
in which residue 41 resides and the dynamical properties of the axial ligand to the heme iron, Met80, 
such that the replacement of glycine by serine promotes the dissociation of the Met80 ligand, thereby 
increasing the population of a peroxidase active state, which is a key non-native conformational state in 
apoptosis.
Mitochondrial cytochrome c (cyt) is a multifunctional protein that can act as an electron carrier in oxidative 
phosphorylation as a peroxidase in the early stages of the intrinsic apoptosis pathway, as a component of the 
apoptosome, a key complex in the apoptotic pathway and as a signalling molecule affecting the activity of the 
nuclear oncoprotein SET/template-activating factor-Iβ (SET/TAF-Iβ ) complex1–4. Cyt possesses a hexacoordi-
nate heme iron, where His18 and Met80 serve as the axial heme iron ligands, with the heme encapsulated in a 
hydrophobic environment created by a polypeptide fold of five α -helices and 3 Ω-loops (Fig. 1A). Under native 
conditions ferricyt possesses a low level of peroxidase activity5 due to the existence of an equilibrium between 
the dominant hexacoordinate native form, and a minor populated pentacoordinate form in which Met80 is not 
coordinated to the heme iron6. Preceding its release from the mitochondrion at the onset of apoptosis, cyt forms 
a complex with the phospholipid cardiolipin (CL), which drives the formation of the pentacoordinate form and 
greatly boosts peroxidase activity2,7. Further to this, at alkaline pH, ferricyt can access a conformational state 
whereby a Lys residue (73 or 79) within the 71–85 Ω-loop replaces the native Met80 ligand8. This alkaline isom-
erisation occurs with an apparent pK of ~8–9, depending on solution conditions and temperature9. Thus ferricyt 
has several energetically accessible conformational states with very different properties from the native state.
Thrombocytopenia 4 (THC4; OMIM 612004) is an inherited autosomal disease, which occurs due to muta-
tions in the human cytochrome c gene (CYCS) resulting in enhanced mitochondrial apoptotic activity10. Two 
mutations in the CYCS gene have been identified that produce the G41S and Y48H variants of human cytochrome 
c (H-cyt)10,11. The G41S and Y48H substitutions are located in the 40–57 Ω-loop12–15, which has the lowest free 
energy of the five cooperative folding/unfolding units (foldons) assigned in cyt16,17 (Fig. 1A). In the absence of 
CL the G41S variant has been shown to have increased peroxidase activity relative to the wild-type (WT) pro-
tein18,19. High-resolution X-ray structures for the WT and G41S variant of H-cyt have been determined20,21 with 
no gross structural differences between them detected. However, subtle differences in a hydrogen-bond network 
in the vicinity of the heme propionate-7 substituent were observed21 (Fig. 1B) and these may be significant as 
the electronic properties of the heme propionates are known to affect heme reactivity22. The increase in polarity 
1   eesǡ ers  sseǡ ee rǡ eserǡ O4 3ǡ . ͸School of Chemistry, 
ers  s ǡ r eser rǡ 4 7ǡ . rrespee  reess r ers s 
e resse  
... ȋe: .re̻e..Ȍ r .... ȋe: rr̻esse..Ȍ
reee: ͸8 pr ͸016
aepe: 0ͻ  ͸016
Pse: ͸7  ͸016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:30447 | DOI: 10.1038/srep30447
of the heme environment of the G41S protein resulting from the movement of Arg38 and the incorporation of 
additional water molecules (Fig. 1B) may also contribute to an ease of access of H2O2 to the heme of the G41S 
variant leading directly to its enhanced peroxidase activity19,23. In addition to the small conformational difference 
between WT and the G41S variant there is a substantial difference in global stability with the free energy of dena-
turation of WT H-ferricyt at 10.5 kcal mol−1 being 2.6 kcal mol−1 greater than that of the G41S variant21.
Based on the inherent ability of ferricyt to access non-native conformations, it is a possibility that the G41S 
variant perturbs the dynamics of the H-ferricyt energy landscape, thereby changing the relative populations and 
kinetics of conversion between the native state and a non-native conformer. Solution state NMR spectroscopy 
is well suited to provide insight at atomic resolution on the dynamics and conformational changes that serve to 
regulate function in biomolecules24,25. Past NMR investigations have probed the backbone dynamics of cyt with 
the rationale of assessing whether differences in dynamics exist between the heme redox states26–28. In addition 
to NMR the dynamics of cyt are open to investigation by a variety of heme-centred approaches, particularly with 
ligand binding studies6,29. From such studies, combined with NMR data, a consensus exists that the energy land-
scapes of mitochondrial cyt differ considerably between redox states with the ferric form being more flexible22,27 
and having a lower stability than the ferrous form22,30. This may have functional implications for cyt function in 
apoptosis, as it is the ferric oxidation state that has been demonstrated to be necessary for interaction with key 
components of the apoptotic pathway such as the Apoptotic protease activating factor 1 (Apaf-1)31 and also to 
facilitate peroxidase activity32.
In the present study we have used azide (N3−) binding to the heme iron of H-ferricyt, backbone amide proton 
H/D exchange and 15N relaxation dynamics of the oxidised protein to assess whether the G41S variant has altered 
dynamics compared to WT H-ferricyt. We find that the population of the pentacoordinate form is significantly 
greater for the G41S variant than the WT protein, and that the G41S variant has distinctly enhanced dynamics, 
particularly in the 40–57 Ω-loop foldon, which give rise to the increased lability of the Met80 ligand. These find-
ings offer a direct structural insight into how main chain dynamics relate to key structural properties of the heme 
iron of H-ferricyt and importantly how the G41S variant is proapoptotic10,19,21,23 in the context of thrombocyto-
penia 4.
Results and Discussion
The pentacoordinate heme form is more populated in the G41S variant.  Exogenous ligand bind-
ing to ferricyt can be used as a diagnostic probe to assess the lability of the Met80 ligand. On mixing N3−  with WT 
or G41S H-ferricyt an optical transition was observed (Fig. 2A) with differing time courses for the two proteins, 
Figure 1. Structure of human cytochrome c. (A) Cartoon representation of H-cyt with the five foldons 
identified in horse cyt indicated and coloured as follows: the blue unit (N and C-terminal helices, residues 1–13, 
86–104), the green unit (residues 14–36 Ω-loop, 62–70), the cyan neck unit (residues 37–39 and 58–61), the 
red unit (residues 71–85 Ω-loop) and the yellow unit (residues 40–57 Ω-loop). The His18 and Met80 ligands 
are labelled (PDB code: 3ZCF)21. (B) Positional movement of the Arg38 and Asn52 side chains identified in 
the G41S variant (yellow, PDB code: 3NWV)20 compared to the WT protein (light blue, PDB code: 3ZCF)21. 
H-bond networks are illustrated as blue (WT) and red broken lines (G41S), with H2O molecules shown as light 
blue (WT) and red (G41S) spheres. Note that in the G41S structure two additional H2O molecules neighbour 
Arg38.
www.nature.com/scientificreports/
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as shown in the inset to Fig. 2A. Such an optical transition reflects the dissociation of the Met80 ligand from the 
heme and the binding of N3−  in its place. Confirmation of this assignment was obtained in separate experiments 
at higher [H-ferricyt] (Fig. S1) that revealed the addition of N3−  to WT and G41S led to the bleaching of the 
695 nm band, which is diagnostic for the loss of the Met80 ligand. The optical transition consisted of a single 
exponential at every wavelength with no intermediates detected (inset Fig. 2A). The normalised amplitudes of 
such time courses, taken over a range of [N3−] conform to a simple hyperbolic binding isotherm (Fig. 2B) to yield 
apparent equilibrium dissociation constants (Kapp) of 0.31 ± 0.03 and 0.11 ± 0.01 M for WT and G41S H-ferricyt, 
respectively. The dependence of the observed rate constant (kobs) for N3−  binding obtained from plots such as 
those in the inset to Fig. 2A is under the [N3−] measureable, almost linear (vide infra) for both WT and G41S 
(Fig. 2C). Since the apparent pK values for the alkaline transitions of WT and G41S H-ferricyt are different, at 
9.3 and 8.2, respectively, N3−  binding experiments at higher pH values (see Figs S2 and S3) were conducted and 
revealed that the alkaline transition is not significant for the binding of N3−  to H-ferricyt at pH 7. It is therefore 
concluded that N3−  binding to the G41S variant occurs faster and with a higher binding affinity than it does to 
WT H-ferricyt.
Ligand binding to the heme iron of ferricyt is generally discussed in terms of an SN1 mechanism as depicted 
in Fig. 3, where the hexacoordinate ferricyt is in equilibrium with a pentacoordinate form in which the Met80 is 
dissociated from the heme. This equilibrium lies strongly in favour of the hexacoordinate form, with N3−  binding 
to the pentacoordinate form yielding the low-spin hexacoordinate N3−  adduct (Fig. 3). The mechanism given is 
amenable to full analysis but this leads to unwieldy equations to describe the kinetic behaviour of the system. 
However, a simplifying assumption can be made in that the concentration of the pentacoordinate species, that is 
at all times small, is in a steady-state throughout the reaction29. Furthermore, as the [N3−] is high relative to the 
[H-ferricyt] the binding kinetics may be considered to be pseudo-first order. These simplifications allow for equa-
tions 1 and 2 to be derived that describe the Kapp (Eq. 1) and the dependence of kobs for N3−binding as a function 
of [N3−] (Eq. 2).
Figure 2. Stopped-flow kinetics of N3− binding to H-ferricyt at pH 7 and 25 °C. (A) Spectra generated on 
mixing H-ferricyt with N3− . Global analysis indicated a single transition with the initial spectrum (black) and 
the N3−  bound spectrum (light blue). Inset: time courses for N3−binding to WT (black) and G41S (red) (5  µ M  
after mixing) are shown together with exponential fits. (B) The normalised amplitudes of the time courses 
recorded at 420 nm plotted against [N3−]. Binding curves are fitted to a hyperbolic equation to yield the Kapp 
values reported in the main text. (C) The rate constant (kobs) determined for N3−  binding with solid lines 
representative of fits to Eq. 2, to give the k1 and k-2 values reported in the main text.
Figure 3. SN1 mechanism of N3− binding to H-ferricyt. The dissociation and re-association of the Met80 
ligand to the Fe(III) occur with rates of k1 and k−1, respectively, prior to N3−  association.
www.nature.com/scientificreports/
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where K = k1/k−1 and KD = k−2/k2, with k2 the pseudo-first order rate constant for N3−  binding i.e. k2 = k’[N3−], k’ 
the second order rate constant and kobs is ~k1 at high [N3−]. Equation 1 shows that if K < 1 (as here where the pen-
tacoordinate concentration is very low) then Kapp is ~KD/K. Assuming that N3−  binding to the pentacoordinate 
species is not directly affected by a distant mutation in the protein, then KD will be the same for both proteins and 
the ratio of Kapp values (WTKapp/G41SKapp) reflect the ratio of K values (G41SK/WTK). On this basis G41SK > WTK and 
thus the pentacoordinate form is more populated in the G41S variant than in the WT protein.
Equation 2 predicts that plots of kobs versus [N3−] follow hyperbolae that intercept the kobs axis at the value of 
k− 2, the N3−  dissociation rate constant, and plateau at k1, the Met80 dissociation rate constant. Fitting the data 
in Fig. 2C to Eq. 2 gives k− 2 values of 3.5 ± 0.4 and 8.9 ± 0.3 s− 1 for WT and G41S, respectively. Over the [N3−] 
range that was accessible experimentally the hyperbolic curvature was not discerned and thus reliable values of 
the Met80 dissociation constants (k1) cannot be provided. However, it is possible to estimate minimum values for 
k1 of 5.77 ± 1.5 and 45 ± 18 s−1, for WT and G41S, respectively, consistent both with Eq. 2 and the data (Fig. 2C). 
The k1 for H-ferricyt may be compared to the value of 11–16 s−1 for horse ferricyt obtained by non-linear fitting 
procedures of the data reported by Sutin and Yandell using N3−  as the competing ligand6. The differences between 
horse and H-ferricyt is possibly associated with the sequence difference at position 83 in the 71–85 Ω-loop that 
may effect the dynamics of the Met80 ligand as proposed by Bowler and co-workers33. Thus the considerably 
larger estimates for the rate of Met80 dissociation for the G41S variant is again consistent with the pentacoordi-
nate form being more populated in the G41S variant than in the WT protein, pointing towards a more flexible 
and labile heme crevice.
The lowest free energy cyt foldon has increased H/D-exchange in the G41S variant.  Monitoring 
H/D exchange for backbone amide protons with NMR spectroscopy is a tool that provides per residue resolution 
of structural features and thermodynamic stability of a protein, with exchange rates influenced mainly by hydro-
gen bonding, particularly in secondary structure, and solvent accessibility34. A convenient form of expressing 
variation in H/D exchange behaviour is to compare the amide protection actors (PF), defined as the ratio between 
the observed experimental and intrinsic exchange rates (kex/kin), where the intrinsic exchange rates are the rates 
of exchange for the given amino acid sequence, pH and temperature determined using unstructured peptides35. 
Table S1 reports the exchange rates, calculated PFs, free energies of exchange (∆ Gex) and proton occupancy val-
ues for each residue. For both WT and G41S H-ferricyt, 32 and 46 amides, respectively, are fully exchanged within 
the first 10 min. Figure 4A shows the sequence dependence of the PFs for the 63 remaining residues of WT for 
which H/D exchange rates could be calculated and Fig. 4B, the comparable figure for the 44 residues for which 
H/D exchange data could be determined for the G41S variant. The H/D exchange profile of WT can be broadly 
divided into six continuous regions of increased protection, residues 6–15, 32–45, 51–54, 64–70, 73–75 and 
90–103 (Fig. 4A). With the exception of segment 32–45, the protected regions correlate well with the presence 
of α -helical secondary structure (Fig. 5A). This profile is largely retained for the G41S variant, however the helix 
2 region (residues 51–54) and residues between 27–43 are notable exceptions (Fig. 4B). As is clear from Fig. 5B, 
many of the residues in the G41S variant having reduced protection to H/D exchange are close to the heme on the 
Met80 side of the heme. This is consistent with the results of the N3−  binding experiments, which shows that there 
is a greater amount of the pentacoordinate form for the G41S variant.
The H/D exchange data for H-ferricyt is comparable to that reported for yeast and horse ferricyt36,37. Protons 
showing the slowest exchange are mostly confined to the N- and C-terminal foldon37,38. In general, H/D exchange 
for amides that are in H-bonds in the ground-state structure of a protein can occur via global unfolding of the 
protein, through local unfolding, or by a combination of the two. An indicator that global unfolding is the key 
event is shown by a correspondence between the ∆ Gstability, as determined from denaturant-induced equilibrium 
unfolding, and ∆ Gex for the amide H/D exchange process. When ∆ Gstability > ∆ Gex local unfolding promotes the 
H/D exchange. This is the case in horse ferricyt where most of the amides involved in H-bonds in the ground-state 
structure have ∆ Gstability > ∆ Gex and thus local unfolding is important for this protein36. This is also the case here 
for WT H-ferricyt as ∆ Gstability measured under the same conditions as the H/D exchange (Table S2) is signifi-
cantly greater than the ∆ Gex values given in Table S1. Maity et al.39 describe H/D exchange in horse cyt in terms of 
five foldon units that fold with different folding free energies in a stepwise sequential manner. The foldon with the 
greatest stability corresponds to the C-terminal and N-terminal α -helices, whilst the two foldons with the lowest 
stability are the 71–85 and 40–57 Ω-loops both involving residues packed around the heme (Fig. 1A)16,39. Our 
H/D exchange data for H-ferricyt are broadly in agreement with their foldon model (Figs 4 and 5).
While WT and G41S H-ferricyt share a broadly similar H/D exchange profile, differences are apparent 
(Fig. 4C). The decreased level of protection in the G41S variant maps onto the three lowest stability foldons 
(Fig. 1A)39 and are assigned to residues 34–43 (the neck), 51–54 (40–57 Ω-loop), 59 and 60 (the neck), 73–75, 79 
and 80 (71–85 Ω-loop) (Fig. 5C), which predominately encompass the heme propionate-7 region of the protein, 
whose conformation is altered in the G41S variant (Fig. 1B)21. The most affected residues of G41S in terms of 
increased susceptibility to H/D exchange are Arg38 and Trp59 (the neck), Ile75 (71–85 Ω-loop) and their near 
neighbours, but Lys27 and Gly34 (14–36 Ω-loop), Ser41, Asp51, Asn52, Lys53 (40–57 Ω-loop), and Lys79 and 
Met80 (71–85 Ω-loop) also stand out with a significantly diminished H/D exchange protection compared to the 
corresponding residues of WT (Fig. 4C). Residues Asn52 and Trp59 are conserved in 99% of the mitochondrial 
www.nature.com/scientificreports/
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cyt sequences and the H-bonds between their side chains and propionate-7 are expected to be conserved in 
90% of the same sequences38. However, there are more potential H-bonding groups within H-bonding distance 
of the heme propionates than can be simultaneously accommodated in H-bonds22. The apparent differences in 
H-bond networks in different structures suggests that some of the weaker H-bonds are continually being broken 
and remade, a view that ties in with the demonstration from H/D exchange that 40–57 Ω-loop has considerable 
dynamics16,17. The rapid H/D exchange for the amide resonances of residues Thr40, Gln42, Gly54, Gly56 and Ile57 
in the G41S variant is further evidence that this region of the variant has increased dynamics since most of these 
residues have significant H/D exchange protection in the WT protein.
Figure 4. Backbone amide proton H/D exchange analysis of H-ferricyt and its G41S variant. PFs for WT 
(A) and the G41S variant (B) plotted against the residue number. For WT, 12 residues underwent fast-exchange 
(logPF ≤ 1), 16 medium (1 < logPF ≤ 2), 23 slow (2 < logPF) and 12 extremely slow-exchange (residual proton 
occupancy > 80% after ~68 h, corresponding to exchange rates < 0.003 h−1, shown in red). For G41S, 4 residue 
underwent fast-exchange, 14 medium, 15 slow and 4 extremely slow-exchange (residual proton occupancy  
> 80%, after ~72 h, corresponding to exchange rates < 0.003 h−1, shown in red). Secondary structure (α -helix)  
is indicated by the bottom red squares, while red squares above represent Pro residues. Unassigned and very 
fast-exchanging residues are indicated in light blue and yellow squares, respectively. Residues for which PFs 
could not be calculated due to the slowness of the exchange in the G41S variant are indicated with black squares  
(7 residues). (C) PF difference plot of [logPWT]-[logPG41S] shown in blue. Residues that are fully exchanged in 
G41S have the PFs observed for WT displayed (light purple). Residues that are unassigned only for the G41S 
variant have the PFs observed for WT displayed (dark purple).
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The G41S variant has enhanced conformational exchange in all three Ω-loops.  Backbone amide 
groups of 15N-labelled proteins have been extensively used to identify regions of proteins that undergo a range of 
dynamics on both a ps-ns and µ s-ms timescale24. Out of the 96 assigned backbone resonances for the WT protein, 
full relaxation data were obtained for 93 residues (Fig. S4). The average relaxation rates (R1 (1/T1) and R2 (1/T2)), 
for the WT protein were R1 = 0.99 ± 0.01 s− 1 and R2 = 14.23 ± 0.22 s− 1 with an average NOE = 0.84 ± 0.01. Full 
relaxation data were obtained for all 92 assigned backbone resonances of the G41S variant (Fig. S4). The average 
values obtained were: R1 = 1.07 ± 0.03 s−1, R2  = 14.48 ± 0.38 s−1 and NOE = 0.84 ± 0.01. Heteronuclear {1H}-15N 
NOE values are indicators of motions in the ps timescale with values close to 1 suggesting rigidity and lower 
values indicating increased local flexibility. Both WT and the G41S variant are rigid in this respect with only the 
C-terminal residue E104 having a NOE value below 0.65 (Fig. 6A,B). The R1 rates are sensitive to motion on the 
ns to ps timescales, and are relatively constant throughout both the WT and G41S sequence. However, a handful 
of R2 rates for the WT are significantly increased above the average, notably those for residues Val20, Gly23, Gly56 
and Asn103, probably reflecting contributions to relaxation from slower conformational exchange contributions, 
as observed with other proteins (Fig. S4). Significantly more residues for the G41S variant have R2 rates deviating 
from the average (Fig. S4). Plots of R2/R1 ratios, which are a useful indicator for identifying residues experiencing 
chemical exchange, show that the G41S variant has significantly more residues displaying slower conformational 
exchange behaviour than the WT protein (Fig. 6A,C). In particular, residues in the 19–35 Ω-loop (Val20, Gly23, 
His33, Gly34), the neck unit (Gly37, Arg38, Lys39 and Ile58), the 40–57 Ω-loop (Ser41, Ser47, Ala51, Asn52, 
Lys53, Lys55), the 71–85 Ω-loop (Gly77) and A101 and N103 at the end of the C-terminal α -helix.
Further analysis of the relaxation data was performed with the Model-free formalism40 (see SI and Table S3), 
which provides three main dynamic parameters: a) the generalized order parameter, S2, b) the effective cor-
relation time, τ e and c) the chemical exchange contribution rate, Rex. The average S2 values, which specify the 
degree of spatial restriction of the N-H bond, for WT and the G41S variant are comparable at 0.924 ± 0.046 and 
0.934 ± 0.050, respectively (Fig. 7). This is consistent with both proteins being relatively rigid, presumably due 
to the α -helical secondary structure and the compact core held together by hydrophobic interactions associated 
with the heme. For WT H-ferricyt, large Rex terms (between 12 and 16 s− 1) were observed for Val20 and Gly23 
(average of 14.52 ± 1.01 s− 1) and smaller Rex terms (< 5 s− 1) for residues Ile9, His18, Gly24, Lys25, Lys39, Gly41, 
Gly45, Ile57, Trp59, Gly60, Ile95, Tyr97 and Ala101 (average of 1.56 ± 0.76 s− 1) (Fig. 7A). For the G41S variant, 
large Rex terms (between 8 and 16 s−1) were observed for Val20, Gly23, His33, Ser41, Lys53, Lys55, Ile58 and Gly77 
(average of 13.40 ± 3.97 s− 1) and smaller Rex terms (< 5 s− 1) for His18, His26, Gly37, Lys39, Gly45 and Thr49 
(average of 2.58 ± 1.29 s−1) (Fig. 7B). Overall, 13 residues have Rex terms of small magnitude and 2 residues large 
Figure 5. PF mapping for H-ferricyt. PFs are colour coded as indicated on (A) the WT and (B) the G41S 
X-ray structures20,21. The WT cartoon representation in Fig. 1A can be used to aid orientation. (C) H/D 
exchange difference profile mapped onto the X-ray structure of the G41S variant. Residues highlighted in violet 
have PF > 0.5 in WT but are fully exchanged in G41S, residues highlighted in dark violet have [∆ (LogPFWT-
LogPFG41S) > 0.5] and residues highlighted in black have PF > 0.5 in WT but are unassigned for G41S.
www.nature.com/scientificreports/
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magnitude for WT, while for the G41S variant 6 residues have Rex terms of small magnitude and 8 residues large 
magnitude, thus indicating enhanced conformational exchange on the ms to µ s timescale in the G41S variant. The 
less informative number of residues with a correlation time (τ e) indicating internal motion was 23 and 20 for the 
WT and G41S variant, respectively (Fig. S5), with many of these assigned to model 5, which reflects both fast and 
slow motions (Table S3) and is difficult to accurately characterise with relaxation data. The significant finding is 
the number of residues exhibiting relatively large Rex terms.
The distribution of residues requiring an Rex term to describe their relaxation data for both WT (15 residues) 
and G41S (14 residues) H-ferricyt have been mapped onto the respective structures in Fig. 8. A striking overall 
resemblance to the H/D exchange difference map shown in Fig. 5C is observed. Furthermore it highlights that 
under native conditions the regions experiencing conformational exchange for both the WT and G41S proteins 
are essentially identical, with the switching of a glycine to a serine at position 41 enhancing the dynamics in 3 
out of the 5 H-ferricyt foldons, and in particular the lowest energy foldon (40–57 Ω-loop). Thus the G41S variant 
nicely illustrates a previous prediction that foldon substructure may determine additional properties16, such as 
apoptotic activity.
Conformational dynamics in the 40–57 Ω-loop modulate the pentacoordinate form and apop-
totic interactions.  The NMR data and N3−  binding kinetics strongly support a linkage in the dynamics of 
the region surrounding heme propionate-7, i.e. the 40–57 Ω-loop and lability of the Met80 heme ligand. A recent 
X-ray structure of the K72A variant of yeast cyt provides further compelling evidence of a direct conformational 
link between Met80 and the heme propionate-7 region by being a conformer in which the Met80 ligand is dis-
sociated from the heme and the Arg38 side chain has moved in a similar manner to that observed in the G41S 
structure (Fig. 1B)20,33. These structural changes coincide with the creation of a H2O channel leading from the 
vacant Met80 position to beyond heme propionate-7 and ending at the Arg38 side chain, resembling more the 
conformation of the G41S H-ferricyt than the WT protein in this region. This channel, with Arg38 proposed to 
act as a seal, has been suggested to enable facile entry of H2O2 into the heme environment and/or provide a H+ 
exit route33. β -sheet formation in the 40s region of the 40–57 Ω-loop has been reported for yeast ferricyt at low pH 
as a result of breaking a H-bond between His26-Pro44. This was suggested to trigger rearrangement in the Met80 
loop since β -sheet formation was accompanied by dissociation of Met80 from the heme iron41,42. This event also 
causes disruption of the H-bonding network associated with heme propionate-7 resulting in a change of the heme 
position relative to the polypeptide and increased mobility for aromatic residues such as Trp5941,42. A further 
Figure 6. 15N Relaxation parameters for H-ferricyt. R2/R1 (in black) and {1H}-15N NOE (in blue) for WT  
(A) and G41S (B). α -helices are indicated by the top red squares while below Pro residues and unassigned 
residues are indicated with red and light blue squares, respectively. Residues excluded from the analysis due  
to peak overlap or weak intensity are indicated with yellow squares.
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recent crystal structure of the T78C/K79G yeast cyt variant reveals a non-native form whereby Lys73 replaces 
the Met80 ligand and a conserved stretch of the Met80 loop (76PGTK79) refolds into a β -hairpin structure, with 
Gly77 being a critical element of this hairpin and central to the flexibility of this peptide fragment43. Furthermore, 
a positional change in helix-2 (residues 51–54) occurs to accommodate the refolded Met80 loop which has the 
effect of increasing the volume of the heme pocket and causing peroxidase activity to increase in this T78C/
K79G variant43. Facets of these structural changes in this non-native conformer are therefore comparable with 
the regions displaying increased dynamics in the G41S variant. This suggests that, in solution, alternative confor-
mations are kinetically and thermodynamically accessible in the G41S variant, whereby the heightened dynamics 
in 40–57 Ω-loop foldon is coupled to an increased population of a peroxidase pentacoodinate state, resulting in 
the elevated peroxidase activity akin to the WT protein when bound to CL18,19. In addition to the X-ray structures 
of the variants mentioned above, an important finding from H/D exchange studies is that the dynamics of the 
40–57 Ω-loop controls the rate of the alkaline isomerisation of ferricyt, which leads to Met80 being replaced by 
a lysine as an axial ligand44. Though the alkaline isomerisation is not a factor in our N3−  binding experiments, 
and thus not a factor in generation of the pentacoordinate, it is a further demonstration that the dynamics of the 
40–57 Ω-loop and Met80 lability are linked and can govern function16.
Finally, the 40–57 Ω-loop is the least conserved in cyt evolution. This has been highlighted recently through 
the discovery of a species-dependent interaction between cyt and Apaf-1 in cytosolic extracts, which is pro-
posed to arise due to sequence variation between mitochondrial species in the 40–57 Ω-loop45. Further to this 
discovery, residues flanking Pro44 have for some time been associated with a conformational change in cells 
undergoing apoptosis46 and recent modelling studies suggest H-cyt interacts with Apaf-1 through contact via 
the 40–57 Ω-loop45,47. Thus based on the present work we propose that the dynamics of 40–57 Ω-loop may be 
species-specific and tuned to regulate interaction with the cognate Apaf-1.
Experimental
NMR sample preparation.  15N-labelled samples of WT H-ferricyt and the G41S variant ranging in concen-
tration from 0.8 to 1 mM were used for all experiments and prepared as described previously48.
NMR Spectroscopy.  All NMR experiments were performed at 288 K (unless specified otherwise) and 
acquired on a Bruker 800 MHz spectrometer equipped with either a 5 mm HCN inverse triple resonance z-axis 
gradient probe or a 5 mm broad band inverse z-axis gradient probe, and a Bruker 500 MHz spectrometer 
Figure 7. Model-free parameters for H-ferricyt. S2 order parameters (in blue) and Rex contributions  
(in black) for WT (A) and G41S (B). α -helices are indicated by the top red squares while below Pro residues 
and unassigned residues are indicated with red and light blue squares, respectively. Residues excluded from the 
analysis due to peak overlap or weak intensity are indicated with yellow squares.
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equipped with a 5 mm HCN inverse triple resonance z-axis gradient probe. Data were processed with either 
Topspin (Bruker Biospin) or the NMRPipe and NMRDraw package49. Data analysis was performed with the 
programs CCPNmr Analysis50 and Sparky51. The amide chemical shifts used in this work for the WT and G41S 
variant have been previously determined (BMRB accession numbers 25418 and 25422, respectively)48.
H/D exchange.  Freeze-dried 15N-labelled and desalted samples of both WT and G41S H-ferricyt at 1 mM 
concentration were re-dissolved in 20 mM sodium phosphate pH 6.5, 50 mM NaCl pre-made in 99.9% 2H2O 
(Sigma). All H/D exchange NMR data were acquired at 500 MHz as matrices of 1024 ×  64 complex data points 
with 4 scans and spectral widths of 15 (1H) and 42 (15N) ppm (39.8 ppm for G41S) centred at 4.7 and 118.6 ppm, 
Figure 8. Dynamic profile mapping of H-ferricyt. Stereo pairs representation of (A) WT with the five 
foldon units coloured as described in the legend to Fig. 1A. NMR dynamics plotted on the X-ray structures of 
WT (B) and G41S (C). Residues highlighted in yellow and red have low (< 5 s−1) and high (> 5 s−1) Rex terms, 
respectively, with those in blue having R2/R1 deviating from the average but without an associated Rex term. In 
all depictions heme and axial ligands are shown in stick representation.
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respectively. The acquisition of consecutive 1H-15N-HSQC spectra started approximately 5 min after sample 
resuspension. Acquisition proceeded for WT with consecutive HSQC spectra of approximately 5 min acquisition 
time for a period of 68 h, totalling 792 experiments. The first 49 experiments (to ensure maximum coverage of the 
fast-exchanging residues) were followed by 74 experiments at 50 min intervals, totalling 123 experiments, which 
were used for the extrapolation of the H/D exchange rates. For the G41S variant, acquisition of 1H-15N-HSQC 
spectra of identical acquisition parameters was executed at specific timed intervals, i.e. 49 consecutive experi-
ments followed by 79 experiments at 50 min intervals. CCPNmr Analysis was used to fit peak volumes as a func-
tion of time to a two-parameter single exponential decay function50. Rates of exchange were extracted from this 
fitting and were used for the calculation of PFs35,52. Intrinsic exchange rate constants required for the calculation 
of PFs were obtained as described previously35. ∆ Gex (Table S1) values were obtained from ∆ Gex = -RTln(PF) 
where R is the gas constant and T is the temperature in Kelvin52.
15N relaxation data.  15N T1, T2, and {1H}-15N NOE data were collected at 800 MHz. Spectra were acquired 
as matrices of 1024 ×  256 complex data points with 8 scans for T1 and T2 data and 64 scans for {1H}-15N NOE 
data. Spectral widths of 15 (1H) and 39.3 (15N) ppm centred at 4.7 and 118.6 ppm respectively, were used. T1 
experiments were acquired with relaxation delays of 10, 50, 80, 200, 500, 750, 2000 and 3500 ms with duplicates 
at 10, 200 and 500 ms. T2 experiments were acquired with relaxation delays of 16.96, 33.92, 50.88, 67.84, 101.76, 
135.68, 203.52 and 254.40 ms with duplicates at 16.96, 50.88 and 101.76 ms. Recycle delays for both experiments 
were 5 s. The repeated relaxation delays were used for the determination of peak height uncertainties53. Identical 
delays were used for both WT and G41S with the exception of the first T1 delay for G41S, which was 20 ms due to 
pulse sequence limitations. Both T1 and T2 series of experiments were acquired with interleaved delay values to 
minimize sample heating. T1 and T2 data for G41S were acquired as a pseudo-3D experiment, and processed as 
individual 2D planes using NMRPipe49. T1 and T2 values were extracted through the fitting of peak heights as a 
function of the relaxation delay to a two-parameter single exponential decay function using the follow intensity 
changes function of CCPN Analysis. These were subsequently converted to R1 and R2 rate constants (R, where 
R1 = 1/T1 and R2  = 1/T2). The fit errors for T1 and T2 were also converted into R1 and R2 errors through the equal-
ity of the T1/T2 and R2/R1 errors. Heteronuclear {1H}-15N NOEs were measured with a proton saturation period 
of 5 s. Interleaved saturated and unsaturated experiments were acquired in triplicate in order to determine the 
experimental errors as the standard deviation of the average NOE value. NOE values were calculated as the ratio 
of the peak heights with and without proton saturation.
Model-free analysis.  Model-free analysis was performed using the Model-free4 program54 complemented 
with the FAST-Modelfree program55 to facilitate and speed-up data analysis and interpretation. The first step 
consisted of the estimation of the rotational correlation time using the program r2r1_tm (http://www.palmer.
hs.columbia.edu/) from the relaxation data. The program quadric_diffusion (http://www.palmer.hs.columbia.
edu/) was used to calculate the rotational diffusion parameters from the output local correlation times. This 
program uses a 3D structure translationally centred on the centre of mass and rotated to the inertia tensor prin-
cipal axes. These manipulations were achieved with the program pdbinertia (http://www.palmer.hs.columbia.
edu/). Initial pdb manipulations preceding the use of pdbinertia were performed with molecular graphics pro-
gram MOLMOL56. Quadric_diffusion also produces a pdb structure rotated to axially symmetric principal axes, 
subsequently used as an input for FAST-Model-free. The paramagnetic contribution from the low-spin (S = ½) 
heme to the nitrogen relaxation rates is considered negligible because of the low gyromagnetic ratio of the 15N 
nucleus57. The Tjandra-Bax conditions58 were applied in order to exclude residues with a large-amplitude fast 
internal motions and residues subject to conformational exchange from the rotational correlation time calcu-
lations. The former applies if the {1H}-15N NOE < 0.65 and the later applies if [(T2,av −  T2,n)/T2,av −  (T1,av −  T1,n)/
T2av] > 1.5 x standard deviation, where T1,av and T2,av the average values, and T1,n and T2,n are the relaxation times 
for each individual residue, n. These conditions identify the ‘rigid’ residues with relaxation parameter values cor-
responding to the global rotational dynamics.
The five models considered for the interpretation of dynamic parameters using the Model-free approach40,59,60 
were: model 1 (with only the generalized order parameter S2), model 2 (with S2 and the correlation time for inter-
nal motion τ e), model 3 (S2 and the exchange contribution to the relaxation rate, Rex, or model 1 with Rex), model 
4 (S2, τ e and Rex or model 2 with Rex) and finally the extended model 5 (with the generalized order parameter for 
faster and slower timescales, S2 = S2fS2s and τ e) which accounts for a fast and a slow internal motion. The models 
with Rex terms (3 and 4) reflect on conformational exchange processes on the ms to µ s timescale. The models with 
effective correlation time reflect on internal motions on the ps to ns timescale. Model-free analysis was performed 
with 15N gyromagnetic ratio of −  2.71, N-H bond distance of 1.02 Å and 15N chemical shift anisotropy of −  160. 
FAST-Model-free calculations were performed with confidence limit for χ 2-testing of 0.95, confidence limit for 
F-testing of 0.80, 50 iterations, sum squared error cut-off of 200, 500–1000 Monte-Carlo simulations and optimi-
zation of the diffusion tensor.
Stopped-flow kinetics.  Kinetic experiments were carried out using an Applied Photophysics (Leatherhead, 
UK) SX20 stopped-flow spectrophotometer equipped with both photomultiplier and diode array detection sys-
tems and thermostatted at 25 °C. Stocks of sodium azide 2 M were prepared in 50 mM sodium phosphate and 
50 mM MES pH 7 and diluted to the desired N3−  concentration with the same buffer but containing 2 M NaCl 
to maintain the ionic strength. Time courses were taken at 420 nm with known [N3−] (between 0.08–2 M before 
mixing) and 10 µ M protein (before mixing) with the transient fitted to a single exponential function yielding both 
pseudo first-order rate constants and amplitudes. All errors reported are standard errors.
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9 ABSTRACT: Proteins performing multiple biochemical functions
10 are called “moonlighting proteins” or extreme multifunctional
11 (EMF) proteins. Mitochondrial cytochrome c is an EMF protein
12 that binds multiple partner proteins to act as a signaling molecule,
13 transfers electrons in the respiratory chain, and acts as a peroxidase in
14 apoptosis. Mutations in the cytochrome c gene lead to the disease
15 thrombocytopenia, which is accompanied by enhanced apoptotic
16 activity. The Y48H variant arises from one such mutation and is
17 found in the 40−57 Ω-loop, the lowest-unfolding free energy
18 substructure of the cytochrome c fold. A 1.36 Å resolution X-ray
19 structure of the Y48H variant reveals minimal structural changes
20 compared to the wild-type structure, with the axial Met80 ligand
21 coordinated to the heme iron. Despite this, the intrinsic peroxidase activity is enhanced, implying that a pentacoordinate heme
22 state is more prevalent in the Y48H variant, corroborated through determination of a Met80 “oﬀ rate” of >125 s−1 compared to a
23 rate of ∼6 s−1 for the wild-type protein. Heteronuclear nuclear magnetic resonance measurements with the oxidized Y48H
24 variant reveal heightened dynamics in the 40−57 Ω-loop and the Met80-containing 71−85 Ω-loop relative to the wild-type
25 protein, illustrating communication between these substructures. Placed into context with the G41S cytochrome c variant, also
26 implicated in thrombocytopenia, a dynamic picture associated with this disease relative to cytochrome c is emerging whereby
27 increasing dynamics in substructures of the cytochrome c fold serve to facilitate an increased population of the peroxidatic
28 pentacoordinate heme state in the following order: wild type < G41S < Y48H.
29 The discovery that many proteins have more than one30 biological function was an important advance in under-
31 standing how complex organisms can have relatively few genes
32 to perform the many thousands of biochemical functions that
33 occur within it.3,4 Jeﬀery listed a variety of mechanisms by
34 which the function of a protein can switch between its diﬀerent
35 activities and termed this ability “moonlighting”.6 In addition to
36 genetic origins governing expression, these mechanisms
37 included diﬀerential localization within the cell, intracellular
38 versus extracellular location, oligomerization, variable ligand/
39 substrate concentrations, chemical regulation of activity,
40 diﬀerent binding sites for diﬀerent partner molecules, and
41 being part of diﬀerent multiprotein complexes.6 Advances in
42 the ﬁeld have led to the recent suggestion that the phrase
43 “extreme multifunctional (EMF) proteins” be employed instead
44 of moonlighting proteins.7 The rebranding is to create focus on
45 the functional aspects of the phenomenon, rather than the
46 mechanistic, noting that what makes moonlighting proteins
47 worth studying is the fact that they perform diverse functions
48 and so that is what their deﬁnition should emphasize.8
49 However, from a chemical perspective, it is important to
50 understand how moonlighting or EMF proteins operate.
51Energy landscape theory9 suggests that one way a protein
52could moonlight is if the ground state structure, which is the
53prevalent form under physiological conditions, is in equilibrium
54with one or more higher-energy forms of diﬀerent structure
55present in small amounts. Such excited states of proteins have
56been identiﬁed in numerous systems in recent years,
57particularly through studies of protein folding, but also in
58ligand binding and enzyme catalysis,10,11 and thus, it is
59reasonable to think that this oﬀers a route to enable proteins
60to moonlight.
61Cytochrome c (Cc) is well-known for its role in
62mitochondrial electron transfer as an electron carrier between
63the cytochrome bc1 and aa3 complexes,
12 but it also plays two
64important roles in apoptosis.13,14 One role is as a peroxidase to
65oxidize lipids as part of the process of creating a pore in the
66outer mitochondrial membrane,15 and the second set of roles is
67as a component of various multiprotein complexes, including
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68 the cytoplasmic apoptosome multiprotein complex,16 heat
69 shock protein 27,17 and inositol triphosphate receptors in the
70 endoplasmic reticulum.18 Cc also functions as an inhibitor of a
71 histone chaperone activity in the nucleus following DNA
72 damage by binding to a nucleosome assembly protein19 and as
73 an extracellular ligand to serum leucine-rich α-2-glycoprotein-
74 1,20 an interaction that helps lymphocytes to survive from the
75 toxicity resulting from Cc being released from cells undergoing
76 apoptosis. From the available structural information, it appears
77 that Cc in its role as a histone chaperone inhibitor19 and as a
78 component of the apoptosome21 binds to the relevant partner
79 proteins at sites overlapping its binding sites for the
80 cytochrome bc1 and aa3 complexes.
22,23 Thus, in these
81 moonlighting roles, Cc appears to ﬁt in well with the possible
82 mechanisms described by Jeﬀery.6 However, to turn Cc from an
83 electron carrier into a peroxidase requires a major change in the
84 way the heme group interacts with the polypeptide chain. The
85 electron-transfer form of Cc, which we can call the ground state
86 conformation, possesses a hexacoordinate heme iron with the
87 side chains of His18 and Met80 acting as the axial heme iron
88 ligands. To act as a peroxidase, Cc needs a pentacoordinate
89 heme to allow the Fe(III) to react directly with H2O2, and it is
90 this pentacoordinate state that we have suggested is the poorly
91 populated excited state in equilibrium with the ground state1
92 Mutations in the human Cc (hCc) gene (CYCS) give rise to
93 an inherited autosomal dominant disease, thrombocytopenia 4
94 (THC4; OMIM 612004), which is accompanied by enhanced
95 mitochondrial apoptotic activity.24 To date, three mutations
96 have been identiﬁed in the CYCS gene that give rise to the
97 G41S, Y48H, and A51V protein variants.24−26 We, and others,
98 have shown that the oxidized form of the hCc G41S variant has
99 an intrinsic peroxidase activity greater than that of the wild-type
100 (WT) protein.27,28 Furthermore, using nuclear magnetic
101 resonance (NMR) and azide binding kinetics, we have shown
102 that an equilibrium exists between the hexacoordinate ground
103 state and a pentacoordinate excited state, with more of the
104 G41S variant in the excited state than for the WT protein.1
105 Here we report on studies of the second pro-apoptotic variant
106 of hCc, Y48H, and show for the ferric form even more of this
107 variant is in the excited pentacoordinate state than the G41S
108 variant, and that this population diﬀerence is correlated with
109 their relative stabilities and peroxidase activities.
110 ■ MATERIALS AND METHODS
111 Site-Directed Mutagenesis and Puriﬁcation of the
112 Y48H Human cyt c Variant. The Y48H variant of hCc was
113 constructed using the QuikChange mutagenesis (Stratagene)
114 protocol. The forward and reverse mutagenic primers were 5′-
115 GCC CCT GGA TAC TCT CAT ACA GCC GCC AAT AAG
116 AAC-3′ and 5′-GTT CTT ATT GGC GGC TGT ATG AGA
117 GTA TCC AGG GGC-3′, respectively. A polymerase chain
118 reaction (PCR) mix consisting of primers (75 ng/μL), the wild-
119 type template (15 ng/μL), 10 mM dNTPs (Fermentas), PFU
120 Turbo polymerase (Stratagene), 10 X Pfu Buﬀer (Agilent), and
121 deionized water to give a ﬁnal volume of 50 μL was prepared
122 and subjected to the following PCR cycle; 95 °C for 3 min; 18
123 cycles of 95 °C for 1 min, 65 °C for 1 min, and 72 °C for 6
124 min; and 72 °C for 10 min. Overexpression of the Y48H variant
125 together with the wild type and G41S variant in Escherichia coli
126 was performed in BL21(DE3) RIL (Invitrogen) cells with
127 isolation and puriﬁcation performed as reported previously.27
128 Protein Preparation. Oxidized Cc proteins were prepared
129 by the addition of excess K3[Fe(CN)6], followed by removal of
130K3[Fe(CN)6] and K4[Fe(CN)6] and exchange into a desired
131buﬀer using a PD-10 column (GE Healthcare). The protein
132concentration was determined with a Cary 60 spectropho-
133tometer (Agilent) and a molar extinction coeﬃcient (ε) of 106
134mM−1 cm−1 at 409 nm.
135Chemical Denaturation and Alkaline pH Titrations.
136Far-ultraviolet (far-UV) circular dichroism (CD) spectra at 15
137°C for oxidized Cc proteins (20 μM) in 10 mM potassium
138phosphate and 50 mM potassium ﬂuoride (pH 6.5) were
139recorded in the wavelength range of 190−250 nm with an
140Applied Photophysics (Leatherhead, U.K.) Chirascan CD
141spectrophotometer. Oxidized Cc stabilities were determined
142by titrating a 6 M stock solution of guanidine hydrochloride
143(GuHCl) (Fluka) to a 20 μM protein sample and the changes
144in molar ellipticity at 222 nm (θ222) monitored. All titrations
145were performed in triplicate. The fraction unfolded (Fu) at any
146given GuHCl concentration was determined,29 and the free
147energy of unfolding (ΔGunf) and dependence of ΔGunf on
148denaturant concentration (m value) were calculated using an
149equation for a two-state unfolding process.2 The pH depend-
150ence of the 695 nm band in the ultraviolet−visible (UV−vis)
151spectrum was monitored at room temperature by determining
152its absorbance at various pH values for a solution of 100 μM
153oxidized Cc in a quartz cuvette (Hellma) with a small aliquot of
154K3[Fe(CN)6] present to maintain an oxidizing environment.
155The pH of the buﬀer [20 mM sodium phosphate (pH 6.0)] was
156adjusted with microliter aliquots of 1 M NaOH and measured
157after each addition using a semimicro glass pH electrode. pH
158titrations were repeated up to three times with diﬀerent batches
159of proteins. Data were ﬁtted to a one-proton ionization
160equilibrium equation to yield an apparent pKa.
161Preparation of Liposomes and Peroxidase Assays. The
162phospholipids 1,1′,2,2′-tetraoleoyl cardiolipin (TOCL) and 1,2-
163dioleoyl-sn-glycero-3-phosphocholine (DOPC) (Avanti Polar
164Lipids, Alabaster, AL) were mixed in a 1:1 ratio, vortexed with
165the appropriate amount of buﬀer [20 mM sodium phosphate
166(pH 6.5)], and sonicated for 5 min in a high-power sonicating
167water bath ﬁlled with ice-cold water to give the desired stock
168concentration as previously described.27 Peroxidase assays of
169the ferriCc proteins were performed in the absence and
170presence of liposomes using H2O2 (Sigma) and 2,2-azinobis(3-
171ethylbenzthiazoline-6-sulfonic acid) (ABTS) (Sigma). The
172oxidation of ABTS was monitored at 730 nm on a Hewlett-
173Packard 8453 diode array spectrophotometer scanning between
174190 and 1100 nm and thermostated at 20 °C. The reaction was
175initiated by the addition of 1 mM H2O2 (after 40 s) to a series
176of cuvettes containing 5 μM ferriCc and 200 μM ABTS with or
177without 25 μM TOCL/DOPC from a 2.5 mM stock. Using the
178wavelength pair of 475 and 730 nm, the slope of each trace
179(post-lag phase) was determined to obtain a rate in absorbance
180units per second. The rate of ferriCc turnover is reported in
181inverse seconds obtained by dividing absorbance units per
182second by the product of the concentration of oxidized ABTS
183(ε = 14 mM−1 cm−1) and the total protein concentration of 5
184μM. All assays were performed in triplicate with errors reported
185as the standard error.
186Stopped-Flow Kinetics. An Applied Photophysics SX20
187stopped-ﬂow spectrophotometer thermostated at 25 °C and
188equipped with both photomultiplier and diode array detection
189systems was used to monitor the kinetics of binding of azide
190(N3
−) to the oxidized Y48H hCc variant. A stock solution of 2
191M sodium azide (Sigma) was prepared in 50 mM MES (pH
1927.0) and diluted to the desired N3
− concentration with the
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193 same buﬀer containing 2 M NaCl to maintain the ionic
194 strength. Reaction time courses were taken at 420 nm with the
195 N3
− concentration varying between 0.08 and 2 M before mixing
196 and 10 μM protein (before mixing). All transients were ﬁtted to
197 a single-exponential function yielding both pseudo-ﬁrst-order
198 rate constants and amplitudes.
199 Crystallization and X-ray Structure Determination.
200 Crystals were grown using the sitting-drop vapor diﬀusion
201 method at 18 °C. A 0.2 μL solution containing 56 mg/mL
202 oxidized Y48H Cc variant in 20 mM sodium phosphate (pH
203 6.5) was mixed with an equal volume of a reservoir solution
204 [33% PEG6000 and 100 mM Tris-HCl (pH 7.5)] using a
205 Crystal Gryphon robot (Art Robbins Instruments). Crystals
206 were transferred to a cryoprotectant solution containing the
207 reservoir solution and 15% glycerol, before being ﬂash-cooled
208 by being plunged into liquid nitrogen. Crystallographic data
209 were measured at the Swiss Light Source (SLS, Villigen,
210 Switzerland) at beamline X10SA using a Pilatus 6M-F detector
211 (Dectris) and an X-ray wavelength of 1.0 Å. Data were indexed
212 using XDS30 and scaled and merged using Aimless31 in the
213 CCP4 suite with the CCP4i2 interface. The structure was
214 determined by molecular replacement in Phaser32 using the
215 WT hCc structure27 [Protein Data Bank (PDB) entry 3zcf] as
216 the search model. The structure was reﬁned with Refmac5,33
217 with model building between reﬁnement cycles in Coot.34
218 Riding hydrogen atoms were added when reﬁnement of the
219 protein atoms had converged. Structures were validated using
220 the Molprobity server35 and the JCSG Quality Control Server
221 and tools within Coot.34 Structural superpositions were
222 performed using GESAMT in CCP4i2.36 Coordinates and
223 structure factors were deposited in the PDB as entry 5O10. A
224 summary of data, reﬁnement statistics, and quality indicators for
t1 225 the structure is given in Table 1.
226 NMR Spectroscopy. All NMR data were collected with a
227 Bruker 500 MHz (H/D exchange) or 800 MHz [one-
228 dimensional (1D), 15N relaxation, and sequence speciﬁc
229 assignments] spectrometer, both equipped with 5 mm HCN
230 inverse triple-resonance z-axis gradient probes. Samples for 1D
231
1H NMR spectroscopy were oxidized and buﬀer exchanged into
23220 mM sodium phosphate (pH 6.5) and freeze-dried. Samples
233were redissolved in 500 μL of 99.9% D2O (sigma) and allowed
234to deuterate at room temperature for ∼72 h. 4,4-Dimethyl-4-
235silapentane-1-sulfonic acid (DSS) (Sigma) (ﬁnal concentration
236of 200 μM) and K3[Fe(CN)6] (ﬁnal concentration of 100 μM
237to maintain an oxidizing environment) were added to each
238sample, and 1D spectra were recorded at temperatures ranging
239from 288 to 313 K using presaturation to suppress the solvent
240signal with spectral widths of 20 and 80 ppm. Spectra were
241processed in Topsin (Bruker Biospin).
242Singly (15N) and doubly (13C and 15N) labeled samples of
243the Y48H hCc variant were prepared using procedures
244previously described.37 NMR samples of the oxidized Y48H
245variant were prepared in 20 mM sodium phosphate (pH 6.5)
246and contained 1 mM protein with 10% D2O (Sigma) for the
247lock. A set of two-dimensional (2D) 1H−15N HSQC and three-
248dimensional (3D) HNCACB and CBCA(CO)NH spectra were
249recorded at 288 K and processed in Topsin (Bruker Biospin).
250Sequence speciﬁc assignments were obtained using the
251CCPNmr Analysis38 and Sparky39 programs.
252H/D exchange NMR data were acquired at 288 K. Freeze-
253dried samples of the oxidized Y48H variant (1 mM) were
254redissolved in 20 mM sodium phosphate (pH 6.5) and 50 mM
255NaCl premade in 99.9% D2O (Sigma). Spectra were recorded
256as matrices of 1024 × 64 complex data points with four scans
257and spectral widths of 15 (1H) and 42 (15N) ppm centered at
2584.7 and 118.6 ppm, respectively. The acquisition of consecutive
259
1H−15N HSQC spectra started ∼5 min after sample
260resuspension. Acquisition proceeded with consecutive HSQC
261spectra with an acquisition time of ∼5 min for a period of 134
262h, totalling 191 experiments. The ﬁrst 100 experiments were
263performed with a 10 s delay between each to ensure maximum
264coverage of the fast-exchanging residues, with the following 74
265experiments at 45 min intervals, followed by 17 experiments at
2664 h intervals. CCPNmr Analysis38 was used to ﬁt peak volumes
267as a function of time to a single-exponential decay function to
268yield decay rates from which protection factors (PFs) were
269calculated40,41 (Table S1). The free energies of exchange
270(ΔGex) were calculated from the equation ΔGex = −RT ln(PF),
271where R is the gas constant and T is the temperature in kelvin41
272(Table S1).
27315N T1 and T2 and [
1H]−15N NOE data were collected at
274288 K with spectra acquired as matrices of 1024 × 256 complex
275data points and eight scans for T1 and T2 data and 64 scans for
276[1H]−15N NOE data. Spectral widths of 15 (1H) and 39.3
277(15N) ppm centered at 4.7 and 118.6 ppm, respectively, were
278used. T1 experiments were performed with relaxation delays of
27920, 50, 80, 200, 500, 750, 2000, and 3500 ms with duplicates at
28020, 200, and 500 ms. T2 experiments were performed with
281relaxation delays of 16.96, 33.92, 50.88, 67.84, 101.76, 135.68,
282203.52, and 254.40 ms with duplicates at 16.96, 50.88, and
283101.76 ms. Recycle delays for both experiments were 5 s. The
284repeated relaxation delays were used for the determination of
285peak height uncertainties.42 The T1 and T2 series of
286experiments were performed as a pseudo-3D experiment and
287processed as individual 2D planes using NMRPipe.43 Residues
288with peak overlap or weak intensity were excluded from the
289analysis. T1 and T2 values were extracted through the ﬁtting of
290peak heights as a function of time to a single-exponential
291function in CCPNmr Analysis.38 These were subsequently
292converted to R1 and R2 rate constants (R1 = 1/T1, and R2 = 1/
293T2). The ﬁt errors for T1 and T2 were also converted into R1
Table 1. Crystallographic Data Processing and Reﬁnement
Statistics for the Y48H hCc Varianta
space group P21
unit cell dimensions a = 56.9 Å, b = 36.5 Å, c = 60.7 Å,
β = 116.7°
resolution (Å) 1.36
Rmerge 0.072 (1.115)
no. of unique reﬂections 45812 (2124)
Mn (I/SD) 13.3 (1.4)
CC1/2 0.998 (0.512)
completeness (%) 95.3 (90.2)
redundancy 6.2 (5.4)
Rcryst 0.144
Rfree 0.175
root-mean-square deviation for bond
lengths (Å)
0.015
root-mean-square deviation for bond
angles (deg)
2.18
Ramachandran favored (%) 97.0
accumulated dose (MGy) 2.54
PDB entry 5O10
aValues in parentheses refer to the outermost resolution shell of 1.39−
1.36 Å.
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294 and R2 errors through the equality of the T1/T2 and R2/R1
295 errors, respectively. Heteronuclear [1H]−15N NOEs were
296 measured with a proton saturation period of 5 s. Interleaved
297 saturated and unsaturated experiments were performed in
298 triplicate to determine the experimental errors as the standard
299 deviation of the average NOE value. NOE values were
300 calculated as the ratio of peak heights with and without proton
301 saturation.
302 ■ RESULTS
303 X-ray Structure of the Pro-Apoptotic Y48H hCc
304 Variant. The X-ray structure of the Y48H variant of hCc
305 was determined to 1.36 Å resolution. A space group of P21 was
306 determined with two hCc molecules found in the crystallo-
307 graphic asymmetric unit, contrasting with the reported X-ray
308 structures of the WT protein27 and G41S variant,44 both of
309 which had a P1 space group and four hCc molecules in the
310 asymmetric unit. The diﬀraction-weighted dose45 incurred
311 during collection of the high-resolution X-ray data set for the
312Y48H variant was 2.54 MGy, a dose greatly exceeding that
313required to fully reduce ferric heme proteins to the ferrous form
314(typically tens to hundreds of kilograys).46,47 Hence, while the
315crystals were obtained from solutions of the ferric protein, in
316light of the extensive previous studies, measuring the doses
317typically required for ferric to ferrous heme protein reduction,
318we consider the structure to likely be predominantly that of the
319ferrous state. It is important to note that earlier X-ray studies of
320tuna Cc48 and Saccharomyces cerevisiae iso-1 Cc49 with X-ray
321doses much smaller than in the study presented here show that
322the conformation of the protein is largely independent of the
323heme oxidation state. Electron density in the heme region is
324consistent with a hexacoordinate species, with the Nε2 atom of
325His18 and the Sδ atom of Met80 coordinating the heme iron.
326The overall fold of each molecule in the asymmetric unit is
327identical to that of the WT protein and the G41S variant, with
328an overall root-mean-square deviation in Cα positions of 0.18 Å
329 f1among the three X-ray structures (Figure 1A). It is noted that
330the Cα deviation between residues 37 and 61 increases to 0.27
Figure 1. X-ray crystal structure of the Y48H variant of hCc. (A) Ribbon representations of a Cα superposition (molecule A) of the Y48H variant
(green, PDB entry 5O10) with the G41S variant (red, PDB entry 3nwv) and WT protein (blue, PDB entry 3zcf). The heme groups are shown as
sticks. (B) Cartoon and stick representation of the region between residues 37 and 49 of the WT protein (blue) and the Y48H (green) and G41S
(red) variants. The coordinate bonds (black dashes) of the axial His18 and Met80 ligands to the heme iron in the Y48H variant are indicated, and H-
bonding is represented as red dashes. The side chain positions of His48, Asn52, and Tyr67 in the Y48H variant are shown together with the side
chain position of Arg38 in all three structures. Water molecules are shown as red spheres for the WT and Y48H structures and as gray spheres for the
G41S variant.
Figure 2. Global stability and pK695 measurement of the oxidized Y48H variant of hCc compared under identical experimental conditions with those
of the WT protein and G41S variant. (A) Plots of fraction unfolded as a function of GuHCl at pH 6.5 and 15 °C. Solid lines are ﬁts to the data using
a two-state equilibrium unfolding equation,2 with the determined ΔGunf values reported in Table 2. (B) pH dependence of the 695 nm absorbance
band. Solid lines are representative ﬁts to the data using a one-proton equilibrium equation with pK695 values reported in Table 2.
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331 Å. Replacing Tyr48 with a His residue alters a H-bonding
332 arrangement involving the heme propionates. In the WT
333 protein structure, the OH group of the Tyr48 side chain forms
334 a H-bond (2.57 Å) to the O1A atom of heme propionate 7.27
335 Such an interaction is lost in the Y48H variant, and the Nδ1
336 atom of the His48 side chain is favorably oriented to form a
337 medium length polar interaction with the O2D atom of heme
338 propionate 6 (3.19 Å) (Figure 1B). The number of H-bond
339 interactions with the OD2 atom of heme propionate 6
340 therefore increases to two, with the second H-bond interaction
341 involving the backbone amide of Thr49. A second medium
342 length polar interaction between the Nδ1 atom of His48 and
343 the OD1 atom of Asn52 (3.19 Å) is also noted, leading to
344 His48 communicating with the Met80 ligand through a H-bond
345 network that extends from Asn52, involving a H2O molecule
346 and Tyr67 (Figure 1B). Interestingly, the Arg38 side chain in
347 the Y48H structure is positioned as in the WT structure, with
348 its ε-amido group coupled to heme propionate 7 via a H2O
349 molecule (Figure 1B). In the G41S structure, the Arg38 side
350 chain moves away from heme propionate 7, leading to the
351 presence of two additional H2O molecules (Figure 1B). These
352 waters enable the ε-amido group of Arg38 to remain coupled to
353 heme propionate 7 via a forked hydrogen bond network
354 (Figure 1B).
355The Y48H Variant Has a Global Stability That Is Lower
356Than That of the G41S Variant but a Similar Alkaline
357Isomerization pK. The Y48H variant of hCc displayed optical
358absorbance properties in the ferric and ferrous oxidation states
359and a far-UV CD spectrum identical to that of the WT protein.
360Far-UV CD spectroscopy is a convenient method for
361determining the global stabilization of a protein through
362chemical denaturation studies using GuHCl as illustrated in
363 f2Figure 2A. It is apparent from Figure 2A that there is a
364progressive loss of cooperativity of unfolding (WT > G41S >
365Y48H), with the Y48H variant having the lowest global stability
366 t2[ΔGunf (Table 2)]. The m value (Table 2), which is a measure
367of the change in hydrophobic surface area that has become
368desolvated upon denaturation, decreases in the following order:
369WT > G41S > Y48H. This suggests that the variants have an
370increasingly more compact denatured state relative to the WT
371protein.50 Interestingly, the K54H variant of S. cerevisiae iso-1
372Cc stabilizes the denatured state through a His−heme loop
373leading to a decreased m value relative to that of the WT
374protein.51 It may be that a similar eﬀect occurs for the Y48H
375variant. Alternatively, the Y48H variant may simply be partially
376unfolded in buﬀer, which would also lower the m value,52 with
377the NMR data (Figure 6A) providing some support for this
378interpretation (vide inf ra).
Table 2. Summary of Thermodynamic and Kinetic Parameters for the Y48H Human Ferricyt c Variant and Comparison with
Those of the WT Protein and the G41S Variant
GuHCl denaturation azide binding
protein ΔGunf (kcal mol−1) m (kcal mol−1 M−1) Cm (M) pK695 Kapp (M) k1 (s−1) k−2 (s−1)
Y48H 5.09 ± 0.16 2.57 ± 0.1 1.98 ± 0.05 8.4 ± 0.1 0.07 ± 0.01 125 12.1 ± 1.1
WT 10.65 ± 0.55 4.10 ± 0.25 2.60 ± 0.05 9.3 ± 0.2 0.31 ± 0.03a 5.77 ± 1.5a 3.5 ± 0.44a
G41S 6.75 ± 0.10 3.0 ± 0.1 2.25 ± 0.05 8.5 ± 0.2 0.11 ± 0.01a 45 ± 18a 8.9 ± 0.3a
aData taken from ref 1.
Figure 3. Binding of azide to the oxidized Y48H variant of the hCc variant compared with data for the WT protein and G41S variant1 at pH 7.0 and
25 °C. (A) Normalized amplitudes from the reaction time courses obtained using stopped-ﬂow absorption spectroscopy at 420 nm plotted vs azide
concentration. Data are ﬁtted to a hyperbolic equation to yield the Kapp values listed in Table 2. (B) Rate constants (kobs) determined for azide
binding with solid lines representing the ﬁts to eq 2, to give the k1 and k−2 values listed in Table 2. (C) SN1 mechanism of binding of azide to
oxidized Cc.
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379 Figure 2B shows the variation in absorbance of the 695 nm
380 band for the oxidized Y48H variant as a function of pH
381 compared to data for WT and the G41S variant. Although the
382 latter pK695 values for the WT and G41S variant have been
383 previously reported,27 they have been re-determined in this
384 study so that a true comparison under identical conditions can
385 be made (i.e., in the absence of NaCl that is known to aﬀect the
386 pK695 value
53). The bleaching of the 695 nm band is a
387 consequence of a deprotonation event in which the axial Met80
388 heme ligand becomes dissociated. The apparent pK695 value for
389 the Y48H variant, which was obtained from these data, is nearly
390 identical to that of the G41S variant but signiﬁcantly lower than
391 that of the WT protein (Table 2). Thus, whereas the global
392 stability for the Y48H variant is clearly decreased, the Met80−
393 Fe(III) bond lability as determined through pK695 values is
394 indistinguishable from that of the G41S pro-apoptotic variant.
395 Exogenous Ligand Binding Reveals the Pentacoordi-
396 nate Form of the Oxidized Y48H Variant Is More
397 Populated Than for the G41S Variant or WT hCc. To
398 probe further variances in Met80−Fe(III) bond lability, the
399 kinetics of N3
− binding was studied using stopped-ﬂow
400 spectrometry. When N3
− is mixed with the oxidized Y48H
401 hCc, an optical transition caused by the dissociation of Met80
402 from the heme iron and the binding of N3
− in its place
403 occurred. The reaction time course of this transition conformed
404 to a simple exponential, as reported previously for the WT
405 protein and the G41S variant under the same experimental
406 conditions.1 Over a broad range of N3
− concentrations, the
407 normalized amplitudes of such reaction time courses follow a
f3 408 simple hyperbolic binding isotherm (Figure 3A), enabling an
409 apparent equilibrium constant (Kapp) for N3
− binding to be
410 determined. From Table 2, it is apparent that the Y48H variant
411 binds N3
− with an aﬃnity higher than that of either the G41S
412 variant or the WT protein. As previously reported, the
413 relationship between kobs and N3
− concentration under the
414 conditions employed is almost linear,1 which is also the case
415 here for the Y48H variant (Figure 3B). Assuming binding of
416 N3
− to oxidized Cc is an SN1 mechanism, in which the
417 hexacoordinate heme form is in equilibrium with a
418 pentacoordinate form, the latter being the form that binds
419 N3
− (Figure 3C), then, as outlined previously,1 eqs 1 and 2 that
420describe the Kapp and the dependence of kobs for N3
− binding as
421a function of N3
− concentration may be derived.
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424where K = k1/k−1, with k1 and k−1 being the rate constants for
425Met80 dissociation and association, respectively, and KD = k−2/
426k2, with k2 being the pseudo-ﬁrst-order rate constant for N3
−
427binding; i.e., k2 = k′[N3−], where k′ is the second-order rate
428constant and kobs ∼ k1 at high N3− concentrations. Equation 2
429predicts that plots of kobs versus N3
− concentration (Figure 3B)
430follow hyperbolae that intercept the kobs axis at the value of k−2
431(N3
− dissociation rate constant) and plateau at k1, the Met80
432ligand dissociation rate constant. Fits of the normalized
433amplitude data are satisfactory and yield the values of Kapp
434listed in Table 2. Fitting the Y48H kinetic data to eq 2
435presented a problem because it was not possible to explore a
436suﬃciently high N3
− concentration where the curve is expected
437to reach a plateau region, and thus, it was diﬃcult to
438discriminate between linear and hyperbolic curves. Given this,
439we have estimated a minimum value of k1 that provides a ﬁt
440(Figure 3B), with a value (125 s−1) quoted without error in
441Table 2, and a reliable k−2 value (Table 2). Nevertheless, from
442this estimation of k1, it is apparent that the Y48H variant has a
443Met80 oﬀ rate signiﬁcantly higher than those of the WT protein
444and the G41S variant. Furthermore, eq 1 shows that when K <
4451, as seen here because the concentration of the pentacoordi-
446nate species is low, then Kapp ∼ KD/K. With the assumption
447that binding of N3
− to the pentacoordinate species is not
448directly aﬀected by a distant mutation in the protein, KD will be
449similar for both the WT protein and the Y48H variant, so that
450the ratio of Kapp values (
WTKapp/
Y48HKapp) reﬂects the ratio of K
451values (Y48HK/WTK). On this basis, Y48HK > G41SK > WTK, and
452thus, the pentacoordinate form of the Y48H variant is more
453populated than in either the G41S variant or the WT protein.
454The Population of the Peroxidase Active Pentacoor-
455dinate Form of the Y48H Variant Does Not Increase
Figure 4. Peroxidase activity at pH 6.5. (A) Illustrative reaction time courses for the oxidation of ABTS in the presence of H2O2 with (+CL) or
without CL-containing liposomes. The vertical dashed line indicates the time point in each assay at which H2O2 was added. (B) Maximum rates of
peroxidation of ABTS with the various forms of ferriCc with (+CL) and without CL-containing liposomes. The error bars are the standard errors
from triplicate measurements.
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456 When CL Binds. The peroxidase activity of the oxidized Y48H
457 hCc variant was compared to that of the WT protein and the
458 G41S variant under the same experimental conditions. From
f4 459 the reaction time courses given in Figure 4A, it is apparent that
460 the WT protein displays a considerable lag phase (∼160 s
461 following addition of H2O2) in the absence of CL-containing
462 liposomes. The lag phase is essentially absent for both the
463 G41S and Y48H variants (Figure 4A). The peroxidase activity
464 of the G41S variant is greater than that of the WT protein but
465 less than that of the Y48H variant (Figure 4B). The progressive
466 increase in peroxidase activity observed correlates with the
467 increase in the level of less cooperative global unfolding (Figure
468 2A). In the presence of CL-containing liposomes, the lag phase
469 is now absent for the WT protein (Figure 4A) with a signiﬁcant
470 boost in peroxidase activity evident (Figure 4B). No change in
471 peroxidase activity is observed for the Y48H variant in the
472 presence of CL-containing liposomes, in contrast to the case for
473 the G41S variant, for which peroxidase activity is increased to a
474 level similar to that of the Y48H variant (Figure 4B). The
475 secondary increase would indicate that the binding of CL to
476 this variant pushes the equilibrium between the hexa- and
477pentacoordinate heme forms farther toward the latter (Figure
4783C), a ﬁnding that further conﬁrms the interpretation from the
479N3
− binding kinetics, that for the Y48H variant the
480pentacoordinate form of the oxidized protein is energetically
481more favored than it is for the G41S variant and the WT
482protein.
483
1H NMR Spectroscopy Reveals an Increase in Heme
484Pocket Dynamics for the Y48H Variant. The 1H NMR
485spectrum of oxidized Cc has many resonances that are shifted
486both downﬁeld and upﬁeld because their nuclei experience a
487hyperﬁne interaction from the unpaired electron on the low-
488spin heme iron.54 These paramagnetic signals can inform the
489electronic structure of the heme and also provide insight into
490heme−ligand dynamics and non-native heme−ligand states.55
491The 1H NMR spectrum of the oxidized WT hCc is shown in
492 f5Figure 5A with some of the upﬁeld- and downﬁeld-shifted
493hyperﬁne resonances of known assignments labeled.56,57 For
494the WT protein and G41S variant, the pattern of chemical shifts
495for the heme−methyl signals is 8 > 3 > 5 > 1 as expected.58
496With an increase in temperature (from 283 to 313 K), the
497hyperﬁne chemical shifts for the 8- and 3-methyl groups of the
Figure 5. Paramagnetic 1H NMR spectra in D2O at pH 6.5 of oxidized hCc. (A) WT Cc spectrum with several well-resolved hyperﬁne-shifted
resonances arising from heme substituents and protein labeled with their assignments. (B and C) Temperature dependence in the downﬁeld and
upﬁeld regions of the spectra for the various hCc proteins. Changes in chemical shift with an increase in temperature for the 8- and 3-methyl heme
substituents are indicated with dashed lines, along with those of Met80 CεH3, Met80 CγH, and His18 C2H.
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498 WT protein and G41S variant display a Curie-type temperature
499 dependence (Figure 5B), whereas the 5-methyl group displays
500 an anti-Curie dependence. A similar temperature dependence is
501 observed for the upﬁeld hyperﬁne-shifted resonances assigned
502 to protons of the axial His18 and Met80 heme−iron ligands
503 (Figure 5C). For the Y48H variant, the spectrum is notably
504 diﬀerent in the upﬁeld or downﬁeld regions (Figure 5B,C). At
505 283 K, there is a splitting of the hyperﬁne peak found at ∼36
506 ppm (Figure 5B). It is known that the 3-methyl group in
507 certain Cc’s, including horse heart Cc, displays excess line
508 broadening compared with the other heme methyl peaks at
509 room temperature and splits into two resonances at lower
510 temperatures.59,60 This view is consistent with exchange
511 broadening due to rapid interconversion between heteroge-
512 neous protein environments around the 3-methyl group.60 The
513 splitting into two peaks at 283 K observed for the peak at ∼36
514 ppm in the Y48H variant is therefore consistent with it being
515 assigned to the 3-methyl group (Figure 5B). Increasing the
516 temperature causes the interconversion rate to increase, and the
517 two components become dynamically averaged leading to a
518 single broadened peak (Figure 5B). Burns and La Mar60
519 showed at 298 K and pH 5.8 that the rate of the exchange
520 process in oxidized horse heart Cc was ∼103 s−1, and a similar
521 rate for Y48H Cc at 283 K and pH 6.5 can be determined from
522 the chemical shift diﬀerence between the heme methyl 3
523 resonances in the two environments (Figure 5B), a rate
524 considerably faster than the rate (k1) we determine for the
525 Met80−Fe(III) bond dissociation (Table 2), showing that the
526 unusual dynamic process aﬀecting heme 3-methyl is not
527 associated with the formation of the pentacoordinate state.
528 Furthermore, the Y48H variant alters the pattern of heme
529 methyl chemical shifts, which now becomes 3 > 8 > 5 > 1. Such
530 an order of heme methyl shifts has not been previously
531 observed in mitochondrially or bacterially oxidized Cc, where
532 the order is either 8 > 3 > 5 > 1 or 5 > 1 > 8 > 3, noting that 8
533 is always >3 and 5 is always >1 in S = 1/2 oxidized Cc.
61 These
534 patterns are governed by the distribution of the unpaired
535 electron, which reﬂects the orientation of heme axial ligands
536 and is largely dependent on two conformers of the Met80 side
537 chain related through inversion of the Met thioether sulfur.58 In
538 this context, we note that the upﬁeld region of the spectrum
539 where hyperﬁne signals for protons of the His18 and Met80
540 side chains are observed in the WT and G41S spectrum is
541 distinctly diﬀerent in the Y48H variant. Thus, although the
542 conformation of the axial ligands is the same in the three X-ray
543 structures, the orientation of at least Met80 for the Y48H
544 variant in solution is diﬀerent. Bren and co-workers61 have
545 demonstrated that ﬂuxional solution behavior of the Met80
546 ligand is commonplace in Cc’s. We suggest that the altered
547 ﬂuxional behavior causes a change in the magnetic susceptibility
548 axes that perturbs the relative chemical shifts of the 3- and 8-
549 methyl resonances.61
550 Finally, we note the presence of non-native hyperﬁne signals
551 in the G41S and Y48H variants in the downﬁeld region
552 between 18 and 26 ppm at ≥303 K (Figure 5B). A similar set of
553 non-native resonances has been observed for oxidized horse Cc
554 at temperatures of >315 K,62 along with the WT resonances,
555 and assigned to the alkaline conformer with Lys and His
556 coordination of the heme Fe(III). For the G41S and Y48H
557 variants, we suggest that as the equilibrium between the hexa-
558 and pentacoordinate heme form is pushed farther toward the
559 latter species with an increase in temperature, these non-native
560 species similarly arise from a fraction of the protein that
561populates the alkaline conformation. The fact that these
562resonances are not observed for the WT protein under similar
563conditions is a further indication that these pro-apoptotic
564variants have a more labile Met80−Fe(III) ligand. Note that the
565N3
− binding study of the G41S variant1 showed that under the
566conditions employed for these measurements the alkaline
567conformer was not signiﬁcantly populated. With the higher
568protein concentrations and longer experimental times needed
569for the NMR experiments, it is clear that at elevated
570temperatures the alkaline conformer becomes populated.
571The Y48H Variant Has Increased Main Chain Mobility
572Relative to That of the G41S Variant. To explore in more
573detail the dynamics of the oxidized Y48H variant, 15N backbone
574amide H/D exchange and 15N relaxation studies using NMR
575spectroscopy were performed. The 1H−15N HSQC spectrum
576 f6of the Y48H variant is shown in Figure 6A overlaid with the
Figure 6. Backbone amide assignments and amide proton H/D
exchange analysis of the oxidized Y48H hCc variant. (A) Overlay of
the 800 MHz 1H−15N HSQC spectrum of the Y48H variant (blue)
with the WT protein spectrum (orange) at 288 K. Assignments for
most of the assigned backbone amide resonances in the Y48H
spectrum are colored blue. (B) PFs for the Y48H variant plotted vs
residue number. For the PFs that could be calculated, three residues
underwent fast (log PF ≤ 1), 13 medium (1 < log PF ≤ 2), 10 slow (2
< log PF), and three extremely slow (residual proton occupancy of
>80% after ∼134 h corresponding to exchange rates of <0.003 h−1;
colored red) exchange. Secondary structure (α-helix) is indicated by
the bottom red squares with the α-helices numbered I−V, while red
squares above represent Pro residues. Unassigned and fast-exchanging
residues are shown as dark blue and yellow squares, respectively.
Residues for which PFs could not be calculated because of the
slowness of the exchange are shown as black squares (three residues).
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577 WT protein spectrum under identical conditions.1 Clear
578 diﬀerences between the two spectra exist (Figure 6A). Most
579 notable is the signiﬁcant number of backbone amide resonances
580 absent in the Y48H spectrum compared with the WT spectrum,
581 with a total of 64 backbone amide resonances of a possible 99
582 non-proline residues being assigned (Table S1). The missing
583 resonances are found predominately in the 40−57 Ω-loop
584 encompassing helix II and the 71−85 Ω-loop. At a lower
585 magnetic ﬁeld strength (500 MHz), no new peaks in the Y48H
586
1H−15N HSQC spectrum arise, which coupled with the
587 increased line widths of the backbone amide resonances at
588 800 MHz is indicative of the Y48H variant having conforma-
589 tional heterogeneity signiﬁcantly greater than that of the WT
590 protein.1,37
591 H/D exchange behavior of the oxidized Y48H hCc variant
592 was monitored, and backbone amide PFs, deﬁned as the ratio
593 between the observed experimental and intrinsic exchange rates
594 (kex/kin), were determined
40 (Table S1). Exchange rates are
595 inﬂuenced by H-bonding, particularly in secondary structure
596 and solvent accessibility.63 Of the 64 assigned backbone amides,
597 32 are fully exchanged within the ﬁrst 10 min, leaving only 32
598 residues for which H/D exchange behavior could be analyzed.
599 From these, PFs were calculated for 29 residues, with three
600 residues having exchange that is too slow to calculate within the
601 experimental time frame (Figure 6B). The rapid H/D exchange
602 of many backbone amide resonances and the absence of
603 resonances for 28 backbone amides can be seen from the
604 sequence dependence of the PFs plotted in Figure 6B for the
605 Y48H variant. Only interlocking helices I and V along with
606 portions of helix III and the 32−36 turn maintain various levels
607 of protection, with the remaining segments of the protein likely
608 to be undergoing extensive dynamic ﬂuctuations (Figure 6B).
609 15N relaxation parameters, T1, T2, and NOE, were obtained
610 for 55 residues, with plots of these parameters versus residue
f7 611 number shown in Figure 7 for the Y48H variant. The average
612 relaxation rates were as follows: R1 = 1.08 ± 0.03 s−1, and R2 =
613 14.99 ± 0.72 s−1, with an average NOE of 0.84 ± 0.06. These
614 values are similar to those of the WT protein (R1 = 0.99, R2 =
615 14.23, and NOE = 0.84) and the G41S variant (R1 = 1.07, R2 =
616 14.48, and NOE = 0.84).1 The T1 values, reporting on
617 nanosecond to picosecond motions, are relatively constant,
618 with the notable exceptions of His18 and Ile75 (Figure 7A). In
619 contrast, the T2 plot reveals a signiﬁcant number of residues
620 that deviate below the average (Figure 7B), probably reﬂecting
621 contributions to relaxation from slower conformational
622 exchange equilibria. A useful indicator to identify residues
623 experiencing chemical exchange is a plot of the R2/R1 ratio
624(Figure 7C). Despite the smaller size of the relaxation data set
625for the Y48H variant (55 residues) compared to that of the
626G41S variant (92 residues),1 a similar pattern of residues
627experiencing slow conformational exchange emerges (i.e., 14−
62836, 40−57, and 71−85 Ω-loops) and is also in keeping with the
629regions experiencing rapid H/D exchange (Figure 6B).
630■ DISCUSSION
631The past two decades of Cc research have placed this essential
632redox protein ﬁrmly into the category of a moonlighting or
633EMF protein.64 For Cc to have a peroxidatic moonlighting
634function, access to an alternative structural state or conformer is
635required. Such a form could come about because Cc binding of
636CL results in a conformational change to create the peroxidatic
637state or because the ground state structure is in equilibrium
638with one or more minor higher-energy forms of diﬀerent
639structure and CL binding displaces the equilibrium by binding
640preferentially to a higher-energy state. We have shown for the
641pro-apoptotic G41S variant of hCc enhanced conformational
642dynamics of the 40−57 Ω-loop exists and is directly linked to
643the dissociation of the Met80−Fe(III) ligand in the 71−85 Ω-
644loop. Cross-talk between Ω-loops results in an increased
645population of the peroxidatic pentacoordinate state,1 which
646under healthy conditions aids in controlling levels of reactive
647oxygen species (ROS) but during the early phase of
648mitochondrial apoptosis results in Cc peroxidizing the
649membrane lipid CL. Furthermore, once released from the
650mitochondrion, Cc has also been implicated in the peroxidation
651of the plasma membrane lipid phosphatidylserine.65 The
652second thrombocytopenia 4-associated mutation of hCc to be
653discovered was the Y48H variant,25 which is also located within
654the 40−57 Ω-loop. In Cc evolution, this is the least conserved
655Ω-loop and has the lowest free energy of the ﬁve cooperative
656folding/unfolding units (foldons) assigned in Cc.66,67 Perhaps
657not surprisingly, therefore, the Y48H variant displays enhanced
658mobility and dynamics. However, it is apparent that the
659dynamics, both local and global, are further enhanced in the
660Y48H variant compared to those in the G41S variant. Such
661behavior is revealed by the fact that ∼35% of backbone amide
662resonances for the Y48H variant remain unassigned because of
663their absence in the 1H−15N HSQC spectrum compared to 2
664and 6% for the WT protein and G41S variant, respectively,
665under identical conditions. Except for Ala43, the whole of the
66640−57 Ω-loop is unassigned, along with the latter half (residues
66779−85) of the 71−85 Ω-loop, the second least stable foldon,67
668housing the Met80−Fe(III) ligand. These missing resonances
669in the Y48H variant are a likely consequence of a decreased T2
Figure 7. 15N relaxation parameters for the oxidized Y48H hCc variant acquired at 800 MHz and 288 K. (A) T1 and (B) T2 times plotted vs residue
number. (C) R2/R1 ratio (black empty circles) and [
1H]−15N NOE (blue circles) plotted vs residue number.
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670 resulting from exchange between diﬀerent conformations.
671 Although we cannot demonstrate unequivocally from direct
672 NMR measurements, because of the missing resonances, that
673 the Y48H variant has enhanced dynamics on the microsecond
674 to millisecond time scale (i.e., compute Rex terms), it is
675 apparent for the resonances that allow an amide H/D exchange
676 PF to be calculated (i.e., those from the N- and C-terminal
677 helices, the end of the 14−36 Ω-loop, and some of helix 3) that
678 these are generally smaller for the Y48H variant than for the
679 other proteins.1 Visualization of the spread in increasing
680 dynamics can be appreciated from mapping amide H/D
f8 681 exchange data onto the respective Cc X-ray structures (Figure
f8 682 8A). From this, it is apparent that helices I, III, and V for all
683 proteins maintain similar H/D proﬁles, with the mutations
684 clearly resulting in more rapid exchange and thus enhanced
685 dynamics (WT < G41S < Y48H) in the 40−57 and 71−85 Ω-
686 loops, as well as helix II (Figure 8A).
687 Englander and colleagues have elegantly determined how Cc
688 folds through uncovering its foldon substructure.66,67 Of the
689 ﬁve foldons, the two with the lowest stability are the 40−57 and
690 71−85 Ω-loops.5,68 The correlation between the conforma-
691 tional dynamics linking the G41S and Y48H mutations with the
692 displacement of the Met80 ligand and the energetics of the
693 foldon substructure is striking. Making the assumption that the
694 pentacoordinate state of oxidized Cc is equivalent to the
695 partially unfolded form, with the two lowest-energy foldons
696 unfolded, places the pentacoordinate state 6 kcal/mol above the
697 ground state structure, based on the analyses of Hu et al.5 and
698 assuming the energetics of horse Cc are the same as those of
699 hCc. From ΔG = −RT ln(WTKapp/Y48HKapp) (determined from
700 the kinetics of N3
− binding), the relative ΔΔG of the
701 pentacoordinate state of the various Cc forms may be calculated
702 as illustrated by the energy level diagrams in Figure 8B,
703 because, as noted above, the WTKapp/
Y48HKapp ratio reﬂects the
704 ratio of equilibrium constants for dissociation and reassociation
705 of the Met80 ligand (Y48HK/WTK), with the assumption that the
706 free energy of the ground state is the same for both the variant
707 and the WT protein. Thus, as illustrated in Figure 8B, the
708pentacoordinate form is 0.9 and 0.6 kcal/mol lower in energy
709for the Y48H and G41S variants, respectively, than for the WT
710protein. Each kilocalorie per mole change denotes an ∼5-fold
711change in the equilibrium constant governing the distribution
712between the hexa- and pentacoordinate forms. If the minor
713component in such an equilibrium, here the pentacoordinate
714form, plays a signiﬁcant mechanistic role, then for a kilocalorie
715per mole change in stability the concentration of this minor
716component increases ∼5-fold. Our proposal that the G41S and
717Y48H variants cause small changes in the oxidized hCc energy
718landscape should be considered alongside the recent ﬁnding
719that the Fe(III)−S(Met) bond of Cc is weak and requires
720constraints imposed by the protein structure, such as extensive
721H-bonding of neighboring residues, to be maintained under
722physiological conditions.69,70 Stabilization of a weak bond by a
723protein structure is an example of entasis, originally proposed
724to account for some of the apparently unusual properties of
725metalloproteins by suggesting that the metal center “con-
726stituted an energetically poised domain”,71 and Mara et al.70
727have determined that the protein entatic contribution to the
728Fe(III)−S(Met) bond is ∼4 kcal/mol. It is readily apparent
729therefore that small changes in the energy landscape can have
730mechanistic eﬀects and contribute to this moonlighting
731function of Cc.
732From the peroxidase assays, it is particularly noteworthy that
733the turnover of H2O2 by the Y48H variant is not boosted in the
734presence of CL liposomes, as is the case for the WT protein
735and the G41S variant (Figure 4B). An absence of a CL boosting
736eﬀect for G41 variants has been reported by others28 and thus
737contrasts with both our previous observations using an Amplex
738red assay27 and in the study presented here using ABTS. Our
739ﬁndings that there is a boost in peroxidase activity for the G41S
740variant in the presence of CL liposomes are wholly consistent
741with our dynamic appraisal of these two variants. The Y48H
742variant is more dynamic than the G41S variant with the
743equilibrium between the hexa- and pentacoordinate species no
744longer being rate-limiting in this peroxidase assay for the Y48H
Figure 8. Dynamics in the hCc variants identiﬁed as causing thrombocytopenia 4. (A) PF mapping onto the respective X-ray structures of hCc, with
PFs color-coded as indicated. The data for the ferric WT protein and ferric G41S variant were taken from ref 1, with the data for the Y48H variant
taken from the LogP plot in Figure 6B. The heme and axial ligands are shown as sticks and helices labeled I−V. (B) Energy diagrams illustrating the
calculated diﬀerences in the free energy change (ΔΔG) between the pentacoordinate forms in the various species derived from the equation ΔG =
−RT ln(WTKapp/variantKapp) from N3− binding kinetics. The ΔG for the WT protein is based on data from ref 5.
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745 variant as the concentration of the reactive pentacoordinate
746 form is further increased (Figure 8B).
747 Access of small molecules such as H2O2 to the heme has
748 been suggested to occur through a gating motion of Arg38
749 based on its side chain repositioning in the G41S variant
750 creating a “channel” to enable H2O molecules to access the
751 heme.27,44 A subsequent X-ray structure of the K72A variant of
752 S. cerevisiae Cc revealed the Met80 ligand to be dissociated from
753 the heme iron and the Arg38 side chain positioned in an “out”
754 position as observed in the G41S structure.72 A network of H-
755 bonded H2O molecules connects the Met80 side of the heme
756 to the bulk solvent in the K72A structure.72 Repositioning of
757 Arg38 thus causes perturbations to the environment of the
758 heme propionate substituent at position 7 and may be
759 considered to inﬂuence the dynamics of the 40−57 Ω-loop,
760 which is linked to the dissociation of the Met80 ligand.1,27
761 However, we note that in the X-ray structure of the Y48H
762 variant the Arg38 side chain is in the same position as in the
763 WT protein (Figure 1B). Comparison of the G41S and Y48H
764 X-ray structures reveals that the introduction of a Ser or His at
765 positions 41 and 48, respectively, creates the opportunity for
766 both side chains to form a H-bond to the side chain of Asn52
767 (Figure 1B). The latter communicates with the Met80 ligand
768 through further H-bond interactions (Figure 1B). Thus, we
769 propose that there are two possible conformational routes by
770 which dynamical changes at the base of the heme could be
771 communicated to the Met80 ligand. Indeed, the literature
772 contains many reports showing that the 40−57 Ω-loop and
773 heme crevice have an important conformational linkage, though
774 this was not something always recognized at the time. For
775 example, Robinson et al.,73 on the basis of incomplete NMR
776 data, showed that residues in the 40−57 Ω-loop rapidly
777 interconverted between diﬀerent local conformational states
778 under native conditions. Our suggested role of Asn52 is
779 consistent with observations of Schejter et al.,74 who present
780 data on binding of CN− to a N52I variant of S. cerevisiae Cc,
781 that are indicative of a reduced population of the
782 pentacoordinate form. A linkage has also been discussed in
783 connection with the alkaline isomerization of oxidized Cc75 and
784 is supported by the NMR structure of a triple variant of S.
785 cerevisiae ferric Cc engineered to stabilize the alkaline
786 conformer.76 The triple variant structure showed that the
787 71−85 Ω-loop with the displaced Met80 ligand and the 40−57
788 Ω-loop were the most perturbed features compared with the
789 WT structure.76
790 Recent studies have highlighted that Cc function can be
791 governed by phosphorylation, where it regulates the electron-
792 transport chain ﬂux preventing hyperpolarization of the
793 mitochondrial membrane potential, a known cause of ROS
794 and trigger of apoptosis.77,78 Three phosphorylation sites on
795 isolates of bovine Cc have been identiﬁed from diﬀerent tissues
796 and include Thr28, Tyr48, and Tyr97.79−81 Considering the
797 reported pro-apoptotic behavior of the Y48H variant,25 it is
798 interesting to note that one of the phosphorylation sites is
799 Tyr48, which when phosphorylated abolishes the capability to
800 trigger apoptosis at the apoptosome level.82−84 A recent study
801 has characterized a Tyr48 phosphomimetic (designated
802 Tyr48p) using a non-native amino acid to assess the eﬀect of
803 phosphorylation at this position on the hCc structure.84
804 Structural studies were conducted with the ferrous form,
805 which is the heme oxidation state that donates an electron to
806 Cc oxidase,12 and not the state that gives rise to the peroxidatic
807 pentacoordinate form, central to our work. The WT reduced
808Cc is more rigid than its oxidized counterpart, and an
809equilibrium between the Met80-on and Met80-oﬀ forms has
810not been detected under non-apoptosis physiological con-
811ditions.85 Despite this, the dynamics on the microsecond to
812millisecond time scale for the reduced Tyr48p Cc showed
813increased mobility compared to that of the WT protein,
814particularly in the 40−57 Ω-loop, but with an overall increase
815signiﬁcantly smaller than those of the G41S and Y48H variants
816in their oxidized forms. Furthermore, an increase in mobility for
817the Tyr48p reduced Cc was also observed for residues 75−78
818in the 71−85 Ω-loop, again highlighting the link between the
81940−57 Ω-loop and the Met80 ligand. In the ferric state, Tyr48p
820exhibits a 3-fold increase in peroxidase activity relative to the
821WT protein,84 in contrast to the Y48H variant, for which a 7-
822fold increase in activity is observed (Figure 4B). In the presence
823of CL liposomes, Tyr48p displays a 7-fold boost in peroxidase
824activity relative to that of the WT protein and thus on par with
825the Y48H variant in the absence or presence of CL (Figure 4B).
826Therefore, these data suggest that the equilibrium constant
827between the hexacoordinate and pentacoordinate heme forms
828(Figure 3C) favors the hexacoordinate form in Tyr48p relative
829to the Y48H variant, enabling CL to further regulate the activity
830of the phosphorylated protein, which may have consequences
831for pro- and anti-apoptotic behavior insofar as we have shown
832that the pentacoordinate heme form is critical for this.
833In conclusion, we have shown that the naturally occurring
834Y48H variant of hCc in its oxidized heme state is more
835peroxidatic than either the WT protein or the G41S variant that
836is also implicated in thrombocytopenia. The dynamic
837ﬂuctuations in the 40−57 Ω-loop resulting in cross-talk with
838the 71−85 Ω-loop containing the Met80 ligand are further
839ampliﬁed in the Y48H variant. Consequently, the Y48H protein
840has intrinsic peroxidase activity that is no longer enhanced in
841the presence of CL because of the increased population of an
842excited pentacoordinate heme state structure with an energy
843that is close to that of to the ground state Met80 coordinated
844structure. This ﬁnding underpins our proposal that the switch
845in function of the moonlighting Cc from electron transfer to
846peroxidase is, at least partly, a result of its preexisting
847conformational equilibrium involving an excited pentacoordi-
848nate state. A third naturally occurring variant, A51V, also
849implicated in thrombocytopenia has not yet been characterized.
850Because of the location of the variant on the 40−57 Ω-loop,
851one may predict that is has traits similar to those of the G41S
852and Y48H variants, and it will therefore be interesting to
853discover where this variant is located within the dynamic
854window (WT < G41S < Y48H) that has emerged from the
855studies so far.
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